FORM 10-K
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
FORM 10-K
(Mark
One)
þ ANNUAL
REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2008
OR
c TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Commission file
number: 1-32258
Reynolds American
Inc.
(Exact name of registrant as
specified in its charter)
|
|
|
North Carolina
(State or other jurisdiction of
incorporation or organization)
|
|
20-0546644
(I.R.S. Employer Identification
Number)
|
401 North Main Street
Winston-Salem, NC 27101
(Address of principal executive
offices) (Zip Code)
(336) 741-2000
(Registrants telephone
number, including area code)
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
|
|
|
Name of each
|
|
|
|
Name of each
|
|
|
exchange on which
|
|
|
|
exchange on which
|
Title of each class
|
|
registered
|
|
Title of each class
|
|
registered
|
Common stock, par value $.0001 per share
|
|
New York
|
|
Rights to Purchase Series A Junior
|
|
New York
|
|
|
|
|
Participating Preferred Stock
|
|
|
Securities registered pursuant to Section 12(g) of the
Act: None
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Exchange
Act. Yes þ No o
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or 15(d) of the
Act. Yes o No þ
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
is not contained herein, and will not be contained, to the best
of registrants knowledge, in definitive proxy or
information statements incorporated by reference in
Part III of this
Form 10-K
or any amendment to this
Form 10-K. o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in
Rule 12b-2
of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer
þ
|
|
Accelerated filer
o
|
|
Non-accelerated filer
o
|
|
Smaller reporting company
o
|
|
|
|
|
(Do not check if a smaller
reporting company)
|
|
|
Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the Exchange
Act). Yes o No þ
The aggregate market value of common stock held by
non-affiliates of Reynolds American Inc. on June 30, 2008,
was approximately $7.9 billion, based on the closing price
of $46.67. Directors, executive officers and a significant
shareholder of Reynolds American Inc. are considered affiliates
for purposes of this calculation, but should not necessarily be
deemed affiliates for any other purpose.
Indicate the number of shares outstanding of each of the
registrants classes of common stock, as of the latest
practicable date: February 13, 2009:
291,458,868 shares of common stock, par value $.0001 per
share.
Documents
Incorporated by Reference:
Portions of the Definitive Proxy Statement of Reynolds American
Inc. to be filed with the Securities and Exchange Commission
pursuant to Regulation 14A of the Securities Exchange Act
of 1934 on or about March 23, 2009, are incorporated by
reference into Part III of this report.
PART I
Reynolds American Inc., referred to as RAI, is a holding company
for the second largest cigarette manufacturer in the United
States, R. J. Reynolds Tobacco Company, and the second largest
smokeless tobacco products manufacturer in the United States,
Conwood Company, LLC. RAI was incorporated in the state of North
Carolina on January 5, 2004, and its common stock is listed
on the NYSE under the symbol RAI. RAIs
headquarters are located in Winston-Salem, North Carolina. On
July 30, 2004, RAI combined the U.S. assets,
liabilities and operations of Brown & Williamson
Holdings, Inc., formerly known as Brown & Williamson
Tobacco Corporation and referred to as B&W, an indirect,
wholly owned subsidiary of British American Tobacco p.l.c.,
referred to as BAT, with R. J. Reynolds Tobacco Company, a
wholly owned operating subsidiary of R.J. Reynolds Tobacco
Holdings, Inc., a wholly owned subsidiary of RAI, referred to as
RJR. These July 30, 2004, transactions generally are
referred to as the B&W business combination. As a result of
the B&W business combination, B&W owns approximately
42% of RAIs outstanding common stock, and previous RJR
stockholders exchanged their shares of RJR common stock for
approximately 58% of RAIs outstanding common stock. Also,
as a result of the B&W business combination, Lane, Limited,
referred to as Lane, became a direct, wholly owned subsidiary of
RAI after being acquired through an indirect subsidiary of BAT.
References to RJR Tobacco prior to July 30, 2004, relate to
R. J. Reynolds Tobacco Company, a New Jersey corporation.
References to RJR Tobacco on and subsequent to July 30,
2004, relate to the combined U.S. assets, liabilities and
operations of B&W and R. J. Reynolds Tobacco Company.
Concurrent with the completion of the B&W business
combination, RJR Tobacco became a North Carolina corporation.
On May 31, 2006, RAI, through its newly formed subsidiary,
Conwood Holdings, Inc., completed its $3.5 billion
acquisition of a group of smokeless tobacco companies
collectively referred to as the Conwood companies. The
acquisition was funded by RAI borrowings, new debt securities
issued by RAI and available cash. The acquisition of the Conwood
companies was treated as a purchase of the Conwood
companies net assets by RAI for financial accounting
purposes.
RAIs Internet web site address is
www.reynoldsamerican.com. RAIs annual reports on
Form 10-K,
quarterly reports on
Form 10-Q,
current reports on
Form 8-K,
insider trading reports on Forms 3, 4 and 5 and all
amendments to those reports are available free of charge through
RAIs web site, as soon as reasonably practicable after
such material is electronically filed with, or furnished to, the
SEC. RAIs Internet web site and the information contained
therein or connected thereto are not intended to be incorporated
into this Annual Report on
Form 10-K.
Pursuant to requirements of the NYSE, in May 2008, the chief
executive officer of RAI filed a form of Annual CEO
Certification with the NYSE regarding RAIs compliance with
the NYSEs corporate governance listing standards. In
addition, RAIs chief executive officer and chief financial
officer have signed certifications required by the SEC regarding
RAIs public disclosures. These SEC certifications have
been included as Exhibits 31.1 and 31.2 to this
Form 10-K
for the year ended December 31, 2008.
RAIs reportable operating segments are RJR Tobacco and
Conwood. The RJR Tobacco segment consists of the primary
operations of R. J. Reynolds Tobacco Company. The Conwood
segment consists of Conwood Holdings, Inc., the primary
operations of the Conwood companies and Lane. RAIs wholly
owned subsidiaries, Santa Fe Natural Tobacco Company, Inc.,
referred to as Santa Fe, and R. J. Reynolds Global
Products, Inc., referred to as GPI, among others, are included
in All Other. The segments were identified based on how
RAIs chief operating decision maker allocates resources
and assesses performance. Some of RAIs wholly owned
operating subsidiaries have entered into intercompany agreements
for products or services with other RAI operating subsidiaries.
As a result, certain activities of an operating subsidiary may
be included in a different segment of RAI. For net sales,
operating income and total assets attributable to each segment,
see Item 8, note 20 to consolidated financial
statements.
3
RAI
Strategy
RAIs strategy is focused on responding to a shift in
consumer preferences by becoming a total tobacco company and
competing through its operating subsidiaries in almost every
category of tobacco products. RAI is also focused on delivering
sustainable earnings growth, strong cash flow and enhanced
long-term shareholder value through growth strategies for its
operating companies. These strategies include growth in certain
brands of RJR Tobaccos cigarette business, growth and
innovation in smokeless tobacco products, super-premium
cigarette brand growth, opportunistic international expansion
and selective portfolio enhancements. RAI remains committed to
maintaining high standards of corporate governance and business
conduct in a high performing culture.
RJR
Tobacco
Overview
RAIs largest reportable operating segment, RJR Tobacco, is
the second largest cigarette manufacturer in the United States.
RJR Tobaccos largest selling cigarette brands, CAMEL,
KOOL, PALL MALL, DORAL and WINSTON, were five of the ten
best-selling brands of cigarettes in the United States as of
December 31, 2008. Those brands, and its other brands,
including SALEM, MISTY and CAPRI, are manufactured in a variety
of styles and marketed in the United States. RJR Tobacco also
manages contract manufacturing of cigarette and tobacco products
through arrangements with BAT affiliates. On January 1,
2008, the contract manufacturing business of GPI was transferred
to RJR Tobacco. On January 1, 2009, the management of
tobacco products sold to certain U.S. territories, U.S
duty-free shops and U.S. overseas military bases was
transferred to RJR Tobacco from GPI.
RJR Tobacco primarily conducts its business in the highly
competitive U.S. cigarette market, which has a few large
manufacturers and many smaller participants. The
U.S. cigarette market is a mature market in which overall
consumer demand has declined since 1981 and is expected to
continue to decline. Management Science Associates, Inc.,
referred to as MSAi, reported that U.S. cigarette shipments
declined 3.3% in 2008, to 345.3 billion cigarettes, 5.0% in
2007 and 2.4% in 2006. From year to year, shipments are impacted
by various factors including price increases and wholesale
inventory adjustments.
Profitability of the U.S. cigarette industry and RJR
Tobacco continues to be adversely impacted by the decreases in
consumption, increases in federal and state excise taxes and
governmental regulations and restrictions, such as marketing
limitations, product standards and smoking bans.
In connection with the B&W business combination in 2004,
RAI entered into a non-competition agreement with BAT under
which RAIs operating subsidiaries generally are
prohibited, subject to certain exceptions, from manufacturing
and marketing certain tobacco products outside the United States
until July 2009. The international rights to substantially all
of RJR Tobaccos brands were sold in 1999 to Japan Tobacco
Inc., referred to as JTI. Therefore, RJR Tobacco is dependent on
the U.S. cigarette market.
Expanding beyond the cigarette market as an innovative tobacco
company, in 2006, RJR Tobacco entered into a category of
smokeless, spitless, tobacco known as snus. CAMEL Snus is
pasteurized tobacco that is sold in a small pouch that provides
convenient tobacco consumption. CAMEL Snus was launched in lead
markets beginning in 2006, and is being expanded nationally
during the first quarter of 2009. In addition, during 2008, RJR
Tobacco announced a new line of smoke-free tobacco products
called CAMEL Dissolvables. CAMEL Dissolvables include CAMEL
Orbs, Sticks and Strips, all of which are made of finely milled
tobacco and dissolve completely in the mouth. CAMEL Dissolvables
will be launched in lead markets beginning in the first half of
2009.
Competition
RJR Tobaccos primary competitors include Philip Morris USA
Inc. and Lorillard Tobacco Company, as well as manufacturers of
deep-discount brands. Deep-discount brands are brands
manufactured by companies that are not original participants in
the Master Settlement Agreement, which with other state
settlement agreements are collectively referred to as the MSA,
and accordingly, do not have cost structures burdened with
MSA-related payments to the same extent as the original
participating manufacturers. For further discussion of the MSA,
see Litigation Affecting the Cigarette
Industry Health-Care Cost Recovery Cases
MSA in note 16 to
4
consolidated financial statements in Item 8 and
Critical Accounting Policies and
Estimates in Managements Discussion and
Analysis of Financial Condition and Results of Operations
in Item 7.
Based on data collected by Information Resources Inc./Capstone
Research, Inc., referred to as IRI, during 2008, 2007 and 2006,
Philip Morris USA Inc. had an overall retail share of the
U.S. cigarette market of 51.2%, 51.1% and 50.8%,
respectively. During these same years, RJR Tobacco had an
overall share of 28.1%, 29.0% and 29.8%, respectively.
Domestic shipment volume and retail share of market data that
appear in this document have been obtained from MSAi and IRI,
respectively. These two organizations are the primary sources of
volume and market share data relating to the cigarette and
tobacco industry. This information is included in this document
because it is used by RJR Tobacco primarily as an indicator of
the relative performance of industry participants. However, you
should not rely on the market share data reported by IRI as
being precise measurements of actual market share because IRI is
not able to effectively track the volume of all cigarette
brands. RJR Tobacco believes that deep-discount brands made by
small manufacturers have combined shipments of approximately 14%
of total U.S. industry shipments. Accordingly, the retail
share of market of RJR Tobacco and its brands as reported by IRI
may overstate their actual market share.
Competition is based primarily on brand positioning, including
price, product attributes and packaging, consumer loyalty,
promotions, advertising and retail presence. Cigarette brands
produced by the major manufacturers generally require
competitive pricing, substantial marketing support, retail
merchandising programs and other incentives to maintain or
improve market position or to introduce a new brand or brand
style. Competition among the major cigarette manufacturers has
begun shifting to product innovation and expansion into new
smokeless tobacco categories, such as moist snuff and snus, as
well as finding efficient and effective means of balancing
market share and profit growth. For example, in January 2009,
Altria Group Inc., the parent company of Phillip Morris USA
Inc., completed its acquisition of UST Inc., the largest
smokeless tobacco products manufacturer in the United States.
Marketing
RJR Tobacco is committed to building and maintaining a portfolio
of profitable brands. RJR Tobaccos marketing programs are
designed to strengthen brand image, build brand awareness and
loyalty, and switch adult smokers of competing brands to RJR
Tobacco brands. In addition to building strong brand equity, RJR
Tobaccos marketing approach utilizes a retail pricing
strategy, including discounting at retail, to defend certain
brands shares of market against competitive pricing
pressure. RJR Tobaccos competitive pricing methods may
include list price changes, discounting programs, such as retail
buydowns, periodic price reductions, free product promotions and
consumer coupons. Retail buydowns refer to payments made to the
retailer to reduce the price that consumers pay at retail.
Consumer coupons generally are distributed by a variety of
methods including in, or on, the cigarette pack and by direct
mail. Free product promotions include offers such as Buy 2
packs, Get 1 pack free. The cost of free product
promotions, including federal excise tax, is recorded in cost of
goods sold.
RJR Tobacco provides trade incentives through trade terms,
wholesale partner programs and retail incentives. Trade
discounts are provided to wholesalers based on compliance with
certain terms. The wholesale partner programs provide incentives
to RJR Tobaccos direct buying customers based on
performance levels. Retail incentives are paid to the retailer
based on compliance with RJR Tobaccos contract terms.
RJR Tobaccos brand portfolio strategy is based upon three
brand categories: growth, support and non-support. During 2008,
RJR Tobacco refined its brand portfolio and reclassified KOOL
from a growth brand to a support brand. As a result, the growth
brands consist of a premium brand, CAMEL, and a value brand,
PALL MALL. Although both of these brands are managed for
long-term market share and profit growth, CAMEL will continue to
receive the most significant investment support. The support
brands include four premium brands, KOOL, WINSTON, SALEM and
CAPRI, and two value brands, DORAL and MISTY, all of which
receive limited marketing support. The non-support brands,
consisting of all other brands, are managed to maximize
near-term profitability. The key objectives of the portfolio
strategy are designed to focus on the long-term market share
growth of the growth brands while managing the support brands
for long-term sustainability and profitability.
5
Anti-tobacco groups have attempted to restrict cigarette sales,
cigarette advertising, and the testing and introduction of new
tobacco products, and have encouraged smoking bans. The MSA and
federal, state and local laws restrict or prohibit utilization
of television, radio or billboard advertising or certain other
marketing and promotional tools for cigarettes and smokeless
tobacco products. RJR Tobacco continues to use direct mailings
and other means to market its brands and enhance their appeal
among age-verified adult smokers. RJR Tobacco continues to
advertise and promote at retail cigarette locations and in adult
venues where permitted. RJR Tobacco suspended the use of print
advertising for cigarettes in newspapers and consumer magazines
in the U.S. during 2008, and is not planning to resume this
type of advertising for cigarettes during 2009. RJR Tobacco is
planning to use print advertising for CAMEL Snus and CAMEL
Dissolvables in 2009.
Manufacturing
and Distribution
RJR Tobacco owns its cigarette manufacturing facilities, located
in the Winston-Salem, North Carolina area, known as the
Tobaccoville manufacturing facility and the Whitaker Park
complex. The Whitaker Park complex includes a manufacturing
facility, a research and development facility, RJR
Tobaccos Central Distribution Center and a pilot plant for
trial manufacturing of new products. RJR Tobacco has a total
production capacity of approximately 160 billion cigarettes
per year.
RJR Tobacco sells its cigarettes primarily through distributors,
wholesalers and other direct customers, some of which are retail
chains. RJR Tobacco distributes its cigarettes primarily to
public warehouses located throughout the United States that
serve as local distribution centers to its customers. No
significant backlog of orders existed at December 31, 2008
or 2007.
Sales made by RJR Tobacco to McLane Company, Inc., a
distributor, comprised 31%, 30% and 29% of RJR Tobaccos
revenue in 2008, 2007 and 2006, respectively. No other customer
accounted for 10% or more of RAIs consolidated revenue
during those years. RJR Tobacco believes that its relationship
with McLane is good. RJR Tobaccos sales to McLane are not
governed by any written supply contract; however, McLane and RJR
Tobacco are parties to an arrangement, whereby RJR Tobacco
observes and manages its supply and level of McLanes
inventory.
RJR Tobacco has entered into various transactions with
affiliates of BAT. RJR Tobacco sells contract-manufactured
cigarettes and processed strip leaf to BAT affiliates. Net sales
to BAT affiliates, primarily cigarettes, represented
approximately 5.0% of RAIs total net sales in 2008 and
approximately 6.0% in each of 2007 and 2006.
Raw
Materials
In its production of tobacco products, RJR Tobacco uses
U.S. and foreign, primarily Brazilian and Thai, burley and
flue-cured leaf tobaccos, as well as Oriental tobaccos grown
primarily in Turkey and Bulgaria. RJR Tobacco believes there is
a sufficient supply of leaf in the worldwide tobacco market to
satisfy its current and anticipated production requirements.
RJR Tobacco purchases the majority of its U.S. flue-cured
and burley leaf directly through contracts with tobacco growers.
These short-term contracts are frequently renegotiated. RJR
Tobacco believes the relationship with its leaf suppliers is
good.
Under the modified terms of settlement agreements with
flue-cured and burley tobacco growers, and quota holders, RJR
Tobacco is required, among other things, to purchase a minimum
amount, in pounds and subject to adjustment based on its annual
total requirements, annually of U.S. green leaf flue-cured
and burley tobacco combined, through the 2015 crop year.
RJR Tobacco also uses other raw materials such as filter tow,
filter rods and fire standards compliant paper, which are
sourced from either one supplier or a few suppliers. RJR Tobacco
believes it has reasonable measures in place designed to
mitigate the risk posed by the limited number of suppliers of
certain raw materials.
6
Conwood
Overview
RAIs other reportable operating segment, Conwood, is the
second largest smokeless tobacco products manufacturer in the
United States. Conwoods primary brands include its largest
selling moist snuff brands, GRIZZLY and KODIAK, two of the seven
best-selling brands of moist snuff in the United States as of
December 31, 2008. Conwoods other products include
loose leaf chewing tobacco, dry snuff, plug and twist tobacco
products, which held the first or second position in market
share in each category as of December 31, 2008. In
addition, Conwood also distributes a variety of other tobacco
products, including WINCHESTER and CAPTAIN BLACK little cigars,
and BUGLER roll-your-own tobacco. The operations of Lane are
included in the Conwood segment.
The moist snuff category is divided into premium and price-value
brands. The moist snuff category has developed many of the
characteristics of the larger, cigarette market, including
multiple pricing tiers with intense competition, focused
marketing programs and product innovation.
In contrast to the declining U.S. cigarette market,
U.S. moist snuff volumes grew over 7% in 2008 and have
grown at an average rate of approximately 6% per year over the
last four years, driven by the accelerated growth of price-value
brands. Profit margins on moist snuff products are generally
higher than on cigarette products. Moist snuffs growth is
partially attributable to cigarette smokers switching from
cigarettes to smokeless tobacco products or using both. Within
the moist snuff category, premium brands have lost market share
to price-value brands, led by the growth of GRIZZLY, in recent
years.
Moist snuff has been the key driver of Conwoods overall
growth and profitability within the U.S. smokeless tobacco
market. Moist snuff accounted for approximately 66% of
Conwoods revenue in 2008 and approximately 60% in 2007.
Conwood offers KODIAK in the premium brand category and GRIZZLY
in the price-value brand category. Conwoods
U.S. moist snuff market share was 27.7% in 2008, 26.0% in
2007 and 25.1% in 2006 based on distributor-reported data
processed by MSAi for distributor shipments to retail. Although
moist snuff volume grew over 7% in 2008, Conwoods moist
snuff volume grew over 13% in 2008, attributable to its
innovation, product development and brand building. GRIZZLY
brand moist snuff had a 23.3% market share in 2008, 21.1% market
share in 2007 and 19.4% market share in 2006.
Competition
Conwood is dependent on the U.S. smokeless tobacco market,
where competition is significant. Conwoods largest
competitor is UST Inc., which had approximately 58.1% of the
moist snuff market share in 2008, 60.6% in 2007 and 62.8% in
2006. The parent company of RJR Tobaccos largest
competitor in the cigarette market, Philip Morris USA Inc.,
completed its acquisition of UST Inc. in January 2009. Conwood
also competes in the U.S. smokeless tobacco market with
other domestic and international companies.
Similar to the cigarette market, competition is based primarily
on brand positioning and price, as well as product attributes
and packaging, consumer loyalty, promotions, advertising and
retail presence.
Marketing
Conwoods brand portfolio strategy consists of investment
brands, KODIAK and GRIZZLY, and selective and non-support brands
that include all other brands. Among Conwoods newest
offerings are, GRIZZLY Wintergreen Pouches, moist snuff in a
fleece pouch, and GRIZZLY Snuff, a traditional moist snuff style
with an ultra-fine cut. GRIZZLY Pouches provide pre-measured
portions that are more convenient than traditional, loose moist
snuff. Pouches represented approximately 6% of the total moist
snuff market as of December 31, 2008, and demand continues
to grow.
Conwood is committed to being an innovative industry leader and
in the servicing of its customers needs, evidenced by the
creative packaging of smokeless products, including the
development of a foil pouch for chewing tobacco and a plastic
can for moist snuff.
7
Manufacturing
and Distribution
Conwoods primary manufacturing facilities are located in
Memphis, Tennessee; Clarksville, Tennessee; and Winston-Salem,
North Carolina. Other facilities are located in Tucker, Georgia;
Bowling Green, Kentucky; Sanford, North Carolina; and
Springfield, Tennessee. Conwood owns all of its facilities.
Conwood sells its products primarily to distributors,
wholesalers and other direct customers, some of which are retail
chains.
Sales made by Conwood to McLane Company, Inc. comprised 17% of
Conwoods consolidated revenue for 2008, 16% in 2007 and
17% in 2006. No other customer accounted for 10% or more of
RAIs consolidated revenue during those periods. Conwood
believes that its relationship with McLane is good.
Conwoods sales to McLane are not governed by any written
supply contract. No significant backlog of orders existed at
December 31, 2008 or 2007.
Raw
Materials
In its production of moist snuff and chewing tobacco, Conwood
uses U.S. fire-cured and air-cured tobaccos as well as
foreign, primarily Brazilian, burley and air-cured leaf
tobaccos. Conwood purchases the majority of its
U.S. flue-cured and air-cured leaf directly through
contracts with tobacco growers. These short-term contracts are
frequently renegotiated. Conwood believes the relationship with
its leaf suppliers is good.
Conwood believes there is a sufficient supply of leaf in the
worldwide tobacco market to satisfy its current and anticipated
production requirements.
Consolidated
RAI
RAIs wholly owned operating subsidiary, Santa Fe,
manufactures and markets cigarettes and other tobacco products
under the NATURAL AMERICAN SPIRIT brand. On January 1,
2008, the management of RJR Tobaccos super premium brands,
including those licensed from BAT, including DUNHILL and STATE
EXPRESS 555, was transferred to Santa Fe.
During 2005, GPI acquired from JTI, its U.S. duty-free and
U.S. overseas military businesses relating to certain
brands. These rights were sold to JTI in 1999 as a part of the
sale of RJRs international tobacco business. During 2008,
GPI sold NATURAL AMERICAN SPIRIT in Europe and Japan, as well as
exported tobacco products to U.S. territories,
U.S. duty-free shops and U.S. overseas military bases.
In January 2009, the activities of GPI were transitioned to
other operating subsidiaries of RAI. The management and export
of tobacco products to certain U.S. territories,
U.S. duty-free shops and U.S. overseas military bases
was transferred to RJR Tobacco, and other indirect subsidiaries
of RAI began selling NATURAL AMERICAN SPIRIT in Europe and Japan.
Sales to
Foreign Countries
RAIs operating subsidiaries sales to foreign
countries, primarily to related parties, for the years ended
December 31, 2008, 2007 and 2006 were $602 million,
$600 million and $578 million, respectively.
Raw
Materials
In 2004, the President signed legislation eliminating the
U.S. governments tobacco production controls and
price support program. The buyout is funded by a direct
quarterly assessment on every tobacco product manufacturer and
importer, on a market-share basis measured on volume to which
federal excise tax is applied. The aggregate cost of the buyout
to the tobacco industry is approximately $9.9 billion,
including approximately $9.6 billion payable to quota
tobacco holders and growers through industry assessments over
ten years and approximately $290 million for the
liquidation of quota tobacco stock. RAIs operating
subsidiaries estimate that their overall share will approximate
$2.4 billion to $2.8 billion prior to the deduction of
permitted offsets under the MSA.
8
Research
and Development
RAIs operating subsidiaries research and development
expense for the years ended December 31, 2008, 2007 and
2006, was $59 million, $57 million and
$58 million, respectively. The primary research and
development activities of the operating subsidiaries are
conducted at RJR Tobaccos Whitaker Park complex.
Scientists and engineers at this facility continue to work to
create more efficient methods of preparing tobacco blends, as
well as develop product enhancements, new products and packaging
innovations. A focus for research and development activity is
the development of potentially reduced exposure products, which
ultimately may be recognized as products that present reduced
risks to health.
Intellectual
Property
RAIs operating subsidiaries own or have the right to use
numerous trademarks, including the brand names of their tobacco
products and the distinctive elements of their packaging and
displays. RAIs operating subsidiaries material
trademarks are registered with the U.S. Patent and
Trademark Office. Rights in these trademarks in the United
States will last as long as RAIs subsidiaries continue to
use the trademarks. The operating subsidiaries consider the
distinctive blends and recipes used to make each of their brands
to be trade secrets. These trade secrets are not patented, but
RAIs operating subsidiaries take appropriate measures to
protect the unauthorized disclosure of such information.
In 1999, RJR Tobacco sold most of its trademarks and patents
outside the United States in connection with the sale of the
international tobacco business to JTI. The sale agreement
granted JTI the right to use certain of RJR Tobaccos trade
secrets outside the United States, but details of the
ingredients or formulas for flavors and the blends of tobacco
may not be provided to any sub-licensees or sub-contractors. The
agreement also generally prohibits JTI and its licensees and
sub-licensees from the sale or distribution of tobacco products
of any description employing the purchased trademarks and other
intellectual property rights in the United States. In 2005, the
U.S. duty-free and U.S. overseas military businesses
relating to certain brands were acquired from JTI. These rights
had been sold to JTI in 1999 as a part of the sale of RJR
Tobaccos international tobacco business.
In addition to intellectual property rights it directly owns,
RJR Tobacco has certain rights with respect to BAT intellectual
property that were available for use by B&W prior to the
completion of the B&W business combination.
Legislation
and Other Matters Affecting the Tobacco Industry
The tobacco industry is subject to a wide range of laws and
regulations regarding the marketing, sale, taxation and use of
tobacco products imposed by local, state, federal and foreign
governments. Various state governments have adopted or are
considering, among other things, legislation and regulations
that would:
|
|
|
|
|
significantly increase their taxes on tobacco products;
|
|
|
|
restrict displays, advertising and sampling of tobacco products;
|
|
|
|
establish fire standards compliance for cigarettes;
|
|
|
|
raise the minimum age to possess or purchase tobacco products;
|
|
|
|
restrict or ban the use of certain flavorings, including
menthol, in tobacco products, or the use of certain flavor
descriptors in marketing of tobacco products;
|
|
|
|
require the disclosure of ingredients used in the manufacture of
tobacco products;
|
|
|
|
require the disclosure of nicotine yield information for
cigarettes;
|
|
|
|
impose restrictions on smoking in public and private
areas; and
|
|
|
|
restrict the sale of tobacco products directly to consumers or
other unlicensed recipients, including over the Internet.
|
9
In addition, during 2009, the U.S. Congress adopted
legislation increasing the federal excise tax on cigarettes and
other tobacco products, and likely will consider legislation
regarding the regulation of the manufacture and sale of tobacco
products by the FDA. The U.S. Congress also may consider
legislation regarding:
|
|
|
|
|
regulation of environmental tobacco smoke;
|
|
|
|
implementation of a national fire standards compliance for
cigarettes;
|
|
|
|
regulation of the retail sale of tobacco products over the
Internet and in other non-face-to-face retail transactions, such
as by mail order and telephone; and
|
|
|
|
banning the delivery of tobacco products by the U.S. Postal
Service.
|
Together with manufacturers price increases in recent
years and substantial increases in state and federal taxes on
tobacco products, these developments have had and likely will
continue to have an adverse effect on the sale of tobacco
products. For further discussion of the regulatory and
legislative environment applicable to the tobacco industry, see
Item 7, Managements Discussion and Analysis of
Financial Condition and Results of Operations
Governmental Activity.
Litigation
and Settlements
Various legal proceedings or claims, including litigation
claiming that lung cancer and other diseases, as well as
addiction, have resulted from the use of, or exposure to,
RAIs operating subsidiaries products, and seeking
damages in amounts ranging into the hundreds of millions or even
billions of dollars, are pending or may be instituted against
RJR Tobacco, the Conwood companies or their affiliates,
including RAI or RJR, or indemnitees, including B&W. For
further discussion of the litigation and legal proceedings
pending against RAI or its affiliates or indemnitees, see
Item 8, note 16 to consolidated financial statements.
RAIs management continues to conclude that the loss of any
particular smoking and health tobacco litigation claim against
RJR Tobacco or its affiliates or indemnitees, or the loss of any
particular claim concerning the use of smokeless tobacco against
the Conwood companies, when viewed on an individual basis, is
not probable. RAI and its subsidiaries believe that they have
valid basis for appeal of adverse verdicts against them and have
valid defenses to all actions and intend to defend all actions
vigorously. Nonetheless, the possibility of material losses
related to tobacco litigation is more than remote. Litigation is
subject to many uncertainties, and generally it is not possible
to predict the outcome of the litigation pending against RJR
Tobacco, the Conwood companies or their affiliates or
indemnitees, or to reasonably estimate the amount or range of
any possible loss. Moreover, notwithstanding the quality of
defenses available to it and its affiliates in tobacco-related
litigation matters, it is possible that RAIs consolidated
results of operations, cash flows or financial position could be
materially adversely affected by the ultimate outcome of certain
pending or future litigation matters.
Employees
At December 31, 2008, RAI and its subsidiaries had
approximately 6,600 full-time employees and approximately
300 part-time employees. The 6,600 full-time employees
include approximately 4,800 RJR Tobacco employees and 1,100
Conwood employees. No employees of RAI or its subsidiaries are
unionized.
RAI and its subsidiaries operate with certain known risks and
uncertainties that could have a material adverse effect on their
results of operations, cash flows and financial position. The
risks below are not the only ones RAI and its subsidiaries face.
Additional risks not currently known or currently considered
immaterial also could affect RAIs business. You should
carefully consider the following risk factors in connection with
other information included in this Annual Report of
Form 10-K.
10
RAIs operating subsidiaries could be subject to
substantial liabilities and bonding difficulties from litigation
related to cigarette products or smokeless tobacco products,
thereby reducing operating margins and cash flows from
operations. Adverse litigation outcomes could have a negative
impact on RAIs ability to continue to operate due to their
impact on cash flows.
RJR Tobacco, the Conwood companies and their affiliates,
including RAI, and indemnitees, including B&W, have been
named in a large number of tobacco-related legal actions,
proceedings or claims. The claimants seek recovery on a variety
of legal theories, including negligence, strict liability in
tort, design defect, fraud, misrepresentation, unfair trade
practices and violations of state and federal antitrust laws.
Various forms of relief are sought, including compensatory and,
where available, punitive damages in amounts ranging in some
cases into the hundreds of millions or even billions of dollars.
The tobacco-related legal actions range from individual lawsuits
to
class-actions
and other aggregate claim lawsuits. In particular,
class-action
suits have been filed in a number of states against individual
cigarette manufacturers, including RJR Tobacco, alleging that
the use of the terms lights and ultra
lights constitutes unfair and deceptive trade practices.
Many of these lights cases were stayed pending
review of the Good v. Altria Group, Inc. case by the
U.S. Supreme Court. On December 15, 2008, the
U.S. Supreme Court decided that these claims are not
preempted by the Federal Cigarette Labeling and Advertising Act
or by the U.S. Federal Trade Commissions, referred to as
FTC, historic regulation of the industry. In light of this
decision, it is likely that the stayed cases will be activated,
additional cases may go to trial, new cases will be filed and
defense costs will increase. In the event RJR Tobacco and its
affiliates and indemnitees lose one or more of the pending
lights
class-action
suits, RJR Tobacco, depending upon the amount of any damages
ordered, could face difficulties in obtaining the bond required
to stay execution of the judgment. For a more complete
description of these cases, see
Class-Action
Suits Lights Cases in
Item 8, note 16 to consolidated financial statements.
In addition, in Engle v. R.J. Reynolds Tobacco Co., et
al. (Circuit Court, Dade County, Florida, filed May 5,
1994), the Florida Supreme Court issued a ruling that, among
other things, determined that the case could not proceed further
as a class action. The ruling also permitted members of the
Engle class to file individual claims, including claims
for punitive damages, through January 11, 2008. RJR Tobacco
refers to these cases as the Engle Progeny Cases.
Although the final number of Engle Progeny Cases is not
yet known, RJR Tobacco has been served in 3,156 cases on behalf
of approximately 8,808 plaintiffs. The Engle Progeny
Cases will result in increased litigation activity, including an
increased number of trials in 2009, and increased expenses. For
a more complete description of the Engle Progeny cases,
see Engle Progeny Cases in Item 8,
note 16 to consolidated financial statements.
It is likely that similar legal actions, proceedings and claims
arising out of the sale, distribution, manufacture, development,
advertising, marketing and claimed health effects of cigarettes
and smokeless tobacco products will continue to be filed against
RJR Tobacco, the Conwood companies, or their affiliates and
indemnitees and other tobacco companies for the foreseeable
future.
Victories by plaintiffs in highly publicized cases against RJR
Tobacco and other tobacco companies regarding the health effects
of smoking may stimulate further claims. A material increase in
the number of pending claims could significantly increase
defense costs. In addition, adverse outcomes in pending cases
could have adverse effects on the ability of RJR Tobacco and its
indemnitees, including B&W, to prevail in other smoking and
health litigation.
For a more complete description of the litigation involving RAI
and its operating subsidiaries, including RJR Tobacco and the
Conwood companies, see Litigation Affecting
the Cigarette Industry and Smokeless
Tobacco Litigation in Item 8, note 16 to
consolidated financial statements.
As a result of the order issued in a case brought by the
U.S. Department of Justice, RJR Tobacco could be subject to
additional, substantial marketing restrictions, which would
negatively impact revenue, increase related compliance costs and
reduce operating margins of RJR Tobacco, and, consequently of
RAI.
In September 1999, the U.S. Department of Justice brought
an action against RJR Tobacco, B&W and other tobacco
companies. The government sought, in addition to other remedies,
pursuant to the civil provisions of RICO, disgorgement of
profits the government contends were earned as a consequence of
a RICO racketeering
11
enterprise. In August 2006, the court found certain
defendants, including RJR Tobacco, liable for the RICO claims,
but did not impose any direct financial penalties. Instead, the
court, among other things, enjoined the defendants from
committing future racketeering acts, participating in certain
trade organizations, making misrepresentations concerning
smoking and health and youth marketing, and using certain brand
descriptors such as low tar, light,
ultra light, mild and
natural, and ordered the defendants to issue
corrective communications on five subjects,
including smoking and health, and addiction.
Both sides have appealed. In October 2006, the U.S. Court
of Appeals granted the defendants motion to stay pending
the outcome of the defendants appeal. Oral argument
occurred on October 14, 2008. A decision is pending. RJR
Tobacco does not know the timing of an appellate decision or, if
the order is affirmed, the compliance deadlines that will be
imposed. If the order is affirmed without modification, then RJR
Tobacco believes that certain provisions of the order would have
adverse business effects on the marketing of RJR Tobaccos
current product portfolio and that such effects could be
material. Also, if the order is affirmed, then RJR Tobacco would
incur costs in connection with complying with the order, such as
the costs of corrective communications.
For a more complete description of this case, see
Health-Care Cost Recovery Cases
Department of Justice Case in Item 8, note 16 to
consolidated financial statements.
RJR Tobaccos overall retail market share of cigarettes
has declined in recent years and is expected to continue to
decline; if RJR Tobacco is not able to continue to grow market
share of its growth brands, or develop, produce or market new
alternative tobacco products profitably, results of operations,
cash flows and financial position of RJR Tobacco and
consequently, of RAI could be adversely impacted.
RJR Tobaccos U.S. retail market share of cigarettes
has been declining for a number of years, and RJR Tobacco
expects this market share to continue to decline. According to
data from IRI, RJR Tobaccos share of the
U.S. cigarette retail market declined to 28.1% in 2008 from
29.0% in 2007, continuing a trend in effect for several years.
If RJR Tobaccos growth brands do not continue to grow
market share, results of operations, cash flows and financial
position will be adversely affected. In addition, consumer
health concerns, changes in adult consumer preferences and
changes in regulations require or cause RJR Tobacco to introduce
new alternative tobacco products. Consumer acceptance of new
products, such as CAMEL Snus or CAMEL Dissolvables, may not be
achieved. Furthermore, RJR Tobacco may not find vendors willing
to produce alternative tobacco products resulting in additional
capital expenditures for RJR Tobacco.
RJR Tobacco is dependent on the U.S. cigarette market,
which it expects to continue to decline, negatively impacting
revenue.
The international rights to substantially all of RJR
Tobaccos brands were sold in 1999 to JTI. In addition, in
connection with the B&W business combination in 2004, RAI
entered into a non-competition agreement with BAT under which
RAIs operating subsidiaries generally are prohibited,
subject to certain exceptions, from manufacturing and marketing
certain tobacco products outside the United States until July
2009. Therefore, RJR Tobacco is dependent on the
U.S. cigarette market. Price increases, restrictions on
advertising and promotions, funding of smoking prevention
campaigns, increases in regulation and excise taxes, health
concerns, a decline in the social acceptability of smoking,
increased pressure from anti-tobacco groups and other factors
have reduced U.S. cigarette consumption.
U.S. cigarette consumption is expected to continue to
decline.
RJR Tobacco is RAIs largest operating segment. As such, it
is the primary source of RAIs revenue, operating income
and cash flows.
RJR Tobaccos contract manufacturing agreements with BAT
may end in 2014.
RJR Tobaccos contract manufacturing for BAT accounted for
5% of total RAI sales and approximately 24% of total RJR Tobacco
cigarette production in 2008. These contract manufacturing
agreements may expire at the end of 2014. If BATs
contracts are not renewed or extended, RJR Tobaccos
revenue, operating income and cash flows will be unfavorably
impacted.
12
RAIs operating subsidiaries are subject to significant
limitations on advertising and marketing of tobacco products,
which could harm the value of their existing brands or their
ability to launch new brands, thus negatively impacting
revenue.
In the United States, television and radio advertisements of
cigarettes have been prohibited since 1971, and television and
radio advertisements of smokeless tobacco products have been
prohibited since 1986. Under the MSA, certain of RAIs
operating subsidiaries, including RJR Tobacco, cannot use
billboard advertising, cartoon characters, sponsorship of
certain events, non-tobacco merchandise bearing their brand
names and various other advertising and marketing techniques. In
addition, the MSA prohibits targeting of youth in advertising,
promotion or marketing of tobacco products, including the
smokeless tobacco products of RJR Tobacco. The Conwood companies
are not participants in the MSA. Although these restrictions
were intended to ensure that tobacco advertising was not aimed
at young people, some of the restrictions also may limit the
ability of RAIs operating subsidiaries to communicate with
adult tobacco users. Additional restrictions may be imposed
legislatively or agreed to in the future. Recent proposals have
included limiting tobacco advertising to
black-and-white,
text-only advertisements. Similar to the potential
U.S. Food and Drug Administration, referred to as the FDA,
restrictions described below, these limitations may make it
difficult to maintain the value of existing brands or brand
styles, and could significantly impair the ability of RAIs
operating subsidiaries to launch new brand styles.
In the U.S., tobacco products are subject to substantial and
increasing regulation and taxation, which has a negative effect
on revenue and profitability.
Tobacco products are subject to substantial federal and state
excise taxes in the United States. On February 4, 2009,
President Obama signed an increase of $0.62 in the federal
excise tax per pack of cigarettes, for a total of $1.01 per pack
of cigarettes, and significant tax increases on other tobacco
products, to fund expansion of the State Childrens Health
Insurance Program, referred to as the SCHIP. These tax increases
are effective on April 1, 2009.
Under the SCHIP, the tax rate for chewing tobacco will increase
$0.3083 per pound to $0.5033 per pound and will increase $0.925
per pound to $1.51 per pound for snuff. The federal tax on small
cigars, defined as those weighing three pounds or less per
thousand, will increase $48.502 per thousand to $50.33 per
thousand. Large cigars currently are taxed at a rate of 20.719%
of the manufacturers price, with a cap of $48.75 per
thousand. Under the SCHIP, the rate on large cigars will
increase to 52.75% of the manufacturers price with a
maximum rate of $0.4026 per cigar. In addition, the tax rate for
roll-your-own tobacco will increase from $1.097 per pound to
$24.78 per pound.
The increases in federal excise tax under the SCHIP are
substantial, and, as a result, RAI expects its operating
subsidiaries volume will be adversely impacted beginning
in the second quarter of 2009.
In addition to federal and state excise taxes, certain city and
county governments also impose substantial excise taxes on
tobacco products sold. Increased excise taxes are likely to
result in declines in overall sales volume and shifts by
consumers to less expensive brands.
A wide variety of federal, state and local laws limit the
advertising, sale and use of cigarettes, and these laws have
proliferated in recent years. For example, many local laws
prohibit smoking in restaurants and other public places. Private
businesses also have adopted regulations that prohibit or
restrict, or are intended to discourage, smoking. Such laws and
regulations also are likely to result in a decline in the
overall sales volume of cigarettes. For additional information
on the issues described above, see
Governmental Activity in
Managements Discussion and Analysis of Financial
Condition and Results of Operations in Item 7.
The proposed regulation of tobacco products by the Food and
Drug Administration may adversely affect RAIs sales and
operating profit.
A bill that would grant the FDA, authority to regulate tobacco
products was introduced in Congress in February 2007. On
July 30, 2008, the U.S. House of Representatives
passed the bill by a vote of
326-102. The
U.S. Senate Health, Education, Labor and Pensions Committee
approved the FDA regulation bill on August 1, 2007, but the
Senate adjourned in 2008 without any further action on the bill.
In 2009, it is likely that Congress will again take up the issue
of FDA regulation of tobacco products.
13
It is anticipated that any proposed FDA regulation bill most
likely would:
|
|
|
|
|
Require larger and more severe health warnings on packs and
cartons;
|
|
|
|
Ban the use of descriptors on tobacco products, such as
low-tar and light;
|
|
|
|
Require the disclosure of ingredients and additives to consumers;
|
|
|
|
Require pre-market approval by the FDA for claims made with
respect to reduced risk or reduced exposure products;
|
|
|
|
Allow the FDA to require the reduction of nicotine and the
reduction or elimination of any other compound in tobacco
products;
|
|
|
|
Prohibit the use of foreign grown tobacco that has been grown or
processed with pesticides not approved under federal law for use
in domestic tobacco farming and processing;
|
|
|
|
Allow the FDA to place more severe restrictions on the
advertising, marketing and sale of cigarettes;
|
|
|
|
Permit inconsistent state regulation of labeling and advertising
and eliminate the existing federal preemption of such
regulation; and
|
|
|
|
Grant the FDA the regulatory authority to impose broad
additional restrictions.
|
It is possible that such additional regulation could result in a
decrease in cigarette and smokeless tobacco sales in the United
States, including sales of RJR Tobaccos and Conwoods
brands, and an increase in costs to RJR Tobacco and Conwood
which may have a material adverse effect on RAIs results
of operations, cash flows and financial condition. RAI believes
that such regulation may adversely affect the ability of its
operating subsidiaries to compete against its larger
competitors, including Philip Morris USA, Inc., who may be able
to more quickly and cost-effectively comply with these new rules
and regulations.
Over the years, various state and local governments have
continued to regulate tobacco products, including smokeless
tobacco products. These regulations relate to, among other
things, the imposition of significantly higher taxes, increases
in the minimum age to purchase tobacco products, sampling and
advertising bans or restrictions, ingredient and constituent
disclosure requirements and significant tobacco control media
campaigns. Additional state and local legislative and regulatory
actions will likely be considered in the future, including,
among other things, restrictions on the use of flavorings.
Additional federal or state regulation relating to the
manufacture, sale, distribution, advertising, labeling,
mandatory ingredients disclosure and nicotine yield information
disclosure of tobacco products could reduce sales, increase
costs and have a material adverse effect on the business of the
operating subsidiaries of RAI.
For additional information on the issues described above, see
Governmental Activity in
Managements Discussion and Analysis of Financial
Condition and Results of Operations in Item 7.
RJR Tobaccos and Conwoods volumes, market share
and profitability may be adversely affected by competitive
actions and pricing pressures in the marketplace.
The tobacco industry is highly competitive. Among the major
manufacturers, brands primarily compete on product quality,
price, brand recognition, brand imagery and packaging.
Substantial marketing support, merchandising display,
discounting, promotions and other financial incentives generally
are required to maintain or improve a brands market
position or introduce a new brand.
In addition, substantial payment obligations under the MSA
adversely affect RJR Tobaccos ability to compete with
manufacturers of deep-discount cigarettes that are not subject
to such substantial obligations. For a more complete description
of the MSA, see Health-Care Recovery
Cases MSA in Item 8, note 16 to
consolidated financial statements.
Conwoods largest competitor, UST Inc., was acquired by the
parent company of Philip Morris USA, Inc. in January 2009. This
acquisition of UST Inc. may change the competitive dynamics by
combining pricing and merchandising display for cigarettes and
smokeless tobacco products. Pricing pressure and limited
merchandising
14
display could adversely affect Conwoods and RJR
Tobaccos market share, which would adversely affect
RAIs profitability and revenues.
Increases in commodity prices will increase costs and may
reduce profitability.
Increases in the cost of tobacco leaf, other raw materials and
other commodities used in RAIs operating
subsidiaries products could cause profits to decline.
Certain of RAIs operating subsidiaries may be required
to write-down intangible assets or goodwill due to impairment,
thus reducing operating profit.
RAI conducts an impairment review of goodwill and intangible
assets at least once a year, or more often if events or changes
in circumstances indicate that the carrying value of the
goodwill or intangible asset may not be recoverable. During
2008, RJR Tobacco repositioned its KOOL brand as a support brand
from a growth brand, which resulted in an impairment charge of
$173 million and an additional $3 million impairment
charge was incurred during the annual testing of RJR
Tobaccos brands. Conwood recorded an impairment of
$142 million related to KODIAK, as well as multiple loose
leaf and little cigar brands, as a result of annual impairment
testing. For more information on intangible asset impairment,
see Item 8, note 3 to consolidated financial
statements.
In addition, the recent passage of the SCHIP increases the
federal excise tax on cigarettes by $0.62 per pack and
significantly increases the federal tax on other tobacco
products. These tax increases are effective April 1, 2009,
and RAIs operating subsidiaries expect the tax increases
to significantly and adversely impact sales volume. RAIs
operating subsidiaries believe that the federal excise tax
increase is an event that will require that their goodwill and
trademarks be tested for impairment during the first quarter of
2009, and the resulting fair value of certain of their
trademarks could be less than their carrying value. In
particular, RJR Tobacco believes that impairment charges related
to support and non-support cigarette brands are possible, and
Conwood also believes that impairment charges related to certain
brands are possible. No reasonable estimate of trademark
impairment charges can be made at this time by RAIs
operating subsidiaries.
Changes in financial market conditions could result in higher
costs and decreased profitability.
Changes in financial market conditions could negatively impact
RAIs foreign currency exchange rate risk, interest rate
risk and the return on corporate cash, thus increasing costs and
reducing profitability. During 2008, adverse conditions in the
financial markets forced RAI to invest excess cash in either low
interest funds or near zero interest funds, thereby, lowering
interest income.
Adverse changes in liquidity in the financial markets could
result in additional realized or unrealized losses on
investments.
Continued adverse changes in the liquidity in the financial
markets could result in additional realized or unrealized losses
associated with the value of RAIs investments, which would
negatively impact RAIs consolidated results of operations,
cash flows and financial position. During 2008, RAI recorded
$35 million of impairment losses from declines in the value
of short-term and long-term investments. As of December 31,
2008, $69 million of unrealized losses remain in other
comprehensive income (loss). For more information on investment
losses, see Item 8, note 9 to consolidated financial
statements.
RAIs access to cash could be impacted by adverse
changes in the financial markets and bankruptcy of financial
institutions.
During 2008, Lehman Commercial Paper Inc., referred to as LCPI,
filed for protection under Chapter 11 of the federal
Bankruptcy Code. LCPI is a lender in RAIs Fifth Amended
and Restated Credit Agreement, which as subsequently amended, is
referred to as the Credit Facility. There can be no assurance
that LCPI would loan LCPIs pro rata share of any borrowing
requests made by RAI. For more information on participants in
RAIs Credit Facility, see Liquidity and
Financial Condition in Managements Discussion
and Analysis of Financial Condition and Results of
Operations in Item 7.
In addition, the adverse conditions in the financial markets
during 2008, caused RAI to invest primarily in Treasury money
market funds. If there were a high demand for cash from the
Treasury money market funds, restrictions could be placed on the
funds, preventing immediate withdrawal and RAIs access to
needed cash.
15
Increases in the cost of pension benefits or pension funding
may reduce RAIs profitability and cash flow.
RAIs profitability is affected by the costs of pension
benefits available to employees generally hired prior to
January 1, 2004. Adverse changes in investment returns
earned on pension assets and discount rates used to calculate
pension and related liabilities or changes in required pension
funding levels may have an unfavorable impact on pension expense
and cash flows. Due to adverse changes in the financial markets,
RAIs rate of return in 2008 on pension assets was negative
30.1%. This unfavorable return, along with an unfavorable
discount rate, will increase RAIs required pension funding
for 2009 to a minimum of $50 million and increase pension
expense approximately $180 million in 2009. RAI actively
seeks to control increases in pension costs, but there can be no
assurance that profitability will not be adversely affected. In
addition, changes to pension legislation or changes in pension
accounting may adversely affect profitability.
RJR Tobacco relies on outside suppliers to manage certain
non-core business processes. Any interruption in these services
could negatively affect the operations of RJR Tobacco and harm
its reputation and consequently the operations and reputation of
RAI.
In an effort to gain cost efficiencies, RJR Tobacco has either
outsourced or is in the process of outsourcing many of its
non-core business processes. Non-core business process functions
include, but are not limited to, information technology, human
resources, trucking and facilities. If any of the suppliers fail
to perform their obligations in a timely manner or at a
satisfactory quality level, RJR Tobacco may fail to operate
effectively and fail to meet shipment demand.
RAIs operating subsidiaries rely on a limited number of
suppliers for direct materials. An interruption in service from
any of these suppliers could adversely affect the results of
operations, cash flows and financial position of RAI.
RAIs operating subsidiaries rely on a limited number of
suppliers for direct materials. If a supplier fails to meet any
of RAIs operating subsidiarys demand for direct
materials, the operating subsidiary may fail to operate
effectively and may fail to meet shipment demand, adversely
impacting RAIs results of operations.
Certain of RAIs operating subsidiaries face a customer
concentration risk. The loss of this customer would result in a
decline in revenue and have an adverse effect on cash flows.
Revenues from McLane Company, Inc., a distributor, comprised 29%
of RAIs consolidated revenues in 2008. The loss of this
customer, or a significant decline in its purchases, could have
a material adverse effect on revenue of RAI.
Fire, violent weather conditions and other disasters may
adversely affect the operations of RAIs operating
subsidiaries.
A major fire, violent weather conditions or other disasters that
affect manufacturing and other facilities of RAIs
operating subsidiaries, or of their suppliers and vendors, could
have a material adverse effect on the operations of RAIs
operating subsidiaries. Despite RAIs insurance coverage
for some of these events, a prolonged interruption in the
manufacturing operations of RAIs operating subsidiaries
could have a material adverse effect on the ability of its
operating subsidiaries to effectively operate their businesses.
The agreement relating to RAIs Credit Facility contains
restrictive covenants that limit the flexibility of RAI and its
subsidiaries. Breach of those covenants will result in a default
under the agreement relating to the facility.
Restrictions in the agreement relating to RAIs Credit
Facility limit the ability of RAI and its subsidiaries to obtain
future financing, and could impact the ability to withstand a
future downturn in their businesses or the economy in general,
conduct operations or otherwise take advantage of business
opportunities that may arise. In addition, if RAI does not
comply with these covenants, any indebtedness outstanding under
the credit facility could become immediately due and payable.
The lenders under RAIs Credit Facility could refuse to
lend funds if RAI is not in compliance with the covenants or
could terminate the Credit Facility. If RAI were unable to repay
accelerated amounts, the lenders under RAIs Credit
Facility could initiate a bankruptcy proceeding or liquidation
proceeding.
16
For more information on the restrictive covenants in RAIs
Credit Facility, see Item 8, note 13 to consolidated
financial statements.
RAI has substantial long-term debt, which could adversely
affect its financial position and its ability to obtain
financing in the future and react to changes in its business.
Because RAI has debt of $4.5 billion:
|
|
|
|
|
its ability to obtain additional financing for working capital,
capital expenditures, acquisitions, debt service requirements or
general corporate purposes, and its ability to satisfy its
obligations with respect to its indebtedness, may be impaired in
the future;
|
|
|
|
a substantial portion of its cash flow from operations must be
dedicated to the payment of principal and interest on its
indebtedness, thereby reducing the funds available to it for
other purposes;
|
|
|
|
it may be at a disadvantage compared to its competitors with
less debt or comparable debt at more favorable interest
rates; and
|
|
|
|
its flexibility to adjust to changing market conditions and
ability to withstand competitive pressures could be limited, and
it may be more vulnerable to a downturn in general economic
conditions or its business, or be unable to carry out capital
spending that is necessary or important to its growth strategy
and its efforts to improve operating margins.
|
It is likely that RAI will refinance, or attempt to refinance, a
significant portion of this indebtedness prior to its maturity
through the incurrence of new indebtedness. There can be no
assurance that RAIs available cash or access to financing
on acceptable terms will be sufficient to satisfy such
indebtedness.
The ability of RAI to access the debt capital markets could
be impaired if the credit rating of its debt securities falls
below investment grade.
The outstanding notes issued by RAI and RJR are rated investment
grade. In certain cases, if RAIs credit rating falls below
investment grade, RAI and certain of RAIs subsidiaries,
including its material domestic subsidiaries, referred to as the
Guarantors, will be required to provide collateral to secure
RAIs Credit Facility and senior notes. In such event, RAI
may not be able to sell additional debt securities or borrow
money in such amounts, at the times, at the lower interest rates
or upon the more favorable terms and conditions that might be
available if its debt was rated investment grade. In addition,
future debt security issuances or other borrowings may be
subject to further negative terms, including limitations on
indebtedness or similar restrictive covenants.
RAIs credit ratings are influenced by some important
factors not entirely within the control of RAI or its
affiliates, such as tobacco litigation, the regulatory
environment and the performance of suppliers and vendors to
RAIs operating subsidiaries. Moreover, because the kinds
of events and contingencies that may impair RAIs credit
ratings and the ability of RAI and its affiliates to access the
debt capital markets are often the same kinds of events and
contingencies that could cause RAI and its affiliates to seek to
raise additional capital on an urgent basis, RAI and its
affiliates may not be able to issue debt securities or borrow
money upon acceptable terms, or at all, at the times at which
they may most need additional capital.
For more complete information on RAIs borrowing
arrangements, see Item 8, note 13 to consolidated
financial statements.
B&Ws significant equity interest in RAI could be
determinative in matters submitted to a vote by RAI
shareholders, resulting in RAI taking actions that RAIs
other shareholders do not support. B&W also has influence
over RAI by virtue of the governance agreement, which requires
B&Ws approval before RAI takes certain actions.
B&W owns approximately 42% of the outstanding shares of RAI
common stock. Only one other stockholder owns more than 10% of
the outstanding shares of RAI common stock. Unless substantially
all of RAIs public shareholders vote together on matters
presented to RAI shareholders, B&W would have the power to
determine the outcome of matters submitted to a shareholder vote.
17
Moreover, in connection with the B&W business combination,
RAI, B&W and BAT entered into an agreement, referred to as
the governance agreement, relating to various aspects of
RAIs corporate governance. Under the governance agreement,
the approval of B&W, as a RAI shareholder, is required in
connection with, among other things, the following matters:
|
|
|
|
|
the sale or transfer of certain RAI intellectual property
associated with B&W brands having an international
presence, other than in connection with a sale of RAI;
|
|
|
|
RAIs adoption of any takeover defense measures that would
apply to the acquisition of equity securities of RAI by B&W
or its affiliates, other than the adoption of the RAI rights
plan; and
|
|
|
|
RAIs participation in any transaction, effected before
July 30, 2009, that would reasonably be expected to
jeopardize B&Ws tax ruling obtained in connection
with, or B&Ws tax-free treatment of, the B&W
business combination.
|
Such influence could result in RAI taking actions that
RAIs other shareholders do not support.
Under the governance agreement, B&W is entitled to
nominate certain persons to RAIs Board, and the approvals
of the majority of such persons is required before certain
actions may be taken, even though such persons represent less
than a majority of the entire Board. In addition, certain
provisions of RAIs articles of incorporation may create
conflicts of interest between RAI and certain of these
persons.
Under the governance agreement, B&W, based upon its current
equity stake in RAI, is entitled to nominate five directors to
RAIs Board, at least three of whom are required to be
independent directors and two of whom may be executive officers
of BAT or any of its subsidiaries. RAIs Board currently is
comprised of 13 persons, including B&Ws five
designees. Matters requiring the approval of RAIs Board
generally require the affirmative vote of a majority of the
directors present at a meeting. Under the governance agreement,
however, the approval of a majority of B&Ws designees
on RAIs Board is required in connection with the following
matters:
|
|
|
|
|
any issuance of RAI securities in excess of 5% of its
outstanding voting stock, unless at such time B&Ws
ownership interest in RAI is less than 32%; and
|
|
|
|
any repurchase of RAI common stock, subject to a number of
exceptions, unless at such time B&Ws ownership
interest in RAI is less than 25%.
|
As a result, B&Ws designees on RAIs Board may
prevent the foregoing transactions from being effected,
notwithstanding a majority of the entire Board may have voted to
approve such transactions.
Under RAIs articles of incorporation, a B&W
designated director who is affiliated with, or employed by, BAT
or its subsidiaries and affiliates is not required to present a
transaction, relationship, arrangement or other opportunity, all
of which are collectively referred to as a business opportunity,
to RAI if that business opportunity does not relate primarily to
the United States.
B&Ws significant ownership interest in RAI, and
RAIs shareholder rights plan, classified board of
directors and other anti-takeover defenses could deter
acquisition proposals and make it difficult for a third party to
acquire control of RAI without the cooperation of B&W. This
could have a negative effect on the price of RAIs common
stock.
As RAIs largest shareholder, B&W could vote its
shares of RAI common stock against any takeover proposal
submitted for shareholder approval or refuse to accept any
tender offer for shares of RAI common stock. This right would
make it very difficult for a third party to acquire RAI without
B&W consent. In addition, RAI has a shareholder rights
plan, a classified board of directors and other takeover
defenses in its articles of incorporation and bylaws.
B&Ws ownership interest in RAI and these defenses
could discourage potential acquisition proposals and could delay
or prevent a change in control of RAI. These deterrents could
adversely affect the price of RAI common stock and make it very
difficult to remove or replace members of the board of directors
or management of RAI without cooperation of B&W.
18
RAI shareholders may be adversely affected by the expiration
of the standstill and transfer restrictions in the governance
agreement, which would enable B&W to, among other things,
transfer all or a significant percentage of its RAI shares to a
third party, seek additional representation on the RAI board of
directors, replace existing RAI directors, solicit proxies or
otherwise acquire effective control of RAI.
The standstill provisions contained in the governance agreement
generally restrict B&W from acquiring additional shares of
RAI common stock and taking other specified actions as a
shareholder of RAI. These restrictions generally will expire
upon the earlier of ten years from the date of the B&W
business combination and the date on which a significant
transaction, as defined in the governance agreement, is
consummated or occurs.
Subject to the terms of the RAI shareholder rights plan,
B&W will be free after expiration of the standstill period
to increase its ownership interest in RAI to more than 50% and
may use this controlling vote to elect any number of or all the
members of RAIs board of directors.
In addition, if the transfer restrictions in the governance
agreement are terminated, subject to the terms of the RAI
shareholder rights plan, there will be no contractual
restrictions on B&Ws ability to sell or transfer its
shares of RAI common stock on the open market, in privately
negotiated transactions or otherwise. These sales or transfers
could create a substantial decline in the price of shares of RAI
common stock or, if these sales or transfers were made to a
single buyer or group of buyers that own RAI shares, could
result in a third party acquiring effective control of RAI.
|
|
Item 1B.
|
Unresolved
Staff Comments
|
None.
The executive offices of RAI and RJR Tobacco are located in
Winston-Salem, North Carolina and the executive offices of the
Conwood companies are located in Memphis, Tennessee. RJR
Tobaccos manufacturing facilities are located in the
Winston-Salem, North Carolina area, and the Conwood
companies manufacturing facilities are located in Memphis,
Tennessee; Clarksville, Tennessee; Winston-Salem, North
Carolina; Bowling Green, Kentucky; Sanford, North Carolina; and
Springfield, Tennessee. Included in the Conwood segment is
Lanes manufacturing facility, which is located in Tucker,
Georgia. Santa Fes primary manufacturing facility is
located in Oxford, North Carolina. An indirect subsidiary of RAI
has a manufacturing facility located in Puerto Rico. All of
RAIs operating subsidiaries executive offices and
manufacturing facilities are owned.
|
|
Item 3.
|
Legal
Proceedings
|
See Item 8, note 16 to consolidated financial
statements for disclosure of legal proceedings involving RAI and
its operating subsidiaries.
|
|
Item 4.
|
Submission
of Matters to a Vote of Security Holders
|
None.
Executive
Officers and Certain Significant Employees of the
Registrant
The executive officers of RAI are set forth below:
Susan M. Ivey. Ms. Ivey, 50, has been
President and Chief Executive Officer of RAI since January 2004,
and was elected the Chairman of the Board of RAI effective
January 1, 2006. She served as Chairman of the Board of RJR
Tobacco from July 2004 to May 2008. From July 2004 to December
2006, she also served as Chief Executive Officer of RJR Tobacco.
She served as President and Chief Executive Officer of B&W
from 2001 to 2004. Ms. Ivey also served as a director of
B&W from 2000 to 2004 and Chairman of the Board of B&W
from January 2003 to 2004. Ms. Ivey commenced serving on
the Board of RAI as of January 2004. She also is a member of the
board of directors of R. R. Donnelley & Sons Company.
In addition, Ms. Ivey is a member of the boards of
directors of the United Way of Forsyth County, the Winston-Salem
YWCA and the University of Florida Foundation; and she
19
serves on the boards of trustees of Wake Forest University,
Senior Services, Inc. of Winston-Salem and Salem College.
Thomas R. Adams. Mr. Adams, 58, was named
Executive Vice President and Chief Financial Officer of RAI in
January 2008, after having served as Senior Vice President and
Chief Accounting Officer of RAI since March 2007. He served as
Senior Vice President-Business Processes of RAI from September
2006 to March 2007 and of RJR Tobacco from May 2005 to November
2006. Mr. Adams also served as Senior Vice President and
Chief Accounting Officer of both RAI and RJR Tobacco from July
2004 to April 2005. From June 1999 to July 2004, he served as
Senior Vice President and Controller of both RJR Tobacco and
RJR. Mr. Adams is a member of the boards of directors of
Technology Concepts & Design, Inc., Allegacy Federal
Credit Union and the Old Hickory Council of the Boy Scouts of
America and the board of commissioners of the Housing Authority
of Winston-Salem.
Lisa J. Caldwell. Ms. Caldwell, 48, was
named Executive Vice President Human Resources of
RAI and RJR Tobacco in June 2008. She served as Senior Vice
President Human Resources of RAI from November 2006
to June 2008, after having served as Vice President
Human Resources of RAI from September 2004 to November 2006. She
also served as Senior Vice President Human Resources
of RJR Tobacco from July 2007 to June 2008, after having served
as Vice President Human Resources of RJR Tobacco
from January 2002 to November 2006. Prior to 2002,
Ms. Caldwell held numerous human resources positions with
RJR Tobacco since joining RJR Tobacco in 1991. Ms. Caldwell
serves on the board of trustees of Winston-Salem State
University and the University of North Carolina Board of
Visitors.
Daniel (Daan) M. Delen. Mr. Delen, 43,
joined RJR Tobacco as President and Chief Executive Officer in
January 2007, and was elected Chairman of the Board of RJR
Tobacco in May 2008. Prior to joining RJR Tobacco,
Mr. Delen was President of BAT Ltd. Japan from
August 2004 to December 2006 and Senior Vice President of
Marketing and Sales for B&W from 2001 to July 2004. He held
various other positions with BAT after joining BAT in 1989.
Daniel A. Fawley. Mr. Fawley, 51, has
served as Senior Vice President and Treasurer of RAI, RJR
Tobacco and RJR since September 2004. He was previously Vice
President and Assistant Treasurer of RJR from 1999 until July
2004 and of RAI from July 2004 until September 2004.
Mr. Fawley is a member of the Board of Trustees of the Arts
Council Endowment Fund, Inc.
McDara P. Folan, III. Mr. Folan, 50,
has been Senior Vice President, Deputy General Counsel and
Secretary of RAI since July 2004. Mr. Folan served as Vice
President, Deputy General Counsel and Secretary of RJR from June
1999 to July 2004, and has been Senior Vice President and
Secretary and Director of RJR since July 2004. He also was Vice
President, Deputy General Counsel and Secretary of RJR Tobacco
from June 1999 to March 2000, and currently serves as Assistant
Secretary of RJR Tobacco. Mr. Folan serves on the advisory
board for Brenner Childrens Hospital, the National
Advisory Council of Reynolda House Museum of American Art and
the board of advisors of Salem College and Academy and is
Chairman of the board of trustees of the Arts Council of
Winston-Salem and Forsyth County and a member of the board of
trustees of the Arts Council Endowment Fund, Inc.
Jeffery S. Gentry. Dr. Gentry, 51, was
named RAI Group Executive Vice President in April 1, 2008.
He was previously Executive Vice President Research
and Development of RJR Tobacco from December 2004, after serving
as Vice President Product Development since 2000.
Dr. Gentry joined RJR Tobacco in 1986 as a research and
development chemist. He is the co-founder of No Limits II, a
non-profit organization providing social opportunities for
disabled adults in the Winston-Salem area.
E. Julia (Judy)
Lambeth. Ms. Lambeth, 57, joined RAI as
Executive Vice President Corporate Affairs, General
Counsel and Assistant Secretary in September 2006. Prior to
joining RAI, Ms. Lambeth served as Corporate Secretary and
Deputy General Counsel, Corporate Services for ConocoPhillips
from 2002 to 2006. Ms. Lambeth is a member of the Wake
Forest Law School Board of Visitors and serves on the board of
directors of the Winston-Salem Symphony.
Tommy J. Payne. Mr. Payne, 51, has been
Executive Vice President Public Affairs of RAI,
after having been Executive Vice President External
Relations of RAI from July 2004 to November 2006 and RJR Tobacco
from September 1999 to November 2006. Mr. Payne served as
Executive Vice President External Relations at RJR
from July 1999 to July 2004. He held various positions after
joining RJR in 1988. Mr. Payne serves on the board
20
of directors and executive committee of the North Carolina
Chamber and the board of directors of the Tobacco Manufacturers
Association.
Frederick W. Smothers. Mr. Smothers, 45,
was named Senior Vice President and Chief Accounting Officer of
RAI in January 2008, after having served as Vice President and
Corporate Controller of RAI from October 2007 to December 2007.
Prior to joining RAI, Mr. Smothers was an independent
management consultant from 2002 until 2007, serving as CEO of
ATRS Consulting from 2005 until October 2007, providing general
management consulting to consumer products and manufacturing
clients, including RAI. From 1986 until 2002, Mr. Smothers
was employed by the accounting firm of Deloitte &
Touche LLP, including four years as partner.
E. Kenan Whitehurst. Mr. Whitehurst,
52, has been Senior Vice President Strategy and
Business Development of RAI since November 2006. He was
previously Vice President Investor Relations of RAI
from July 2004 until November 2006. From January 2001 to July
2004, Mr. Whitehurst served as Vice President
Corporate Business Development for RJR Tobacco, after serving as
its Vice President Marketing from 2000 to 2001.
Prior to 2000, he held various positions with RJR Tobacco after
joining RJR Tobacco in 1988.
The chief executive officers of RAIs other principal
operating subsidiaries and other key employees are set forth
below:
Nicholas Bumbacco. Mr. Bumbacco, 44, will
become President and Chief Executive Officer of Santa Fe
effective March 1, 2009. Previously he served as President
of GPI from September 2007 until March 2009. Mr. Bumbacco
served as Vice President Strategy Development for
RJR Tobacco from January 2007 until September 2007. He served as
President and Chief Executive Officer of Lane from October 2005
until January 2007 after being promoted from Vice
President Trade Marketing of Lane. Prior to October
2005, he held various positions with B&W since joining
B&W in 1999.
William M. Rosson. Mr. Rosson, 60, was
President and Chief Executive Officer of Conwood Company, LLC
from January 2005 until February 1, 2009. Mr. Rosson
will remain an employee of Conwood Company, LLC in an advisory
capacity until his retirement later in 2009. From 2001 until
January 2005, Mr. Rosson served as Vice President of
Administration of Conwood Company, LLC. Prior to 2001,
Mr. Rosson held a number of positions at the Conwood
companies since joining them in 1975.
Richard M. Sanders. Mr. Sanders, 55, has
been President and Chief Executive Officer of Santa Fe
since RJRs acquisition of Santa Fe in January 2002,
and plans to resign from this position on March 1, 2009.
Mr. Sanders will remain an employee of Santa Fe in an
advisory capacity until his retirement later in 2009. From
December 1999 until January 2002, he served as Senior Vice
President Marketing of RJR Tobacco while continuing
his role as President Sports Marketing Enterprises,
a former division of RJR Tobacco. He is Chairman of the board of
directors of the Santa Fe Natural Tobacco Company
Foundation, Vice-Chair of the board of directors of
Santa Fe Economic Development, Inc., Chair of Santa Fe
Future and a board member of Minnesota Resources.
Bryan K. Stockdale. Mr. Stockdale, 50,
was named President and Chief Executive Officer of Conwood
Company, LLC effective February 1, 2009. He was previously
Senior Vice President Marketing Operations for RJR
Tobacco from January 2006 until February 2009 and Vice
President Trade Marketing from September 1996
through December 2005.
21
PART II
|
|
Item 5.
|
Market
for Registrants Common Equity, Related Stockholder Matters
and Issuer Purchases of Equity Securities
|
RAIs common stock, par value $.0001 per share, is listed
on the NYSE under the trading symbol RAI. On
February 13, 2009, there were approximately 18,100 holders
of record of RAIs common stock. Shareholders whose shares
are held of record by a broker or clearing agency are not
included in this amount; however, each of those brokers or
clearing agencies is included as one holder of record. The
closing price of RAIs common stock on February 13,
2009, was $37.76 per share.
The cash dividends declared, and high and low sales prices per
share for RAIs common stock on the NYSE Composite Tape, as
reported by the NYSE, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
|
|
|
|
|
|
|
|
|
|
Dividends
|
|
|
|
Price Per Share
|
|
|
Declared per
|
|
|
|
High
|
|
|
Low
|
|
|
Share
|
|
|
2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
72.00
|
|
|
$
|
58.86
|
|
|
$
|
0.85
|
|
Second Quarter
|
|
|
60.80
|
|
|
|
46.40
|
|
|
|
0.85
|
|
Third Quarter
|
|
|
57.73
|
|
|
|
45.61
|
|
|
|
0.85
|
|
Fourth Quarter
|
|
|
50.00
|
|
|
|
37.21
|
|
|
|
0.85
|
|
2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
66.19
|
|
|
$
|
58.55
|
|
|
$
|
0.75
|
|
Second Quarter
|
|
|
67.60
|
|
|
|
60.15
|
|
|
|
0.75
|
|
Third Quarter
|
|
|
67.02
|
|
|
|
60.34
|
|
|
|
0.85
|
|
Fourth Quarter
|
|
|
71.72
|
|
|
|
60.68
|
|
|
|
0.85
|
|
On February 3, 2009, the board of directors of RAI declared
a quarterly cash dividend of $0.85, or $3.40 on an annualized
basis, per common share. The dividends will be paid on
April 1, 2009, to shareholders of record as of
March 10, 2009.
The dividends reflect the stated policy of paying dividends to
the holders of RAIs common stock in an aggregate amount
that is approximately 75% of RAIs annual consolidated net
income.
RAI repurchases and cancels shares of its common stock forfeited
with respect to the tax liability associated with certain option
exercises and vesting of restricted stock grants under the RAI
Long-Term Incentive Plan, referred to as the LTIP. On
February 5, 2008, the board of directors of RAI authorized
the repurchase of up to $30 million of outstanding shares
of RAI common stock to offset the dilution from shares issued
under certain equity-based benefit plans. This $30 million
repurchase program was superseded on April 29, 2008, when
RAIs board of directors authorized RAIs repurchase,
from time to time on or before April 30, 2009, of up to
$350 million of outstanding shares of RAI common stock in
open-market or privately negotiated transactions. The
repurchases are subject to prevailing market and business
conditions, and the program may be terminated or suspended at
any time. In connection with the share repurchase program, RAI
and B&W entered into an agreement, pursuant to which
B&W has agreed to participate in the repurchase program on
a basis approximately proportionate with B&Ws 42%
ownership of RAIs common stock.
During 2008, RAI repurchased and cancelled 3,817,095 shares
of RAI common stock for $207 million under the above share
repurchase programs. To preserve liquidity, RAI did not make any
stock purchases under the repurchase program in the fourth
quarter of 2008.
22
Additionally during 2008, at a cost of $3 million, RAI
purchased 57,223 shares that were forfeited with respect to
tax liabilities associated with restricted stock vesting under
its LTIP.
The following table summarizes RAIs purchases of its
common stock during the fourth quarter of 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Number of
|
|
|
Approximate Dollar
|
|
|
|
|
|
|
|
|
|
Shares purchased
|
|
|
Value that May
|
|
|
|
Total Number
|
|
|
|
|
|
as Part of Publicly
|
|
|
Yet Be Purchased
|
|
|
|
of Shares
|
|
|
Average Price
|
|
|
Announced Plans
|
|
|
Under the Plans
|
|
|
|
Purchased
|
|
|
Paid Per Share
|
|
|
or Programs
|
|
|
or Programs
|
|
|
October 1, 2008 to October 31, 2008
|
|
|
3,149
|
|
|
$
|
48.80
|
|
|
|
|
|
|
$
|
143
|
|
November 1, 2008 to November 30, 2008
|
|
|
633
|
|
|
|
41.08
|
|
|
|
|
|
|
$
|
143
|
|
December 1, 2008 to December 31, 2008
|
|
|
3,507
|
|
|
|
40.78
|
|
|
|
|
|
|
$
|
143
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fourth Quarter Total
|
|
|
7,289
|
|
|
$
|
44.27
|
|
|
|
|
|
|
$
|
143
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For equity-based benefit plan information, see Item 8,
note 18 to consolidated financial statements.
23
Performance
Graph
Set forth below is a line graph comparing, for the period which
commenced on July 30, 2004, and ended on December 31,
2008, the cumulative shareholder return of $100 invested in RAI
common stock with the cumulative return of $100 invested in the
Standard & Poors 500 Index and the
Standard & Poors Tobacco Index.
COMPARISON
OF 53 MONTH CUMULATIVE TOTAL RETURN(1)
Among Reynolds American Inc. Common Stock, the S&P 500 Index
and the S&P Tobacco Index
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7/30/04(1)
|
|
|
12/31/04
|
|
|
12/31/05
|
|
|
12/31/06
|
|
|
12/31/07
|
|
|
12/31/08
|
|
Reynolds American Inc.
|
|
|
100.00
|
|
|
|
108.49
|
|
|
|
138.18
|
|
|
|
198.80
|
|
|
|
210.52
|
|
|
|
137.48
|
|
S&P 500 Index
|
|
|
100.00
|
|
|
|
110.86
|
|
|
|
116.31
|
|
|
|
134.68
|
|
|
|
142.08
|
|
|
|
89.51
|
|
S&P Tobacco Index(2)
|
|
|
100.00
|
|
|
|
129.88
|
|
|
|
162.60
|
|
|
|
198.64
|
|
|
|
238.07
|
|
|
|
194.62
|
|
|
|
|
(1) |
|
Assumes that $100 was invested in RAI common stock on
August 2, 2004 (the first day of trading of RAI common
stock), or in each index on July 30, 2004, and that in each
case all dividends were reinvested. |
|
(2) |
|
The S&P Tobacco Index includes the following companies:
Altria Group Inc.; Lorillard Inc.; Philip Morris International;
Reynolds American Inc.; and UST Inc. |
24
|
|
Item 6.
|
Selected
Financial Data
|
The selected historical consolidated financial data as of
December 31, 2008 and 2007, and for each of the years in
the three-year period ended December 31, 2008, are derived
from the consolidated financial statements and accompanying
notes, which have been audited by RAIs independent
registered public accounting firm. The selected historical
consolidated financial data as of December 31, 2006, 2005
and 2004, and for the years ended December 31, 2005 and
2004, are derived from audited consolidated financial statements
not presented or incorporated by reference. The consolidated
financial statements of RAI include the results of RJR through
July 30, 2004, and of RAI from July 30, 2004 through
December 31, 2008, including the acquired operations of
B&W and Lane subsequent to July 30, 2004, and the
Conwood companies subsequent to May 31, 2006. For further
information, including the impact of new accounting
developments, restructuring and impairment charges, you should
read this table in conjunction with Managements
Discussion and Analysis of Financial Condition and Results of
Operations in Item 7 and the consolidated financial
statements.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
(Dollars in Millions, Except Per Share Amounts)
|
|
|
Results of Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales(1)
|
|
$
|
8,845
|
|
|
$
|
9,023
|
|
|
$
|
8,510
|
|
|
$
|
8,256
|
|
|
$
|
6,437
|
|
Income from continuing operations before extraordinary
item(1)(2)(3)(4)
|
|
|
1,338
|
|
|
|
1,307
|
|
|
|
1,136
|
|
|
|
985
|
|
|
|
627
|
|
Income from discontinued operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
12
|
|
Extraordinary item gain on acquisition
|
|
|
|
|
|
|
1
|
|
|
|
74
|
|
|
|
55
|
|
|
|
49
|
|
Net income
|
|
|
1,338
|
|
|
|
1,308
|
|
|
|
1,210
|
|
|
|
1,042
|
|
|
|
688
|
|
Per Share Data(5):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic income from continuing operations
|
|
|
4.58
|
|
|
|
4.44
|
|
|
|
3.85
|
|
|
|
3.34
|
|
|
|
2.83
|
|
Diluted income from continuing operations
|
|
|
4.57
|
|
|
|
4.43
|
|
|
|
3.85
|
|
|
|
3.34
|
|
|
|
2.81
|
|
Basic income from discontinued operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.01
|
|
|
|
0.06
|
|
Diluted income from discontinued operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.01
|
|
|
|
0.06
|
|
Basic income from extraordinary item
|
|
|
|
|
|
|
|
|
|
|
0.25
|
|
|
|
0.18
|
|
|
|
0.22
|
|
Diluted income from extraordinary item
|
|
|
|
|
|
|
|
|
|
|
0.25
|
|
|
|
0.18
|
|
|
|
0.22
|
|
Basic net income
|
|
|
4.58
|
|
|
|
4.44
|
|
|
|
4.10
|
|
|
|
3.53
|
|
|
|
3.11
|
|
Diluted net income
|
|
|
4.57
|
|
|
|
4.43
|
|
|
|
4.10
|
|
|
|
3.53
|
|
|
|
3.09
|
|
Basic weighted average shares, in thousands
|
|
|
292,445
|
|
|
|
294,385
|
|
|
|
295,033
|
|
|
|
294,790
|
|
|
|
221,556
|
|
Diluted average shares, in thousands
|
|
|
293,074
|
|
|
|
294,889
|
|
|
|
295,384
|
|
|
|
295,172
|
|
|
|
222,873
|
|
Cash dividends declared per share of common stock
|
|
$
|
3.40
|
|
|
$
|
3.20
|
|
|
$
|
2.75
|
|
|
$
|
2.10
|
|
|
$
|
1.90
|
|
Balance Sheet Data (at end of periods):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
18,154
|
|
|
|
18,629
|
|
|
|
18,178
|
|
|
|
14,519
|
|
|
|
14,428
|
|
Long-term debt (less current maturities)
|
|
|
4,486
|
|
|
|
4,515
|
|
|
|
4,389
|
|
|
|
1,558
|
|
|
|
1,595
|
|
Shareholders equity
|
|
|
6,237
|
|
|
|
7,466
|
|
|
|
7,043
|
|
|
|
6,553
|
|
|
|
6,176
|
|
Cash Flow Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash from operating activities
|
|
|
1,315
|
|
|
|
1,331
|
|
|
|
1,457
|
|
|
|
1,273
|
|
|
|
736
|
|
Net cash from (used in) investing activities
|
|
|
278
|
|
|
|
763
|
|
|
|
(3,531
|
)
|
|
|
(989
|
)
|
|
|
260
|
|
Net cash (used in) from financing activities
|
|
|
(1,206
|
)
|
|
|
(1,312
|
)
|
|
|
2,174
|
|
|
|
(450
|
)
|
|
|
(467
|
)
|
Other Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ratio of earnings to fixed charges(6)
|
|
|
8.5
|
|
|
|
7.0
|
|
|
|
7.4
|
|
|
|
12.2
|
|
|
|
9.5
|
|
|
|
|
(1) |
|
Net sales and cost of products sold exclude excise taxes of
$1,890 million, $2,026 million, $2,124 million,
$2,175 million and $1,850 million for the years ended
December 31, 2008, 2007, 2006, 2005 and 2004, respectively. |
|
(2) |
|
Includes gain on termination of joint venture of
$328 million in 2008. |
|
(3) |
|
Includes restructuring and/or asset impairment charges of
$90 million, $1 million, $2 million and
$5 million for the years ended December 31, 2008,
2006, 2005 and 2004, respectively. |
25
|
|
|
(4) |
|
Includes trademark and/or goodwill impairment charges of
$318 million, $65 million, $90 million,
$200 million and $199 million for the years ended
December 31, 2008, 2007, 2006, 2005 and 2004, respectively. |
|
(5) |
|
All share and per share amounts have been retroactively adjusted
to reflect the August 14, 2006, two-for-one stock split. |
|
(6) |
|
Earnings consist of income from continuing operations before
equity earnings, income taxes and fixed charges. Fixed charges
consist of interest on indebtedness, amortization of debt
issuance costs and one-third of operating rental expense,
representative of the interest factor. |
|
|
Item 7.
|
Managements
Discussion and Analysis of Financial Condition and Results of
Operations
|
The following is a discussion and analysis of RAIs
business, initiatives, critical accounting policies and its
consolidated results of operations and financial position.
Following the overview and discussion of business initiatives,
the critical accounting policies disclose certain accounting
policies that are material to RAIs results of operations
and financial position for the periods presented in this report.
The discussion and analysis of RAIs results of operations
is presented in two comparative sections, 2008 compared with
2007, and 2007 compared with 2006. Disclosures related to
liquidity and financial position complete managements
discussion and analysis. You should read this discussion and
analysis of RAIs consolidated financial position and
results of operations in conjunction with the consolidated
financial statements and the related notes as of
December 31, 2008 and 2007, and for each of the years in
the three-year period ended December 31, 2008.
Overview
and Business Initiatives
RAIs reportable operating segments are RJR Tobacco and
Conwood. The RJR Tobacco segment consists of the primary
operations of R. J. Reynolds Tobacco Company. The Conwood
segment consists of Conwood Holdings, Inc., the primary
operations of the Conwood companies and Lane. RAIs wholly
owned subsidiaries, Santa Fe and GPI, among others, are
included in All Other. Some of RAIs wholly owned operating
subsidiaries have entered into intercompany agreements for
products or services with other RAI operating subsidiaries. As a
result, certain activities of an operating subsidiary may be
included in a different segment of RAI.
RAIs largest reportable operating segment, RJR Tobacco, is
the second largest cigarette manufacturer in the United States.
RJR Tobaccos largest selling cigarette brands, CAMEL,
KOOL, PALL MALL, DORAL and WINSTON, were five of the ten
best-selling brands of cigarettes in the United States as of
December 31, 2008. Those brands, and its other brands,
including SALEM, MISTY and CAPRI, are manufactured in a variety
of styles and marketed in the United States. RJR Tobacco also
manages contract manufacturing of cigarettes and tobacco
products through arrangements with BAT affiliates. As of
January 1, 2008, the contract manufacturing business of GPI
was transferred to RJR Tobacco.
RAIs other reportable operating segment, Conwood, is the
second largest smokeless tobacco products manufacturer in the
United States. Conwoods primary brands include its largest
selling moist snuff brands, GRIZZLY and KODIAK, two of the seven
best-selling brands of moist snuff in the United States as of
December 31, 2008. Conwoods other products include
loose leaf chewing tobacco, dry snuff, plug and twist tobacco
products. Conwoods products held the first or second
position in market share in each category as of
December 31, 2008. As a result of combining certain
operations of Lane with the Conwood companies in 2007, Conwood
began distributing a variety of other tobacco products,
including WINCHESTER and CAPTAIN BLACK little cigars, and BUGLER
roll-your-own tobacco.
Santa Fe manufactures and markets cigarettes and other
tobacco products under the NATURAL AMERICAN SPIRIT brand. On
January 1, 2008, the management of RJR Tobaccos super
premium brands, including those licensed from BAT, including
DUNHILL and STATE EXPRESS 555, was transferred to Santa Fe.
During 2008, GPI sold NATURAL AMERICAN SPIRIT in Europe and
Japan, as well as exported tobacco products to
U.S. territories, U.S. duty-free shops and
U.S. overseas military bases. In January 2009, the
activities of GPI were transitioned to other operating
subsidiaries of RAI. The management and export of tobacco
products sold to certain U.S. territories,
U.S. duty-free shops and U.S. overseas military bases
was transferred to RJR Tobacco and other indirect subsidiaries
of RAI began selling NATURAL AMERICAN SPIRIT in Europe and Japan.
26
RJR
Tobacco
RJR Tobacco primarily conducts business in the highly
competitive U.S. cigarette market, which has a few large
manufacturers and many smaller participants. The
U.S. cigarette market is a mature market in which overall
consumer demand has declined since 1981 and is expected to
continue to decline. Trade inventory adjustments may result in
short-term changes in demand for RJR Tobaccos products
when wholesale and retail tobacco distributors adjust the timing
of their purchases of product to manage their inventory levels.
RJR Tobacco believes it is not appropriate for it to speculate
on other external factors that may impact the purchasing
decisions of the wholesale and retail tobacco distributors.
RJR Tobaccos brand portfolio strategy is based upon three
brand categories: growth, support and non-support. During 2008,
RJR Tobacco refined its brand portfolio strategy and
reclassified KOOL from a growth brand to a support brand. As a
result, the growth brands consist of a premium brand, CAMEL, and
a value brand, PALL MALL. Although both of these brands are
managed for long-term market share and profit growth, CAMEL will
continue to receive the most significant investment support. The
support brands include four premium brands, KOOL, WINSTON, SALEM
and CAPRI, and two value brands, DORAL and MISTY, all of which
receive limited marketing support. The non-support brands,
consisting of all other brands, are managed to maximize
near-term profitability. The key objectives of the portfolio
strategy are to ensure the long-term market share growth of the
growth brands while managing the support brands for long-term
sustainability and profitability.
Competition is based primarily on brand positioning, including
price, product attributes and packaging, consumer loyalty,
promotions, advertising and retail presence. Cigarette brands
produced by the major manufacturers generally require
competitive pricing, substantial marketing support, retail
programs and other incentives to maintain or improve market
position or to introduce a new brand style. Expanding beyond the
cigarette market as an innovative tobacco company, in 2006, RJR
Tobacco entered into a category of smokeless, spitless tobacco,
known as snus. CAMEL Snus is pasteurized tobacco that is sold in
a small pouch that provides convenient tobacco consumption.
CAMEL Snus was launched in lead markets beginning in 2006, and
is being expanded nationally during the first quarter of 2009.
In addition, during 2008, RJR Tobacco announced new smoke-free
tobacco products called CAMEL Dissolvables. CAMEL Dissolvables
include CAMEL Orbs, Sticks and Strips, all of which are made of
finely milled tobacco and dissolve completely in the mouth.
CAMEL Dissolvables will be launched in lead markets beginning in
the first half of 2009.
RJR Tobacco is committed to building and maintaining a portfolio
of profitable brands. RJR Tobaccos marketing programs are
designed to strengthen brand image, build brand awareness and
loyalty, and switch adult smokers of competing brands to RJR
Tobacco brands. In addition to building strong brand equity, RJR
Tobaccos marketing approach utilizes a retail pricing
strategy, including discounting at retail, to defend certain
brands shares of market against competitive pricing
pressure. RJR Tobaccos competitive pricing methods may
include list price changes, discounting programs, such as retail
buydowns, periodic price reductions, free product promotions and
consumer coupons. Retail buydowns refer to payments made to the
retailer to reduce the price that consumers pay at retail.
Consumer coupons generally are distributed by a variety of
methods, including in, or on, the cigarette pack and by direct
mail. Free product promotions include offers such as Buy 2
packs, Get 1 pack free. The cost of free product
promotions, including federal excise tax, is recorded in cost of
goods sold.
Conwood
Conwood offers a range of differentiated smokeless and other
tobacco products to adult consumers. The moist snuff category is
divided into premium and price-value brands. The moist snuff
category has developed many of the characteristics of the
larger, cigarette market, including multiple pricing tiers with
intense competition, focused marketing programs and significant
product innovation.
In contrast to the declining U.S. cigarette market,
U.S. moist snuff volumes grew over 7% in 2008 and have
grown at an average rate of approximately 6% per year over the
last four years, driven by the accelerated growth of price-value
brands. Profit margins on moist snuff products are generally
higher than on cigarette products. Moist snuffs growth is
partially attributable to cigarette smokers switching from
cigarettes to smokeless tobacco products or using both. Within
the moist snuff category, premium brands have lost market share
to price-value brands, led by the growth of GRIZZLY, in recent
years.
27
Conwood faces significant competition in the smokeless tobacco
categories. Similar to the cigarette market, competition is
based primarily on brand positioning and price, as well as
product attributes and packaging, consumer loyalty, promotions,
advertising and retail presence. The parent company of RJR
Tobaccos largest competitor in the cigarette market,
Philip Morris USA, Inc., completed its acquisition of
Conwoods largest competitor, UST, in January 2009.
Critical
Accounting Policies and Estimates
Accounting principles generally accepted in the United States,
referred to as GAAP, require estimates and assumptions to be
made that affect the reported amounts in RAIs consolidated
financial statements and accompanying notes. Some of these
estimates require difficult, subjective
and/or
complex judgments about matters that are inherently uncertain,
and as a result, actual results could differ from those
estimates. Due to the estimation processes involved, the
following summarized accounting policies and their application
are considered to be critical to understanding the business
operations, financial position and results of operations of RAI
and its subsidiaries. For information related to these and other
significant accounting policies, see Item 8, note 1 to
consolidated financial statements.
Litigation
RAI discloses information concerning litigation for which an
unfavorable outcome is more than remote. RAI and its
subsidiaries record their legal expenses and other litigation
costs and related administrative costs as selling, general and
administrative expenses as those costs are incurred. RAI and its
subsidiaries will record any loss related to litigation at such
time as an unfavorable outcome becomes probable and the amount
can be reasonably estimated. When the reasonable estimate is a
range, the recorded loss will be the best estimate within the
range. If no amount in the range is a better estimate than any
other amount, the minimum amount of the range will be recorded.
As discussed in Item 8, note 16 to consolidated
financial statements, RJR Tobacco, the Conwood companies and
their affiliates, including RAI, and indemnitees, have been
named in a number of tobacco-related legal actions, proceedings
or claims seeking damages in amounts ranging into the hundreds
of millions or even billions of dollars. Unfavorable judgments
have been returned in a number of tobacco-related cases and
state enforcement actions. As of February 6, 2009, RJR
Tobacco had paid approximately $12 million since
January 1, 2006, related to unfavorable judgments.
RAI and its subsidiaries believe that they have valid bases for
appeal of adverse verdicts against them and have valid defenses
to all actions and they intend to defend all actions vigorously.
RAIs management continues to conclude that the loss of any
particular smoking and health tobacco litigation claim against
RJR Tobacco or its affiliates or indemnitees, including
B&W, or the loss of any particular claim concerning the use
of smokeless tobacco against the Conwood companies, when viewed
on an individual basis, is not probable or estimable. RJR,
including its subsidiary RJR Tobacco, have liabilities totaling
$94 million that were recorded in connection with certain
indemnification claims, not related to smoking and health,
asserted by JTI against RJR and RJR Tobacco, relating to the
activities of Northern Brands and related litigation.
Litigation is subject to many uncertainties, and it is possible
that some of the tobacco-related legal actions, proceedings or
claims could ultimately be decided against RJR Tobacco, the
Conwood companies or their affiliates, including RAI, and
indemnitees. Any unfavorable outcome of such actions could have
a material adverse effect on the consolidated results of
operations, cash flows or financial position of RAI or its
subsidiaries. For further discussion of the litigation and legal
proceedings pending against RAI or its affiliates or
indemnitees, see Item 8, note 16 to consolidated
financial statements.
Settlement
Agreements
RJR Tobacco, Santa Fe and Lane are participants in the
Master Settlement Agreement, and RJR Tobacco is a participant in
other state settlement agreements related to governmental
health-care cost recovery actions. Their obligations and the
related expense charges under the MSA are subject to adjustments
based upon, among other things, the volume of cigarettes sold by
the operating subsidiaries, their relative market share and
inflation. Since relative market share is based on cigarette
shipments, the best estimate of the allocation of charges to RJR
Tobacco under these
28
agreements is recorded in cost of products sold as the products
are shipped. Adjustments to these estimates are recorded in the
period that the change becomes probable and the amount can be
reasonably estimated. The Conwood companies are not participants
in the MSA. For more information related to historical and
expected settlement expenses and payments under the MSA, see
Litigation Affecting the Cigarette
Industry Health-Care Cost Recovery Cases
MSA and MSA Enforcement and
Validity in Item 8, note 16 to consolidated
financial statements.
Intangible
Assets
Intangible assets include goodwill, trademarks and other
intangibles and are accounted for under Statement of Financial
Accounting Standards, referred to as SFAS, No. 142,
Goodwill and Other Intangible Assets. The
determination of fair value involves considerable estimates and
judgment. In particular, the fair value of a reporting unit
involves, among other things, developing forecasts of future
cash flows, determining an appropriate discount rate, and when
goodwill impairment is implied, determining the fair values of
individual assets and liabilities, including unrecorded
intangibles. Although RAI believes it has based its impairment
testing and impairment charges on reasonable estimates and
assumptions, the use of different estimates and assumptions
could result in materially different results. Generally, if the
current competitive or regulatory environment worsens or
RAIs operating companies strategic initiatives
adversely affect their financial performance, the fair value of
goodwill, trademarks and other intangibles could be impaired in
future periods. See Item 8, note 3 to consolidated
financial statements for a discussion of the impairment charges
in connection with RAIs ongoing application of
SFAS No. 142.
Fair
Value Measurement
On January 1, 2008, RAI adopted SFAS No. 157,
Fair Value Measurements, for financial assets and
financial liabilities. SFAS No. 157 provides a
definition of fair value, establishes a framework for measuring
fair value and expands disclosure about fair value measurements.
SFAS No. 157 establishes a fair value hierarchy that
distinguishes between market participant assumptions developed
based on market data obtained from sources independent of the
reporting entity, and the reporting entitys own
assumptions about market participant assumptions developed based
on the best information available in the circumstances.
On October 10, 2008, the Financial Accounting Standards
Board, referred to as FASB, issued FASB Staff Position, referred
to as FSP,
No. FAS 157-3,
Determining the Fair Value of a Financial Asset When the
Market for That Asset Is Not Active. FSP No.
FAS 157-3
clarifies the application of SFAS No. 157, Fair
Value Measurements, in a market that is not active and
provides an example to illustrate key considerations in
determining the fair value of a financial asset when the market
for that financial asset is not active.
SFAS No. 157 defines fair value as the price that
would be received to sell an asset or paid to transfer a
liability in an orderly transaction between market participants
at the measurement date, essentially an exit price.
The levels of the fair value hierarchy established by
SFAS No. 157 are:
Level 1: inputs are quoted prices, unadjusted, in active
markets for identical assets or liabilities that the reporting
entity has the ability to access at the measurement date.
Level 2: inputs are other than quoted prices included
within Level 1 that are observable for the asset or
liability, either directly or indirectly. A Level 2 input
must be observable for substantially the full term of the asset
or liability.
Level 3: inputs are unobservable and reflect the reporting
entitys own assumptions about the assumptions that market
participants would use in pricing the asset or liability.
Investments
As of December 31, 2008, RAI held investments primarily in
money market funds, auction rate securities and mortgage-backed
securities. During 2008, certain money market funds were
reclassified to short-term investments from cash equivalents due
to the liquidity restrictions by the fund managers preventing
immediate withdrawal. Adverse changes in financial markets
caused certain auction rate securities and mortgage-backed
securities to
29
revalue lower than carrying value and become less liquid.
Auction rate securities and mortgage-backed securities will not
become liquid until a successful auction occurs or a buyer is
found. These investments will be evaluated on a quarterly basis
to determine if it is probable that RAI will realize some
portion of the unrealized loss.
RAI reviews impairments associated with the above in accordance
with SFAS No. 115, Accounting for Certain
Investments in Debt and Equity Securities, FSP
No. FAS 115-1
and
FAS 124-1,
The Meaning of Other-Than-Temporary Impairment and Its
Application to Certain Investments, and FSP
No. EITF 99-20-1,
Amendments to the Impairment Guidance of EITF Issue
No. 99-20,
to determine the classification of the impairment as temporary
or other-than-temporary. For additional information relating to
these investments, see Item 8, note 9 to consolidated
financial statements.
Pension
and Postretirement Benefits
RAI and certain of its subsidiaries sponsor a number of
non-contributory defined benefit pension plans covering most of
their employees, and also provide certain health and life
insurance benefits for most of their retired employees and their
dependents. These benefits are generally no longer provided to
employees hired on or after January 1, 2004. For additional
information relating to pension and postretirement benefits, see
Item 8, note 19 to consolidated financial statements.
Pension and postretirement expenses and reporting are determined
in accordance with the provisions of SFAS No. 87,
Employers Accounting for Pensions,
SFAS No. 88, Employers Accounting for
Settlements and Curtailments of Defined Benefit Pension Plans
and for Termination Benefits, SFAS No. 106,
Employers Accounting for Postretirement Benefits
Other Than Pensions and SFAS No. 158,
Employers Accounting for Defined Benefit Pension and
Other Postretirement Plans-an amendment of FASB Statements
No. 87, 88, 106, and 132(R). Because pension and
other postretirement obligations ultimately will be settled in
future periods, the determination of annual expense and
liabilities is subject to estimates and assumptions. RAI reviews
these assumptions annually based on historic experience and
expected future trends or coincidental with a major event and
modifies them as needed. Demographic assumptions such as
termination of employment, mortality or retirement are reviewed
periodically as expectations change.
Gains or losses are annual changes in the amount of either the
benefit obligation or the market-related value of plan assets
resulting from experience different from that assumed or from
changes in assumptions. The minimum amortization of unrecognized
gains or losses, as described in SFAS No. 87, is
included in pension expense. Prior service costs, which are
changes in benefit obligations due to plan amendments, are
amortized on a straight-line basis over the average remaining
service period for active employees, or average remaining life
expectancies for inactive employees if most of the plan
obligations are due to inactive employees.
The minimum amortization of unrecognized gains or losses, as
described in SFAS No. 106, is also included in the
postretirement benefit expense. Prior service costs, which are
changes in benefit obligations due to plan amendments, are
amortized on a straight-line basis over the service to expected
full eligibility age for active employees, or average remaining
life expectancies for inactive employees if most of the plan
obligations are due to inactive employees.
Differences between actual results and actuarial assumptions are
accumulated and amortized over future periods. In recent years,
actual results have varied significantly from actuarial
assumptions. In particular, pension and postretirement assets
have decreased due to significant decreases in fair value. These
changes have resulted in an increase in charges to other
comprehensive income (loss). These changes are expected to
result in an increase in pension and postretirement expense in
future years. The Pension Protection Act may require additional
cash funding of the pension obligations in the future.
30
The most critical assumptions and their sensitivity to change
are presented below:
Assumed asset return and discount rates have a significant
effect on the amounts reported for the benefit plans. A
one-percentage-point change in assumed discount rate for the
pension plans and other postretirement plans would have had the
following effects:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1-Percentage Point
|
|
|
|
|
|
|
Increase
|
|
|
1-Percentage Point Decrease
|
|
|
|
Pension
|
|
|
Postretirement
|
|
|
Pension
|
|
|
Postretirement
|
|
|
|
Plans
|
|
|
Plans
|
|
|
Plans
|
|
|
Plans
|
|
|
Effect on 2008 net periodic benefit cost
|
|
$
|
(26
|
)
|
|
$
|
(6
|
)
|
|
$
|
16
|
|
|
$
|
5
|
|
Effect on December 31, 2008, projected benefit obligation
and accumulated postretirement benefit obligation
|
|
|
(485
|
)
|
|
|
(127
|
)
|
|
|
538
|
|
|
|
139
|
|
A one-percentage point change in assumed asset return would have
had the following effects:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1-Percentage Point Increase
|
|
1-Percentage Point Decrease
|
|
|
Pension
|
|
Postretirement
|
|
Pension
|
|
Postretirement
|
|
|
Plans
|
|
Plans
|
|
Plans
|
|
Plans
|
|
Effect on 2008 net periodic benefit cost
|
|
$
|
(51
|
)
|
|
$
|
(3
|
)
|
|
$
|
51
|
|
|
$
|
3
|
|
Income
Taxes
Tax law requires certain items to be excluded or included in
taxable income at different times than is required for book
reporting purposes under SFAS No. 109,
Accounting for Income Taxes. These differences may
be permanent or temporary in nature. FASB Interpretation,
referred to as FIN, No. 48, Accounting for
Uncertainty in Income Taxes, clarifies
SFAS No. 109 by providing guidance for consistent
reporting of uncertain income tax positions recognized in a
companys financial statements.
RAI determines its annual effective income tax rate based on
forecasted pre-tax book income and forecasted permanent book and
tax differences. The rate is established at the beginning of the
year and is evaluated on a quarterly basis. Any changes to the
forecasted information may cause the effective rate to be
adjusted. Additional tax, interest and penalties associated with
uncertain tax positions are recognized in tax expense on a
quarterly basis.
To the extent that any book and tax differences are temporary in
nature, that is, the book realization will occur in a different
period than the tax realization, a deferred tax asset or
liability is established as required under
SFAS No. 109. To the extent that a deferred tax asset
is created, management evaluates RAIs ability to realize
this asset. Management currently believes it is more likely than
not that the deferred tax assets recorded in RAIs
consolidated balance sheets will be realized. To the extent a
deferred tax liability is established under
SFAS No. 109, it is recorded, tracked and, once it
becomes currently due and payable, paid to the taxing
authorities.
The financial statements reflect managements best estimate
of RAIs current and deferred tax liabilities and assets.
Future events, including but not limited to, additional
resolutions with taxing authorities could have an impact on
RAIs current estimate of tax liabilities, realization of
tax assets and upon RAIs effective income tax rate.
Recently
Adopted Accounting Pronouncements
Effective January 1, 2008, RAI adopted
SFAS No. 157, Fair Value Measurements, for
financial assets and financial liabilities.
SFAS No. 157 does not require any new fair value
measurements but provides a definition of fair value,
establishes a framework for measuring fair value and expands
disclosure about fair value measurements. SFAS No. 157
also establishes a fair value hierarchy that distinguishes
between independent and observable inputs and unobservable
inputs based on the best information available. The adoption of
SFAS No. 157 on financial assets and financial
liabilities did not have a material impact on RAIs
consolidated results of operations, cash flows or financial
position.
In February 2008, the FASB issued FSP
No. 157-2,
Effective Date of FASB Statement No. 157, to
allow entities to electively defer the effective date of
SFAS No. 157 for nonfinancial assets and liabilities,
except for those items recognized or disclosed at fair value on
an annual or more frequently recurring basis, until fiscal years
31
beginning after November 15, 2008. RAI elected to defer
SFAS No. 157 for nonfinancial assets and nonfinancial
liabilities to be effective as of January 1, 2009. For RAI,
the deferral primarily applies to (1) nonfinancial assets
and liabilities initially measured at fair value in business
combinations; (2) reporting units or nonfinancial assets
and liabilities measured at fair value in conjunction with
goodwill, trademark and other intangible impairment testing;
(3) other nonfinancial assets measured at fair value in
conjunction with impairment assessments; and (4) asset
retirement obligations initially measured at fair value. RAI
believes that the fair value measurements made in these
circumstances would not necessarily be different from those that
would be made had the provision of SFAS No. 157 been
applied, and therefore the impact of the adoption of
SFAS No. 157 for nonfinancial assets and nonfinancial
liabilities is not expected to have a material impact on
RAIs consolidated results of operations, cash flows or
financial position.
On October 10, 2008, the FASB, issued FSP
No. FAS 157-3,
Determining the Fair Value of a Financial Asset When the
Market for That Asset Is Not Active. FSP
No. FAS 157-3
clarifies the application of SFAS No. 157, Fair
Value Measurements, in a market that is not active and
provides an example to illustrate key considerations in
determining the fair value of a financial asset when the market
for that financial asset is not active. FSP
No. FAS 157-3
is effective immediately, including prior periods for which
financial statements had not been issued. RAI adopted FSP
No. FAS 157-3
effective with the financial statements ended September 30,
2008. The adoption of FSP
No. FAS 157-3
had no impact on RAIs consolidated results of operations,
cash flows or financial position.
On January 13, 2009, the FASB issued FSP
No. EITF 99-20-1,
Amendments to the Impairment Guidance of EITF Issue
No. 99-20.
FSP
No. EITF 99-20-1
provides a more consistent determination of whether an
other-than-temporary impairment, referred to as OTTI, has
occurred and retains and emphasizes the OTTI guidance and
required disclosures in SFAS No. 115, and FSP
No. FAS 115-1
and
FAS 124-1.
RAI adopted FSP
No. EITF 99-20-1
effective for periods ending after December 15, 2008.
Recently
Issued Accounting Pronouncements
In March 2008, the FASB issued SFAS No. 161,
Disclosures about Derivative Instruments and Hedging
Activities-an amendment of FASB Statement No. 133.
SFAS No. 161 seeks qualitative disclosures about the
objectives and strategies for using derivatives, quantitative
data about the fair value of and gains and losses on derivative
contracts, and details of credit-risk-related contingent
features in hedged positions. SFAS No. 161 also seeks
enhanced disclosure around derivative instruments in financial
statements, accounted for under SFAS No. 133,
Accounting for Derivative Instruments and Hedging
Activities, and how hedges affect an entitys
financial position, financial performance and cash flows.
SFAS No. 161 is effective for RAI as of
January 1, 2009, and is not expected to impact results of
operations, cash flows or financial position.
In April 2008, the FASB issued FSP
No. FAS 142-3,
Determination of the Useful Life of Intangible
Assets. FSP
No. FAS 142-3
amends the factors that should be considered in developing
renewal or extension assumptions used to determine the useful
life of a recognized intangible asset under
SFAS No. 142, Goodwill and Other Intangible
Assets. The objective of FSP
No. FAS 142-3
is to improve the consistency between the useful life of a
recognized intangible asset under SFAS No. 142 and the
period of expected cash flows used to measure the fair value of
the asset under SFAS No. 141(R) and GAAP. FSP
No. FAS 142-3
is effective for financial statements issued for years beginning
after December 15, 2008, and interim periods within those
years and is applied prospectively to intangible assets acquired
after the effective date. The adoption of FSP
No. FAS 142-3
will require additional disclosure regarding renewal or
extension assumptions and will not have a material impact on
RAIs results of operations, cash flows or financial
position.
On December 30, 2008, the FASB issued FSP
No. FAS 132(R)-1, Employers Disclosures
about Postretirement Benefit Plan Assets. FSP
No. FAS 132(R)-1 amends SFAS No. 132(R),
Employers Disclosures about Pensions and Other
Postretirement Benefits, to provide guidance on an
employers disclosures about plan assets of a defined
benefit pension or other postretirement plan. The disclosures
about plan assets required by FSP No. FAS 132(R)-1 are
to be provided for fiscal years ending after December 15,
2009. The adoption of FSP No. FAS 132(R)-1 in 2009
will not have an impact on RAIs results of operations,
cash flows or financial position.
32
Results
of Operations
2008
Compared with 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
% Change
|
|
|
Net sales:(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
RJR Tobacco
|
|
$
|
7,678
|
|
|
$
|
7,945
|
|
|
|
(3.4
|
)%
|
Conwood
|
|
|
723
|
|
|
|
670
|
|
|
|
7.9
|
%
|
All other
|
|
|
444
|
|
|
|
408
|
|
|
|
8.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
|
8,845
|
|
|
|
9,023
|
|
|
|
(2.0
|
)%
|
Cost of products sold(1)(2)
|
|
|
4,863
|
|
|
|
4,960
|
|
|
|
(2.0
|
)%
|
Selling, general and administrative expenses
|
|
|
1,500
|
|
|
|
1,687
|
|
|
|
(11.1
|
)%
|
Amortization expense
|
|
|
22
|
|
|
|
23
|
|
|
|
(4.3
|
)%
|
Restructuring charge
|
|
|
90
|
|
|
|
|
|
|
|
NM
|
(3)
|
Trademark impairment charges
|
|
|
318
|
|
|
|
65
|
|
|
|
NM
|
(3)
|
Operating income:
|
|
|
|
|
|
|
|
|
|
|
|
|
RJR Tobacco
|
|
|
1,756
|
|
|
|
1,940
|
|
|
|
(9.5
|
)%
|
Conwood
|
|
|
232
|
|
|
|
312
|
|
|
|
(25.6
|
)%
|
All other
|
|
|
153
|
|
|
|
142
|
|
|
|
7.7
|
%
|
Corporate expense
|
|
|
(89
|
)
|
|
|
(106
|
)
|
|
|
(16.0
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,052
|
|
|
$
|
2,288
|
|
|
|
(10.3
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Excludes excise taxes of: |
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
RJR Tobacco
|
|
$
|
1,689
|
|
|
$
|
1,847
|
|
Conwood
|
|
|
20
|
|
|
|
18
|
|
All other
|
|
|
181
|
|
|
|
161
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,890
|
|
|
$
|
2,026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2) |
|
See below for further information related to MSA settlement and
federal tobacco buyout expense included in cost of products sold. |
|
(3) |
|
Percentage change not meaningful. |
In the third quarter of 2008, RAI and RJR Tobacco announced
changes in their organizational structures to streamline
non-core business processes and programs in order to allocate
additional resources to strategic growth initiatives. The
reorganizations will result in the elimination of approximately
600 full-time jobs, expected to be substantially completed
by December 31, 2009.
Under existing benefit plans, $83 million of
severance-related cash benefits and $7 million of non-cash
pension-related benefits comprised a restructuring charge of
$90 million. Of this charge, $81 million was recorded
in the RJR Tobacco segment. Of the cash portion of the charge,
$5 million was paid as of December 31, 2008. The cash
benefits are expected to be substantially paid by
December 31, 2010. Cost savings related to the
restructuring are expected to be $42 million in 2009,
$53 million in 2010 and $55 million on an annualized
basis thereafter.
33
RJR
Tobacco
Net
Sales
Domestic shipment volume, in billions of units for RJR Tobacco
and the industry, were as
follows(1):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
% Change
|
|
|
Growth brands:
|
|
|
|
|
|
|
|
|
|
|
|
|
CAMEL excluding non-filter
|
|
|
23.3
|
|
|
|
24.2
|
|
|
|
(3.8
|
)%
|
PALL MALL
|
|
|
8.6
|
|
|
|
7.1
|
|
|
|
20.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.8
|
|
|
|
31.3
|
|
|
|
1.7
|
%
|
Support brands(2)
|
|
|
46.6
|
|
|
|
52.0
|
|
|
|
(10.3
|
)%
|
Non-support brands
|
|
|
11.0
|
|
|
|
14.3
|
|
|
|
(23.3
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total domestic
|
|
|
89.5
|
|
|
|
97.6
|
|
|
|
(8.4
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total premium
|
|
|
55.9
|
|
|
|
60.9
|
|
|
|
(8.2
|
)%
|
Total value
|
|
|
33.5
|
|
|
|
36.7
|
|
|
|
(8.7
|
)%
|
Premium/Total mix
|
|
|
62.5
|
%
|
|
|
62.4
|
%
|
|
|
|
|
Industry(3):
|
|
|
|
|
|
|
|
|
|
|
|
|
Premium
|
|
|
251.1
|
|
|
|
259.9
|
|
|
|
(3.4
|
)%
|
Value
|
|
|
94.2
|
|
|
|
97.3
|
|
|
|
(3.1
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total domestic
|
|
|
345.3
|
|
|
|
357.2
|
|
|
|
(3.3
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premium/Total mix
|
|
|
72.7
|
%
|
|
|
72.8
|
%
|
|
|
|
|
|
|
|
(1) |
|
Amounts presented in this table are rounded on an individual
basis and, accordingly, may not sum on an aggregate basis.
Percentages are calculated on unrounded numbers. |
|
(2) |
|
During 2008, the KOOL brand was reclassified from a growth brand
to a support brand. |
|
(3) |
|
Based on information from MSAi. Prior year amounts have been
restated to reflect current methodology. |
RJR Tobaccos net sales are dependent upon its shipment
volume in a declining market, premium versus value-brand mix and
list pricing, offset by promotional spending, trade incentives
and federal excise taxes. During 2008, RJR Tobacco selectively
reduced the number of products sold by discontinuing a number of
low-margin and non-core brands and styles to reduce complexity
and improve efficiency.
RJR Tobaccos net sales for the year ended
December 31, 2008, decreased $267 million, or 3.4%,
from the year ended December 31, 2007, driven by
$339 million attributable to lower volume, partially offset
by improved pricing, net of promotional spending. RJR
Tobaccos decreases in net sales and shipment volume
reflect intensified competitive activity in the first half of
2008, a decrease in consumption, wholesale inventory reductions,
and the impact of RJR Tobaccos selective brand and style
reduction. In addition, RJR Tobaccos consumers are
believed to be more price-sensitive than consumers of competing
brands and, therefore, are more negatively affected by the
current adverse economic pressures. RJR Tobaccos total
domestic shipment volume decreased 8.4% in 2008 compared with
2007. Industry shipment volume for 2008 was down 3.3% compared
with 2007.
34
The shares of RJR Tobaccos brands as a percentage of total
share of U.S. retail cigarette sales according to
data(1)
from IRI, were as
follows(2)(3):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended December 31,
|
|
|
|
|
|
|
|
|
|
Share Point
|
|
|
|
2008
|
|
|
2007
|
|
|
Change
|
|
|
Growth brands:
|
|
|
|
|
|
|
|
|
|
|
|
|
CAMEL excluding non-filter
|
|
|
8.0
|
%
|
|
|
7.8
|
%
|
|
|
0.3
|
|
PALL MALL
|
|
|
2.6
|
%
|
|
|
2.1
|
%
|
|
|
0.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total growth brands
|
|
|
10.7
|
%
|
|
|
9.9
|
%
|
|
|
0.8
|
|
Support brands
|
|
|
13.8
|
%
|
|
|
14.7
|
%
|
|
|
(0.9
|
)
|
Non-support brands
|
|
|
3.6
|
%
|
|
|
4.4
|
%
|
|
|
(0.8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total domestic
|
|
|
28.1
|
%
|
|
|
29.0
|
%
|
|
|
(1.0
|
)
|
|
|
|
(1) |
|
Retail share of U.S. cigarette sales data is included in
this document because it is used by RJR Tobacco primarily as an
indicator of the relative performance of industry participants,
and brands and market trends. You should not rely on the market
share data reported by IRI as being a precise measurement of
actual market share because IRI is not able to effectively track
all volume. Moreover, you should be aware that in a product
market experiencing overall declining consumption, a particular
product can experience increasing market share relative to
competing products, yet still be subject to declining
consumption volumes. |
|
(2) |
|
Amounts presented in this table are rounded on an individual
basis and, accordingly, may not sum on an aggregate basis. |
|
(3) |
|
In 2009, at the request of RJR Tobacco, IRI will revise its
sampling model to better reflect the current retail environment. |
The retail share of market of CAMELs filtered styles
increased 0.3 share points in 2008 compared with 2007.
During the first half of 2008, CAMEL launched updated packaging
and smoother blends for its core styles. CAMEL also introduced
CAMEL Crush in lead markets during the first quarter of 2008.
CAMEL Crush is an innovative cigarette that uses RJR
Tobaccos technology to provide adult smokers the option of
changing each cigarette from regular to menthol by crushing a
capsule in the filter. CAMEL Crush was expanded nationally
during the third quarter of 2008 and had a market share of
0.74 share points in the fourth quarter of 2008. As a
result of repositioning KOOL to a support brand, RJR Tobacco is
shifting focus to CAMELs menthol styles as the key driver
in the growing menthol category.
CAMEL Snus expanded into a total of 17 markets in 2008 and is
planning to expand nationally in the first quarter of 2009.
Additionally, in October 2008, RJR Tobacco introduced new
smoke-free tobacco products called CAMEL Dissolvables that
include CAMEL Orbs, Sticks and Strips. CAMEL Dissolvables are
made of finely milled tobacco, and dissolve completely in the
mouth. They are designed to provide current adult smokers and
smokeless tobacco users with additional, convenient, alternative
ways to enjoy tobacco products. CAMEL Dissolvables are being
launched in three lead markets beginning in the first half of
2009.
PALL MALLs market share increased 0.5 share points in
2008 compared with 2007. PALL MALLs growth is believed to
be the result of the brands position as a product that
offers a longer-lasting cigarette at a value price. PALL MALL
introduced more stylish, round-corner packs in the second
quarter of 2008.
The combined share of market of RJR Tobaccos growth brands
during 2008 showed improvement over 2007. However, the decline
in share of support and non-support brands more than offset the
gains on the growth brands.
Operating
Income
RJR Tobaccos operating income for the year ended
December 31, 2008, decreased $184 million to
$1,756 million, or 22.9% of net sales, from
$1,940 million, or 24.4% of net sales, for the year ended
December 31, 2007. The reclassification of KOOL to a
support brand from a growth brand in the third quarter of 2008
triggered a non-cash trademark impairment of $173 million.
An additional impairment charge of $3 million was recorded
in the fourth quarter of 2008 as the result of annual impairment
testing of all brand trademarks. The impairment charges
35
were based on the excess of each brands carrying value
over its fair value using the present value of estimated future
cash flows assuming a discount rate of 10.5%. The discount rate
was determined by adjusting the enterprise discount rate by an
appropriate risk premium to reflect an asset group risk.
In addition, RJR Tobacco incurred a restructuring charge of
$81 million in the second half of 2008 as a result of
streamlining non-core business processes and programs and
eliminating approximately 540 full-time positions. The
trademark impairment charge and restructuring charge were
partially offset by higher pricing and improvements in
productivity. RJR Tobaccos operating income was also
negatively impacted by decreases in shipment volume due to
intensified competitive activity in the first half of 2008, a
decrease in consumption, wholesale inventory reductions, as well
as RJR Tobaccos selective style and brand reduction.
RJR Tobaccos MSA settlement and federal tobacco buyout
expenses, included in cost of products sold, are detailed in the
schedule below:
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
Settlements
|
|
$
|
2,664
|
|
|
$
|
2,791
|
|
|
|
|
|
|
|
|
|
|
Federal tobacco quota buyout
|
|
$
|
240
|
|
|
$
|
247
|
|
|
|
|
|
|
|
|
|
|
MSA settlement expenses are expected to be approximately
$2.6 billion in 2009, subject to adjustment for changes in
volume and other factors, and expense for the federal tobacco
quota buyout is expected to be approximately $230 million
to $240 million in 2009. For additional information, see
Litigation Affecting the Cigarette
Industry Health-Care Cost Recovery Cases
MSA in Item 8, note 16 to consolidated financial
statements and Governmental Activity
below.
Selling, general and administrative expenses include the costs
of litigating and administering product liability claims, as
well as other legal expenses. For the years ended
December 31, 2008 and 2007, RJR Tobaccos product
liability defense costs were $96 million and
$88 million, respectively.
Product liability cases generally include the
following types of smoking and health related cases:
|
|
|
|
|
Individual Smoking and Health;
|
|
|
|
Engle Progeny;
|
|
|
|
Broin II;
|
|
|
|
Class Actions; and
|
|
|
|
Health-Care Cost Recovery Claims.
|
Product liability defense costs include the
following items:
|
|
|
|
|
direct and indirect compensation, fees and related costs and
expenses for internal legal and related administrative staff
administering product liability claims;
|
|
|
|
fees and cost reimbursements paid to outside attorneys;
|
|
|
|
direct and indirect payments to third party vendors for
litigation support activities;
|
|
|
|
expert witness costs and fees; and
|
|
|
|
payments to fund legal defense costs for the now dissolved
Council for Tobacco Research U.S.A.
|
Numerous factors affect product liability defense costs. The
most important factors are the number of cases pending and the
number of cases in trial or in preparation for trial, that is,
with active discovery and motions practice. See
Litigation Affecting the Cigarette
Industry Overview in Item 8, note 16
to consolidated financial statements for detailed information
regarding the number and type of cases pending, and
Litigation Affecting the Cigarette
Industry Scheduled Trials in Item 8,
note 16 to consolidated financial statements for
36
detailed information regarding the number and nature of cases in
trial and scheduled for trial through December 31, 2009.
RJR Tobacco expects that the factors described above will
continue to have the primary impact on its product liability
defense costs in the future. Given RJR Tobaccos experience
in defending its product liability cases and the reasonably
anticipated level of activity in RJR Tobaccos pending
cases and possible new cases, RJR Tobacco anticipates that its
product liability defense costs will increase in 2009, compared
with the most recent years. See Litigation
Affecting the Cigarette Industry Engle
Progeny Cases and Litigation Affecting
the Cigarette Industry Class Action
Suits Engle Case in Item 8,
note 16 to consolidated financial statements for additional
information. However, it is possible that adverse developments
in the factors discussed above, as well as other circumstances
beyond the control of RJR Tobacco, could have a material adverse
effect on the consolidated results of operations, cash flows or
financial position of RAI or its subsidiaries. Those other
circumstances beyond the control of RJR Tobacco include the
results of present and future trials and appeals, and the
development of possible new theories of liability by plaintiffs
and their counsel.
Conwood
Net
Sales
The moist snuff shipment volume, in millions of cans, for
Conwood was as
follows(1):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
% Change
|
|
|
|
|
|
Premium:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
KODIAK
|
|
|
51.0
|
|
|
|
53.2
|
|
|
|
(4.2
|
)%
|
|
|
|
|
Other
|
|
|
2.8
|
|
|
|
3.2
|
|
|
|
(12.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
53.8
|
|
|
|
56.4
|
|
|
|
(4.5
|
)%
|
|
|
|
|
Price-value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GRIZZLY
|
|
|
279.6
|
|
|
|
237.0
|
|
|
|
18.0
|
%
|
|
|
|
|
Other
|
|
|
1.7
|
|
|
|
2.2
|
|
|
|
(22.7
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
281.3
|
|
|
|
239.2
|
|
|
|
17.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total moist snuff
|
|
|
335.2
|
|
|
|
295.6
|
|
|
|
13.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Amounts presented in this table are rounded on an individual
basis and, accordingly, may not sum on an aggregate basis.
Percentages are calculated on unrounded numbers. |
Moist snuff has been the key driver to Conwoods overall
growth and profitability within the U.S. smokeless tobacco
market. Moist snuff accounted for approximately 66% of
Conwoods revenue in 2008 and approximately 60% in 2007.
Conwoods key brands include KODIAK in the premium brand
category and GRIZZLY in the price-value brand category.
Conwoods U.S. moist snuff market share was 27.7% in
2008 and 26.0% in 2007 based on distributor-reported data
processed by MSAi, for distributor shipments to retail. Although
moist snuff volume grew over 7% in 2008, Conwoods moist
snuff volume grew over 13% in 2008, attributable to its
innovation, product development and brand building.
37
The Conwood shares of the moist snuff category as a percentage
of total share of U.S. shipments of moist snuff, according
to distributor reported
data(1)
processed by MSAi, were as
follows(2):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended
|
|
|
|
December 31,
|
|
|
|
|
|
|
|
|
|
Share
|
|
|
|
2008
|
|
|
2007
|
|
|
Point Change
|
|
|
Premium:
|
|
|
|
|
|
|
|
|
|
|
|
|
KODIAK
|
|
|
4.0
|
%
|
|
|
4.4
|
%
|
|
|
(0.4
|
)
|
Other
|
|
|
0.3
|
%
|
|
|
0.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.3
|
%
|
|
|
4.7
|
%
|
|
|
(0.4
|
)
|
Price-value:
|
|
|
|
|
|
|
|
|
|
|
|
|
GRIZZLY
|
|
|
23.3
|
%
|
|
|
21.1
|
%
|
|
|
2.2
|
|
Other
|
|
|
0.1
|
%
|
|
|
0.2
|
%
|
|
|
(0.1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.4
|
%
|
|
|
21.3
|
%
|
|
|
2.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total moist snuff
|
|
|
27.7
|
%
|
|
|
26.0
|
%
|
|
|
1.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Distributor shipments-to-retail share of U.S. moist snuff is
included in this document because it is used by Conwood
primarily as an indicator of the relative performance of
industry participants, and brands and market trends. You should
not rely on the market share data reported by distributors and
processed by MSAi as being a precise measurement of actual
market share because this distributor data set is not able to
effectively track all volume. |
|
(2) |
|
Amounts presented in this table are rounded on an individual
basis and, accordingly, may not sum on an aggregate basis. |
Conwoods net sales for the year ended December 31,
2008, were $723 million compared with $670 million for
the year ended December 31, 2007. Moist snuff sales
generated the increase over the prior-year period, led by
GRIZZLY, Conwoods leading price-value moist snuff brand.
GRIZZLY had a 23.3% share of moist snuff shipments in 2008, an
increase of 2.2 share points from 2007, despite further
narrowing of the price gap between premium brands and value
brands, such as GRIZZLY. In 2008, Conwood expanded nationally
the launch of two new GRIZZLY styles, GRIZZLY Wintergreen
Pouches and GRIZZLY Snuff, to build on the brands momentum
and aid in its share growth. Building on its pouch success,
GRIZZLY is launching mint and straight styles in the first
quarter of 2009.
The shipment share of KODIAK, Conwoods leading premium
moist snuff brand, declined 0.4 share points in 2008
compared with 2007 due to competitive promotional activity and
the brands core markets being burdened by high tobacco
taxes and the current economic recession.
Operating
Income
Conwoods operating income for the year ended
December 31, 2008, decreased to $232 million, or 32.1%
of net sales, from $312 million, or 46.5% of net sales for
2007. This change is due to increased price-value volume and
higher pricing offset primarily by trademark impairment. The
annual impairment testing of trademarks in the fourth quarter of
2008 resulted in a charge of $142 million compared with
$32 million in 2007. The 2008 impairment occurred on
several of Conwoods brands, including KODIAK, which
reflected the demand shift from premium to price-value brands,
as well as multiple loose leaf and little cigar brands. The
impairment charges were based on the excess of each brands
carrying value over its fair value using the present value of
estimated future cash flows assuming a discount rate of 10.5%.
The discount rate was determined by adjusting the enterprise
discount rate by an appropriate risk premium to reflect an asset
group risk.
All
Other
All Other sales for the year ended December 31, 2008, were
favorably impacted by the growth of Santa Fes NATURAL
AMERICAN SPIRIT brand. Operating income for the 2008 year
increased as a result of lower marketing expenses in 2008 as
compared with 2007.
38
RAI
Consolidated
Gain on termination of joint venture of $328 million
in 2008 resulted from the termination of the Reynolds-Gallaher
International Sarl joint venture. See Item 8, note 5
to consolidated financial statements for additional information
related to the joint venture termination.
Interest and debt expense was $275 million for the
year ended December 31, 2008, a decrease of
$63 million over the comparable prior year. This decrease
was primarily due to lower effective interest rates and lower
outstanding debt in 2008 as compared with 2007.
Interest income was $60 million for the year ended
December 31, 2008, a decrease of $74 million compared
with the year ended December 31, 2007. This decrease was
the result of investing available cash at lower interest rates
in 2008.
Other expense (income) net was expense of
$37 million for the year ended December 31, 2008, an
increase of $26 million compared with the year ended
December 31, 2007. Impairments on investments deemed
other-than-temporary of $35 million were expensed in 2008.
Provision for income taxes was $790 million, or an
effective rate of 37.1%, for the year ended December 31,
2008, compared with $766 million, or an effective rate of
37.0%, for the year ended December 31, 2007. The 2008
provision was favorably impacted by a lower tax rate related to
the gain on the termination of the Reynolds-Gallaher
International Sarl joint venture, but was offset by
unfavorability related to tax reserves and U.S. taxes
recorded on foreign earnings. The effective tax rates exceeded
the federal statutory rate of 35% primarily due to the impact of
state taxes and certain non-deductible items, offset by the
domestic production activities deduction of the American Jobs
Creation Act, enacted on October 22, 2004.
RAI expects its effective tax rate to be approximately 38% in
2009.
2007
Compared with 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
% Change
|
|
|
Net sales:(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
RJR Tobacco
|
|
$
|
7,945
|
|
|
$
|
7,707
|
|
|
|
3.1
|
%
|
Conwood
|
|
|
670
|
|
|
|
409
|
|
|
|
NM
|
(3)
|
All other
|
|
|
408
|
|
|
|
394
|
|
|
|
3.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
|
9,023
|
|
|
|
8,510
|
|
|
|
6.0
|
%
|
Cost of products sold(1)(2)
|
|
|
4,960
|
|
|
|
4,803
|
|
|
|
3.3
|
%
|
Selling, general and administrative expenses
|
|
|
1,687
|
|
|
|
1,658
|
|
|
|
1.7
|
%
|
Amortization expense
|
|
|
23
|
|
|
|
28
|
|
|
|
(17.9
|
)%
|
Restructuring and asset impairment charges
|
|
|
|
|
|
|
1
|
|
|
|
NM
|
(3)
|
Goodwill and trademark impairment charges
|
|
|
65
|
|
|
|
90
|
|
|
|
NM
|
(3)
|
Operating income:
|
|
|
|
|
|
|
|
|
|
|
|
|
RJR Tobacco
|
|
|
1,940
|
|
|
|
1,682
|
|
|
|
15.3
|
%
|
Conwood
|
|
|
312
|
|
|
|
181
|
|
|
|
NM
|
(3)
|
All other
|
|
|
142
|
|
|
|
165
|
|
|
|
(13.9
|
)%
|
Corporate expense
|
|
|
(106
|
)
|
|
|
(98
|
)
|
|
|
8.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,288
|
|
|
$
|
1,930
|
|
|
|
18.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
39
|
|
|
(1) |
|
Excludes excise taxes of: |
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
RJR Tobacco
|
|
$
|
1,847
|
|
|
$
|
1,966
|
|
Conwood
|
|
|
18
|
|
|
|
13
|
|
All other
|
|
|
161
|
|
|
|
145
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,026
|
|
|
$
|
2,124
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2) |
|
See below for further information related to MSA settlement and
federal tobacco buyout expense included in cost of products sold. |
|
(3) |
|
Percentage change is not meaningful. |
RJR
Tobacco
Net
Sales
RJR Tobaccos net sales for the year ended
December 31, 2007, increased $238 million from the
prior year, primarily due to higher pricing coupled with lower
discounting, partially offset by the impact of total volume
decrease of $479 million.
Domestic shipment volume, in billions of units for RJR Tobacco
and the industry, were as
follows(1):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
% Change
|
|
|
Growth brands:
|
|
|
|
|
|
|
|
|
|
|
|
|
CAMEL excluding non-filter
|
|
|
24.2
|
|
|
|
23.5
|
|
|
|
3.1
|
%
|
PALL MALL
|
|
|
7.1
|
|
|
|
6.4
|
|
|
|
10.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.3
|
|
|
|
29.9
|
|
|
|
4.7
|
%
|
Support brands(2)
|
|
|
52.0
|
|
|
|
55.8
|
|
|
|
(6.8
|
)%
|
Non-support brands
|
|
|
14.3
|
|
|
|
18.3
|
|
|
|
(21.9
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total domestic
|
|
|
97.6
|
|
|
|
104.0
|
|
|
|
(6.2
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total premium
|
|
|
60.9
|
|
|
|
64.0
|
|
|
|
(4.8
|
)%
|
Total value
|
|
|
36.7
|
|
|
|
40.0
|
|
|
|
(8.1
|
)%
|
Premium/Total mix
|
|
|
62.4
|
%
|
|
|
61.6
|
%
|
|
|
|
|
Industry(3):
|
|
|
|
|
|
|
|
|
|
|
|
|
Premium
|
|
|
259.9
|
|
|
|
270.4
|
|
|
|
(3.9
|
)%
|
Value
|
|
|
97.3
|
|
|
|
105.6
|
|
|
|
(7.9
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total domestic
|
|
|
357.2
|
|
|
|
376.0
|
|
|
|
(5.0
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premium/Total mix
|
|
|
72.8
|
%
|
|
|
71.9
|
%
|
|
|
|
|
|
|
|
(1) |
|
Amounts presented in this table are rounded on an individual
basis and, accordingly, may not sum on an aggregate basis.
Percentages are calculated on unrounded numbers. |
|
(2) |
|
During 2008, the KOOL brand was reclassified from a growth brand
to a support brand. |
|
(3) |
|
Based on information from MSAi. Prior year amounts have been
restated to reflect current methodology. |
RJR Tobaccos total domestic shipment volume decreased 6.2%
in 2007 compared with the prior year, reflecting both a decline
in total cigarette consumption and a decline in market share.
RJR Tobaccos premium shipments as a percentage of total
shipments increased during 2007 compared with the prior year,
driven by CAMEL. CAMEL provided innovation with CAMEL No. 9
and CAMEL Signature
40
Blends, which were introduced during the first half of 2007, and
the expansion to national distribution of two new CAMEL
No. 9 styles in the third quarter of 2007. CAMELs
menthol styles increased in popularity in 2007 as well. CAMEL
Snus pioneered the development of a new category of smokeless,
spitless tobacco products in the U.S. RJR Tobacco expanded
the introduction of CAMEL Snus from two lead markets into six
additional markets in 2007.
The shares of RJR Tobaccos brands as a percentage of total
share of U.S. retail cigarette sales according to
data(1)
from IRI, were as
follows(2):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended December 31,
|
|
|
|
|
|
|
|
|
|
Share Point
|
|
|
|
2007
|
|
|
2006
|
|
|
Change
|
|
|
Growth brands:
|
|
|
|
|
|
|
|
|
|
|
|
|
CAMEL excluding non-filter
|
|
|
7.8
|
%
|
|
|
7.4
|
%
|
|
|
0.4
|
|
PALL MALL
|
|
|
2.1
|
%
|
|
|
1.9
|
%
|
|
|
0.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total growth brands
|
|
|
9.9
|
%
|
|
|
9.3
|
%
|
|
|
0.6
|
|
Support brands
|
|
|
14.7
|
%
|
|
|
15.2
|
%
|
|
|
(0.5
|
)
|
Non-support brands
|
|
|
4.4
|
%
|
|
|
5.3
|
%
|
|
|
(0.8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total domestic
|
|
|
29.0
|
%
|
|
|
29.8
|
%
|
|
|
(0.7
|
)
|
|
|
|
(1) |
|
Retail share of U.S. cigarette sales data is included in this
document because it is used by RJR Tobacco primarily as an
indicator of the relative performance of industry participants,
and brands and market trends. You should not rely on the market
share data reported by IRI as being a precise measurement of
actual market share because IRI is not able to effectively track
all volume. Moreover, you should be aware that in a product
market experiencing overall declining consumption, a particular
product can experience increasing market share relative to
competing products, yet still be subject to declining
consumption volumes. |
|
(2) |
|
Amounts presented in this table are rounded on an individual
basis and, accordingly, may not sum on an aggregate basis. |
The retail share of market of CAMELs filtered styles
increased 0.4 share points in 2007 from 2006. CAMELs
focus remained on brand innovation in 2007. In the first half of
2007, CAMEL introduced CAMEL Signature Blends, a collaborative
effort with adult smokers. Also in the first half of 2007, CAMEL
introduced CAMEL No. 9 in regular and menthol styles
designed to appeal to adult female smokers. CAMEL No. 9,
100mm styles, were introduced during the third quarter of 2007.
PALL MALLs market share continued to grow, gaining
0.3 share points in 2007 over 2006. PALL MALL offers a
longer-lasting cigarette with a premium heritage at a
less-than-premium price.
The combined share of market of RJR Tobaccos growth brands
during 2007 showed improvement over the prior year. However, the
decline in share of support and non-support brands more than
offset the gains on the growth brands.
Operating
Income
RJR Tobaccos operating income for the year ended
December 31, 2007 increased $258 million to
$1,940 million, or 24.4% of net sales, from
$1,682 million, or 21.8% of net sales for the year ended
December 31, 2006. Improvements in pricing, product mix,
productivity and pension expense were partially offset by volume
declines and increased MSA settlement payments during 2007.
In connection with the annual impairment testing of goodwill and
certain intangible assets in the fourth quarter of 2007,
impairment of $33 million occurred on RJR Tobaccos
non-growth brand, WINSTON. The impairment primarily reflects
lower projected net sales compared with that assumed in the 2006
annual impairment test. The impairment charge was based on the
excess of the brands carrying value over its fair value
using the present value of estimated future cash flows assuming
a discount rate of 10.5%.
41
RJR Tobaccos MSA settlement and federal tobacco buyout
expenses, included in cost of products sold, are detailed in the
schedule below:
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Settlements
|
|
$
|
2,791
|
|
|
$
|
2,589
|
|
|
|
|
|
|
|
|
|
|
Federal tobacco quota buyout
|
|
|
247
|
|
|
|
258
|
|
Federal quota tobacco stock liquidation assessment
|
|
|
|
|
|
|
(9
|
)
|
|
|
|
|
|
|
|
|
|
Total quota buyout expense
|
|
$
|
247
|
|
|
$
|
249
|
|
|
|
|
|
|
|
|
|
|
For additional information, see Litigation
Affecting the Cigarette Industry Health-Care Cost
Recovery Cases MSA in Item 8,
note 16 to consolidated financial statements and
Governmental Activity below.
Selling, general and administrative expenses include the costs
of litigating and administering product liability claims, as
well as other legal expenses. For the years ended
December 31, 2007 and 2006, RJR Tobaccos product
liability defense costs were $88 million and
$105 million, respectively. An improved litigation
environment and efficient and effective management of cost
contributed to the decline in product liability cost in 2007.
Conwood
Net
Sales
Conwoods net sales for the year ended December 31,
2007, were $670 million compared with $409 million for
the year ended December 31, 2006. The acquisition of the
Conwood companies occurred on May 31, 2006, and
consequently, the RAI consolidated statements of income include
only the results of operations of the Conwood companies
subsequent to May 31, 2006. Additionally, prior year
comparative results of Lane operations that were transferred to
Conwood on January 1, 2007, have been reclassified.
The shares of Conwoods moist snuff products and volume
discussion presented below include periods prior to the
acquisition by RAI for enhanced analysis. The shipment volume,
in millions of cans, for Conwood was as
follows(1):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
% Change
|
|
|
Premium:
|
|
|
|
|
|
|
|
|
|
|
|
|
KODIAK
|
|
|
53.2
|
|
|
|
56.7
|
|
|
|
(6.2
|
)%
|
Other
|
|
|
3.2
|
|
|
|
3.5
|
|
|
|
(8.6
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
56.4
|
|
|
|
60.2
|
|
|
|
(6.3
|
)%
|
Price-value:
|
|
|
|
|
|
|
|
|
|
|
|
|
GRIZZLY
|
|
|
237.0
|
|
|
|
202.1
|
|
|
|
17.3
|
%
|
Other
|
|
|
2.2
|
|
|
|
3.1
|
|
|
|
(29.0
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
239.2
|
|
|
|
205.2
|
|
|
|
16.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total moist snuff
|
|
|
295.6
|
|
|
|
265.4
|
|
|
|
11.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Amounts presented in this table are rounded on an individual
basis and, accordingly, may not sum on an aggregate basis. |
42
The Conwood shares of the moist snuff category as a percentage
of total share of U.S. shipments of moist snuff, according
to distributor reported
data(1)
processed by MSAi, were as
follows(2):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended
|
|
|
|
December 31,
|
|
|
|
|
|
|
|
|
|
Share
|
|
|
|
2007
|
|
|
2006
|
|
|
Point Change
|
|
|
Premium:
|
|
|
|
|
|
|
|
|
|
|
|
|
KODIAK
|
|
|
4.4
|
%
|
|
|
5.1
|
%
|
|
|
(0.7
|
)
|
Other
|
|
|
0.3
|
%
|
|
|
0.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.7
|
%
|
|
|
5.4
|
%
|
|
|
(0.7
|
)
|
Price-value:
|
|
|
|
|
|
|
|
|
|
|
|
|
GRIZZLY
|
|
|
21.1
|
%
|
|
|
19.4
|
%
|
|
|
1.7
|
|
Other
|
|
|
0.2
|
%
|
|
|
0.3
|
%
|
|
|
(0.1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21.3
|
%
|
|
|
19.7
|
%
|
|
|
1.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total moist snuff
|
|
|
26.0
|
%
|
|
|
25.1
|
%
|
|
|
0.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Distributor shipments-to-retail share of U.S. moist snuff is
included in this document because it is used by Conwood
primarily as an indicator of the relative performance of
industry participants, and brands and market trends. You should
not rely on the market share data reported by distributors and
processed by MSAi as being a precise measurement of actual
market share because this distributor data set is not able to
effectively track all volume. |
|
(2) |
|
Amounts presented in this table are rounded on an individual
basis and, accordingly, may not sum on an aggregate basis. |
GRIZZLY, Conwoods leading price-value moist snuff brand,
had a market share of 21.1% of moist snuff shipments for 2007,
an increase of 1.7 points from the prior year. Conwood completed
its national roll-out of GRIZZLY Long-Cut Natural in the second
quarter of 2007 and began testing two new GRIZZLY styles,
GRIZZLY Wintergreen Pouches and GRIZZLY Snuff, to build on the
brands momentum. GRIZZLY Wintergreen Pouches are moist
snuff in a fleece pouch, and GRIZZLY Snuff is a traditional
moist snuff style with an ultra-fine cut. The shipment share of
KODIAK, Conwoods leading premium moist snuff brand, was
adversely impacted compared with the prior year due to
competitive discounting and promotions.
Operating
Income
Conwoods operating income for the year ended
December 31, 2007, increased to $312 million, or 46.5%
of net sales, from $181 million, or 44.4% of net sales, for
the year ended December 31, 2006. A full year of the
Conwood companies activities is the primary driver of the
year over year increase. In addition, Conwood also benefited
from higher volume and higher prices in 2007.
In connection with the annual impairment testing of goodwill and
certain intangible assets in the fourth quarter of 2007,
impairment occurred on five of Conwoods non-investment
brands. The impairment primarily reflects a shift in the level
of support among loose leaf product brands and for little cigar
brands. In 2007, Conwood recorded impairment charges of
$32 million based on the excess of certain brands
carrying values over their fair values, using the present value
of estimated future cash flows assuming a discount rate of 10.5%.
All
Other
All Other sales for the year ended December 31, 2007, were
favorably impacted by the growth of Santa Fes NATURAL
AMERICAN SPIRIT brand. Operating income for 2007 was unfavorably
impacted by an increase in corporate expenses as well as an
increase in selling expenses associated with an increase in
Santa Fes sales force.
43
RAI
Consolidated
Interest and debt expense was $338 million for the
year ended December 31, 2007, an increase of
$68 million over the prior year. This increase was
primarily due to a full year of interest on the debt incurred by
RAI to fund the acquisition of the Conwood companies in May 2006.
Other expense (income) net was expense of
$11 million for the year ended December 31, 2007.
Year-to-date foreign exchange gains and equity income were more
than offset by the expensing of unamortized debt fees associated
with the term loan that RAI pre-paid in full in June 2007 and
the loss on the sale of investment securities. For the year
ended December 31, 2006, other income was $13 million
consisting primarily of foreign exchange gain and equity income.
Provision for income taxes was $766 million, or an
effective rate of 37.0%, for the year ended December 31,
2007, compared with $673 million, or an effective rate of
37.2%, for the year ended December 31, 2006. The 2007
provision was favorably impacted by a decrease in nondeductible
items and an increase in the Qualified Production Activity
Income deduction. The 2006 provision was adversely impacted by
nondeductible items, including certain expenditures related to
ballot initiatives, offset by the resolution of certain prior
years tax matters that resulted in a reduction of income
tax expense of $17 million.
Extraordinary item included a gain of $1 million for
the year ended December 31, 2007, and $74 million for
the year ended December 31, 2006, related to the 2000
acquisition of RJRs former parent, Nabisco Group Holdings
Corp., referred to as NGH, primarily from settlement of tax
matters. Including these adjustments, the net after-tax gain on
the acquisition of NGH was $1.8 billion.
Liquidity
and Financial Condition
Liquidity
At present, the principal sources of liquidity for RAIs
operating subsidiaries businesses and operating needs are
internally generated funds from their operations and
intercompany loans and advances, mainly from RAI and RJR. The
principal capital resources and sources of liquidity for RAI and
RJR, in turn, are proceeds from issuances of debt securities by
RAI and RJR and the RAI Credit Facility described below under
Borrowing Arrangements. Cash flows from
operating activities are believed to be sufficient for the
foreseeable future to enable the operating subsidiaries to meet
their obligations under the MSA, to fund their capital
expenditures and to make payments to RAI and RJR that, when
combined with RAIs and RJRs cash balances, will
enable RAI and RJR to make their required debt-service payments,
and enable RAI to pay dividends to its shareholders.
The negative impact, if any, on the sources of liquidity that
could result from a decrease in demand for products due to
short-term inventory adjustments by wholesale and retail
distributors, changes in competitive pricing, accelerated
declines in consumption, particularly from increases in
regulation or excise taxes, or adverse impacts from financial
markets, cannot be predicted. RAI cannot predict its cash
requirements or those of its subsidiaries related to any future
settlements or judgments, including cash required to be held in
escrow or to bond any appeals, if necessary, and RAI makes no
assurance that it or its subsidiaries will be able to meet all
of those requirements.
RAI has evaluated the liquidity of key suppliers and significant
customers in 2008. Where there were liquidity concerns
identified with key suppliers, contingency plans are being
developed. To date, no business interruptions have occurred
caused by key supplier liquidity. No liquidity issues were
identified regarding significant customers.
As of December 31, 2008, RAI held investments primarily in
money market funds, auction rate securities and mortgage-backed
securities. During 2008, certain money market funds were
reclassified to short-term investments from cash equivalents due
to liquidity restrictions by the fund managers preventing
immediate withdrawal. Given such restrictions, these funds will
not be available until the underlying investments mature or are
sold. Adverse changes in financial markets caused the auction
rate securities and the mortgage-backed security to revalue
lower than carrying value and become less liquid. During 2008,
the auction rate securities and mortgage-backed security were
reclassified to long-term investments from short-term
investments as liquidation of these securities was not expected
to occur within one year. The auction rate securities and
mortgage-backed security will not become liquid until a
successful auction occurs or a buyer is found. RAI intends, and
has the ability, to hold these money market
44
funds, auction rate securities and mortgage-backed security for
a period of time sufficient to allow for sale, redemption or
anticipated recovery in fair value. At December 31, 2008,
RAI considered the mortgage-backed security, the auction rate
securities linked to corporate credit risk and one of the
auction rate securities related to financial insurance companies
to be temporarily impaired. The remaining auction rate
securities related to financial insurance companies were
considered
other-than-temporarily
impaired by RAI at December 31, 2008.
Contractual obligations as of December 31, 2008 were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due by Period
|
|
|
|
|
|
|
Less than 1
|
|
|
1-3 Years
|
|
|
4-5 Years
|
|
|
|
|
|
|
Total
|
|
|
Year-2009
|
|
|
2010-2011
|
|
|
2012-2013
|
|
|
Thereafter
|
|
|
Long-term notes, exclusive of interest(1)
|
|
$
|
4,410
|
|
|
$
|
200
|
|
|
$
|
700
|
|
|
$
|
1,135
|
|
|
$
|
2,375
|
|
Interest payments related to long-term notes(1)
|
|
|
2,034
|
|
|
|
233
|
|
|
|
425
|
|
|
|
336
|
|
|
|
1,040
|
|
Operating leases(2)
|
|
|
68
|
|
|
|
16
|
|
|
|
26
|
|
|
|
18
|
|
|
|
8
|
|
Non-qualified pension obligations(3)
|
|
|
67
|
|
|
|
6
|
|
|
|
13
|
|
|
|
13
|
|
|
|
35
|
|
Postretirement benefit obligations(3)
|
|
|
814
|
|
|
|
79
|
|
|
|
164
|
|
|
|
165
|
|
|
|
406
|
|
Qualified pension funding(3)
|
|
|
44
|
|
|
|
44
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase obligations(4)
|
|
|
905
|
|
|
|
141
|
|
|
|
287
|
|
|
|
194
|
|
|
|
283
|
|
Other noncurrent liabilities(5)
|
|
|
98
|
|
|
|
N/A
|
|
|
|
63
|
|
|
|
10
|
|
|
|
25
|
|
MSA obligations(6)
|
|
|
12,400
|
|
|
|
2,650
|
|
|
|
4,950
|
|
|
|
4,800
|
|
|
|
|
|
Gross unrecognized tax benefit(7)
|
|
|
97
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal tobacco buyout obligations(8)
|
|
|
1,470
|
|
|
|
250
|
|
|
|
480
|
|
|
|
490
|
|
|
|
250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash obligations
|
|
$
|
22,407
|
|
|
$
|
3,619
|
|
|
$
|
7,108
|
|
|
$
|
7,161
|
|
|
$
|
4,422
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
For more information about RAIs long-term notes, see
Item 8, note 14 to consolidated financial statements. |
|
(2) |
|
Operating lease obligations represent estimated lease payments
primarily related to office space, automobiles, warehouse space
and computer equipment. See Item 8, note 16 to
consolidated financial statements for additional information. |
|
(3) |
|
For more information about RAIs pension plans and
postretirement benefits, see Item 8, note 19 to
consolidated financial statements. Non-qualified pension and
postretirement benefit obligations captioned under
Thereafter include obligations during the next five
years only. These obligations are not reasonably estimable
beyond ten years. Qualified pension plan funding is based on the
Pension Protection Act and tax deductibility and is not
reasonably estimable beyond one year. |
|
(4) |
|
Purchase obligations primarily include commitments to acquire
tobacco leaf. Purchase orders for the purchase of other raw
materials and other goods and services are not included in the
table. RAIs operating subsidiaries are not able to
determine the aggregate amount of such purchase orders that
represent contractual obligations, as purchase orders typically
represent authorizations to purchase rather than binding
agreements. For purposes of this table, contractual obligations
for the purchase of goods or services are defined by RAIs
operating subsidiaries as agreements that are enforceable and
legally binding that specify all significant terms, including
fixed or minimum quantities to be purchased; fixed, minimum or
variable price provisions; and the approximate timing of the
transaction. Purchase orders of RAIs operating
subsidiaries are based on current demand expectations and are
fulfilled by vendors within short time horizons. RAIs
operating subsidiaries do not have significant non-cancelable
agreements for the purchase of raw materials or other goods or
services specifying minimum quantities or set prices that exceed
our expected requirements. RAIs operating subsidiaries
also enter into contracts for outsourced services; however, the
obligations under these contracts were generally not significant
and the contracts generally contain clauses allowing for the
cancellation without significant penalty. |
|
(5) |
|
Other noncurrent liabilities include primarily restructuring and
bonus compensation. Certain other noncurrent liabilities are
excluded from the table above, including RJRs liabilities
recorded in 1999 related to certain indemnification claims, for
which timing of payments are not estimable. For more information
about RJRs indemnification obligations, see Item 8,
note 16 to consolidated financial statements. |
45
|
|
|
(6) |
|
MSA obligation amounts in the aggregate beyond five years are
not meaningful as these are obligations into perpetuity. For
more information about the MSA, see Item 8, note 16 to
consolidated financial statements. |
|
(7) |
|
Gross unrecognized tax benefit of $97 million relates to
the adoption of FIN No. 48. For more information, see
Item 8, note 12 to consolidated financial statements.
Due to inherent uncertainties regarding the timing of payment of
these amounts, RAI cannot reasonably estimate the payment period. |
|
(8) |
|
For more information about the tobacco buyout legislation, see
Governmental Activity below and Item 8,
note 16 to consolidated financial statements. |
Commitments as of December 31, 2008 were as follows:
|
|
|
|
|
|
|
|
|
|
|
Commitment Expiration
|
|
|
|
Period
|
|
|
|
|
|
|
Less than
|
|
|
|
Total
|
|
|
1 Year
|
|
|
Standby letters of credit backed by revolving credit facility
|
|
$
|
12
|
|
|
$
|
12
|
|
|
|
|
|
|
|
|
|
|
Total commitments
|
|
$
|
12
|
|
|
$
|
12
|
|
|
|
|
|
|
|
|
|
|
Cash
Flows
2008
Compared with 2007
Net cash flows from operating activities were
$1,315 million in 2008, compared with $1,331 million
in 2007. This change was driven primarily by higher MSA and tax
payments, partially offset by lower pension funding in 2008.
Net cash flows from investing activities were $278 million
in 2008, compared with $763 million for the prior year.
This change was primarily driven by higher short-term investing
net proceeds in 2007 that more than offset the proceeds received
as a result of the termination of the joint venture in 2008.
Net cash flows used in financing activities were
$1,206 million in 2008, compared with $1,312 million
in 2007. This change was due to prior-year repayment of
long-term debt, offset by higher stock repurchases and higher
dividends per share in 2008.
2007
Compared with 2006
Net cash flows from operating activities were
$1,331 million in 2007, compared with net cash flows from
operating activities of $1,457 million in 2006. This
decrease was the result of higher income tax and interest
payments in 2007, partially offset by increased net income in
2007.
Net cash flows from investing activities were $763 million
in 2007, compared with net cash flows used in investing
activities of $3,531 million in 2006. This change was
primarily driven by the acquisition of the Conwood companies in
2006 and higher net proceeds from the sale of short-term
investments in 2007.
Net cash flows used in financing activities were
$1,312 million in 2007, compared with net cash flows
provided by financing activities of $2,174 million in 2006.
This change reflects prior year RAI debt issuances related to
the acquisition of the Conwood companies, as well as increased
dividend payments, long-term debt repayment and repurchase of
RAI common stock in 2007.
Borrowing
Arrangements
As of December 31, 2008, RAIs total consolidated debt
consisted of RAI notes in the aggregate principal amount of
$4.3 billion, with maturity dates ranging from 2009 to
2037, and RJR notes in the aggregate principal amount of
$129 million, with maturity dates ranging from 2009 to
2015. See Item 8, note 14 to consolidated financial
statements for more information on these notes.
RAI and RJR use interest rate swaps to manage interest rate risk
on a portion of their debt obligations. Under certain
conditions, any fair value that results in a liability position
of certain interest rate swaps may require full
collateralization with cash or securities. On December 31,
2008, interest rate swaps existed on $1.6 billion of fixed-
46
rate notes. When entered into, these swaps were designated as
hedges of underlying exposures. On January 6, 2009, RAI and
RJR entered into offsetting interest rate swap agreements in the
notional amount of $1.5 billion with maturity dates ranging
from June 1, 2012 to June 15, 2017. These swaps were
entered into with the same financial institution that holds
notional amount of $1.5 billion of current swaps and have a
technical right of offset. The future cash flows, established as
a result of entering into the January 6, 2009, swaps,
totals $321 million, and will be amortized and effectively
reduce net interest costs over the remaining life of the notes.
Concurrent with entering the swap agreements on January 6,
2009, RAI de-designated the current swaps as fair value hedges.
On January 7, 2009, RAI and RJR terminated an interest rate
swap agreement in the notional amount of $100 million with
a maturity date of June 1, 2012. The resulting gain of
approximately $12 million will be amortized to effectively
reduce interest expense over the remaining life of the notes.
As a result of these actions, RAI and RJR have effectively
converted $1.6 billion of fixed-rate notes swapped to a
variable rate of interest, to a fixed rate of interest of
approximately 4.0%.
At their option, RAI and RJR, as applicable, may redeem any or
all of their outstanding fixed-rate notes, in whole or in part
at any time, subject to the payment of a make-whole premium.
RAIs floating rate notes are redeemable at par on any
interest payment date after December 15, 2008.
On June 28, 2007, RAI entered into the Credit Facility,
which provides for a five-year, $550 million revolving
credit facility, which may be increased to $900 million at
the discretion of the lenders upon the request of RAI. The
Credit Facilitys maturity date of June 28, 2012, may
be extended by one year, at the discretion of the lenders upon
RAIs request.
Lenders and their respective commitments in the Credit Facility,
which are several, not joint, commitments, are listed below:
|
|
|
|
|
Lender
|
|
Commitment
|
|
|
JP Morgan Chase Bank, N.A.
|
|
$
|
52.89
|
|
Citibank N.A.
|
|
|
52.89
|
|
Morgan Stanley Bank
|
|
|
52.00
|
|
Lehman Commercial Paper Inc. (LCPI)
|
|
|
52.00
|
|
Mizuho Corporate Bank, Ltd.
|
|
|
52.00
|
|
General Electric Capital Corporation
|
|
|
52.00
|
|
AG First Farm Credit Bank
|
|
|
52.00
|
|
Goldman Sachs Bank USA
|
|
|
35.00
|
|
Wachovia Bank, National Association
|
|
|
35.00
|
|
The Bank of Nova Scotia
|
|
|
35.00
|
|
The Bank of New York
|
|
|
35.00
|
|
Farm Credit Services of Minnesota Valley, PCA DBA FCS Commercial
Finance Group
|
|
|
20.00
|
|
City National Bank of New Jersey
|
|
|
14.22
|
|
Farm Credit Bank of Texas
|
|
|
10.00
|
|
|
|
|
|
|
|
|
$
|
550.00
|
|
|
|
|
|
|
At December 31, 2008, RAI had $12 million in letters
of credit outstanding under the Credit Facility. At such date,
no borrowings were outstanding, and the remaining
$538 million of the Credit Facility was available for
borrowing.
On December 31, 2008, Wells Fargo & Company
completed its merger with Wachovia Corporation, the parent
company of Wachovia Bank, National Association, pursuant to
which Wells Fargo acquired all of Wachovia Corporation and all
its businesses and its obligations.
47
On October 5, 2008, LCPI filed for protection under
Chapter 11 of the federal Bankruptcy Code. RAI has never
borrowed under the Credit Facility, but given LCPIs
bankruptcy filing, there can be no assurance that LCPI would
loan LCPIs pro rata share of any borrowing requests made
by RAI. Subject to the terms and conditions in the Credit
Facility, RAI has the right to replace a lender in certain
circumstances, including upon a lender defaulting in its
obligation to make loans. If any lender were to default in its
obligation to make loans, there can be no assurance as to when
or whether RAI could find an acceptable replacement lender.
Certain of RAIs subsidiaries, including the Guarantors,
have guaranteed RAIs obligations under the Credit Facility
and under RAIs outstanding senior notes, referred to as
the Notes. During the second quarter of 2008, the collateral
securing the Credit Facility, Notes and related guarantees was
released as a result of certain corporate credit ratings actions
by S&P and Moodys. The collateral for the Credit
Facility, Notes and related guarantees will be reinstated if
RAIs corporate credit rating issued by each of S&P
and Moodys is lowered to at least one level below the
lowest rating level established as investment grade, or if
RAIs corporate credit rating issued by either S&P or
Moodys is lowered to at least two levels below the lowest
rating level established as investment grade. For more
information on the release of collateral, see note 13 to
consolidated financial statements.
Prior to the credit ratings actions described above, RAI had
pledged substantially all of its assets, including the stock of
its direct subsidiaries, to secure its obligations under the
Credit Facility, and the Guarantors had pledged substantially
all of their assets to secure their guarantees of RAIs
obligations under the Credit Facility. Also prior to such credit
ratings actions, the Notes and related guarantees had been
secured by any Principal Property, as such term is defined in
the indenture governing the Notes, of RAI and certain of the
Guarantors, and the stock, indebtedness or other obligations of
RJR Tobacco.
Concerns about, or lowering of, RAIs ratings by S&P
or Moodys could have an adverse impact on RAIs
ability to access the debt markets and could increase borrowing
costs. However, given the cash balances and operating
performance of RAI and its subsidiaries, RAIs management
believes that such concerns about, or lowering of, such ratings
would not have a material adverse impact on RAIs cash
flows.
RAI, RJR and their affiliates were in compliance with all
covenants and restrictions imposed by their indebtedness at
December 31, 2008.
Dividends
On February 3, 2009, RAIs board of directors declared
a quarterly cash dividend of $0.85 per common share. The
dividend will be paid on April 1, 2009, to shareholders of
record as of March 10, 2009. On an annualized basis, the
dividend rate is $3.40 per common share. The current dividend
reflects RAIs policy of paying dividends to the holders of
RAIs common stock in an aggregate amount that is
approximately 75% of RAIs annual consolidated net income.
Stock
Repurchases
On April 29, 2008, RAIs board of directors authorized
RAIs repurchase, from time to time on or before
April 30, 2009, of up to $350 million of outstanding
shares of RAI common stock in open market or privately
negotiated transactions. The repurchases are subject to
prevailing market and business conditions, and the program may
be terminated or suspended at any time. In connection with the
share repurchase program, RAI and B&W entered into an
agreement, pursuant to which B&W has agreed to participate
in the repurchase program on a basis approximately proportionate
with B&Ws 42% ownership of RAIs equity. This
repurchase program supersedes the $30 million repurchase
program authorized by RAIs board of directors on
February 5, 2008, to offset the dilution from shares issued
under certain equity-based benefit plans.
Due to RAIs incorporation in North Carolina, which does
not recognize treasury shares, the shares repurchased are
cancelled at the time of repurchase. As of December 31,
2008, RAI had repurchased and cancelled 3,817,095 shares of
RAI common stock for $207 million under the above share
repurchase programs. To preserve liquidity, RAI did not make any
stock purchases under the repurchase program in the fourth
quarter of 2008.
48
Additionally during 2008, at a cost of $3 million, RAI
purchased 57,223 shares that were forfeited with respect to
tax liabilities associated with restricted stock vesting under
its LTIP.
Capital
Expenditures
RAIs operating subsidiaries recorded cash capital
expenditures of $113 million, $142 million and
$136 million in 2008, 2007 and 2006, respectively. Of the
2008 amount, $62 million related to RJR Tobacco and
$34 million related to Conwood. RJR Tobacco plans to spend
$60 million to $70 million for capital expenditures
during 2009, primarily on non-discretionary business
requirements, and Conwood plans to spend $100 million to
$110 million in 2009, primarily on non-discretionary
capacity expansion. Capital expenditures are funded primarily by
cash flows from operations. RAIs operating
subsidiaries capital expenditure programs are expected to
continue at a level sufficient to support their strategic and
operating needs. There were no material long-term commitments
for capital expenditures as of December 31, 2008.
Retirement
Benefits
Due to the adverse changes in the financial markets, RAIs
pension assets have been negatively impacted. In 2008, the
overall rate of return on the investments for the pension assets
was approximately negative 30.1%. RAI assessed the asset
allocation and investment strategy and will phase in appropriate
changes to balance funded status, interest rate risk and asset
returns. Once fully implemented, these changes will reduce the
pension funds exposure to equities and increase exposure
to fixed income and alternatives. As a result of changes to the
asset allocation and investment strategy, RAI lowered the
expected long-term return on pension assets, referred to as the
ELTRA, to 8.25%, beginning in 2009, from 8.74% . The ELTRA,
asset allocation, current asset performance and the discount
rate may impact the funded status of RAIs pension plans,
and as a result RAI will contribute a minimum of
$50 million to the pension assets in 2009 and pension
expense will increase approximately $180 million in 2009.
Litigation
and Settlements
As discussed in Item 8, note 16 to consolidated
financial statements, RJR Tobacco, the Conwood companies and
their affiliates, including RAI, and indemnitees, including
B&W, have been named in a number of tobacco-related legal
actions, proceedings or claims seeking damages in amounts
ranging into the hundreds of millions or even billions of
dollars. Unfavorable judgments have been returned in a number of
tobacco-related cases and state enforcement actions. As of
February 6, 2009, RJR Tobacco has paid approximately
$12 million since January 1, 2006, related to
unfavorable judgments. RJR, including its subsidiary RJR
Tobacco, have liabilities totaling $94 million that were
recorded in connection with certain indemnification claims, not
related to smoking and health, asserted by JTI against RJR and
RJR Tobacco, relating to the activities of Northern Brands and
related litigation.
RAIs management continues to conclude that the loss of any
particular smoking and health tobacco litigation claim against
RJR Tobacco or its affiliates or indemnitees, or the loss of any
particular claim concerning the use of smokeless tobacco against
the Conwood companies, when viewed on an individual basis, is
not probable. RAI and its subsidiaries believe that they have
valid basis for appeal of adverse verdicts against them and have
valid defenses to all actions and intend to defend all actions
vigorously. Nonetheless, the possibility of material losses
related to tobacco litigation is more than remote. Litigation is
subject to many uncertainties, and generally it is not possible
to predict the outcome of the litigation pending against RJR
Tobacco, the Conwood companies or their affiliates or
indemnitees, or to reasonably estimate the amount or range of
any possible loss. Moreover, notwithstanding the quality of
defenses available to it and its affiliates in tobacco-related
litigation matters, it is possible that RAIs consolidated
results of operations, cash flows or financial position could be
materially adversely affected by the ultimate outcome of certain
pending or future litigation matters.
In November 1998, RJR Tobacco, B&W and the other major
U.S. cigarette manufacturers entered into the MSA with
attorneys general representing most U.S. states,
territories and possessions. As described in Item 8,
note 16 to consolidated financial statements, the MSA
imposes a perpetual stream of future payment obligations on RJR
Tobacco and the other major U.S. cigarette manufacturers
and places significant restrictions on their ability to market
and sell cigarettes in the future. For more information related
to historical and expected settlement expenses
49
and payments under the MSA, see Litigation
Affecting the Cigarette Industry Health-Care Cost
Recovery Cases MSA in Item 8,
note 16 to consolidated financial statements. The MSA has
materially adversely affected RJR Tobaccos shipment
volumes. RAI believes that these settlement obligations may
materially adversely affect the results of operations, cash
flows or financial position of RAI and RJR Tobacco in future
periods. The degree of the adverse impact will depend, among
other things, on the rate of decline in U.S. cigarette
sales in the premium and value categories, RJR Tobaccos
share of the domestic premium and value cigarette categories,
and the effect of any resulting cost advantage of manufacturers
not subject to the MSA.
RJR Tobacco and certain of the other participating manufacturers
under the MSA are currently involved in litigation with the
settling states with respect to the availability for certain
market years of a downward adjustment to the annual MSA
settlement payment obligation, known as the Non-Participating
Manufacturer Adjustment. Pending the resolution of these
disputes, RJR Tobacco and certain of the other participating
manufacturers have placed the disputed portions of their 2006,
2007 and 2008 annual payments into the MSA disputed funds
account. RJR Tobacco currently has approximately
$1.6 billion deposited in the MSA disputed funds account.
For more information related to this litigation, see
Litigation Affecting the Cigarette
Industry MSA Enforcement and
Validity in Item 8, note 16 to consolidated
financial statements.
Governmental
Activity
The marketing, sale, taxation and use of tobacco products have
been subject to substantial regulation by government and health
officials for many years. Various state governments have adopted
or are considering, among other things, legislation and
regulations that would:
|
|
|
|
|
significantly increase their taxes on tobacco products;
|
|
|
|
restrict displays, advertising and sampling of tobacco products;
|
|
|
|
establish fire standards compliance for cigarettes;
|
|
|
|
raise the minimum age to possess or purchase tobacco products;
|
|
|
|
restrict or ban the use of certain flavorings, including
menthol, in tobacco products, or the use of certain flavor
descriptors in the marketing of tobacco products;
|
|
|
|
require the disclosure of ingredients used in the manufacture of
tobacco products;
|
|
|
|
require the disclosure of nicotine yield information for
cigarettes;
|
|
|
|
impose restrictions on smoking in public and private
areas; and
|
|
|
|
restrict the sale of tobacco products directly to consumers or
other unlicensed recipients, including over the Internet.
|
In addition, during 2009, the U.S. Congress adopted
legislation increasing the federal excise tax on cigarettes and
other tobacco products, and likely will consider legislation
regarding the regulation of the manufacture and sale of tobacco
products by the FDA. The U.S. Congress also may consider
legislation regarding:
|
|
|
|
|
regulation of environmental tobacco smoke;
|
|
|
|
implementation of a national fire standards compliance for
cigarettes;
|
|
|
|
regulation of the retail sale of tobacco products over the
Internet and in other non-face-to-face retail transactions, such
as by mail order and telephone; and
|
|
|
|
banning of the delivery of tobacco products by the
U.S. Postal Service.
|
Together with manufacturers price increases in recent
years and substantial increases in state and federal taxes on
tobacco products, these developments have had and will likely
continue to have an adverse effect on the sale of tobacco
products.
50
Cigarettes are subject to substantial excise taxes in the United
States. The federal excise tax per pack of 20 cigarettes is
currently $0.39. On February 4, 2009, President Obama
signed an increase of $0.62 in the excise tax per pack of
cigarettes, and significant tax increases on other tobacco
products, to fund expansion of the SCHIP. The tax increases are
effective April 1, 2009.
Under the SCHIP, the tax rate for chewing tobacco will increase
$0.3083 per pound to $0.5033 per pound and will increase $0.925
per pound to $1.51 per pound for snuff. The federal tax on small
cigars, defined as those weighing three pounds or less per
thousand, will increase $48.502 per thousand to $50.33 per
thousand. Large cigars currently are taxed at a rate of 20.719%
of the manufacturers price, with a cap of $48.75 per
thousand. Under the SCHIP, the rate on large cigars will
increase to 52.75% of the manufacturers price, with a
maximum rate of $0.4026 per cigar. In addition, the tax rate for
roll-your-own tobacco will increase from $1.097 per pound to
$24.78 per pound.
RAIs operating subsidiaries expect the tax increases to
significantly and adversely impact sales volume, but at this
time, cannot quantify the sales volume decline, nor the
resulting adverse impacts to RAIs consolidated results of
operations, financial condition or cash flows. Additionally,
RAIs operating subsidiaries believe that the federal
excise tax increase is an event that will require that their
goodwill and trademarks be tested for impairment during the
first quarter of 2009, and the resulting fair value of certain
of their trademarks could be less than carrying value. In
particular, RJR Tobacco believes that impairment charges related
to support and non-support cigarette brands are possible and
Conwood also believes that impairment charges related to certain
brands are possible. No reasonable estimate of trademark
impairment charges can be made at this time by RAIs
operating subsidiaries. Because annual impairment testing of the
goodwill of RAIs operating subsidiaries as of
November 30, 2008, indicated significant excesses of fair
value over carrying value, RAIs operating subsidiaries
believe that goodwill impairment as a result of testing in the
first quarter of 2009 is unlikely.
All states and the District of Columbia currently impose excise
taxes at levels ranging from $0.07 per pack in South Carolina to
$2.75 per pack in New York. As of December 31, 2008, the
weighted average state cigarette excise tax per pack, calculated
on a
12-month
rolling average basis, was approximately $1.011, an increase
compared to the
12-month
rolling average of $0.914 as of December 31, 2007. Three
states passed excise tax per pack increases in 2008: New York, a
$1.25 increase, from $1.50 to $2.75 per pack, effective
June 3, 2008; Massachusetts, a $1.00 increase, from $1.51
to $2.51 per pack, effective July 1, 2008; and New
Hampshire, a $0.25 increase, from $1.08 to $1.33 per pack,
effective October 15, 2008. In addition, on January 1,
2008, the cigarette excise tax increased by $1.00 per pack in
two states as a result of legislation passed in 2007: Maryland,
from $1.00 to $2.00, and Wisconsin, from $0.77 to $1.77. On
July 1, 2008, Vermont increased its cigarette excise tax
rate by $0.20, to $1.99 per pack, the result of an increase
passed in 2006 and implemented in 2006 and 2008. Hawaii
increased its cigarette excise tax on September 30, 2008,
as a result of a $1.20 tax passed in 2006, which is being
implemented in $0.20 increments until 2011. Certain city and
county governments, such as New York and Chicago, also impose
substantial excise taxes on cigarettes sold in those
jurisdictions. The District of Columbia passed a $1.00 per pack
increase, from $1.00 to $2.00, effective October 1, 2008.
Cigars are generally taxed by states on an ad valorem basis,
ranging from 5% in South Carolina to 75% in Alaska and
Washington. Other states have unit-based tax schemes for cigars
or tax little cigars the same as cigarettes.
Forty-nine states also subject smokeless tobacco to excise taxes
and the Commonwealth of Pennsylvania, which currently levies no
tax on other tobacco products, considered one during its 2008
legislative session. As of December 31, 2008,
35 states taxed moist snuff, and 46 states taxed
chewing tobacco, on an ad valorem basis at rates that range from
5% in South Carolina to 90% in Massachusetts. Other states have
a unit tax or a weight-based tax. In 2008, two states passed
legislation that changed their tax on moist snuff from an ad
valorem tax to a weight-based tax: Utahs tax changed from
35% to $0.75 per ounce, and New Yorks tax changed from 37%
to $0.96 per ounce, both effective July 1, 2008.
Legislation to convert from an ad valorem to a weight-based tax
is expected to be introduced in several other states in 2009.
51
On October 25, 2006, the Alcohol and Tobacco Tax and Trade
Bureau of the U.S. Department of Treasury, referred to as
the TTB, issued a Notice of Proposed Rulemaking, proposing
changes to the regulations that govern the classification and
labeling of cigars and cigarettes for federal excise tax
purposes. The TTB now is considering written comments that were
received prior to the March 26, 2007, deadline. Both the
CAPTAIN BLACK and WINCHESTER little cigar brands manufactured by
Lane, which are classified and sold as little
cigars, would be re-classified as cigarettes
under these proposed regulations. Although it is not possible to
fully assess and quantify the negative impact of the proposed
regulations, if adopted, on the little cigar products of Lane,
the immediate impact would be to increase the federal excise tax
on such products by more than tenfold. In addition, if little
cigars are classified as cigarettes for federal excise tax
purposes, it is possible that the states would take the position
that MSA obligations also apply to these products.
In 1964, the Report of the Advisory Committee to the Surgeon
General of the U.S. Public Health Service concluded that
cigarette smoking was a health hazard of sufficient importance
to warrant appropriate remedial action. Since 1966, federal law
has required a warning statement on cigarette packaging, and
cigarette advertising in other media also is required to contain
a warning statement. Since 1971, television and radio
advertising of cigarettes has been prohibited in the United
States.
During the past four decades, various laws affecting the
cigarette industry have been enacted. In 1984, Congress enacted
the Comprehensive Smoking Education Act. Among other things,
this act:
|
|
|
|
|
establishes an interagency committee on smoking and health that
is charged with carrying out a program to inform the public of
any dangers to human health presented by cigarette smoking;
|
|
|
|
requires a series of four health warnings to be printed on
cigarette packages and advertising on a rotating basis;
|
|
|
|
increases type size and area of the warning required in
cigarette advertisements; and
|
|
|
|
requires that cigarette manufacturers provide annually, on a
confidential basis, a list of ingredients added to tobacco in
the manufacture of cigarettes to the Secretary of Health and
Human Services.
|
The warnings currently required on cigarette packages and
advertisements are:
|
|
|
|
|
SURGEON GENERALS WARNING: Smoking Causes Lung
Cancer, Heart Disease, Emphysema, And May Complicate
Pregnancy;
|
|
|
|
SURGEON GENERALS WARNING: Quitting Smoking Now
Greatly Reduces Serious Risks to Your Health;
|
|
|
|
SURGEON GENERALS WARNING: Smoking By Pregnant Women
May Result in Fetal Injury, Premature Birth, And Low Birth
Weight; and
|
|
|
|
SURGEON GENERALS WARNING: Cigarette Smoke Contains
Carbon Monoxide.
|
Since the initial report in 1964, the Secretary of Health,
Education and Welfare, now the Secretary of Health and Human
Services, and the Surgeon General have issued a number of other
reports which purport to find the nicotine in cigarettes
addictive and to link cigarette smoking and exposure to
cigarette smoke with certain health hazards, including various
types of cancer, coronary heart disease and chronic obstructive
lung disease. These reports have recommended various
governmental measures to reduce the incidence of smoking. In
1992, the federal Alcohol, Drug Abuse and Mental Health Act was
signed into law. This act required states to adopt a minimum age
of 18 for purchase of tobacco products and to establish a system
to monitor, report and reduce the illegal sale of tobacco
products to minors in order to continue receiving federal
funding for mental health and drug abuse programs. In 1996, the
U.S. Department of Health and Human Services announced
regulations implementing this legislation. And in 2006, the
Surgeon General released a report entitled The Health
Consequences of Involuntary Exposure to Tobacco Smoke.
Among its conclusions, the report found the following: exposure
of adults to secondhand smoke causes coronary heart disease and
lung cancer, exposure of children to secondhand smoke
52
results in an increased risk of sudden infant death syndrome,
acute respiratory infections, ear problems and more severe
asthma; and that there is no risk-free level of exposure to
secondhand smoke.
In 1986, Congress enacted the Comprehensive Smokeless Tobacco
Health Education Act of 1986, which, among other things,
required health warning notices on smokeless tobacco packages
and advertising and prohibited the advertising of smokeless
tobacco products on any medium of electronic communications
subject to the jurisdiction of the Federal Communications
Commission. The warnings currently required on smokeless tobacco
packages and advertising, which appear on a rotating basis, are:
|
|
|
|
|
WARNING: THIS PRODUCT MAY CAUSE MOUTH CANCER;
|
|
|
|
WARNING: THIS PRODUCT MAY CAUSE GUM DISEASE AND TOOTH
LOSS; and
|
|
|
|
WARNING: THIS PRODUCT IS NOT A SAFE ALTERNATIVE TO
CIGARETTES.
|
In 2000, the seven largest U.S. cigar companies, including
Lane, entered into agreements with the FTC, to clearly and
conspicuously display on virtually every cigar package and
advertisement one of the following warnings, which appear on a
rotating basis:
|
|
|
|
|
SURGEON GENERAL WARNING: Cigar Smoking Can Cause Cancers
Of The Mouth And Throat, Even If You Do Not Inhale;
|
|
|
|
SURGEON GENERAL WARNING: Cigar Smoking Can Cause Lung
Cancer And Heart Disease;
|
|
|
|
SURGEON GENERAL WARNING: Tobacco Use Increases The Risk Of
Infertility, Stillbirth And Low Birth Weight;
|
|
|
|
SURGEON GENERAL WARNING: Cigars Are Not A Safe Alternative
To Cigarettes; and
|
|
|
|
SURGEON GENERAL WARNING: Tobacco Smoke Increases The Risk
Of Lung Cancer And Heart Disease, Even In Nonsmokers.
|
A bill that would grant the FDA authority to regulate tobacco
products was introduced in Congress in February 2007. On
July 30, 2008, the U.S. House of Representatives
passed the bill by a vote of
326-102. The
U.S. Senate Health, Education, Labor and Pensions Committee
approved the FDA regulation bill on August 1, 2007, but the
Senate adjourned in 2008 without any further action on the bill.
In 2009, it is likely that Congress will again take up the issue
of FDA regulation of tobacco products.
It is anticipated that any proposed FDA regulation bill most
likely would:
|
|
|
|
|
Require larger and more severe health warnings on packs and
cartons;
|
|
|
|
Ban the use of descriptors on tobacco products, such as
low-tar and light;
|
|
|
|
Require the disclosure of ingredients and additives to consumers;
|
|
|
|
Require pre-market approval by the FDA for claims made with
respect to reduced risk or reduced exposure products;
|
|
|
|
Allow the FDA to require the reduction of nicotine and the
reduction or elimination of any other compound in tobacco
products;
|
|
|
|
Prohibit the use of foreign grown tobacco that has been grown or
processed with pesticides not approved under federal law for use
in domestic tobacco farming and processing;
|
|
|
|
Allow the FDA to place more severe restrictions on the
advertising, marketing and sale of cigarettes;
|
|
|
|
Permit inconsistent state regulation of labeling and advertising
and eliminate the existing federal preemption of such
regulation; and
|
|
|
|
Grant the FDA the regulatory authority to impose broad
additional restrictions.
|
It is possible that such additional regulation could result in a
decrease in cigarette and smokeless tobacco sales in the United
States, including sales of RJR Tobaccos and Conwoods
brands, and an increase in costs to RJR
53
Tobacco and Conwood which may have a material adverse effect on
RAIs financial condition, results of operations, and cash
flows. RAI believes that such regulation may adversely affect
the ability of its operating subsidiaries to compete against
their larger competitor, Philip Morris USA, Inc., who may be
able to more quickly and cost-effectively comply with these new
rules and regulations.
On November 26, 2008, the FTC rescinded its guidance,
issued in 1966, indicating that factual statements of tar and
nicotine yields based on the Cambridge Filter Method generally
would not violate the FTC Act. In light of the rescission, the
FTC has stated that advertisers should not use terms such as
per FTC method or other phrases that would suggest
the FTC endorses or approves the Cambridge Filter Method or
other machine-based test methods. In its notice, the FTC did not
directly address whether its decision prohibited the use of
descriptors such as light and ultra low,
citing the fact that the trial judge in the RICO lawsuit brought
by the U.S. Department of Justice against the cigarette
manufacturer has already determined that such descriptors should
be banned and that that determination, among others, is
currently before the D.C. Circuit of Appeals. In terms of
enforcing the rescission, the FTC has stated that it would not
consider challenging any packaging, advertising or marketing
materials that conformed to the 1966 guidance prior to
January 1, 2009 and, in any event, would not challenge
actions taken in reliance on that guidance where altering or
withdrawing the material would be impracticable. RAIs
operating companies have assessed the steps necessary to comply
with the FTC notice and will be implementing these changes in
2009.
Legislation imposing various restrictions on public smoking also
has been enacted by 49 states and many local jurisdictions,
and many employers have initiated programs restricting or
eliminating smoking in the workplace. A number of states have
enacted legislation designating a portion of increased cigarette
excise taxes to fund either anti-smoking programs, health-care
programs or cancer research. In addition, educational and
research programs addressing health-care issues related to
smoking are being funded from industry payments made or to be
made under settlements with state attorneys general. Federal law
prohibits smoking in scheduled passenger aircraft, and the
U.S. Interstate Commerce Commission has banned smoking on
buses transporting passengers interstate. Certain common
carriers have imposed additional restrictions on passenger
smoking.
In 2003, the California Environmental Protection Agency Air
Resources Board issued a Proposed Identification of
Environmental Tobacco Smoke as a Toxic Air Contaminant for
public review. In 2006, the Air Resources Board identified
environmental tobacco smoke as a Toxic Air Contaminant,
following a three-year administrative process. The Air Resources
Board is now required to prepare a report assessing the need and
appropriate degree of control of environmental tobacco smoke.
RJR Tobacco cannot predict the form any future California
regulation may take.
In 2003, the New York Office of Fire Prevention and Control
issued a final standard with accompanying regulations that
requires all cigarettes offered for sale in New York State after
June 28, 2004, to achieve specified test results when
placed on ten layers of filter paper in controlled laboratory
conditions. The cigarettes that RAIs operating companies
sell in New York State comply with this standard. As of
December 31, 2008, 36 states in addition to New York,
as well as Washington, D.C., had enacted fire standards
compliance legislation of their own, adopting the same testing
standard set forth in the OFPC regulations described above.
Similar legislation is being considered in a number of other
states and Washington, D.C. Consistent with these state
legislative trends and its effort to increase productivity and
reduce complexity, on October 25, 2007, RJR Tobacco
announced its plans to voluntarily convert all its brands to
fire standards compliant paper by the end of 2009. Varying
standards from state to state could have an adverse effect on
the business or results of operations of RJR Tobacco.
In July 2007, the State of Maine became the first state to enact
a statute that prohibits the sale of cigarettes and cigars that
have a characterizing flavor. The legislation defines
characterizing flavor as a distinguishable taste or aroma
that is imparted to tobacco or tobacco smoke either prior to or
during consumption, other than a taste or aroma from tobacco,
menthol, clove, coffee, nuts or peppers. In October 2008,
the State of New Jersey passed a similar ban on flavored
cigarettes with a similar definition of characterizing flavor
but excluding only tobacco, menthol or clove. Additionally, New
Jersey extended the ban not only to whether the product itself
has a characterizing flavor as part of the aroma of the product
or smoke, but also if the product was marketed or advertised as
producing such a flavor, taste or aroma. Similar bills are
pending in other states.
54
Effective October 1, 2008, the San Francisco Board of
Supervisors adopted a ban on the sale of tobacco products in
some pharmacies. The Boston Public Health Commission instituted
a similar ban on February 9, 2009.
A price differential exists between cigarettes manufactured for
sale abroad and cigarettes manufactured for sale in the United
States. Consequently, a domestic gray market has developed in
cigarettes manufactured for sale abroad, but instead diverted
for domestic sales that compete with cigarettes that RJR Tobacco
manufactures for domestic sale. The U.S. federal government
and all states, except Massachusetts, have enacted legislation
prohibiting the sale and distribution of gray market cigarettes.
In addition, RJR Tobacco has taken legal action against
distributors and retailers who engage in such practices.
RJR Tobacco expects to benefit from certain state legislative
activity aimed at leveling the playing field between
original participating manufacturers under the MSA
and nonparticipating manufacturers under the MSA,
referred to as NPMs. Forty-six states have passed legislation to
ensure NPMs are making required escrow payments. Under this
legislation, a state would only permit distribution of brands by
manufacturers who are deemed by the states to be MSA-compliant.
Failure to make escrow payments could result in the loss of an
NPMs ability to sell tobacco products in a respective
state.
Additionally, 44 states have enacted legislation that
closes a loophole in the MSA. The loophole allows NPMs that
concentrate their sales in a single state, or a limited number
of states, to recover most of the funds from their escrow
accounts. To obtain the refunds, the manufacturers must
establish that their escrow deposit was greater than the amount
the state would have received had the manufacturer been a
subsequent participating manufacturer under the MSA,
that is, the states allocable share. The
National Association of Attorneys General, referred to as NAAG,
has endorsed adoption of the allocable share legislation needed
to eliminate this loophole. Following a challenge by NPMs, the
U.S. District Court for the Southern District of New York
has issued an order enjoining New York from enforcing allocable
share legislation. It is possible that NPMs will challenge
allocable share legislation passed in other states.
Finally, four states, Alaska, Michigan, Minnesota and Utah, have
enacted equity assessments on NPMs products.
This legislative initiative has not been endorsed by NAAG, and
one NPM has filed a challenge to the equity assessment in
Michigan.
Forty-two states by statute or court rule have limited, and
several additional states are considering limiting, the amount
of the bonds required to file an appeal of an adverse judgment
in state court. The limitation on the amount of such bonds
generally ranges from $1 million to $150 million.
Bonding statutes in 37 states allow defendants that are
subject to large adverse judgments, such as cigarette
manufacturers, to reasonably bond such judgments and pursue the
appellate process. In five other states and Puerto Rico, the
filing of a notice of appeal automatically stays the judgment of
the trial court.
In 2003, the World Health Organization adopted a broad
tobacco-control treaty. The treaty recommends and requires
enactment of legislation establishing specific actions to
prevent youth smoking, restrict and gradually eliminate tobacco
products marketing, provide greater regulation and disclosure of
ingredients, increase the size and scope of package warning
labels to cover at least 30% of each package and include graphic
pictures on packages. The treaty entered into force on
February 27, 2005 90 days after
ratification by the 40th country. In February 2006, the
first session of the Conference of the Parties, referred to as
the COP, occurred in Geneva, Switzerland. The COP, among other
actions taken, established a permanent secretariat, adopted a
budget, and created working groups to begin to develop protocols
on cross-border advertising and illegal trade and guidelines on
establishing smoke-free places and regulating tobacco products.
Among the decisions taken at the COPs second session, in
July 2007, the COP adopted guidelines from the working group on
the protection from exposure to tobacco smoke and called for an
intergovernmental negotiating body to negotiate a protocol on
illicit trade. At the COPs third conference, in November
2008, the parties adopted guidelines with respect to various
provisions of the tobacco control treaty, including the
packaging and labeling of tobacco products. The fourth COP
session is scheduled to be held in Uruguay in late 2010.
Although the U.S. delegate to the World Health Organization
voted for the treaty in May 2003, and the Secretary for Health
and Human Services signed the document in May 2004, the Bush
Administration did not send the treaty to the U.S. Senate
for ratification. Ratification by the United States could lead
to broader regulation of the industry.
55
It is not possible to determine what additional federal, state
or local legislation or regulations relating to smoking or
cigarettes will be enacted or to predict the effect of new
legislation or regulations on RJR Tobacco or the cigarette
industry in general, but any new legislation or regulations
could have an adverse effect on RJR Tobacco or the cigarette
industry in general. Similarly, it is not possible to determine
what additional federal, state or local legislation or
regulations relating to smokeless tobacco products will be
enacted or to predict the effect of new regulation on Conwood or
smokeless tobacco products in general, but any new legislation
or regulations could have an adverse effect on Conwood or
smokeless tobacco products in general.
Tobacco
Buyout Legislation
For information relating to tobacco buyout legislation, see
Tobacco Buyout Legislation and Related
Litigation in note 16 to consolidated financial
statements.
Other
Contingencies
For information relating to other contingencies of RAI, RJR, RJR
Tobacco and Conwood, see Other
Contingencies in note 16 to consolidated financial
statements.
Off-Balance
Sheet Arrangements
RAI has no off-balance sheet arrangements that have or are
reasonably likely to have a current or future material effect on
its financial position, results of operations, liquidity,
capital expenditures or capital resources.
Cautionary
Information Regarding Forward-Looking Statements
Statements included in this report that are not historical in
nature are forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform
Act of 1995. These statements regarding future events or the
future performance or results of RAI and its subsidiaries
inherently are subject to a variety of risks and uncertainties
that could cause actual results to differ materially from those
described in the forward-looking statements. These risks and
uncertainties include:
|
|
|
|
|
the substantial and increasing taxation and regulation of
tobacco products, including the recent federal excise tax
increase, and the possible regulation of tobacco products by the
FDA;
|
|
|
|
the possibility of further restrictions or bans on the use of
certain flavorings, including menthol, in tobacco products, or
the use of certain flavor descriptors in the marketing of
tobacco products;
|
|
|
|
various legal actions, proceedings and claims relating to the
sale, distribution, manufacture, development, advertising,
marketing and claimed health effects of tobacco products that
are pending or may be instituted against RAI or its subsidiaries;
|
|
|
|
the potential difficulty of obtaining bonds as a result of
litigation outcomes;
|
|
|
|
the substantial payment obligations and limitations on the
advertising and marketing of cigarettes under the MSA;
|
|
|
|
the continuing decline in volume in the domestic cigarette
industry and RAIs dependence on the U.S. cigarette
industry;
|
|
|
|
concentration of a material amount of sales with a single
customer or distributor;
|
|
|
|
competition from other manufacturers, including any new entrants
in the marketplace, and further industry consolidations;
|
|
|
|
increased promotional activities by competitors, including
deep-discount cigarette brands;
|
|
|
|
the success or failure of new product innovations and
acquisitions;
|
|
|
|
the responsiveness of both the trade and consumers to new
products, marketing strategies and promotional programs;
|
56
|
|
|
|
|
the ability to achieve efficiencies in the businesses of
RAIs operating companies, including outsourcing functions,
without negatively affecting sales;
|
|
|
|
the reliance on a limited number of suppliers for certain raw
materials;
|
|
|
|
the cost of tobacco leaf and other raw materials and other
commodities used in products;
|
|
|
|
the effect of market conditions on foreign currency exchange
rate risk, interest rate risk and the return on corporate cash;
|
|
|
|
declining liquidity in the financial markets, including
bankruptcy of lenders participating in the Credit Facility and
decreased availability of money market funds;
|
|
|
|
the impairment of goodwill and other intangible assets,
including trademarks;
|
|
|
|
the effect of market conditions on the performance of pension
assets or any adverse effects of any new legislation or
regulations changing pension expense accounting or required
pension funding levels;
|
|
|
|
the substantial amount of RAI debt;
|
|
|
|
the credit rating of RAI and its securities;
|
|
|
|
any restrictive covenants imposed under RAIs debt
agreements;
|
|
|
|
the possibility of fire, violent weather and other disasters
that may adversely affect manufacturing and other facilities;
|
|
|
|
the significant ownership interest of B&W, RAIs
largest shareholder, in RAI and the rights of B&W under the
governance agreement between the companies;
|
|
|
|
the expiration of the standstill provisions of the governance
agreement; and
|
|
|
|
the potential existence of significant deficiencies or material
weaknesses in internal control over financial reporting that may
be identified during the performance of testing required under
Section 404 of the Sarbanes-Oxley Act of 2002.
|
Due to these uncertainties and risks, you are cautioned not to
place undue reliance on these forward-looking statements, which
speak only as of the date of this report. Except as provided by
federal securities laws, RAI is not required to publicly update
or revise any forward-looking statement, whether as a result of
new information, future events or otherwise.
|
|
Item 7A.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
Market risk represents the risk of loss that may impact the
consolidated results of operations, cash flows and financial
position due to adverse changes in financial market prices and
rates. RAI and its subsidiaries are exposed to interest rate
risk directly related to their normal investing and funding
activities. In addition, RAI and its subsidiaries have
immaterial exposure to foreign currency exchange rate risk
concerning obligations for, and service agreements related to,
foreign operations denominated in euros, British pounds, Swiss
francs, Chinese renminbi and Japanese yen. RAI and its
subsidiaries have established policies and procedures to manage
their exposure to market risks and use major institutions as
counterparties to minimize their investment and credit risk.
Frequently, these institutions are also members of the bank
group that provide RAI credit, and management believes this
further minimizes the risk of nonperformance. Derivative
financial instruments are not used for trading or speculative
purposes.
57
The table below provides information about RAIs financial
instruments, as of December 31, 2008, that are sensitive to
changes in interest rates. The table presents notional amounts
and weighted average interest rates by contractual maturity
dates for the years ending December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair
|
|
|
|
2009
|
|
|
2010
|
|
|
2011
|
|
|
2012
|
|
|
2013
|
|
|
Thereafter
|
|
|
Total
|
|
|
Value(1)
|
|
|
Investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Variable Rate
|
|
$
|
2,555
|
|
|
$
|
28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
48
|
|
|
$
|
2,631
|
|
|
$
|
2,631
|
|
Average Interest Rate
|
|
|
0.4
|
%
|
|
|
1.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.0
|
%
|
|
|
0.4
|
%
|
|
|
|
|
Fixed-Rate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
4
|
|
|
$
|
4
|
|
|
$
|
4
|
|
Average Interest Rate(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.7
|
%
|
|
|
4.7
|
%
|
|
|
|
|
Debt:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed-Rate
|
|
$
|
200
|
|
|
$
|
300
|
|
|
|
|
|
|
$
|
450
|
|
|
$
|
685
|
|
|
$
|
2,375
|
|
|
$
|
4,010
|
|
|
$
|
3,391
|
|
Average Interest Rate(2)
|
|
|
7.9
|
%
|
|
|
6.5
|
%
|
|
|
|
|
|
|
7.3
|
%
|
|
|
7.4
|
%
|
|
|
7.3
|
%
|
|
|
7.3
|
%
|
|
|
|
|
Variable Rate
|
|
|
|
|
|
|
|
|
|
$
|
400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
400
|
|
|
$
|
342
|
|
Average Interest Rate(2)
|
|
|
|
|
|
|
|
|
|
|
2.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.7
|
%
|
|
|
|
|
Swaps:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notional Amount(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
450
|
|
|
|
|
|
|
$
|
1,150
|
|
|
$
|
1,600
|
|
|
$
|
287
|
|
Average Variable Interest Pay Rate(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.5
|
%
|
|
|
|
|
|
|
2.8
|
%
|
|
|
3.2
|
%
|
|
|
|
|
Average Fixed Interest Receive Rate(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7.3
|
%
|
|
|
|
|
|
|
7.1
|
%
|
|
|
7.1
|
%
|
|
|
|
|
|
|
|
(1) |
|
Fair values are based on current market rates available or on
rates available for instruments with similar terms and
maturities and quoted fair values. |
|
(2) |
|
Based upon contractual interest rates for fixed-rate
indebtedness or current market rates for LIBOR plus negotiated
spreads until maturity for variable rate indebtedness. |
|
(3) |
|
As of December 31, 2008, RAI had swapped $1.6 billion
of fixed-rate debt to variable rate debt. |
RAIs exposure to foreign currency transactions was not
material to results of operations for the year ended
December 31, 2008, but may become material in future
periods in relation to activity associated with RAIs
international operations. RAI currently has no hedges for its
exposure to foreign currency. See Liquidity
and Financial Condition in Item 7 for additional
information.
58
|
|
Item 8.
|
Financial
Statements and Supplementary Data
|
Report of
Independent Registered Public Accounting Firm
The Board of
Directors and Shareholders
Reynolds American Inc.:
We have audited the accompanying consolidated balance sheets of
Reynolds American Inc. and subsidiaries as of December 31,
2008 and 2007, and the related consolidated statements of
income, shareholders equity and comprehensive income
(loss), and cash flows for each of the years in the three-year
period ended December 31, 2008. These consolidated
financial statements are the responsibility of the
Companys management. Our responsibility is to express an
opinion on these consolidated financial statements based on our
audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred
to above present fairly, in all material respects, the financial
position of Reynolds American Inc. and subsidiaries as of
December 31, 2008 and 2007, and the results of their
operations and their cash flows for each of the years in the
three-year period ended December 31, 2008, in conformity
with U.S. generally accepted accounting principles.
As discussed in Note 1 to the consolidated financial
statements, the Company adopted the provisions of Statement of
Financial Accounting Standards No. 157, Fair Value
Measurements, effective January 1, 2008, Financial
Accounting Standards Board Interpretation No. 48,
Accounting for Uncertainty in Income Taxes, effective
January 1, 2007, and, Statement of Financial Accounting
Standards No. 158, Employers Accounting for
Defined Benefit Pension and Other Postretirement Plans,
effective December 31, 2006.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States),
Reynolds American Inc.s internal control over financial
reporting as of December 31, 2008, based on criteria
established in Internal Control Integrated
Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission (COSO), and our report
dated February 23, 2009, expressed an unqualified opinion
on the effectiveness of the Companys internal control over
financial reporting.
Greensboro,
North Carolina
February 23, 2009
59
Managements
Report on Internal Control over Financial Reporting
Management is responsible for establishing and maintaining
adequate internal control over financial reporting, as such term
is defined in
Rule 13a-15(f)
of the Securities Exchange Act of 1934. Internal control over
financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and
the preparation of financial statements in accordance with
generally accepted accounting principles and includes those
policies and procedures that:
(i) pertain to the maintenance of records that, in
reasonable detail, accurately and fairly reflect the
transactions and dispositions of the assets of RAI,
(ii) provide reasonable assurance that transactions are
recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of RAI are being
made only in accordance with authorizations of management and
directors of RAI, and
(iii) provide reasonable assurance regarding prevention or
timely detection of unauthorized acquisition, use, or
disposition of RAIs assets that could have a material
effect on the financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements and
even when determined to be effective, can only provide
reasonable assurance with respect to financial statement
preparation and presentation. Also, projections of any
evaluation of effectiveness to future periods are subject to the
risk that controls may become inadequate because of changes in
conditions, or that the degree of compliance with the policies
and procedures may deteriorate.
Management conducted an evaluation of the effectiveness of
RAIs internal control over financial reporting based on
the framework in Internal Control Integrated
Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission. Based on this
evaluation, management concluded that RAIs system of
internal control over financial reporting was effective as of
December 31, 2008.
KPMG LLP, independent registered public accounting firm, has
audited RAIs consolidated financial statements and issued
an attestation report on RAIs internal control over
financial reporting as of December 31, 2008.
Dated: February 23, 2009
60
Report of
Independent Registered Public Accounting Firm
The Board of
Directors and Shareholders
Reynolds American Inc.:
We have audited Reynolds American Inc.s internal control
over financial reporting as of December 31, 2008, based on
criteria established in Internal Control
Integrated Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission (COSO). Reynolds
American Inc.s management is responsible for maintaining
effective internal control over financial reporting and for its
assessment of the effectiveness of internal control over
financial reporting, included in the accompanying
Managements Report on Internal Control over Financial
Reporting. Our responsibility is to express an opinion on the
Companys internal control over financial reporting based
on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control
over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of
internal control over financial reporting, assessing the risk
that a material weakness exists, and testing and evaluating the
design and operating effectiveness of internal control based on
the assessed risk. Our audit also included performing such other
procedures as we considered necessary in the circumstances. We
believe that our audit provides a reasonable basis for our
opinion.
A companys internal control over financial reporting is a
process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles. A companys
internal control over financial reporting includes those
policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of
management and directors of the company; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the
companys assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.
In our opinion, Reynolds American Inc. maintained, in all
material respects, effective internal control over financial
reporting as of December 31, 2008, based on criteria
established in Internal Control Integrated
Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission (COSO).
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
consolidated balance sheets of Reynolds American Inc. and
subsidiaries as of December 31, 2008 and 2007, and the
related consolidated statements of income, shareholders
equity and comprehensive income (loss), and cash flows for each
of the years in the three-year period ended December 31,
2008, and our report dated February 23, 2009 expressed an
unqualified opinion on those consolidated financial statements.
Greensboro, North Carolina
February 23, 2009
61
REYNOLDS
AMERICAN INC.
CONSOLIDATED
STATEMENTS OF INCOME
(Dollars
in Millions, Except Per Share Amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Net sales(1)
|
|
$
|
8,377
|
|
|
$
|
8,516
|
|
|
$
|
8,010
|
|
Net sales, related party
|
|
|
468
|
|
|
|
507
|
|
|
|
500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
|
8,845
|
|
|
|
9,023
|
|
|
|
8,510
|
|
Costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of products sold(1)(2)(3)
|
|
|
4,863
|
|
|
|
4,960
|
|
|
|
4,803
|
|
Selling, general and administrative expenses
|
|
|
1,500
|
|
|
|
1,687
|
|
|
|
1,658
|
|
Amortization expense
|
|
|
22
|
|
|
|
23
|
|
|
|
28
|
|
Restructuring charge
|
|
|
90
|
|
|
|
|
|
|
|
1
|
|
Trademark impairment charge
|
|
|
318
|
|
|
|
65
|
|
|
|
90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
2,052
|
|
|
|
2,288
|
|
|
|
1,930
|
|
Interest and debt expense
|
|
|
275
|
|
|
|
338
|
|
|
|
270
|
|
Interest income
|
|
|
(60
|
)
|
|
|
(134
|
)
|
|
|
(136
|
)
|
Gain on termination of joint venture
|
|
|
(328
|
)
|
|
|
|
|
|
|
|
|
Other (income) expense, net
|
|
|
37
|
|
|
|
11
|
|
|
|
(13
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes and
extraordinary item
|
|
|
2,128
|
|
|
|
2,073
|
|
|
|
1,809
|
|
Provision for income taxes
|
|
|
790
|
|
|
|
766
|
|
|
|
673
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before extraordinary
item
|
|
|
1,338
|
|
|
|
1,307
|
|
|
|
1,136
|
|
Extraordinary item gain on acquisition
|
|
|
|
|
|
|
1
|
|
|
|
74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1,338
|
|
|
$
|
1,308
|
|
|
$
|
1,210
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before extraordinary item
|
|
$
|
4.58
|
|
|
$
|
4.44
|
|
|
$
|
3.85
|
|
Extraordinary item
|
|
|
|
|
|
|
|
|
|
|
0.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
4.58
|
|
|
$
|
4.44
|
|
|
$
|
4.10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before extraordinary item
|
|
$
|
4.57
|
|
|
$
|
4.43
|
|
|
$
|
3.85
|
|
Extraordinary item
|
|
|
|
|
|
|
|
|
|
|
0.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
4.57
|
|
|
$
|
4.43
|
|
|
$
|
4.10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per share
|
|
$
|
3.40
|
|
|
$
|
3.20
|
|
|
$
|
2.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Excludes excise taxes of $1,890 million,
$2,026 million and $2,124 million for the years ended
December 31, 2008, 2007 and 2006, respectively. |
|
(2) |
|
Includes Master Settlement Agreement and other state settlement
agreements, collectively referred to as the MSA, expense of
$2,703 million, $2,821 million and $2,611 million
for the years ended December 31, 2008, 2007 and 2006,
respectively. |
|
(3) |
|
Includes federal tobacco quota buyout expenses of
$249 million, $255 million and $256 million for
the years ended December 31, 2008, 2007 and 2006,
respectively. |
See Notes to Consolidated Financial Statements
62
REYNOLDS
AMERICAN INC.
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(Dollars
in Millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Cash flows from (used in) operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1,338
|
|
|
$
|
1,308
|
|
|
$
|
1,210
|
|
Adjustments to reconcile to net cash flows from (used in)
continuing operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
142
|
|
|
|
143
|
|
|
|
162
|
|
Gain on termination of joint venture
|
|
|
(328
|
)
|
|
|
|
|
|
|
|
|
Restructuring charges, net of cash payments
|
|
|
75
|
|
|
|
(12
|
)
|
|
|
(95
|
)
|
Trademark impairment charges
|
|
|
318
|
|
|
|
65
|
|
|
|
90
|
|
Investment impairment charge
|
|
|
35
|
|
|
|
|
|
|
|
|
|
Deferred income tax expense
|
|
|
16
|
|
|
|
69
|
|
|
|
105
|
|
Loss on extinguishment of debt
|
|
|
|
|
|
|
19
|
|
|
|
|
|
Extraordinary item
|
|
|
|
|
|
|
(1
|
)
|
|
|
(74
|
)
|
Other changes, net of acquisition effects, that provided (used)
cash:
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts and other receivables
|
|
|
(27
|
)
|
|
|
8
|
|
|
|
151
|
|
Inventories
|
|
|
26
|
|
|
|
(41
|
)
|
|
|
58
|
|
Related party, net
|
|
|
|
|
|
|
(47
|
)
|
|
|
(24
|
)
|
Accounts payable
|
|
|
(12
|
)
|
|
|
(57
|
)
|
|
|
226
|
|
Accrued liabilities including income taxes and other working
capital
|
|
|
(67
|
)
|
|
|
(72
|
)
|
|
|
(124
|
)
|
Litigation bonds
|
|
|
5
|
|
|
|
94
|
|
|
|
24
|
|
Tobacco settlement and related expenses
|
|
|
(125
|
)
|
|
|
205
|
|
|
|
(20
|
)
|
Pension and postretirement
|
|
|
(88
|
)
|
|
|
(328
|
)
|
|
|
(265
|
)
|
Other, net
|
|
|
7
|
|
|
|
(22
|
)
|
|
|
33
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows from operating activities
|
|
|
1,315
|
|
|
|
1,331
|
|
|
|
1,457
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of short-term investments
|
|
|
(56
|
)
|
|
|
(3,764
|
)
|
|
|
(7,677
|
)
|
Proceeds from sale of short-term investments
|
|
|
238
|
|
|
|
4,655
|
|
|
|
7,760
|
|
Proceeds from settlement of long-term investments
|
|
|
8
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
(113
|
)
|
|
|
(142
|
)
|
|
|
(136
|
)
|
Distributions from equity investees
|
|
|
27
|
|
|
|
15
|
|
|
|
18
|
|
Acquisitions, net of cash acquired
|
|
|
|
|
|
|
(3
|
)
|
|
|
(3,519
|
)
|
Net proceeds from the sale of businesses
|
|
|
|
|
|
|
|
|
|
|
3
|
|
Net proceeds from the sale of fixed assets
|
|
|
8
|
|
|
|
3
|
|
|
|
24
|
|
Proceeds from termination of joint venture
|
|
|
164
|
|
|
|
|
|
|
|
|
|
Other, net
|
|
|
2
|
|
|
|
(1
|
)
|
|
|
(4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows from (used in) investing activities
|
|
|
278
|
|
|
|
763
|
|
|
|
(3,531
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid on common stock
|
|
|
(999
|
)
|
|
|
(916
|
)
|
|
|
(775
|
)
|
Proceeds from exercise of stock options
|
|
|
1
|
|
|
|
1
|
|
|
|
4
|
|
Excess tax benefit from stock-based compensation
|
|
|
2
|
|
|
|
2
|
|
|
|
4
|
|
Repurchase of common stock
|
|
|
(210
|
)
|
|
|
(60
|
)
|
|
|
|
|
Repayments of long-term debt
|
|
|
|
|
|
|
(329
|
)
|
|
|
(190
|
)
|
Repayments of term loan
|
|
|
|
|
|
|
(1,542
|
)
|
|
|
(8
|
)
|
Proceeds from issuance of long-term debt
|
|
|
|
|
|
|
1,547
|
|
|
|
1,641
|
|
Principal borrowings under term loan
|
|
|
|
|
|
|
|
|
|
|
1,550
|
|
Deferred debt issuance costs
|
|
|
|
|
|
|
(15
|
)
|
|
|
(52
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows from (used in) financing activities
|
|
|
(1,206
|
)
|
|
|
(1,312
|
)
|
|
|
2,174
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents
|
|
|
(24
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents
|
|
|
363
|
|
|
|
782
|
|
|
|
100
|
|
Cash and cash equivalents at beginning of year
|
|
|
2,215
|
|
|
|
1,433
|
|
|
|
1,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year
|
|
$
|
2,578
|
|
|
$
|
2,215
|
|
|
$
|
1,433
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes paid, net of refunds
|
|
$
|
846
|
|
|
$
|
655
|
|
|
$
|
573
|
|
Interest paid
|
|
$
|
268
|
|
|
$
|
334
|
|
|
$
|
238
|
|
See Notes to Consolidated Financial Statements
63
REYNOLDS
AMERICAN INC.
CONSOLIDATED
BALANCE SHEETS
(Dollars
in Millions)
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
Assets
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
2,578
|
|
|
$
|
2,215
|
|
Short-term investments
|
|
|
23
|
|
|
|
377
|
|
Accounts receivable, net of allowance (2008 $1;
2007 $1)
|
|
|
84
|
|
|
|
73
|
|
Accounts receivable, related party
|
|
|
91
|
|
|
|
80
|
|
Notes receivable
|
|
|
35
|
|
|
|
1
|
|
Other receivables
|
|
|
37
|
|
|
|
25
|
|
Inventories
|
|
|
1,170
|
|
|
|
1,196
|
|
Deferred income taxes, net
|
|
|
838
|
|
|
|
845
|
|
Prepaid expenses and other
|
|
|
163
|
|
|
|
180
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
5,019
|
|
|
|
4,992
|
|
Property, plant and equipment, at cost:
|
|
|
|
|
|
|
|
|
Land and land improvements
|
|
|
95
|
|
|
|
96
|
|
Buildings and leasehold improvements
|
|
|
692
|
|
|
|
682
|
|
Machinery and equipment
|
|
|
1,756
|
|
|
|
1,738
|
|
Construction-in-process
|
|
|
37
|
|
|
|
74
|
|
|
|
|
|
|
|
|
|
|
Total property, plant and equipment
|
|
|
2,580
|
|
|
|
2,590
|
|
Less accumulated depreciation
|
|
|
1,549
|
|
|
|
1,517
|
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net
|
|
|
1,031
|
|
|
|
1,073
|
|
Trademarks and other intangible assets, net of accumulated
amortization (2008 $619; 2007 $597)
|
|
|
3,270
|
|
|
|
3,609
|
|
Goodwill
|
|
|
8,174
|
|
|
|
8,174
|
|
Other assets and deferred charges
|
|
|
660
|
|
|
|
781
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
18,154
|
|
|
$
|
18,629
|
|
|
|
|
|
|
|
|
|
|
Liabilities and shareholders equity
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
206
|
|
|
$
|
218
|
|
Tobacco settlement accruals
|
|
|
2,321
|
|
|
|
2,449
|
|
Due to related party
|
|
|
3
|
|
|
|
7
|
|
Deferred revenue, related party
|
|
|
50
|
|
|
|
35
|
|
Current maturities of long-term debt
|
|
|
200
|
|
|
|
|
|
Other current liabilities
|
|
|
1,143
|
|
|
|
1,194
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
3,923
|
|
|
|
3,903
|
|
Long-term debt (less current maturities)
|
|
|
4,486
|
|
|
|
4,515
|
|
Deferred income taxes, net
|
|
|
282
|
|
|
|
1,184
|
|
Long-term retirement benefits (less current portion)
|
|
|
2,836
|
|
|
|
1,167
|
|
Other noncurrent liabilities
|
|
|
390
|
|
|
|
394
|
|
Commitments and contingencies:
|
|
|
|
|
|
|
|
|
Shareholders equity:
|
|
|
|
|
|
|
|
|
Common stock (shares issued: 2008 291,450,762;
2007 295,007,327)
|
|
|
|
|
|
|
|
|
Paid-in capital
|
|
|
8,463
|
|
|
|
8,653
|
|
Accumulated deficit
|
|
|
(531
|
)
|
|
|
(873
|
)
|
Accumulated other comprehensive loss (Defined
benefit pension and
post-retirement
plans: 2008 $(1,643) and 2007 $(306),
net of tax)
|
|
|
(1,695
|
)
|
|
|
(314
|
)
|
|
|
|
|
|
|
|
|
|
Total shareholders equity
|
|
|
6,237
|
|
|
|
7,466
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
18,154
|
|
|
$
|
18,629
|
|
|
|
|
|
|
|
|
|
|
See Notes to Consolidated Financial Statements
64
REYNOLDS
AMERICAN INC.
CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY AND
COMPREHENSIVE INCOME (LOSS)
(Dollars in Millions, Except Per Share Amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
Total
|
|
|
|
|
|
|
Common
|
|
|
Paid-In
|
|
|
Accumulated
|
|
|
Comprehensive
|
|
|
Shareholders
|
|
|
Comprehensive
|
|
|
|
Stock
|
|
|
Capital
|
|
|
Deficit
|
|
|
Loss
|
|
|
Equity
|
|
|
Income (Loss)
|
|
|
Balance at December 31, 2005
|
|
$
|
|
|
|
$
|
8,694
|
|
|
$
|
(1,638
|
)
|
|
$
|
(503
|
)
|
|
$
|
6,553
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
1,210
|
|
|
|
|
|
|
|
1,210
|
|
|
$
|
1,210
|
|
Minimum pension liability, net of $317 tax expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
491
|
|
|
|
491
|
|
|
|
491
|
|
Cumulative translation adjustment and other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
1
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,702
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Implementation of SFAS 158, net of $257 tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(407
|
)
|
|
|
(407
|
)
|
|
|
|
|
Dividends $2.75 per share
|
|
|
|
|
|
|
|
|
|
|
(813
|
)
|
|
|
|
|
|
|
(813
|
)
|
|
|
|
|
Stock options exercised
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
Tax benefit on equity awards
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2006
|
|
|
|
|
|
|
8,702
|
|
|
|
(1,241
|
)
|
|
|
(418
|
)
|
|
|
7,043
|
|
|
|
|
|
Cumulative effect of adoption of FIN No. 48
|
|
|
|
|
|
|
|
|
|
|
5
|
|
|
|
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted balance as of January 1, 2007
|
|
|
|
|
|
|
8,702
|
|
|
|
(1,236
|
)
|
|
|
(418
|
)
|
|
|
7,048
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
1,308
|
|
|
|
|
|
|
|
1,308
|
|
|
$
|
1,308
|
|
Retirement benefits SFAS 158, net of $72 tax expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
112
|
|
|
|
112
|
|
|
|
112
|
|
Unrealized loss on investments, net of $8 tax benefit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(11
|
)
|
|
|
(11
|
)
|
|
|
(11
|
)
|
Cumulative translation adjustment and other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3
|
|
|
|
3
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,412
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends $3.20 per share
|
|
|
|
|
|
|
|
|
|
|
(945
|
)
|
|
|
|
|
|
|
(945
|
)
|
|
|
|
|
Equity incentive award plan and stock-based compensation
|
|
|
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
|
9
|
|
|
|
|
|
Common stock repurchased
|
|
|
|
|
|
|
(60
|
)
|
|
|
|
|
|
|
|
|
|
|
(60
|
)
|
|
|
|
|
Excess tax benefit on stock-based compensation plans
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2007
|
|
|
|
|
|
|
8,653
|
|
|
|
(873
|
)
|
|
|
(314
|
)
|
|
|
7,466
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
1,338
|
|
|
|
|
|
|
|
1,338
|
|
|
$
|
1,338
|
|
Retirement benefits SFAS 158, net of $884 tax benefit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,337
|
)
|
|
|
(1,337
|
)
|
|
|
(1,337
|
)
|
Unrealized loss on investments, net of $20 tax benefit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(30
|
)
|
|
|
(30
|
)
|
|
|
(30
|
)
|
Cumulative translation adjustment and other, net of $6 tax
benefit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(14
|
)
|
|
|
(14
|
)
|
|
|
(14
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(43
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends $3.40 per share
|
|
|
|
|
|
|
|
|
|
|
(996
|
)
|
|
|
|
|
|
|
(996
|
)
|
|
|
|
|
Equity incentive award plan and stock-based compensation
|
|
|
|
|
|
|
18
|
|
|
|
|
|
|
|
|
|
|
|
18
|
|
|
|
|
|
Common stock repurchased
|
|
|
|
|
|
|
(210
|
)
|
|
|
|
|
|
|
|
|
|
|
(210
|
)
|
|
|
|
|
Excess tax benefit on stock-based compensation plans
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
$
|
|
|
|
$
|
8,463
|
|
|
$
|
(531
|
)
|
|
$
|
(1,695
|
)
|
|
$
|
6,237
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Notes to Consolidated Financial Statements
65
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
Note 1
Business and Summary of Significant Accounting
Policies
Overview
The consolidated financial statements include the accounts of
Reynolds American Inc., referred to as RAI, and its wholly owned
subsidiaries. RAIs wholly owned subsidiaries include R. J.
Reynolds Tobacco Company; Santa Fe Natural Tobacco Company,
Inc., referred to as Santa Fe; Lane, Limited, referred to
as Lane; R. J. Reynolds Global Products, Inc., referred to as
GPI; Conwood Holdings Inc.; and Conwood Company, LLC and Rosswil
LLC, collectively referred to as the Conwood companies. On
December 31, 2008, Conwood Sales Co., LLC and Scott Tobacco
LLC merged into Conwood Company, LLC.
RAI was incorporated as a holding company in the state of North
Carolina on January 5, 2004, and its common stock is listed
on the NYSE under the symbol RAI. RAI was created to
facilitate the transactions on July 30, 2004, to combine
the U.S. assets, liabilities and operations of
Brown & Williamson Holdings, Inc., formerly known as
Brown & Williamson Tobacco Company and referred to as
B&W, an indirect, wholly owned subsidiary of British
American Tobacco p.l.c., referred to as BAT, with R. J. Reynolds
Tobacco Company, a wholly owned operating subsidiary of R.J.
Reynolds Tobacco Holdings, Inc., referred to as RJR. These
July 30, 2004, transactions generally are referred to as
the B&W business combination.
References to RJR Tobacco prior to July 30, 2004, relate to
R. J. Reynolds Tobacco Company, a New Jersey corporation and a
wholly owned subsidiary of RJR. References to RJR Tobacco on and
subsequent to July 30, 2004, relate to the combined
U.S. assets, liabilities and operations of B&W and R.
J. Reynolds Tobacco Company, a North Carolina corporation. The
consolidated financial statements of RAI include the results of
the Conwood companies operations subsequent to
May 31, 2006.
RAIs reportable operating segments are RJR Tobacco and
Conwood. The RJR Tobacco segment consists of the primary
operations of R. J. Reynolds Tobacco Company. The Conwood
segment consists of Conwood Holdings, Inc., the primary
operations of the Conwood companies and Lane. RAIs wholly
owned subsidiaries, Santa Fe and GPI, among others, are
included in All Other. The segments were identified based on how
RAIs chief operating decision maker allocates resources
and assesses performance. Some of RAIs wholly owned
operating subsidiaries have entered into intercompany agreements
for products or services with other RAI operating subsidiaries.
As a result, certain activities of an operating subsidiary may
be included in a different segment of RAI.
RAIs operating subsidiaries primarily conduct their
business in the United States.
Basis of
Presentation
The preparation of the consolidated financial statements in
conformity with accounting principles generally accepted in the
United States of America, referred to as GAAP, requires
estimates and assumptions to be made that affect the reported
amounts in the consolidated financial statements and
accompanying notes. Actual results could differ from those
estimates. Certain reclassifications were made to conform prior
years financial statements to the current presentation.
The equity method is used to account for investments in
businesses that RAI does not control, but has the ability to
significantly influence operating and financial policies. The
cost method is used to account for investments in which RAI does
not have the ability to significantly influence operating and
financial policies. RAI has no investments in entities greater
than 20% for which it accounts by the cost method, and has no
investments in entities greater than 50% for which it accounts
by the equity method. All material intercompany balances have
been eliminated.
All dollar amounts, other than per share amounts, are presented
in millions, except for amounts set forth in note 16 and as
otherwise noted.
66
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Cash and
Cash Equivalents
Cash balances are recorded net of book overdrafts when a bank
right-of-offset exists. All other book overdrafts are recorded
in accounts payable. Cash equivalents may include money market
funds, commercial paper and time deposits in major institutions
to minimize investment risk. As short-term, highly liquid
investments readily convertible to known amounts of cash, with
remaining maturities of three months or less at the time of
purchase, cash equivalents have carrying values that approximate
fair values. Debt securities included in cash equivalents are
classified and accounted for as held-to-maturity. The
appropriate classification of cash equivalents is determined at
the time of purchase and the classification is reassessed at
each reporting date.
Fair
Value Measurement
Financial assets and liabilities required to be carried at fair
value are valued in accordance with Statement of Financial
Accounting Standards, referred to as SFAS, No. 157,
Fair Value Measurements, as clarified by Financial
Accounting Standards Board, referred to as FASB Staff Position,
referred to as FSP,
No. FAS 157-3,
Determining the Fair Value of a Financial Asset When the
Market for That Asset Is Not Active.
SFAS No. 157 defines fair value as the price that
would be received to sell an asset or paid to transfer a
liability in an orderly transaction between market participants
at the measurement date, essentially an exit price.
Investments
As of December 31, 2008, RAI held investments primarily in
money market funds, auction rate securities and mortgage-backed
securities. During 2008, certain money market funds were
reclassified to short-term investments from cash equivalents due
to the liquidity restrictions by the fund managers preventing
immediate withdrawal. Adverse changes in financial markets
caused certain auction rate securities and mortgage-backed
securities to revalue lower than carrying value and become less
liquid. The fair values of the auction rate securities and the
mortgage-backed securities were determined using pricing,
projected future cash flows and credit ratings actions or
valuation models that assessed the credit quality of the
underlying collateral. During 2008, the auction rate securities
and mortgage-backed securities were reclassified to long-term
investments, included in other assets and deferred charges in
the consolidated balance sheet as of December 31, 2008,
from short-term investments as liquidation of these funds was
not expected to occur within one year.
The funds associated with these auction rate securities and
mortgage-backed securities will not be accessible until a
successful auction occurs or a buyer is found. These investments
will be evaluated on a quarterly basis to determine if it is
probable that RAI will realize some portion of the unrealized
loss. RAI reviews impairments associated with the above in
accordance with SFAS No. 115, Accounting for
Certain Investments in Debt and Equity Securities, FSP
FAS 115-1
and
FAS 124-1,
The Meaning of Other-Than-Temporary Impairment and Its
Application to Certain Investments and FSP
No. EITF 99-20-1,
Amendments to the Impairment Guidance of EITF Issue
No. 99-20,
to determine the classification of the impairment as temporary
or other-than-temporary.
67
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Accounts
Receivable
Accounts receivable are reported net of allowance for doubtful
accounts. A summary of activity in the allowance for doubtful
accounts is as follows:
|
|
|
|
|
Balance at December 31, 2005
|
|
$
|
7
|
|
Bad debt expense
|
|
|
1
|
|
Bad debt recoveries
|
|
|
(2
|
)
|
Write-off of bad debt
|
|
|
(2
|
)
|
|
|
|
|
|
Balance at December 31, 2006
|
|
|
4
|
|
Bad debt recoveries
|
|
|
(2
|
)
|
Write-off of bad debt
|
|
|
(1
|
)
|
|
|
|
|
|
Balance at December 31, 2007
|
|
|
1
|
|
Bad debt expense
|
|
|
1
|
|
Write-off of bad debt
|
|
|
(1
|
)
|
|
|
|
|
|
Balance at December 31, 2008
|
|
$
|
1
|
|
|
|
|
|
|
Inventories
Inventories are stated at the lower of cost or market. The cost
of tobacco inventories is determined principally under the
last-in,
first-out, or LIFO, method and is calculated at the end of each
year. The cost of work in process and finished goods includes
materials, direct labor, variable costs and overhead, and full
absorption of fixed manufacturing overhead. Stocks of tobacco,
which have an operating cycle that exceeds 12 months due to
curing requirements, are classified as current assets,
consistent with recognized industry practice.
Long-lived
Assets
Long-lived assets, such as property, plant and equipment,
trademarks and other intangible assets with finite lives, are
reviewed for impairment whenever events or changes in
circumstances indicate that the book value of the asset may not
be recoverable. Impairment of the carrying value of long-lived
assets would be indicated if the best estimate of future
undiscounted cash flows expected to be generated by the asset is
less than the carrying value. If an impairment is indicated, any
loss is measured as the difference between estimated fair value
and carrying value.
Property,
Plant and Equipment
Property, plant and equipment are recorded at cost and
depreciated using the straight-line method over the estimated
useful lives of the assets. Useful lives range from 20 to
50 years for buildings and improvements, and from 3 to
30 years for machinery and equipment. The cost and related
accumulated depreciation of assets sold or retired are removed
from the accounts and the gain or loss on disposition is
recognized in operating income.
Intangible
Assets
Intangible assets include goodwill, trademarks and other
intangibles. Trademarks and other intangibles are capitalized
when acquired. Trademarks and other intangible assets with
indefinite lives and goodwill are not amortized, but are tested
for impairment annually, during the fourth quarter, or more
frequently if events and circumstances indicate that the asset
might be impaired. An impairment loss is recognized to the
extent that the carrying amount exceeds the assets fair
value.
Accounting
for Derivative Instruments and Hedging Activities
SFAS No. 133, Accounting for Derivative
Instruments and Hedging Activities, requires RAI to
measure every derivative instrument, including certain
derivative instruments embedded in other contracts, at fair
value and
68
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
record them in the balance sheet as either an asset or
liability. Changes in fair value of derivatives are recorded in
earnings unless special hedge accounting criteria are met. For
derivatives designated as fair value hedges, the changes in fair
value of both the derivative instrument and the hedged item are
recorded in earnings. For derivatives designated as cash flow
hedges, the effective portions of changes in the fair value of
the derivative are reported in accumulated other comprehensive
loss. The ineffective portions of hedges are recognized in
earnings in the current period.
RAI formally assesses at inception of the hedge and on an
ongoing basis, whether each derivative is highly effective in
offsetting changes in fair values or cash flows of the hedged
item. If it is determined that a derivative is not highly
effective as a hedge or if a derivative ceases to be a highly
effective hedge, RAI will discontinue hedge accounting
prospectively.
Software
Costs
Computer software and software development costs incurred in
connection with developing or obtaining computer software for
internal use that has a useful life of greater than three years
are capitalized. These costs are amortized over five years or
less. During 2008 and 2007, costs of $25 million and
$29 million, respectively, were capitalized or included in
construction in process. At December 31, 2008, and
December 31, 2007, the unamortized balance was
$81 million and $79 million, respectively. Software
amortization expense was $24 million, $16 million and
$21 million for the years ended December 31, 2008,
2007 and 2006, respectively.
Revenue
Recognition
Revenue from product sales is recognized when persuasive
evidence of an arrangement exists, delivery has occurred, the
sellers price to the buyer is fixed or determinable, and
collectibility is reasonably assured. For RAIs operating
subsidiaries, these criteria are generally met when title and
risk of loss pass to the customer. Certain sales of leaf,
considered as
bill-and-hold
for accounting purposes, are recorded as deferred revenue when
all of the above revenue recognition criteria are met except
delivery, postponed at the customers request. Revenue is
subsequently recognized upon delivery. Shipping and handling
costs are classified as cost of products sold. Net sales include
certain sales incentives, including coupons, buydowns and
slotting allowances.
Advertising
and Research and Development
Advertising costs, which are expensed as incurred, were
$127 million, $165 million and $93 million for
the years ended December 31, 2008, 2007 and 2006,
respectively. Research and development costs, which are expensed
as incurred, were $59 million, $57 million and
$58 million for the years ended December 31, 2008,
2007 and 2006, respectively.
Income
Taxes
Income taxes are accounted for under the asset and liability
method. Deferred tax assets and liabilities are recognized for
the future tax consequences attributable to differences between
the financial statement carrying amounts of existing assets and
liabilities and their respective tax bases and operating loss
and tax credit carryforwards. Deferred tax assets and
liabilities are measured using enacted tax rates expected to
apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. The effect
on deferred tax assets and liabilities of a change in tax rates
is recognized in income in the period that includes the
enactment date. Interest and penalties related to uncertain tax
positions are accounted for as tax expense. Income taxes for RAI
and its subsidiaries are calculated on a separate return basis.
RAI adopted FASB Interpretation, referred to as FIN,
No. 48, Accounting for Uncertainty in Income
Taxes, on January 1, 2007. FIN No. 48
clarifies SFAS No. 109, Accounting for Income
Taxes, by providing specific guidance for consistent
reporting of uncertain income taxes recognized in a
companys financial statements, including classification,
interest and penalties and disclosures. RAIs adoption of
FIN No. 48 resulted in a
69
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
cumulative adjustment to retained earnings of $5 million.
See note 12 for additional disclosure related to income
taxes as required by SFAS No. 109 and
FIN No. 48.
Stock-Based
Compensation
Stock-based compensation is recognized in accordance with
SFAS No. 123(R), Share-Based Payment.
SFAS No. 123(R) addresses all forms of share-based
payment awards, including shares issued under employee stock
purchase plans, stock options, restricted stock and stock
appreciation rights. See note 18 for additional disclosures
related to stock-based compensation as required by
SFAS No. 123(R).
Pension
and Postretirement
Pension and postretirement benefits are accounted for under
SFAS No. 158, Employers Accounting for
Defined Benefit Pension and Other Postretirement Plans-an
amendment of FASB Statements No. 87, 88, 106, and
132(R), which requires balance sheet recognition of the
net asset or liability for the overfunded or underfunded status
of defined benefit pension and other postretirement benefit
plans, on a
plan-by-plan
basis, and recognition of changes in the funded status in the
year in which the changes occur. These changes are reported in
accumulated other comprehensive income (loss), as a separate
component of shareholders equity.
Recognized gains or losses are annual changes in the amount of
either the benefit obligation or the market-related value of
plan assets resulting from experience different from that
assumed or from changes in assumptions. The minimum amortization
of unrecognized gains or losses, as described in
SFAS No. 87, Employers Accounting for
Pensions, was included in pension expense, and as
described in SFAS No. 106, Employers
Accounting for Postretirement Benefits other than
Pensions, was included in the postretirement benefit cost.
Prior service costs, which are changes in benefit obligations
due to plan amendments, are amortized on a straight-line basis
over the average remaining service period for active employees.
The market-related value of plan assets recognizes changes in
fair value in a systematic and rational manner over five years.
See note 19 for additional disclosures related to pensions
and postretirement in accordance with SFAS No. 158.
Litigation
Contingencies
In accordance with SFAS No. 5, Accounting for
Contingencies, RAI and its operating subsidiaries will
record any loss related to litigation at such time that an
unfavorable outcome becomes probable and the amount can be
reasonably estimated. When the reasonable estimate is a range,
the recorded loss will be the best estimate within the range. If
no amount in the range is a better estimate than any other
amount, the minimum amount of the range would be recorded. RAI
discloses information concerning litigation for which an
unfavorable outcome is more than remote. RAI and its operating
subsidiaries record their legal expenses and other litigation
costs and related administrative costs as selling, general and
administrative expenses as those costs are incurred. See
note 16 for additional information on litigation.
Recently
Adopted Accounting Pronouncements
Effective January 1, 2008, RAI adopted
SFAS No. 157, Fair Value Measurements, for
financial assets and financial liabilities.
SFAS No. 157 does not require any new fair value
measurements but provides a definition of fair value,
establishes a framework for measuring fair value and expands
disclosure about fair value measurements. SFAS No. 157
also establishes a fair value hierarchy that distinguishes
between independent and observable inputs and unobservable
inputs based on the best information available. The adoption of
SFAS No. 157 on financial assets and financial
liabilities did not have a material impact on RAIs
consolidated results of operations, cash flows or financial
position.
In February 2008, FASB issued FSP
No. 157-2,
Effective Date of FASB Statement No. 157, to
allow entities to electively defer the effective date of
SFAS No. 157 for nonfinancial assets and liabilities,
except for those items recognized or disclosed at fair value on
an annual or more frequently recurring basis, until fiscal years
beginning after November 15, 2008. RAI elected to defer
SFAS No. 157 for nonfinancial assets and nonfinancial
liabilities to
70
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
be effective as of January 1, 2009. For RAI, the deferral
primarily applies to (1) nonfinancial assets and
liabilities initially measured at fair value in business
combinations; (2) reporting units or nonfinancial assets
and liabilities measured at fair value in conjunction with
goodwill, trademark and other intangible impairment testing;
(3) other nonfinancial assets measured at fair value in
conjunction with impairment assessments; and (4) asset
retirement obligations initially measured at fair value. The
impact of the adoption of SFAS No. 157 for
nonfinancial assets and nonfinancial liabilities is not expected
to have a material impact on RAIs consolidated results of
operations, cash flows or financial position.
On October 10, 2008, the FASB issued FSP
No. FAS 157-3,
Determining the Fair Value of a Financial Asset When the
Market for That Asset Is Not Active. FSP
No. FAS 157-3
clarifies the application of SFAS No. 157, Fair
Value Measurements, in a market that is not active and
provides an example to illustrate key considerations in
determining the fair value of a financial asset when the market
for that financial asset is not active. FSP
No. FAS 157-3
was effective immediately, including prior periods for which
financial statements had not been issued. RAI adopted FSP
No. FAS 157-3
effective with the financial statements ended September 30,
2008. The adoption of FSP
No. FAS 157-3
had no impact on RAIs consolidated results of operations,
cash flows or financial position.
On January 13, 2009, the FASB issued FSP
No. EITF 99-20-1,
Amendments to the Impairment Guidance of EITF Issue
No. 99-20.
FSP
No. EITF 99-20-1
provides a more consistent determination of whether an
other-than-temporary impairment, referred to as OTTI, has
occurred, and retains and emphasizes the OTTI guidance and
required disclosures in SFAS No. 115 and FSP
No. FAS 115-1
and
FAS 124-1.
RAI adopted FSP
No. EITF 99-20-1
effective for the quarter and year ended December 31, 2008.
The adoption of FSP
No. EITF 99-20-1
had no impact on RAIs consolidated results of operations,
cash flows or financial position.
Recently
Issued Accounting Pronouncements
In March 2008, the FASB issued SFAS No. 161,
Disclosures about Derivative Instruments and Hedging
Activities-an amendment of FASB Statement No. 133.
SFAS No. 161 seeks qualitative disclosures about the
objectives and strategies for using derivatives, quantitative
data about the fair value of and gains and losses on derivative
contracts, and details of credit-risk-related contingent
features in hedged positions. SFAS No. 161 also seeks
enhanced disclosure around derivative instruments in financial
statements, accounted for under SFAS No. 133, and how
hedges affect an entitys financial position, financial
performance and cash flows. SFAS No. 161 is effective
for RAI as of January 1, 2009, and is not expected to
impact results of operations, cash flows or financial position.
In April 2008, the FASB issued FSP
No. FAS 142-3,
Determination of the Useful Life of Intangible
Assets. FSP
No. FAS 142-3
amends the factors that should be considered in developing
renewal or extension assumptions used to determine the useful
life of a recognized intangible asset under
SFAS No. 142, Goodwill and Other Intangible
Assets. The objective of FSP
No. FAS 142-3
is to improve the consistency between the useful life of a
recognized intangible asset under SFAS No. 142 and the
period of expected cash flows used to measure the fair value of
the asset under SFAS No. 141(R) and GAAP. FSP
No. FAS 142-3
is effective for financial statements issued for years beginning
after December 15, 2008, and interim periods within those
years and is applied prospectively to intangible assets acquired
after the effective date. The adoption of FSP
No. FAS 142-3
will require additional disclosure regarding renewal or
extension assumptions and will not have a material impact on
RAIs results of operations, cash flows or financial
position.
On December 30, 2008, the FASB issued FSP
No. FAS 132(R)-1, Employers Disclosures
about Postretirement Benefit Plan Assets. FSP
No. FAS 132(R)-1 amends SFAS No. 132(R),
Employers Disclosures about Pensions and Other
Postretirement Benefits, to provide guidance on an
employers disclosures about plan assets of a defined
benefit pension or other postretirement plan. The disclosures
about plan assets required by FSP No. FAS 132(R)-1
shall be provided for years ending after December 15, 2009.
The adoption of FSP No. FAS 132(R)-1 in 2009 will not
have an impact on RAIs results of operations, cash flows
or financial position.
71
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Note 2
Acquisitions
In 2007, a subsidiary of GPI acquired, for $4 million, a
business that imports and distributes NATURAL AMERICAN SPIRIT
tobacco products in Japan. The purchase price was allocated on
the basis of fair value of assets acquired and liabilities
assumed, primarily to distribution rights.
In 2006, RAI, through its newly formed subsidiary, Conwood
Holdings, Inc., acquired the Conwood companies, in a
$3.5 billion stock acquisition. The Conwood companies are
engaged in the business of developing, manufacturing and
marketing smokeless tobacco products. The Conwood
companies acquisition was treated as a purchase of the
Conwood companies net assets by RAI for financial
accounting purposes. The consolidated financial statements of
RAI include the results of the Conwood companies
operations subsequent to May 31, 2006.
Note 3
Intangible Assets
The carrying amount of goodwill by segment as of
December 31, 2008 and 2007, was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RJR
|
|
|
|
|
|
|
|
|
|
|
|
|
Tobacco
|
|
|
Conwood
|
|
|
All Other
|
|
|
Consolidated
|
|
|
Balance as of December 31, 2008
|
|
$
|
5,302
|
|
|
$
|
2,648
|
|
|
$
|
224
|
|
|
$
|
8,174
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In 2007, RJR Tobaccos goodwill decreased $1 million
as a result of an adjustment to the B&W business
combination restructuring accrual. There were no changes in
goodwill in 2008.
For the annual impairment testing of the goodwill of RAIs
reporting units during the fourth quarter, RAI compared each
reporting units estimated fair value with its carrying
value. A reporting unit is an operating segment or one level
below an operating segment. The determination of estimated fair
value of each reporting unit was calculated primarily utilizing
an income approach model, based on the present value of the
estimated future cash flows of the reporting unit assuming a
discount rate. The determination of the discount rate was based
on a weighted average cost of capital using a risk-free rate
adjusted by a stock-beta-adjusted risk premium and a size
premium. Additionally, the aggregate estimated fair value of the
reporting units, determined with the use of the income approach
model, was compared with RAIs market capitalization and
tested for reasonableness using the market approach, including
key multiples of comparables. In considering RAIs market
capitalization, an estimated premium to reflect the fair value
on a control basis was applied. This premium was estimated based
on an evaluation of control premiums identifiable in comparable
transactions. The estimated fair value of each reporting unit,
determined utilizing the income approach and RAIs market
capitalization, was greater than their carrying value.
The carrying amounts of indefinite-lived intangible assets by
segment not subject to amortization were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RJR
|
|
|
|
|
|
|
|
|
|
|
|
|
Tobacco
|
|
|
Conwood
|
|
|
All Other
|
|
|
Consolidated
|
|
|
Trademarks
|
|
$
|
1,653
|
|
|
$
|
1,222
|
|
|
$
|
155
|
|
|
$
|
3,030
|
|
Other intangibles
|
|
|
55
|
|
|
|
|
|
|
|
48
|
|
|
|
103
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2008
|
|
$
|
1,708
|
|
|
$
|
1,222
|
|
|
$
|
203
|
|
|
$
|
3,133
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trademarks
|
|
$
|
1,826
|
|
|
$
|
1,374
|
|
|
$
|
155
|
|
|
$
|
3,355
|
|
Other intangibles
|
|
|
55
|
|
|
|
|
|
|
|
47
|
|
|
|
102
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2007
|
|
$
|
1,881
|
|
|
$
|
1,374
|
|
|
$
|
202
|
|
|
$
|
3,457
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
72
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Details of finite-lived intangible assets subject to
amortization as of December 31, 2008, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
Gross
|
|
|
Amortization
|
|
|
Net
|
|
|
Contract manufacturing
|
|
$
|
151
|
|
|
$
|
67
|
|
|
$
|
84
|
|
Trademarks
|
|
|
102
|
|
|
|
49
|
|
|
|
53
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
253
|
|
|
$
|
116
|
|
|
$
|
137
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pre-tax amortization expense for intangible assets was
$22 million, $23 million and $28 million during
2008, 2007 and 2006, respectively. The estimated remaining
amortization associated with finite-lived intangible assets is
expected to be expensed as follows:
|
|
|
|
|
Year
|
|
Amount
|
|
|
2009
|
|
$
|
29
|
|
2010
|
|
|
26
|
|
2011
|
|
|
24
|
|
2012
|
|
|
21
|
|
2013
|
|
|
16
|
|
Thereafter
|
|
|
21
|
|
|
|
|
|
|
|
|
$
|
137
|
|
|
|
|
|
|
The impairment testing of trademarks in the fourth quarters of
2008, 2007 and 2006, included modification to the previously
anticipated level of support among certain brands, and an
increased rate of decline in projected net sales of certain
brands, compared with that assumed in the prior year strategic
plan.
As a result of annual impairment testing, RJR Tobacco recorded
impairment charges of $3 million, $33 million and
$90 million, during 2008, 2007 and 2006, respectively.
Also, as a result of annual impairment testing, Conwood recorded
impairment charges of $142 million and $32 million
during 2008 and 2007, respectively. These charges were based on
the excess of certain brands carrying values over their
estimated fair values using the present value of estimated
future cash flows assuming a discount rate of 10.50% in 2008 and
2007 and 10.75% in 2006. The discount rate was determined by
adjusting the enterprise discount rate by an appropriate risk
premium to reflect an asset group risk.
During the third quarter of 2008, RJR Tobacco made the decision
to reclassify the KOOL brand from a growth brand to a support
brand. Since impairment testing is completed more frequently
than the fourth quarter if events or circumstances indicate that
an asset might be impaired, this change in classification
triggered impairment testing on the KOOL trademark and resulted
in RJR Tobacco recording an impairment charge of
$173 million during the third quarter of 2008. This charge
was based on the excess of KOOLs carrying value over its
estimated fair value using the present value of estimated future
cash flows assuming a discount rate of 10.50%. The discount rate
was determined by adjusting the enterprise discount rate by an
appropriate risk premium to reflect an asset group risk.
These impairment charges are reflected as decreases in the
carrying value of the trademarks in the consolidated balance
sheets as of December 31, 2008 and 2007, as trademark
impairment charges in the consolidated statements of income for
the years ended December 31, 2008, 2007 and 2006, and had
no impact on cash flows. In addition, certain brands that would
no longer receive marketing support indicated that a finite life
was probable. As a result, these brands are being amortized over
their remaining lives, which range from 4 to 20 years,
consistent with the pattern of economic benefits estimated to be
received.
For information related to a subsequent event concerning
impairment testing, see note 25.
73
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Note 4
Restructuring Charges
2008
Restructuring Charge
In the third quarter of 2008, RAI and RJR Tobacco announced
changes in their organizational structures to streamline
non-core business processes and programs in order to allocate
additional resources to strategic growth initiatives. The
reorganizations will result in the elimination of approximately
600 full-time jobs, expected to be substantially completed
by December 31, 2009.
Under existing benefit plans, $83 million of
severance-related cash benefits and $7 million of non-cash
pension-related benefits comprised a restructuring charge of
$90 million. Of this charge, $81 million was recorded
in the RJR Tobacco segment. Of the cash portion of the charge,
$5 million was paid as of December 31, 2008.
Accordingly, in the consolidated balance sheet as of
December 31, 2008, $39 million was included in other
current liabilities and $39 million was included in other
noncurrent liabilities. The cash benefits are expected to be
substantially paid by December 31, 2010.
The component of the restructuring charge accrued and utilized
was as follows:
|
|
|
|
|
|
|
Employee
|
|
|
|
Severance
|
|
|
|
and Benefits
|
|
|
Original accrual
|
|
$
|
91
|
|
Utilized in 2008
|
|
|
(12
|
)
|
Adjusted in 2008
|
|
|
(1
|
)
|
|
|
|
|
|
Balance as of December 31, 2008
|
|
$
|
78
|
|
|
|
|
|
|
2004
B&W Business Combination Restructuring Costs
In connection with the allocation of the cost of the B&W
business combination to assets acquired and liabilities assumed,
RJR Tobacco accrued restructuring costs of $272 million in
2004. Of these costs, $171 million relate to the severance
of approximately 2,450 former B&W employees in operations,
sales and corporate functions, which was significantly completed
by midyear 2006. Other accruals include the cost to relocate
former B&W employees retained and transferred from
facilities that were to be exited. Additionally, other exit
costs include contract terminations and the closure of the
acquired headquarters, a leased facility in Louisville,
Kentucky, as well as the closure of a leased warehouse and
certain leased sales offices, net of expected sub-lease income.
During 2005, RJR Tobacco determined that, under the B&W
business combination restructuring plan, the employment of
approximately 15 additional former B&W employees would be
terminated, which resulted in an accrual of $1 million. The
2005 reduction in relocation/exit costs of $16 million was
primarily due to lower-than-expected losses on home sales. Also,
in 2005, $9 million was included in selling, general and
administrative expenses, primarily relating to
lower-than-expected sub-lease income on closed facilities.
During 2006, RJR Tobacco recorded an $8 million reduction
to the reserve primarily due to lower-than-expected losses on
home sales and a $2 million reduction to the reserve due to
lower-than-expected costs for severance and related benefits.
During 2007, RJR Tobacco recorded a $1 million reduction to
the reserve primarily reflecting an early warehouse lease
termination.
As of December 31, 2008, $245 million of the accrual
had been paid. In the consolidated balance sheet as of
December 31, 2008, $3 million is included in other
current liabilities and $7 million is included in other
noncurrent liabilities.
As part of the integration of operations acquired through the
B&W business combination, RJR Tobacco transitioned
production from the former B&W manufacturing facility in
Macon, Georgia to RJR Tobaccos
74
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Winston-Salem, North Carolina facilities. The Macon facility was
sold in 2006 for $8 million after recognizing an impairment
of $8 million on remeasured assets in selling, general and
administrative expenses in 2006.
The components of the B&W business combination
restructuring costs accrued and utilized were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee
|
|
|
|
|
|
|
|
|
|
Severance
|
|
|
Relocation/
|
|
|
|
|
|
|
and Benefits
|
|
|
Exit Costs
|
|
|
Total
|
|
|
Original accrual
|
|
$
|
171
|
|
|
$
|
101
|
|
|
$
|
272
|
|
Utilized in 2004
|
|
|
(60
|
)
|
|
|
(26
|
)
|
|
|
(86
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2004
|
|
|
111
|
|
|
|
75
|
|
|
|
186
|
|
Utilized in 2005
|
|
|
(40
|
)
|
|
|
(28
|
)
|
|
|
(68
|
)
|
Adjusted in 2005
|
|
|
|
|
|
|
9
|
|
|
|
9
|
|
Adjustment to goodwill
|
|
|
1
|
|
|
|
(16
|
)
|
|
|
(15
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2005
|
|
|
72
|
|
|
|
40
|
|
|
|
112
|
|
Utilized in 2006
|
|
|
(69
|
)
|
|
|
(12
|
)
|
|
|
(81
|
)
|
Adjustment to goodwill
|
|
|
(2
|
)
|
|
|
(8
|
)
|
|
|
(10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2006
|
|
|
1
|
|
|
|
20
|
|
|
|
21
|
|
Utilized in 2007
|
|
|
(1
|
)
|
|
|
(7
|
)
|
|
|
(8
|
)
|
Adjustment to goodwill
|
|
|
|
|
|
|
(1
|
)
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2007
|
|
|
|
|
|
|
12
|
|
|
|
12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Utilized in 2008
|
|
|
|
|
|
|
(2
|
)
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2008
|
|
$
|
|
|
|
$
|
10
|
|
|
$
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note 5
Termination of Joint Venture
In 2002, R.J. Reynolds Tobacco C.V., an indirect wholly owned
subsidiary of RAI and referred to as RJRTCV, and an affiliate of
Gallaher Group Plc, referred to as Gallaher, formed a joint
venture, with each party owning a 50% membership interest. The
joint venture, R. J. Reynolds-Gallaher International Sarl,
marketed American-blend cigarettes primarily in Italy, France
and Spain.
In 2007, an affiliate of Japan Tobacco Inc., referred to as JTI,
acquired Gallaher, and Gallaher subsequently notified RJRTCV
that the acquisition constituted a change of control of Gallaher
within the meaning of the joint venture agreement. Pursuant to
the terms of the joint venture agreement, RJRTCV elected to
terminate the joint venture prior to its expiration date. The
joint venture was terminated on December 31, 2007.
The joint venture agreement provided that upon a termination of
the joint venture, the value of all the trademarks each joint
venture member or its affiliate licensed to the joint venture,
other than NATURAL AMERICAN SPIRIT, would be calculated and that
the party whose licensed trademarks were determined to be of
greater value would be required to pay the other party an
amount, referred to as the Termination Amount, equal to one-half
of the difference between the values of the parties
respective trademarks. On February 20, 2008, following the
parties negotiations regarding the trademarks
values, RJRTCV and Gallaher Limited, an affiliate of Gallaher,
entered into a valuation payment settlement agreement, pursuant
to which Gallaher Limited agreed to pay RJRTCV a Termination
Amount equal to euros 265 million, or approximately
$388 million using a February 20, 2008, exchange rate
of 1.4625. Of this amount, euros 106 million, or 40%, was
paid in April 2008, and the remaining 60% is to be paid in six
equal annual installments commencing April 2009. Of this
receivable, $34 million, including imputed interest, and
$160 million are included in notes receivable and other
assets and deferred charges, respectively, in RAIs
consolidated balance sheet as of December 31, 2008. Related
to the gain on termination of the joint venture of
$328 million, approximately $118 million of deferred
tax was recognized and
75
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
included in deferred income taxes, net in the noncurrent
liability section of the consolidated balance sheet as of
December 31, 2008.
In the first quarter of 2008, an indirect subsidiary of RJR
Tobacco sold the AUSTIN trademark, a brand formerly sold through
the joint venture, resulting in a gain of $6 million.
Indirect subsidiaries of RAI continue to sell NATURAL AMERICAN
SPIRIT to the primary markets of the former joint venture in
addition to other international markets.
Note 6
Extraordinary Item
Extraordinary item reflects an adjustment to the gain related to
the acquisition of RJRs former parent, Nabisco Group
Holdings Corp., referred to as NGH, which occurred in 2000,
primarily reflecting the favorable resolution of associated tax
matters. During 2007 and 2006, after-tax gains were
$1 million and $74 million, respectively. Including
these adjustments, the net after-tax gain on the acquisition of
NGH was $1.8 billion.
Note 7
Income Per Share
The components of the calculation of income per share were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Income from continuing operations before extraordinary item
|
|
$
|
1,338
|
|
|
$
|
1,307
|
|
|
$
|
1,136
|
|
Extraordinary item gain on acquisition
|
|
|
|
|
|
|
1
|
|
|
|
74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1,338
|
|
|
$
|
1,308
|
|
|
$
|
1,210
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic weighted average shares, in thousands(1)
|
|
|
292,445
|
|
|
|
294,385
|
|
|
|
295,033
|
|
Effect of dilutive potential shares:
|
|
|
|
|
|
|
|
|
|
|
|
|
Options
|
|
|
199
|
|
|
|
246
|
|
|
|
58
|
|
Restricted stock
|
|
|
430
|
|
|
|
258
|
|
|
|
293
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted average shares, in thousands
|
|
|
293,074
|
|
|
|
294,889
|
|
|
|
295,384
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Outstanding contingently issuable restricted stock of
0.9 million shares, 0.8 million shares and
0.5 million shares were excluded from the basic share
calculation for the years ended December 31, 2008, 2007,
and 2006, respectively, as the related vesting provisions had
not been met. |
Note 8
Fair Value Measurement
On January 1, 2008, RAI adopted SFAS No. 157, as
clarified by FSP
No. FAS 157-3,
for financial assets and financial liabilities.
SFAS No. 157 provides a definition of fair value,
establishes a framework for measuring fair value and expands
disclosure about fair value measurements. SFAS No. 157
establishes a fair value hierarchy that distinguishes between
market participant assumptions developed based on market data
obtained from sources independent of the reporting entity, and
the reporting entitys own assumptions about market
participant assumptions developed based on the best information
available in the circumstances.
SFAS No. 157 defines fair value as the price that
would be received to sell an asset or paid to transfer a
liability in an orderly transaction between market participants
at the measurement date, essentially an exit price.
The levels of the fair value hierarchy established by
SFAS No. 157 are:
Level 1: inputs are quoted prices, unadjusted, in active
markets for identical assets or liabilities that the reporting
entity has the ability to access at the measurement date.
76
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Level 2: inputs are other than quoted prices included
within Level 1 that are observable for the asset or
liability, either directly or indirectly. A Level 2 input
must be observable for substantially the full term of the asset
or liability.
Level 3: inputs are unobservable and reflect the reporting
entitys own assumptions about the assumptions that market
participants would use in pricing the asset or liability.
Financial assets carried at fair value as of December 31,
2008, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
|
Money market funds
|
|
$
|
2,269
|
|
|
$
|
|
|
|
$
|
23
|
|
|
$
|
2,292
|
|
Auction rate securities corporate credit risk
|
|
|
|
|
|
|
|
|
|
|
44
|
|
|
|
44
|
|
Auction rate securities financial insurance companies
|
|
|
|
|
|
|
|
|
|
|
15
|
|
|
|
15
|
|
Mortgage-backed securities
|
|
|
|
|
|
|
|
|
|
|
21
|
|
|
|
21
|
|
Assets held in grantor trusts
|
|
|
16
|
|
|
|
|
|
|
|
|
|
|
|
16
|
|
Interest rate swaps
|
|
|
|
|
|
|
287
|
|
|
|
|
|
|
|
287
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total financial assets at fair value
|
|
$
|
2,285
|
|
|
$
|
287
|
|
|
$
|
103
|
|
|
$
|
2,675
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The fair values of the interest rate swaps, classified as a
Level 2, utilized a market approach model using the
notional amount of the interest rate swap multiplied by the
observable inputs of time to maturity, interest rates and credit
spreads. See note 15 for additional information on interest
rate swaps.
The fair values of the money market funds, classified as a
Level 3, utilized an income approach model and was based
upon expected future cash flows from accumulated cash in the
fund and future maturities of the remaining securities held in
the fund. During September 2008, the managers of the Reserve
Fund-Primary Fund and Reserve Fund-International Liquidity Fund,
both AAA-rated money market funds, quit accepting purchases into
the funds and did not honor redemption requests that would cause
the funds to liquidate outstanding holdings into a volatile
market at a loss. During the fourth quarter of 2008, redemptions
of $29 million were received from the Reserve Fund-Primary
Fund. In addition, no current valuations had been issued by
either fund. RAI was unable to identify a similar fund that
carried identical holdings. As a result, the observable
transactions and pricing were not current. The funds did issue a
detailed listing of the securities that were held and not
matured, as well as their face value and maturity date. This
observable data, along with unobservable factors such as
discount rate, and assumptions about fund liquidation of
accumulated cash and the collectability of the outstanding
underlying securities were used to determine the fair value of
the funds as of December 31, 2008.
The fair values of the auction rate securities, either related
to certain financial insurance companies or linked to the
longer-term credit risk of a diverse range of corporations,
including, but not limited to, manufacturing, financial and
insurance sectors, classified as a Level 3, utilized an
income approach model and were based upon calculating the
weighted average present value of future cash payments, given
the probability of certain events occurring within the market.
RAI considers the market for auction rate securities to be
inactive. The income approach models utilized observable inputs,
including LIBOR-based interest rate curves, corporate credit
spreads and corporate ratings/market valuations. Additionally,
unobservable factors incorporated into the models included
default probability assumptions, recovery potential and how
these factors changed as collateral ratings migrated from one
level to another.
The fair values for the mortgage-backed securities, classified
as a Level 3, utilized a market approach and were based
upon the calculation of an overall weighted average valuation,
derived from the actual, or modeled, market pricing of the
specific collateral, depending on availability. The market
approach utilized actual pricing inputs when observable and
modeled pricing when unobservable. These mortgage-backed
securities have not had any market activity throughout 2008, and
therefore, RAI has deemed the market for these securities to be
inactive. However, the underlying collateral continues to
perform favorably, and the security continues to pay interest on
time and within terms.
77
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The changes in the Level 3 investments as of
December 31, 2008, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds
|
|
|
Mortgage-Backed Securities
|
|
|
|
|
|
|
Gross
|
|
|
|
|
|
|
|
|
Gross
|
|
|
|
|
|
|
|
|
|
Realized
|
|
|
Estimated
|
|
|
|
|
|
Unrealized
|
|
|
Estimated
|
|
|
|
Cost
|
|
|
Loss
|
|
|
Fair Value
|
|
|
Cost
|
|
|
Loss
|
|
|
Fair Value
|
|
|
Balance as of January 1, 2008
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
45
|
|
|
$
|
(1
|
)
|
|
$
|
44
|
|
Transfers into Level 3
|
|
|
54
|
|
|
|
|
|
|
|
54
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized losses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15
|
)
|
|
|
(15
|
)
|
Realized losses
|
|
|
|
|
|
|
(2
|
)
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Settlements
|
|
|
(29
|
)
|
|
|
|
|
|
|
(29
|
)
|
|
|
(8
|
)
|
|
|
|
|
|
|
(8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2008
|
|
$
|
25
|
|
|
$
|
(2
|
)
|
|
$
|
23
|
|
|
$
|
37
|
|
|
$
|
(16
|
)
|
|
$
|
21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Auction Rate Securities Corporate
|
|
|
Auction Rate Securities
|
|
|
|
Credit Risk
|
|
|
Financial Insurance Companies
|
|
|
|
|
|
|
Gross
|
|
|
|
|
|
|
|
|
Gross
|
|
|
Gross
|
|
|
|
|
|
|
|
|
|
Unrealized
|
|
|
Estimated
|
|
|
|
|
|
Realized
|
|
|
Unrealized
|
|
|
Estimated
|
|
|
|
Cost
|
|
|
Loss
|
|
|
Fair Value
|
|
|
Cost
|
|
|
Loss
|
|
|
Loss
|
|
|
Fair Value
|
|
|
Balance as of January 1, 2008
|
|
$
|
95
|
|
|
$
|
(13
|
)
|
|
$
|
82
|
|
|
$
|
50
|
|
|
$
|
|
|
|
$
|
(5
|
)
|
|
$
|
45
|
|
Unrealized losses
|
|
|
|
|
|
|
(38
|
)
|
|
|
(38
|
)
|
|
|
|
|
|
|
|
|
|
|
(30
|
)
|
|
|
(30
|
)
|
Unrealized losses transferred to realized losses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33
|
|
|
|
33
|
|
Realized losses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(33
|
)
|
|
|
|
|
|
|
(33
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2008
|
|
$
|
95
|
|
|
$
|
(51
|
)
|
|
$
|
44
|
|
|
$
|
50
|
|
|
$
|
(33
|
)
|
|
$
|
(2
|
)
|
|
$
|
15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transfers in and out of Level 3 occur using the fair value
at the end of the period. Transfers out of unrealized losses to
realized losses occur using the fair value at the end of the
period.
Short-term investments classified as available-for-sale were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
December 31, 2007
|
|
|
|
|
|
|
Gross
|
|
|
|
|
|
|
|
|
|
|
|
Gross
|
|
|
|
|
|
|
|
|
|
Realized
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
Unrealized
|
|
|
Estimated
|
|
|
|
Cost
|
|
|
Loss
|
|
|
Redemptions
|
|
|
Fair Value
|
|
|
Cost
|
|
|
Loss
|
|
|
Fair Value
|
|
|
Reserve Fund Primary Fund
|
|
$
|
37
|
|
|
$
|
(1
|
)
|
|
$
|
(29
|
)
|
|
$
|
7
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Reserve Fund International Liquidity Fund
|
|
|
17
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal agency securities and treasury bills and notes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
206
|
|
|
|
|
|
|
|
206
|
|
Auction rate securities corporate credit risk
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95
|
|
|
|
(13
|
)
|
|
|
82
|
|
Auction rate securities financial insurance companies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50
|
|
|
|
(5
|
)
|
|
|
45
|
|
Mortgage-backed securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45
|
|
|
|
(1
|
)
|
|
|
44
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
54
|
|
|
$
|
(2
|
)
|
|
$
|
(29
|
)
|
|
$
|
23
|
|
|
$
|
396
|
|
|
$
|
(19
|
)
|
|
$
|
377
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
78
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
During the third quarter of 2008, the Reserve Funds, which are
money market funds, were reclassified to short-term investments
from cash equivalents due to the liquidity restrictions issued
by the fund managers preventing immediate withdrawals. As of
September 30, 2008, the Reserve Fund Primary
Fund was made up of investments in securities that primarily
included bank notes, certificates of deposit, commercial paper
and floating rate discount notes. As of September 30, 2008,
the Reserve Fund International Liquidity Fund
consisted of investments in securities that include bank notes,
certificates of deposit, commercial paper and floating-rate
discount notes. Included in both the Reserve Fund
Primary Fund and the Reserve Fund International
Liquidity Fund were investments in Lehman Brothers Holdings
Inc., referred to as Lehman. On September 15, 2008, Lehman
filed for protection under Chapter 11 of the federal
Bankruptcy Code. The value of RAIs pro rata share of
indirect holdings in the Lehman investments was impaired
$2 million and a loss was recognized in other (income)
expense, net in the consolidated statement of income for the
year ended December 31, 2008.
No additional impairment was recorded on the Reserve Funds
beyond the Lehman impairment as the Reserve Funds will
distribute cash as assets mature or are sold. During the fourth
quarter of 2008, redemptions of $29 million were received
from the Reserve Funds. RAI has the intent and the ability to
hold the investments in the Reserve Funds until maturity and, at
this time, the Reserve Funds expect maturity at stated face
value.
The investments in federal agency securities and treasury bills
and notes were liquidated during the second quarter of 2008 to
meet working capital needs.
Auction rate securities are instruments with long-term
contractual maturities, but historically have been highly
liquid, repricing at intervals ranging from 7 to 49 days,
and therefore, the fair values have approximated carrying
values. However, during 2007, adverse changes in the financial
markets caused certain auction rate securities to revalue lower
than their carrying value and become less liquid. The auction
rate securities were reclassified to a long-term investment
during the second quarter of 2008 as RAI believes a successful
auction is not likely to occur within the next year. The auction
rate securities were included in other assets and deferred
charges in RAIs consolidated balance sheet as of
December 31, 2008. The funds associated with the auction
rate securities will not be accessible until a successful
auction occurs or a buyer is found.
The mortgage-backed securities were reclassified to a long-term
investment as of March 31, 2008, as a result of a
restructuring with the original issuer. These securities were
included in other assets and deferred charges in RAIs
consolidated balance sheet as of December 31, 2008. This
restructured investment extends the life of the security to
March 2010, but is supported by the same underlying collateral
that carries the same economic risks.
Long-term investments classified as available-for-sale were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
|
|
|
Gross
|
|
|
Gross
|
|
|
|
|
|
|
|
|
|
Realized
|
|
|
Unrealized
|
|
|
Estimated
|
|
|
|
Cost
|
|
|
Loss
|
|
|
Loss
|
|
|
Fair Value
|
|
|
Auction rate securities corporate credit risk
|
|
$
|
95
|
|
|
$
|
|
|
|
$
|
(51
|
)
|
|
$
|
44
|
|
Auction rate securities financial insurance companies
|
|
|
50
|
|
|
|
(33
|
)
|
|
|
(2
|
)
|
|
|
15
|
|
Mortgage-backed securities
|
|
|
37
|
|
|
|
|
|
|
|
(16
|
)
|
|
|
21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
182
|
|
|
$
|
(33
|
)
|
|
$
|
(69
|
)
|
|
$
|
80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
There were no long-term investments classified as
available-for-sale at December 31, 2007.
RAI reviews these investments on a quarterly basis to determine
if it is probable that RAI will realize some portion of the
unrealized loss in accordance with SFAS No. 115, FSP
No.
FAS 115-1
and
FAS 124-1,
and FSP No.
EITF 99-20-1,
and to determine the classification of the impairment as
temporary or other-than-temporary.
In determining if the difference between cost and estimated fair
value of the auction rate securities or the mortgage-backed
securities was deemed either temporary or other-than-temporary
impairment, RAI evaluated each type of long-term investment
using a set of criteria including decline in value, duration of
the decline, period until
79
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
anticipated recovery, nature of investment, probability of
recovery, financial condition and near-term prospects of the
issuer, RAIs intent and ability to retain the investment,
attributes of the decline in value, status with rating agencies,
status of principal and interest payments and any other issues
related to the underlying securities.
RAI has five investments in auction rate securities linked to
corporate credit risk, four investments in auction rate
securities related to financial insurance companies and one
investment in a mortgage-backed security. The fair value of each
of these investments has continued to decline since the date of
the initial impairment in December 2007.
RAI determined the decline in the fair values in all of the
investments in the auction rate securities linked to corporate
credit risk were temporary as of December 31, 2008,
primarily based on estimated cash flows of the investments,
present and expected defaults of the underlying collateral and
RAIs ability and intent to hold such investments. RAI
believes the decline in the fair values of the securities are
related to present market conditions and that the investments
will continue to be carried at less than cost until economic
conditions improve. RAI believes it is probable these securities
will eventually recover, and RAI has no intention of selling
these securities in the foreseeable future.
RAI determined the decline in the fair value of the investment
of the mortgage-backed securities, classified above sub-prime at
inception, was also temporary as of December 31, 2008,
primarily based on estimated cash flows of the security and the
underlying collateral of the security. RAI believes the decline
in the fair value of the mortgage-backed security is related to
present market conditions and that this investment will continue
to be carried at less than cost until economic conditions
surrounding the housing markets improve. RAI believes it is
probable this security will recover as the lowering of interest
rates and the assistance of government-related funds will result
in refinancing opportunities. In addition, as of
December 31, 2008, RAI received $8 million in
principal payments on the mortgage-backed security. RAI has no
intention of selling this security in the foreseeable future and
has the ability to allow financial markets to recover and
ultimately realize the value of this investment.
The decline in the fair value of one investment in an auction
rate security related to financial insurance companies has been
determined by RAI to be temporary as of December 31, 2008,
primarily based on estimated cash flows of the security, present
and expected defaults of the underlying collateral and
RAIs ability and intent to hold the investment. RAI
believes the decline in the fair value of this security is
related to present market conditions and that the investment
will continue to be carried at less than cost until economic
conditions improve. This investment was rated as investment
grade by rating agencies at December 31, 2008. In addition,
RAI has the ability to settle this security at full recovery
with the brokering financial institution in 2010.
The cumulative unrealized losses of $69 million through
December 31, 2008, on the previously mentioned long-term
investments were included in accumulated other comprehensive
loss in the consolidated balance sheet as of December 31,
2008. Such unrealized losses did not reduce net income for the
years ended December 31, 2008 or 2007.
Based on the status of the three other auction rate securities
related to financial insurance companies, RAI determined it is
not probable that the decline in investments is temporary. In
these three investments, the related financial insurance company
exercised its option to put preferred stock, which RAI believes
is an adverse change in the investment. In addition, the fair
values declined by approximately 75% to 90% from their original
cost, primarily in the fourth quarter. RAI believes the decline
in the fair values of these securities are related to present
market conditions and that the investments will continue to be
carried at less than cost until economic conditions improve.
Therefore, RAI cannot support the impairment of these auction
rate securities as being temporary and the difference between
the cost and the estimated fair value of these investments has
been recognized as an impairment totaling $33 million in
other (income) expense, net in the consolidated statement of
income for the year ended December 31, 2008.
80
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Note 10
Inventories
The major components of inventories at December 31 were as
follows:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
Leaf tobacco
|
|
$
|
993
|
|
|
$
|
967
|
|
Other raw materials
|
|
|
60
|
|
|
|
45
|
|
Work in process
|
|
|
58
|
|
|
|
48
|
|
Finished products
|
|
|
145
|
|
|
|
163
|
|
Other
|
|
|
26
|
|
|
|
24
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
1,282
|
|
|
|
1,247
|
|
Less LIFO allowance
|
|
|
112
|
|
|
|
51
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,170
|
|
|
$
|
1,196
|
|
|
|
|
|
|
|
|
|
|
Inventories valued under the LIFO method were $765 million
and $889 million at December 31, 2008 and 2007,
respectively, net of the LIFO allowance. The LIFO allowance
reflects the excess of the current cost of LIFO inventories at
December 31, 2008 and 2007, over the amount at which these
inventories were carried on the consolidated balance sheets. RAI
recorded expense of $61 million, income of $12 million
and expense of $2 million from LIFO inventory liquidations
during 2008, 2007 and 2006, respectively.
Note 11
Other Current Liabilities
Other current liabilities at December 31 included the following:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
Payroll and employee benefits
|
|
$
|
222
|
|
|
$
|
233
|
|
Pension and other post-retirement benefits
|
|
|
85
|
|
|
|
86
|
|
Marketing and advertising
|
|
|
137
|
|
|
|
165
|
|
Declared dividends
|
|
|
248
|
|
|
|
251
|
|
Excise, franchise and property tax
|
|
|
66
|
|
|
|
80
|
|
Other
|
|
|
385
|
|
|
|
379
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,143
|
|
|
$
|
1,194
|
|
|
|
|
|
|
|
|
|
|
81
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Note 12
Income Taxes
The components of the provision for income taxes from continuing
operations were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Current:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
632
|
|
|
$
|
588
|
|
|
$
|
501
|
|
State and other
|
|
|
142
|
|
|
|
109
|
|
|
|
67
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
774
|
|
|
|
697
|
|
|
|
568
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
27
|
|
|
|
42
|
|
|
|
50
|
|
State and other
|
|
|
(11
|
)
|
|
|
27
|
|
|
|
55
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16
|
|
|
|
69
|
|
|
|
105
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
790
|
|
|
$
|
766
|
|
|
$
|
673
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The current net deferred income tax asset shown on the
consolidated balance sheets at December 31 included the
following:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
Deferred tax assets (liabilities):
|
|
|
|
|
|
|
|
|
LIFO inventories
|
|
$
|
(203
|
)
|
|
$
|
(246
|
)
|
Pension and other postretirement liabilities
|
|
|
48
|
|
|
|
42
|
|
Tobacco settlement accruals
|
|
|
925
|
|
|
|
966
|
|
Other accrued liabilities
|
|
|
68
|
|
|
|
83
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
838
|
|
|
$
|
845
|
|
|
|
|
|
|
|
|
|
|
The composition of the net current deferred income tax asset by
jurisdiction at December 31 was as follows:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
Federal
|
|
$
|
683
|
|
|
$
|
696
|
|
State and other
|
|
|
155
|
|
|
|
149
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
838
|
|
|
$
|
845
|
|
|
|
|
|
|
|
|
|
|
82
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The net noncurrent deferred income tax liability shown on the
consolidated balance sheets at December 31 included the
following:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
Deferred tax assets:
|
|
|
|
|
|
|
|
|
Pension and other postretirement liabilities
|
|
$
|
1,134
|
|
|
$
|
293
|
|
Other noncurrent liabilities
|
|
|
139
|
|
|
|
96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,273
|
|
|
|
389
|
|
|
|
|
|
|
|
|
|
|
Deferred tax liabilities:
|
|
|
|
|
|
|
|
|
Property and equipment
|
|
|
(236
|
)
|
|
|
(246
|
)
|
Trademarks and other intangibles
|
|
|
(1,200
|
)
|
|
|
(1,318
|
)
|
Other
|
|
|
(119
|
)
|
|
|
(9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,555
|
)
|
|
|
(1,573
|
)
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(282
|
)
|
|
$
|
(1,184
|
)
|
|
|
|
|
|
|
|
|
|
The composition of net noncurrent deferred income tax liability
by jurisdiction at December 31 was as follows:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
Federal
|
|
$
|
(319
|
)
|
|
$
|
(1,042
|
)
|
State and other
|
|
|
37
|
|
|
|
(142
|
)
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(282
|
)
|
|
$
|
(1,184
|
)
|
|
|
|
|
|
|
|
|
|
The total deferred tax assets were $2,314 million and
$1,480 million as of December 31, 2008 and 2007,
respectively. The total deferred tax liabilities were
$1,758 million and $1,819 million as of
December 31, 2008 and 2007, respectively.
There were total net deferred tax assets of $556 million as
of December 31, 2008, and total net deferred tax
liabilities of $339 million as of December 31, 2007.
No valuation allowance has been provided on the deferred tax
assets as of December 31, 2008 or 2007, as RAI believes it
is more likely than not that all of the deferred tax assets will
be realized.
Pre-tax income for domestic and foreign operations consisted of
the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Domestic (includes U.S. exports)
|
|
$
|
1,774
|
|
|
$
|
2,043
|
|
|
$
|
1,768
|
|
Foreign
|
|
|
354
|
|
|
|
30
|
|
|
|
41
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,128
|
|
|
$
|
2,073
|
|
|
$
|
1,809
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A gain of $328 million from the termination of the R. J.
Reynolds-Gallaher International Sarl joint venture was included
in foreign income during 2008.
83
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The differences between the provision for income taxes from
continuing operations and income taxes computed at statutory
U.S. federal income tax rates were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Income taxes computed at statutory U.S. federal income tax rates
|
|
$
|
745
|
|
|
$
|
725
|
|
|
$
|
633
|
|
State and local income taxes, net of federal tax benefits
|
|
|
73
|
|
|
|
86
|
|
|
|
58
|
|
Favorable resolution of federal tax matters
|
|
|
(2
|
)
|
|
|
(1
|
)
|
|
|
(17
|
)
|
Other items, net
|
|
|
(26
|
)
|
|
|
(44
|
)
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes from continuing operations
|
|
$
|
790
|
|
|
$
|
766
|
|
|
$
|
673
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective tax rate
|
|
|
37.1
|
%
|
|
|
37.0
|
%
|
|
|
37.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In 2008, 2007 and 2006, the resolution of prior years
federal tax matters resulted in a reduction of income tax
expense of $2 million, $1 million and
$17 million, respectively. The 2006 adjustment finalizes
the IRSs audit of tax returns for the years 1986 through
2001.
As of December 31, 2008, there were $437 million of
accumulated and undistributed foreign earnings. Included in the
$437 million was $10 million of foreign earnings that
were previously taxed under Subpart F of the Internal Revenue
Code and $328 million of foreign earnings related to the
gain from the termination of the
R. J. Reynolds-Gallaher International Sarl, joint
venture. RAI does not have specific long-term plans to reinvest
the $328 million joint venture gain overseas, and
therefore, recorded $118 million of deferred income taxes.
RAI also has undistributed foreign earnings in excess of its
historical and planned future investments and therefore,
recorded deferred income taxes of $10 million.
In 2007 and 2006, RAI recorded an adjustment of $1 million
and $74 million, respectively, to the gain related to the
acquisition of NGH, which occurred in 2000, primarily reflecting
the favorable resolution of associated tax matters. Including
these adjustments, the net after-tax gain on the acquisition of
NGH was $1.8 billion.
As of December 31, 2008, the deferred tax benefits included
in accumulated other comprehensive loss were $1,076 million
for retirement benefits and $28 million for unrealized
losses on long-term investments. For the year ended
December 31, 2007, the tax benefits included in accumulated
other comprehensive loss were $192 million for retirement
benefits and $8 million for unrealized losses on short-term
investments.
In 2007, as a result of adopting FIN No. 48, RAI
recorded a cumulative effect for a change in accounting
principle of $5 million concerning a decrease of accruals
related to uncertain tax positions. This change was accounted
for as an increase to the opening balance of retained earnings.
The gross accruals for unrecognized income tax benefits,
including interest and penalties, reflected in other noncurrent
liabilities were $159 million and $172 million at
December 31, 2008 and 2007, respectively. RAI accrues
interest and penalties related to accruals for income taxes and
reflects these amounts in tax expense. The gross amount of
interest accrued at December 31, 2008 and 2007, was
$50 million and $49 million, respectively. The gross
amount of penalties accrued was $12 million at
December 31, 2008 and 2007.
84
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
A reconciliation of the beginning and ending amount of
unrecognized gross tax benefits is as follows:
|
|
|
|
|
Balance at January 1, 2007
|
|
$
|
115
|
|
Gross increases related to current period tax positions
|
|
|
15
|
|
Gross increases related to tax positions in prior periods
|
|
|
3
|
|
Gross decreases related to tax positions in prior periods
|
|
|
(9
|
)
|
Gross decreases related to audit settlements paid
|
|
|
(9
|
)
|
Gross decreases related to lapse of applicable statute of
limitations
|
|
|
(4
|
)
|
|
|
|
|
|
Balance at December 31, 2007
|
|
|
111
|
|
|
|
|
|
|
Gross increases related to current period tax positions
|
|
|
10
|
|
Gross increases related to tax positions in prior periods
|
|
|
3
|
|
Gross decreases related to tax positions in prior periods
|
|
|
(3
|
)
|
Gross decreases related to audit settlements paid
|
|
|
(16
|
)
|
Gross decreases related to lapse of applicable statute of
limitations
|
|
|
(8
|
)
|
|
|
|
|
|
Balance at December 31, 2008
|
|
$
|
97
|
|
|
|
|
|
|
As of December 31, 2008, $57 million of unrecognized
tax benefits and $43 million of interest and penalties, if
recognized, would affect RAIs effective tax rate.
Major jurisdictions audit activities are summarized below:
RAI and its subsidiaries may be subject to income taxes in the
United States, certain foreign jurisdictions and multiple state
jurisdictions. A number of years may elapse before a particular
matter, for which RAI has established an accrual, is audited and
finally resolved. The number of years with open tax audits
varies depending on the tax jurisdiction. RAIs major
taxing jurisdictions and related open tax audits are discussed
below.
The Internal Revenue Service completed its examination and
issued an assessment for the years 2002 and 2003. RAI filed a
protest in 2006, and a formal settlement agreement was signed
during the first quarter of 2008. Overpayments from prior year
audits exceed the settlement agreement amount, and a refund of
$2 million was received in April 2008. Amended state
returns were filed during the fourth quarter of 2008 to reflect
these federal adjustments.
RAI filed a federal consolidated income tax return for the years
2004 through 2007. The statute of limitations remains open for
the years 2005 through 2007. There are no IRS examinations
scheduled at this time for these open years.
In 2007, the State of North Carolina completed its examination
of RJR Tobacco for years 2000 through 2002 and issued a total
assessment of $37 million: $21 million related to tax,
$8 million related to interest and $8 million related
to penalties. RJR Tobacco filed a protest in January 2008. RJR
Tobacco will continue to work with North Carolina to resolve
issues identified and assessed for years 2000 through 2002. A
complete resolution is not anticipated within the next
12 months. However, in the event a complete resolution of
this audit is reached during the next 12 months, RJR
Tobacco could recognize additional expense up to
$13 million, inclusive of tax, interest, net of federal
benefit, and penalties.
It is expected that the amount of unrecognized tax benefits will
change in the next 12 months. Excluding the impact of North
Carolinas assessment for years 2000 through 2002, RAI does
not expect the change to have a significant impact on its
consolidated results of operations, cash flows or financial
position.
Note 13
Borrowing Arrangements
On June 28, 2007, RAI entered into a Fifth Amended and
Restated Credit Agreement, which, as subsequently amended, is
referred to as the Credit Facility. The Credit Facility provides
for a five-year, $550 million revolving
85
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
credit facility, which may be increased to $900 million at
the discretion of the lenders upon the request of RAI. The
Credit Facilitys maturity date of June 28, 2012, may
be extended by one year, at the discretion of the lenders upon
RAIs request. Effective March 31, 2008, the Credit
Facility was amended by:
|
|
|
|
|
adding a further exception to the covenant that restricts the
sale of assets, so as to permit the disposition of real
properties and related assets, whether by donation or sale below
market value, in an aggregate amount not to exceed
$15 million;
|
|
|
|
modifying the covenant limiting the amount of cash, Marketable
Investments and Investment Equities that a Non-Guarantor
Subsidiary, that is not a Domestic Subsidiary, as such terms are
defined in the Credit Facility, may hold; and
|
|
|
|
modifying certain related definitions.
|
On October 5, 2008, Lehman Commercial Paper Inc., a lender
in the Credit Facility and referred to as LCPI, filed for
protection under Chapter 11 of the federal Bankruptcy Code.
RAI has never borrowed under the Credit Facility, but given
LCPIs bankruptcy filing, there can be no assurance that
LCPI would loan to RAI LCPIs pro rata share of any
borrowing requests made by RAI. Subject to the terms and
conditions in the Credit Facility, RAI has the right to replace
a lender in certain circumstances, including upon a lender
defaulting in its obligation to make loans. If any lender were
to default in its obligation to make loans, there can be no
assurance as to when or whether RAI could find an acceptable
replacement lender. LCPIs commitment under the Credit
Facility is $52 million.
The Credit Facility contains, among others, the following
restrictive covenants that limit, and in some circumstances
prohibit, the ability of RAI and its subsidiaries to:
|
|
|
|
|
incur or guarantee additional debt;
|
|
|
|
pay dividends;
|
|
|
|
make capital expenditures, investments or other restricted
payments;
|
|
|
|
engage in transactions with shareholders and affiliates;
|
|
|
|
create, incur or assume liens;
|
|
|
|
engage in mergers, acquisitions and consolidations;
|
|
|
|
sell assets;
|
|
|
|
issue or sell capital stock of subsidiaries;
|
|
|
|
exceed a Consolidated Total Leverage Ratio of 3.25:1.00; and
|
|
|
|
fall below a Consolidated Interest Coverage Ratio of 3.00:1.00.
|
These covenants are subject to a number of qualifications and
exceptions.
The Credit Facility contains customary events of default,
including upon a change in control, that could result in the
acceleration of the repayment of all amounts and cancellation of
all commitments outstanding thereunder.
RAI is able to use the Credit Facility for borrowings and
issuances of letters of credit at its option. Issuances of
letters of credit reduce availability under the facility. As of
December 31, 2008, there were no borrowings, and
$12 million of letters of credit outstanding, under the
Credit Facility.
Under the terms of the Credit Facility, RAI is not required to
maintain compensating balances; however, RAI is required to pay
a commitment fee of between 0.25% and 1.0% per annum on the
unused portion of the Credit Facility. During 2008, RAI incurred
$3 million in commitment fees.
86
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Borrowings under the Credit Facility bear interest, at the
option of RAI, at a rate equal to an applicable margin plus:
|
|
|
|
|
the reference rate, which is the higher of (1) the federal
funds effective rate from time to time plus 0.5% and
(2) the prime rate; or
|
|
|
|
the eurodollar rate, which is the rate at which eurodollar
deposits for one, two, three or six months are offered in the
interbank eurodollar market.
|
Certain of RAIs subsidiaries, including its material
domestic subsidiaries, referred to as the Guarantors, have
guaranteed RAIs obligations under the Credit Facility and
under RAIs outstanding senior notes, referred to as the
Notes. Until the credit ratings actions described below, RAI had
pledged substantially all of its assets, including the stock of
its direct subsidiaries, to secure its obligations under the
Credit Facility, and the Guarantors had pledged substantially
all of their assets to secure their guarantees of RAIs
obligations under the Credit Facility. Until such credit ratings
actions, the Notes and related guarantees had been secured by
any Principal Property, as such term is defined in the indenture
governing the Notes, of RAI and certain of the Guarantors, and
the stock, indebtedness or other obligations of RJR Tobacco.
On May 2, 2008, S&P raised its corporate credit rating
for RAI from BB+, a non-investment grade rating, and a positive
outlook, to BBB-, an investment grade rating, and a stable
outlook. On June 20, 2008, Moodys, consistent with
its notching practices for an investment grade issuer, withdrew
its corporate credit rating of Ba1, a non-investment grade
rating, for RAI, and upgraded the Notes from Ba1 to Baa3, an
investment grade rating. Moodys also revised its outlook
for RAI from positive to stable.
Pursuant to the terms of the loan documents relating to the
Credit Facility, Notes and related guarantees, which terms
provide for a release of collateral if RAI obtains investment
grade corporate credit ratings, with not worse than stable
outlooks, from each of S&P and Moodys, the collateral
securing the Credit Facility, Notes and related guarantees was
released automatically on June 20, 2008, upon the ratings
issued by Moodys on that date. The relevant loan documents
do not provide for a release of the Guarantors guarantees
of the Credit Facility and the Notes upon any ratings upgrades
and, therefore, such guarantees remain in effect. In addition,
on June 20, 2008, given the release of the collateral which
had secured the Credit Facility and the related guarantees,
Moodys lowered the investment grade rating for the Credit
Facility from Baa1 to Baa3. The collateral for the Credit
Facility, Notes and related guarantees will be reinstated if
RAIs corporate credit rating issued by each of S&P
and Moodys is lowered to at least one level below the
lowest rating level established as investment grade, or if
RAIs corporate credit rating issued by either S&P or
Moodys is lowered to at least two levels below the lowest
rating level established as investment grade.
87
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Note 14
Long-Term Debt
Long-term debt, net of discount and including fair value
adjustments associated with interest rate swaps, as of December
31 consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
RJR debt:
|
|
|
|
|
|
|
|
|
9.25%, notes due 2013
|
|
$
|
60
|
|
|
$
|
60
|
|
7.25% guaranteed, notes due 2012
|
|
|
64
|
|
|
|
60
|
|
7.3% guaranteed, notes due 2015
|
|
|
1
|
|
|
|
1
|
|
7.875% guaranteed, notes due 2009
|
|
|
|
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
Total RJR debt
|
|
|
125
|
|
|
|
132
|
|
|
|
|
|
|
|
|
|
|
RAI debt:
|
|
|
|
|
|
|
|
|
6.5% guaranteed, notes due 2010
|
|
|
299
|
|
|
|
299
|
|
6.75% guaranteed, notes due 2017
|
|
|
846
|
|
|
|
754
|
|
7.25% guaranteed, notes due 2012
|
|
|
439
|
|
|
|
418
|
|
7.25% guaranteed, notes due 2013
|
|
|
622
|
|
|
|
622
|
|
7.25% guaranteed, notes due 2037
|
|
|
447
|
|
|
|
447
|
|
7.3% guaranteed, notes due 2015
|
|
|
199
|
|
|
|
199
|
|
7.625% guaranteed, notes due 2016
|
|
|
860
|
|
|
|
806
|
|
7.75% guaranteed, notes due 2018
|
|
|
249
|
|
|
|
249
|
|
7.875% guaranteed, notes due 2009
|
|
|
|
|
|
|
189
|
|
Floating rate, guaranteed, notes due 2011
|
|
|
400
|
|
|
|
400
|
|
|
|
|
|
|
|
|
|
|
Total RAI debt
|
|
|
4,361
|
|
|
|
4,383
|
|
|
|
|
|
|
|
|
|
|
Total long-term debt (less current maturities)
|
|
|
4,486
|
|
|
|
4,515
|
|
Current maturities of long-term debt
|
|
|
200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
4,686
|
|
|
$
|
4,515
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2008, the maturities of RAIs and
RJRs notes, net of discount and excluding fair value
adjustments associated with interest rate swaps, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Year
|
|
RAI
|
|
|
RJR
|
|
|
Total
|
|
|
2009
|
|
$
|
189
|
|
|
$
|
11
|
|
|
$
|
200
|
|
2010
|
|
|
300
|
|
|
|
|
|
|
|
300
|
|
2011
|
|
|
400
|
|
|
|
|
|
|
|
400
|
|
2012
|
|
|
392
|
|
|
|
57
|
|
|
|
449
|
|
2013
|
|
|
622
|
|
|
|
60
|
|
|
|
682
|
|
Thereafter
|
|
|
2,367
|
|
|
|
|
|
|
|
2,367
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
4,270
|
|
|
$
|
128
|
|
|
$
|
4,398
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In conjunction with their obligations under the Credit Facility,
RAIs material domestic subsidiaries, including RJR, RJR
Tobacco, Santa Fe, Lane, GPI and the Conwood companies
guarantee RAIs notes.
The estimated fair value of RAIs and RJRs
outstanding long-term notes, net of current maturities, was
$3.5 billion and $4.6 billion with an effective
average annual interest rate of 5.67% and 6.76%, as of
December 31, 2008 and 2007, respectively. The fair values
are based on available market quotes, credit spreads and
discounted cash flows, as appropriate.
88
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
At its option, RAI and RJR, as applicable, may redeem any or all
of their outstanding fixed-rate notes, in whole or in part, at
any time, subject to the payment of a make-whole premium. The
floating rate notes, with the variable component of interest
based on three-month LIBOR, are redeemable at par on any
interest payment date after December 15, 2008.
Note 15
Financial Instruments
Interest
Rate Management
RAI and RJR use interest rate swaps to manage interest rate risk
on a portion of their respective debt obligations. When entered
into, these financial instruments are designated as hedges of
underlying exposures.
Swaps existed on the following principal amount of debt as of
December 31, 2008 and 2007:
|
|
|
|
|
RJR 7.25% notes, due 2012
|
|
$
|
57
|
|
|
|
|
|
|
Total swapped RJR debt
|
|
|
57
|
|
|
|
|
|
|
RAI 7.25% notes, due 2012
|
|
|
393
|
|
RAI 7.625% notes, due 2016
|
|
|
450
|
|
RAI 6.75% notes, due 2017
|
|
|
700
|
|
|
|
|
|
|
Total swapped RAI debt
|
|
|
1,543
|
|
|
|
|
|
|
Total swapped debt
|
|
$
|
1,600
|
|
|
|
|
|
|
The interest rate swaps notional amounts and termination
dates match those of the corresponding outstanding notes. As of
December 31, 2008, these fair value hedges were perfectly
effective, resulting in no recognized net gain or loss. The
unrealized gain on the hedges resulting from the change in the
hedges fair value was $287 million and
$119 million at December 31, 2008 and 2007,
respectively, included in other assets and deferred charges in
the consolidated balance sheets, and is equal to the increase in
the fair value of the hedged long-term debt.
Under certain conditions, any fair value that results in a
liability position of certain interest rate swaps may require
full collateralization with cash or securities. No swaps were in
a liability position as of December 31, 2008.
Credit
Risk
RAI and its subsidiaries minimize counterparty credit risk
related to their financial instruments by using major
institutions.
See note 14 for additional disclosures regarding long-term
debt.
Note 16
Commitments and Contingencies
Tobacco
Litigation General
Introduction
Various legal proceedings or claims, including litigation
claiming that cancer and other diseases, as well as addiction,
have resulted from the use of, or exposure to, RAIs
operating subsidiaries products, are pending or may be
instituted against RJR Tobacco, the Conwood companies or their
affiliates, including RAI and RJR, or indemnitees, including
B&W. These pending legal proceedings include claims
relating to cigarette products manufactured by RJR Tobacco or
certain of its affiliates and indemnitees, as well as claims
relating to smokeless tobacco products manufactured by the
Conwood companies. A discussion of the legal proceedings
relating to cigarette products is set forth below under the
heading Litigation Affecting the Cigarette
Industry. All of the references under that heading to
tobacco-related litigation, smoking and health litigation and
other similar references are references to legal proceedings
relating to cigarette products and are not references to legal
proceedings involving smokeless tobacco products, and case
numbers under that heading include only cases
89
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
involving cigarette products. The legal proceedings relating to
the smokeless tobacco products manufactured by the Conwood
companies are discussed separately under the heading
Smokeless Tobacco Litigation below.
In connection with the B&W business combination, RJR
Tobacco has agreed to indemnify B&W and its affiliates
against certain liabilities, costs and expenses incurred by
B&W or its affiliates arising out of the
U.S. cigarette and tobacco business of B&W. As a
result of this indemnity, RJR Tobacco has assumed the defense of
pending B&W-specific tobacco-related litigation, has paid
the judgments and costs related to certain pre-business
combination tobacco-related litigation of B&W, and has
posted bonds on behalf of B&W, where necessary, in
connection with cases decided since the B&W business
combination. In addition, pursuant to this indemnity, RJR
Tobacco expensed less than $1 million, $1 million and
$4 million during 2008, 2007 and 2006 respectively, for
funds to be reimbursed to BAT for costs and expenses incurred
arising out of certain tobacco-related litigation.
Certain
Terms and Phrases
Certain terms and phrases used in this disclosure may require
some explanation. The term judgment or final
judgment refers to the final decision of the court
resolving the dispute and determining the rights and obligations
of the parties. At the trial court level, for example, a final
judgment generally is entered by the court after a jury verdict
and after post-verdict motions have been decided. In most cases,
the losing party can appeal a verdict only after a final
judgment has been entered by the trial court.
The term damages refers to the amount of money
sought by a plaintiff in a complaint, or awarded to a party by a
jury or, in some cases, by a judge. Compensatory
damages are awarded to compensate the prevailing party for
actual losses suffered, if liability is proved. In cases in
which there is a finding that a defendant has acted willfully,
maliciously or fraudulently, generally based on a higher burden
of proof than is required for a finding of liability for
compensatory damages, a plaintiff also may be awarded
punitive damages. Although damages may be awarded at
the trial court stage, a losing party generally may be protected
from paying any damages until all appellate avenues have been
exhausted by posting a supersedeas bond. The amount of such a
bond is governed by the law of the relevant jurisdiction and
generally is set at the amount of damages plus some measure of
statutory interest, modified at the discretion of the
appropriate court or subject to limits set by court or statute.
The term settlement refers to certain types of cases
in which cigarette manufacturers, including RJR Tobacco and
B&W, have agreed to resolve disputes with certain
plaintiffs without resolving the case through trial. The
principal terms of certain settlements entered into by RJR
Tobacco and B&W are explained below under
Accounting for Tobacco-Related Litigation
Contingencies.
Theories
of Recovery
The plaintiffs seek recovery on a variety of legal theories,
including negligence, strict liability in tort, design defect,
special duty, voluntary undertaking, breach of warranty, failure
to warn, fraud, misrepresentation, unfair trade practices,
conspiracy, unjust enrichment, medical monitoring, public
nuisance and violations of state and federal antitrust laws. In
certain of these cases, the plaintiffs claim that cigarette
smoking exacerbated injuries caused by exposure to asbestos.
The plaintiffs seek various forms of relief, including
compensatory and punitive damages, treble or multiple damages
and statutory damages and penalties, creation of medical
monitoring and smoking cessation funds, disgorgement of profits,
and injunctive and other equitable relief. Although alleged
damages often are not determinable from a complaint, and the law
governing the pleading and calculation of damages varies from
state to state and jurisdiction to jurisdiction, compensatory
and punitive damages have been specifically pleaded in a number
of cases, sometimes in amounts ranging into the hundreds of
millions and even billions of dollars.
Defenses
The defenses raised by RJR Tobacco, the Conwood companies and
their affiliates and indemnitees include, where applicable and
otherwise appropriate, preemption by the Federal Cigarette
Labeling and Advertising Act of
90
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
some or all claims arising after 1969, or by the Comprehensive
Smokeless Tobacco Health Education Act, the lack of any defect
in the product, assumption of the risk, contributory or
comparative fault, lack of proximate cause, remoteness, lack of
standing and statutes of limitations or repose. RAI and RJR have
asserted additional defenses, including jurisdictional defenses,
in many of the cases in which they are named.
Accounting
for Tobacco-Related Litigation Contingencies
In accordance with GAAP, RAI and its subsidiaries, including RJR
Tobacco and the Conwood companies, as applicable, record any
loss concerning litigation at such time as an unfavorable
outcome becomes probable and the amount can be reasonably
estimated. For the reasons set forth below, RAIs
management continues to conclude that the loss of any particular
pending smoking and health tobacco litigation claim against RJR
Tobacco or its affiliates or indemnitees, or the loss of any
particular claim concerning the use of smokeless tobacco against
the Conwood companies, when viewed on an individual basis, is
not probable.
RJR Tobacco and its affiliates believe that they have valid
defenses to the smoking and health tobacco litigation claims
against them, as well as valid bases for appeal of adverse
verdicts against them. RAI, RJR Tobacco and their affiliates and
indemnitees have, through their counsel, filed pleadings and
memoranda in pending smoking and health tobacco litigation that
set forth and discuss a number of grounds and defenses that they
and their counsel believe have a valid basis in law and fact.
RJR Tobacco and its affiliates and indemnitees continue to win
the majority of smoking and health tobacco litigation claims
that reach trial, and a very high percentage of the
tobacco-related litigation claims brought against them continue
to be dismissed at or before trial. Based on their experience in
the smoking and health tobacco litigation against them and the
strength of the defenses available to them in such litigation,
RJR Tobacco and its affiliates believe that their successful
defense of smoking and health tobacco litigation in the past
will continue in the future.
No liability for pending smoking and health tobacco litigation
was recorded in RAIs consolidated balance sheet as of
December 31, 2008. RJR, including its subsidiary RJR
Tobacco, have liabilities totaling $94 million that were
recorded in 1999 in connection with certain indemnification
claims not related to smoking and health asserted by JTI against
RJR and RJR Tobacco relating to certain activities of Northern
Brands International, Inc., a now inactive, indirect subsidiary
of RAI formerly involved in the international tobacco business,
referred to as Northern Brands. For further information on
Northern Brands and related litigation and the indemnification
claims of JTI, see Litigation Affecting the
Cigarette Industry Other Litigation and
Developments and Other
Contingencies below.
Generally, RJR Tobacco and its affiliates and indemnitees have
not settled, and currently RJR Tobacco and its affiliates do not
intend to settle, any smoking and health tobacco litigation
claims. It is the policy of RJR Tobacco and its affiliates to
vigorously defend all tobacco-related litigation claims.
The only smoking and health tobacco litigation claims settled by
RJR Tobacco and B&W involved:
|
|
|
|
|
the Master Settlement Agreement and other settlement agreements
with the states of Mississippi, Florida, Texas and Minnesota,
and the funding by various tobacco companies of a
$5.2 billion trust fund contemplated by the Master
Settlement Agreement to benefit tobacco growers; and
|
|
|
|
the original Broin flight attendant case discussed below under
Litigation Affecting the Cigarette
Industry
Class-Action
Suits.
|
The circumstances surrounding the MSA and the funding of a trust
fund to benefit the tobacco growers are readily distinguishable
from the current categories of smoking and health cases
involving RJR Tobacco or its affiliates and indemnitees. The
claims underlying the MSA were brought on behalf of the states
to recover funds paid for health-care and medical and other
assistance to state citizens suffering from diseases and
conditions allegedly related to tobacco use. The MSA settled all
the health-care cost recovery actions brought by, or on behalf
of, the settling jurisdictions and contain releases of various
additional present and future claims. In accordance with the
MSA, various tobacco companies agreed to fund a
$5.2 billion trust fund to be used to address the possible
adverse economic impact of the MSA on tobacco growers. A
discussion of the MSA, and a table depicting the
91
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
related payment schedule, is set forth below under
Litigation Affecting the Cigarette
Industry Health-Care Cost Recovery Cases
MSA.
The states were a unique set of plaintiffs and are not involved
in any of the smoking and health cases remaining against RJR
Tobacco or its affiliates and indemnitees. Although RJR Tobacco
and certain of its affiliates and indemnitees continue to be
defendants in health-care cost recovery cases similar in theory
to the state cases but involving other plaintiffs, such as
hospitals, Native American tribes and foreign governments, the
vast majority of such cases have been dismissed on legal
grounds. RJR Tobacco and its affiliates, including RAI, believe
that the same legal principles that have resulted in dismissal
of health-care cost recovery cases either at the trial court
level or on appeal should compel dismissal of the similar
pending cases.
The pending U.S. Department of Justice case brought against
various industry members, including RJR Tobacco and B&W,
discussed below under Litigation Affecting the
Cigarette Industry Health-Care Cost Recovery
Cases, also can be distinguished from the circumstances
surrounding the MSA. Under its Medical Care Recovery Act and
Medicare Secondary Payer Act claims, the federal government made
arguments similar to the states and sought to recover federal
funds expended in providing health care to smokers who have
developed diseases and injuries alleged to be smoking-related.
These claims were dismissed, and the only claim remaining in the
case involves alleged violations of civil provisions of the
federal Racketeer Influenced and Corrupt Organizations Act,
referred to as RICO. A comprehensive discussion of this case is
set forth below under Litigation Affecting the
Cigarette Industry Health-Care Cost Recovery
Cases.
As with claims that were resolved by the MSA, the other cases
settled by RJR Tobacco can be distinguished from existing cases
pending against RJR Tobacco and its affiliates and indemnitees.
The original Broin case, discussed below under
Litigation Affecting the Cigarette
Industry
Class-Action
Suits, was settled in the middle of trial during
negotiations concerning a possible nation-wide settlement of
claims similar to those underlying the MSA.
Likewise, RJR Tobacco and B&W separately settled the
antitrust case DeLoach v. Philip Morris Cos., Inc.,
which was brought by a unique class of plaintiffs: a class
of all tobacco growers and tobacco allotment holders. Despite
valid legal defenses, RJR Tobacco and B&W separately
settled this case to avoid a long and contentious trial with the
tobacco growers. The DeLoach case and the antitrust cases
currently pending against RJR Tobacco and B&W involve
different types of plaintiffs and different theories of recovery
under the antitrust laws than other cases pending against RJR
Tobacco and its affiliates and indemnitees.
Finally, as discussed under Litigation
Affecting the Cigarette Industry MSA
Enforcement and Validity, RJR Tobacco and B&W each
has settled certain cases brought by states concerning the
enforcement of the MSA. Despite valid legal defenses, these
cases were settled to avoid further contentious litigation with
the states involved. Each MSA enforcement action involves
alleged breaches of the MSA based on specific actions taken by
the particular defendant. Accordingly, any future MSA
enforcement action will be reviewed by RJR Tobacco on the merits
and should not be affected by the settlement of prior MSA
enforcement cases.
The Conwood companies also believe that they have valid defenses
to the smokeless tobacco litigation against them. The Conwood
companies have asserted and will continue to assert some or all
of these defenses in each case at the time and in the manner
deemed appropriate by the Conwood companies and their counsel.
No verdict or judgment has been returned or entered against the
Conwood companies on any claim for personal injuries allegedly
resulting from the use of smokeless tobacco. The Conwood
companies intend to defend vigorously all smokeless tobacco
litigation claims asserted against them. No liability for
pending smokeless tobacco litigation was recorded in RAIs
consolidated balance sheet as of December 31, 2008.
Cautionary
Statement
Even though RAIs management continues to conclude that the
loss of any particular pending smoking and health tobacco
litigation claim against RJR Tobacco or its affiliates or
indemnitees, or the loss of any particular case concerning the
use of smokeless tobacco against the Conwood companies, when
viewed on an individual basis, is
92
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
not probable, the possibility of material losses related to such
litigation is more than remote. Litigation is subject to many
uncertainties, and generally it is not possible to predict the
outcome of any particular litigation pending against RJR
Tobacco, the Conwood companies or their affiliates or
indemnitees, or to reasonably estimate the amount or range of
any possible loss.
Although RJR Tobacco believes that it has valid bases for
appeals of adverse verdicts in its pending cases, and RJR
Tobacco and RAI believe they have valid defenses to all actions,
and intend to defend all actions vigorously, it is possible that
there could be further adverse developments in pending cases,
and that additional cases could be decided unfavorably against
RAI, RJR Tobacco or their affiliates or indemnitees.
Determinations of liability or adverse rulings in such cases or
in similar cases involving other cigarette manufacturers as
defendants, even if such judgments are not final, could
materially adversely affect the litigation against RJR Tobacco
or its affiliates or indemnitees and could encourage the
commencement of additional tobacco-related litigation. In
addition, a number of political, legislative, regulatory and
other developments relating to the tobacco industry and
cigarette smoking have received wide media attention. These
developments may negatively affect the outcomes of
tobacco-related legal actions and encourage the commencement of
additional similar litigation.
Although it is impossible to predict the outcome of such events
on pending litigation and the rate new lawsuits are filed
against RJR Tobacco or its affiliates or indemnitees, a
significant increase in litigation or in adverse outcomes for
tobacco defendants could have a material adverse effect on any
or all of these entities. Moreover, notwithstanding the quality
of defenses available to it and its affiliates and indemnitees
in litigation matters, it is possible that RAIs results of
operations, cash flows or financial position could be materially
adversely affected by the ultimate outcome of certain pending
litigation matters against RJR Tobacco or its affiliates or
indemnitees.
Similarly, smokeless tobacco litigation is subject to many
uncertainties. Notwithstanding the quality of defenses available
to the Conwood companies, it is possible that RAIs results
of operations, cash flows or financial position could be
materially adversely affected by the ultimate outcome of certain
pending litigation matters against the Conwood companies.
Litigation
Affecting the Cigarette Industry
Overview
Introduction. In connection with the B&W
business combination, RJR Tobacco agreed to indemnify B&W
and its affiliates against, among other things, certain
litigation liabilities, costs and expenses incurred by B&W
or its affiliates arising out of the U.S. cigarette and
tobacco business of B&W. Accordingly, the cases discussed
below include cases brought solely against RJR Tobacco and its
affiliates, including RAI and RJR; cases brought against both
RJR Tobacco, its affiliates and B&W; and cases brought
solely against B&W and assumed by RJR Tobacco in the
B&W business combination.
During the fourth quarter of 2008, 14 tobacco-related cases were
served against RJR Tobacco or its affiliates or indemnitees. On
December 31, 2008, there were 3,953 cases, including 687
individual smoker cases pending in West Virginia state court as
a consolidated action and 3,094 Engle Progeny Cases,
involving 8,851 individual plaintiffs, pending in the United
States against RJR Tobacco or its affiliates or indemnitees, as
compared with 1,399 total cases on December 31, 2007, and
1,237 on December 31, 2006, pending in the United States
against RJR Tobacco or its affiliates or indemnitees.
As of February 6, 2009, 198 tobacco-related cases were
pending against RJR Tobacco or its affiliates or indemnitees:
194 in the United States; one in Puerto Rico; two in Canada; and
one in Israel. Of the 194 total U.S. cases, 25 cases
are pending against B&W that are not also pending against
RJR Tobacco. The U.S. case number does not include the
2,620 Broin II or the 3,156 Engle Progeny
Cases, as discussed below, pending as of February 6,
93
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
2009. The following table lists the number of
U.S. tobacco-related cases by state that were pending
against RJR Tobacco or its affiliates or indemnitees as of
February 6, 2009, exclusive of the Broin II and
Engle Progeny Cases:
|
|
|
|
|
|
|
Number of
|
|
State
|
|
U.S. Cases
|
|
|
New York
|
|
|
24
|
|
Florida
|
|
|
22
|
|
Missouri
|
|
|
20
|
|
Louisiana
|
|
|
17
|
|
California
|
|
|
13
|
|
Mississippi
|
|
|
10
|
|
Maryland
|
|
|
7
|
|
Illinois
|
|
|
6
|
|
West Virginia
|
|
|
6
|
*
|
Connecticut
|
|
|
4
|
|
Ohio
|
|
|
4
|
|
Georgia
|
|
|
4
|
|
Pennsylvania
|
|
|
3
|
|
Kentucky
|
|
|
3
|
|
District of Columbia
|
|
|
3
|
|
Delaware
|
|
|
2
|
|
Washington
|
|
|
2
|
|
Alabama
|
|
|
2
|
|
Kansas
|
|
|
2
|
|
Minnesota
|
|
|
2
|
|
New Mexico
|
|
|
2
|
|
North Carolina
|
|
|
2
|
|
South Dakota
|
|
|
2
|
|
Tennessee
|
|
|
2
|
|
Vermont
|
|
|
2
|
|
Wisconsin
|
|
|
2
|
|
New Jersey
|
|
|
2
|
|
Maine
|
|
|
1
|
|
Arizona
|
|
|
1
|
|
Michigan
|
|
|
1
|
|
Oregon
|
|
|
1
|
|
South Carolina
|
|
|
1
|
|
Alaska
|
|
|
1
|
|
Arkansas
|
|
|
1
|
|
Colorado
|
|
|
1
|
|
Hawaii
|
|
|
1
|
|
Idaho
|
|
|
1
|
|
Indiana
|
|
|
1
|
|
Iowa
|
|
|
1
|
|
Mariana Islands
|
|
|
1
|
|
Massachusetts
|
|
|
1
|
|
Montana
|
|
|
1
|
|
Nebraska
|
|
|
1
|
|
Nevada
|
|
|
1
|
|
New Hampshire
|
|
|
1
|
|
North Dakota
|
|
|
1
|
|
Oklahoma
|
|
|
1
|
|
Rhode Island
|
|
|
1
|
|
Utah
|
|
|
1
|
|
Virginia
|
|
|
1
|
|
Wyoming
|
|
|
1
|
|
|
|
|
|
|
Total
|
|
|
194
|
**
|
|
|
|
|
|
|
|
|
* |
|
Includes as one case the 687 cases pending as a consolidated
action in re: Tobacco Litigation Personal Injury Cases,
described below. |
|
** |
|
Of the 194 pending U.S. cases, 29 are pending in federal court,
164 in state court and 1 in tribal court. |
The following table lists the categories of the
U.S. tobacco-related cases pending against RJR Tobacco or
its affiliates or indemnitees as of February 6, 2009,
compared with the number of cases pending against RJR Tobacco,
its affiliates or indemnitees as of October 10, 2008, as
reported in RAIs Quarterly Report on
Form 10-Q
for the
94
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
fiscal quarter ended September 30, 2008, filed with the SEC
on October 24, 2008, and a cross-reference to the
discussion of each case type.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
RJR Tobaccos
|
|
|
Cases Since
|
|
|
|
|
|
|
Case Numbers as
|
|
|
October 10, 2008
|
|
|
Page
|
|
Case Type
|
|
of February 6, 2009
|
|
|
Increase/(Decrease)
|
|
|
Reference
|
|
|
Individual Smoking and Health
|
|
|
102
|
|
|
|
(36
|
)
|
|
|
106
|
|
West Virginia IPIC (Number of Plaintiffs)*
|
|
|
1(687
|
)
|
|
|
|
|
|
|
107
|
|
Engle Progeny (Number of Plaintiffs)**
|
|
|
3,156 (8,808
|
)
|
|
|
846
|
|
|
|
108
|
|
Broin II
|
|
|
2,620
|
|
|
|
No Change
|
|
|
|
108
|
|
Class-Action
|
|
|
15
|
|
|
|
No Change
|
|
|
|
108
|
|
Health-Care Cost Recovery
|
|
|
4
|
|
|
|
No Change
|
|
|
|
115
|
|
MSA-Enforcement and Validity
|
|
|
60
|
|
|
|
No Change
|
|
|
|
119
|
|
Antitrust
|
|
|
2
|
|
|
|
No Change
|
|
|
|
122
|
|
Other Litigation
|
|
|
10
|
|
|
|
(1
|
)
|
|
|
122
|
|
|
|
|
* |
|
Beginning with this report, the West Virginia Individual
Personal Injury Cases have been separated from the Individual
Smoking and Health cases for reporting purposes. |
|
** |
|
The Engle Progeny Cases have been separated from the
Individual Smoking and Health cases for reporting purposes.
Plaintiffs counsel are attempting to include multiple
plaintiffs in most of the cases filed. The increase in the
number of cases includes new cases served and new cases filed by
severed plaintiffs. |
Four pending cases against RJR Tobacco and B&W have
attracted significant attention: the Florida state court
class-action
case, Engle v. R. J. Reynolds Tobacco Co., the
Louisiana state court
class-action
case, Scott v. American Tobacco Co., the federal
RICO case brought by the U.S. Department of Justice, and
the federal lights class action Schwab [McLaughlin] v.
Philip Morris USA, Inc.
In 2000, a jury in Engle rendered a punitive damages
verdict in favor of the Florida class of
approximately $145 billion against all defendants. On
July 6, 2006, the Florida Supreme Court, among other
things, affirmed an appellate courts reversal of the
punitive damages award, decertified the class going forward,
preserved several
class-wide
findings from the trial, including that nicotine is addictive
and cigarettes are defectively designed, and authorized class
members to avail themselves of these findings in individual
lawsuits under certain conditions. After subsequent motions were
resolved, the Florida Supreme Court issued its mandate on
January 11, 2007, thus beginning a one-year period in which
former class members were permitted to file individual lawsuits.
On October 1, 2007, the U.S. Supreme Court denied the
defendants petition for writ of certiorari. As of
February 6, 2009, RJR Tobacco had been served in 3,156
Engle Progeny Cases in both state and federal courts in
Florida. These cases include approximately 8,808 plaintiffs. The
number of cases will likely change due to individual plaintiffs
being severed from multi-plaintiff cases.
In 2004, a jury in Scott returned a verdict in favor of
the Louisiana class for $591 million to
establish a state-wide smoking cessation program. In 2007, the
Louisiana Court of Appeals upheld class certification,
significantly reduced the scope of recovery, and remanded the
case for further proceedings. The Louisiana and
U.S. Supreme Courts denied the defendants
applications for writ of certiorari. In July 2008, the trial
court entered an amended judgment in favor of the class for
approximately $263 million plus interest from June 30,
2004. On December 15, 2008, the trial court signed the
order for appeal of the amended judgment. The briefing schedule
with the Court of Appeals has not been set.
In the U.S. Department of Justice case, brought in 1999 in
the U.S. District Court for the District of Columbia, the
government sought, among other forms of relief, the disgorgement
of profits pursuant to the civil provisions of RICO. The
U.S. Court of Appeals for the District of Columbia ruled in
2005 that disgorgement is not an available remedy in the case.
The bench trial ended in June 2005, and the court, in August
2006, issued its ruling, among other
95
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
things, finding certain defendants, including RJR Tobacco and
B&W, liable for the RICO claims, imposing no direct
financial penalties on the defendants, but ordering the
defendants to make certain corrective communications
in a variety of media and enjoining the defendants from using
certain brand descriptors. Both sides have appealed to the
U.S. Court of Appeals for the District of Columbia, and the
trial courts order has been stayed pending the appeal.
Oral argument occurred on October 14, 2008. A decision is
pending.
In September 2006, the U.S. District Court for the Eastern
District of New York in Schwab certified a nation-wide
class of lights smokers. On November 16, 2006,
the U.S. Court of Appeals for the Second Circuit granted
the defendants motions to stay the district court
proceedings and for review of the class certification ruling. On
April 3, 2008, the Second Circuit decertified the class.
The case was returned to the trial court for further proceedings.
For a detailed description of these cases, see
Class-Action
Suits Engle Case,
Class Action Suits Medical
Monitoring and Smoking Cessation Cases,
Health-Care Cost Recovery Cases
Department of Justice Case and
Class-Action
Suits Lights Cases below.
In November 1998, the major U.S. cigarette manufacturers,
including RJR Tobacco and B&W, entered into the MSA with 46
U.S. states and certain U.S. territories and
possessions. These cigarette manufacturers previously settled
four other cases, brought on behalf of Mississippi, Florida,
Texas and Minnesota, by separate agreements with each state. The
MSA, including the four other state settlement agreements:
|
|
|
|
|
settled all health-care cost recovery actions brought by, or on
behalf of, the settling jurisdictions;
|
|
|
|
released the major U.S. cigarette manufacturers from
various additional present and potential future claims;
|
|
|
|
imposed future payment obligations in perpetuity on RJR Tobacco,
B&W and other major U.S. cigarette
manufacturers; and
|
|
|
|
placed significant restrictions on their ability to market and
sell cigarettes.
|
The aggregate cash payments made by RJR Tobacco under the MSA
were $2.8 billion, $2.6 billion and $2.6 billion
in 2008, 2007 and 2006, respectively. RJR Tobacco estimates its
payments will be approximately $2.7 billion in 2009 and
between approximately $2.4 million-$2.6 billion each
year thereafter. These payments are subject to adjustments for,
among other things, the volume of cigarettes sold by RJR
Tobacco, RJR Tobaccos market share and inflation. See
Health-Care Cost Recovery Cases
MSA below for a detailed discussion of the MSA, including
RJR Tobaccos monetary obligations under these agreements.
RJR Tobacco records the allocation of settlement charges as
products are shipped.
Scheduled Trials. Trial schedules are subject
to change, and many cases are dismissed before trial. It is
likely, however, that RJR Tobacco and other cigarette
manufacturers will face an increased number of trials in 2009
compared to recent years. The following table lists the trial
schedule, as of February 6, 2009, for RJR Tobacco or its
affiliates and indemnitees through December 31, 2009.
|
|
|
|
|
|
|
Trial Date
|
|
Case Name/Type
|
|
Defendant(s)
|
|
Jurisdiction
|
|
October 6, 2008 [ONGOING]
|
|
Vermont v. R. J. Reynolds Tobacco Co. [MSA
Enforcement (Eclipse)]
|
|
RJR Tobacco
|
|
Superior Court Chittenden County (Burlington, VT)
|
March 9, 2009
|
|
Gelep v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Pinellas County (St. Petersburg, FL)
|
April 13, 2009
|
|
Kalyvas v. Philip Morris USA, Inc.. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Hillsborough County (Tampa, FL)
|
April 14, 2009
|
|
Levine v. R.J. Reynolds Tobacco Co. [Individual]
|
|
RJR Tobacco
|
|
Circuit Court
Palm Beach County
(West Palm Beach, FL)
|
96
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
Trial Date
|
|
Case Name/Type
|
|
Defendant(s)
|
|
Jurisdiction
|
|
April 27, 2009
|
|
Abbott v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
April 27, 2009
|
|
Barbanell v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
April 27, 2009
|
|
Bronstein v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
April 27, 2009
|
|
Cohen v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
April 27, 2009
|
|
Dawson v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
April 27, 2009
|
|
Kaplan v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
April 27, 2009
|
|
Lapidus-Carlson v. R.J. Reynolds Tobacco Co.
[Engle Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
April 27, 2009
|
|
Marrazzo v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
April 27, 2009
|
|
Morrissette-Stege v. R.J. Reynolds Tobacco Co.
[Engle Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
April 27, 2009
|
|
Palmieri v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
April 27, 2009
|
|
Rohr v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
April 27, 2009
|
|
Tucci v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
April 27, 2009
|
|
Walsh v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
May 11, 2009
|
|
Martin v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Escambia County (Pensacola, FL)
|
June 1, 2009
|
|
Allen v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Hillsborough County (Tampa, FL)
|
June 29, 2009
|
|
Budnick v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
97
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
Trial Date
|
|
Case Name/Type
|
|
Defendant(s)
|
|
Jurisdiction
|
|
June 29, 2009
|
|
Greene v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
June 29, 2009
|
|
Grossman v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
June 29, 2009
|
|
Naugle v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
June 29, 2009
|
|
Buonomo v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
June 29, 2009
|
|
Calloway v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
June 29, 2009
|
|
Goldthorpe v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
June 29, 2009
|
|
Hatziyannakis v. R.J. Reynolds Tobacco Co.
[Engle Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County
(Ft. Lauderdale, FL)
|
June 29, 2009
|
|
Putney v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
June 29, 2009
|
|
Stephens v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
June 29, 2009
|
|
Talenfeld v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
July 6, 2009
|
|
Hargroves v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Broward County (Ft. Lauderdale, FL)
|
July 13, 2009
|
|
Blanche v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Charlotte County (Punta Gorda, FL)
|
July 13, 2009
|
|
Bell v. Brown & Williamson Tobacco Corp.
[Individual]
|
|
RJR Tobacco, B&W
|
|
Circuit Court Jackson County (Independence, MO)
|
August 3, 2009
|
|
Long v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Hillsborough County (Tampa, FL)
|
August 3, 2009
|
|
Woods v. R.J. Reynolds Tobacco Co. [Individual]
|
|
RJR Tobacco, B&W
|
|
U.S. District Court Southern District (Jackson, MS)
|
August 5, 2009
|
|
Coley v. 3M Company.
[Other]
|
|
RJR Tobacco
|
|
Superior Court
New Castle County (Wilmington, DE)
|
98
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
Trial Date
|
|
Case Name/Type
|
|
Defendant(s)
|
|
Jurisdiction
|
|
October 5, 2009
|
|
Willis v. R.J. Reynolds Tobacco Co. [Engle
Progeny]
|
|
RJR Tobacco
|
|
Circuit Court Manatee County (Bradenton, FL)
|
October 19, 2009
|
|
Nuzum v. Brown & Williamson Tobacco Corp.
[Individual]
|
|
RJR Tobacco, B&W
|
|
Circuit Court Jackson County (Kansas City, MO)
|
November 17, 2009
|
|
Grisham v. Philip Morris Inc. [Individual],
|
|
B&W
|
|
U.S. District Court Central District
(Los Angeles, CA)
|
Trial Results. From January 1, 1999
through February 6, 2009, 54 smoking and health and
health-care cost recovery cases in which RJR Tobacco or B&W
were defendants were tried. Verdicts in favor of RJR Tobacco,
B&W and, in some cases, RJR Tobacco, B&W and other
defendants, were returned in 37 cases, including four mistrials,
tried in Florida (11), New York (4), Missouri (4), Tennessee
(3), Mississippi (2), California (2), West Virginia (2), Ohio
(2), Connecticut (1), Louisiana (1), New Jersey (1),
Pennsylvania (1), South Carolina (1), Texas (1) and
Washington (1).
Additionally, from January 1, 1999 through February 6,
2009, 23 smoking and health cases in which RJR Tobacco,
B&W, or their respective affiliates were not defendants
were tried. Verdicts were returned in favor of the defendants in
14 cases, including two mistrials, tried in Florida (6),
California (3), New Hampshire (1), New York (1), Pennsylvania
(1), Rhode Island (1) and Tennessee (1). Verdicts in favor
of the plaintiffs were returned in nine cases tried in
California (4), Florida (2), Oregon (2) and Illinois (1).
No smoking and health or health-care cost recovery cases in
which RJR Tobacco was a defendant were tried in 2008.
The following chart reflects the verdicts and post-trial
developments in the smoking and health cases that have been
tried and remain pending as of February 6, 2009, in which
verdicts have been returned in favor of the plaintiffs and
against RJR Tobacco or B&W, or both.
99
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
Date of Verdict
|
|
Case Name/Type
|
|
Jurisdiction
|
|
Verdict
|
|
Post-Trial Status
|
|
July 7, 1999-Phase I April 7, 2000-Phase II
July 14, 2000-Phase III
|
|
Engle v. R. J. Reynolds Tobacco
Co. [Class Action]
|
|
Circuit Court, Miami-Dade County
(Miami, FL)
|
|
$12.7 million compensatory damages against all the defendants;
$145 billion punitive damages against all the defendants, of
which approximately $36.3 billion and $17.6 billion was assigned
to RJR Tobacco and B&W, respectively.
|
|
On May 21, 2003, Floridas Third District Court of Appeal
reversed the trial court and remanded the case to the Miami-Dade
County Circuit Court with instructions to decertify the class.
The Florida Supreme Court on July 6, 2006, affirmed the
dismissal of the punitive damages award and decertified, on a
going-forward basis, the class. The court preserved a number of
classwide findings from Phase I of the Engle trial, and
authorized class members to avail themselves of those findings
in individual lawsuits, provided they commence those lawsuits
within one year of the date the courts decision becomes
final. In addition, the court reinstated compensatory damage
verdicts in favor of two plaintiffs in the amounts of $2.85
million and $4.023 million, respectively. In the third quarter
of 2007, the U.S. Supreme Court denied the defendants
petition for writ of certiorari and petition for rehearing. As
a result, on February 8, 2008, RJR Tobacco paid approximately
$5.9 million relating to the damages verdicts mentioned above,
which amount was determined using the total amount of the
verdicts together with accrued interest beginning November 7,
2000.
|
100
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
Date of Verdict
|
|
Case Name/Type
|
|
Jurisdiction
|
|
Verdict
|
|
Post-Trial Status
|
|
June 11, 2002
|
|
Lukacs v. R. J. Reynolds Tobacco Co. [Engle
class member]
|
|
Circuit Court, Miami-Dade County
(Miami, FL)
|
|
$500,000 economic damages, $24.5 million non-economic damages
and $12.5 million loss of consortium damages against Philip
Morris, B&W and Liggett, of which B&W was assigned
22.5% of liability. Final judgment was entered in the amount of
$24.8 million plus interest applicable at the yearly statutory
rates from July 11, 2002. RJR Tobacco was dismissed from the
case in May 2002, prior to trial.
|
|
Judge reduced damages to $25.125 million of which
B&Ws share is approximately $6 million. On January
2, 2007, the defendants moved to set aside the June 11, 2002,
verdict and to dismiss the plaintiffs punitive damages
claim. On January 3, 2007, the plaintiffs filed a motion for
entry of judgment, which the court deferred until the U.S.
Supreme Court completed review of Engle and after further
submissions by the parties. On January 28, 2008, the defendants
filed a submission asking the court to set aside the verdict and
to dismiss the case. The court granted the plaintiffs
motion for entry of judgment on August 14, 2008. Pursuant to
that verdict, the plaintiff will recover the sum of $24.8
million plus interest at the yearly statutory rates from July
11, 2002. On October 30, 2008, the defendants motion for
reconsideration of or, in the alternative, to alter or amend the
order on the plaintiffs motion for entry of judgment was
denied. On November 12, 2008, the court entered the final
judgment. On December 1, 2008, the defendants filed a notice of
appeal. Briefing is underway.
|
101
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
Date of Verdict
|
|
Case Name/Type
|
|
Jurisdiction
|
|
Verdict
|
|
Post-Trial Status
|
|
December 18, 2003
|
|
Frankson v. Brown & Williamson Tobacco Corp.
[Individual]
|
|
Supreme Court, Kings County
(Brooklyn, NY)
|
|
$350,000 compensatory damages; 50% fault assigned to B&W
and two industry organizations; $20 million in punitive damages,
of which $6 million was assigned to B&W, $2 million to a
predecessor company and $12 million to two industry
organizations.
|
|
On January 21, 2005, the plaintiff stipulated to the
courts reduction in the amount of punitive damages from
$20 million to $5 million, apportioned as follows: $0 to
American Tobacco; $4 million to B&W; $500,000 to the
Council for Tobacco Research and $500,000 to the Tobacco
Institute. On June 26, 2007, final judgment was entered in the
amount of approximately $6.8 million, including interest
and costs. The defendants filed a notice of appeal on
July 3, 2007. Oral argument occurred on January 26, 2009.
A decision is pending. Pursuant to its agreement to indemnify
B&W, RJR Tobacco posted a supersedeas bond in the amount of
$8.018 million on July 5, 2007.
|
102
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
Date of Verdict
|
|
Case Name/Type
|
|
Jurisdiction
|
|
Verdict
|
|
Post-Trial Status
|
|
May 21, 2004
|
|
Scott v. American Tobacco Co.
[Class Action]
|
|
District Court, Orleans Parish
(New Orleans, LA)
|
|
$591 million against RJR Tobacco, B&W, Philip Morris,
Lorillard, and the Tobacco Institute, jointly and severally, for
a smoking cessation program.
|
|
On September 29, 2004, the defendants posted a $50 million bond
and noticed their appeal to the Louisiana Court of Appeal. RJR
Tobacco posted $25 million toward the bond. On February 7,
2007, the Louisiana Court of Appeal limited the size of the
class, and rejected the award of pre-judgment interest and most
of the specific components of the smoking cessation program.
However, the court upheld the class certification and found the
defendants responsible for funding smoking cessation for
eligible class members. On July 21, 2008, the trial court
entered an amended judgment in the case. The court found that
the defendants are jointly and severally liable for funding the
cost of a court-supervised smoking cessation program and ordered
the defendants to deposit approximately $263 million, together
with interest from June 30, 2004, into a trust for the funding
of the program. The court also stated that it would favorably
consider a motion to return to defendants a portion of unused
funds at the close of each program year in the event the monies
allocated for the preceding program year were not fully expended
because of a reduction in class size or the underutilization by
the remaining plaintiffs.
|
103
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
Date of Verdict
|
|
Case Name/Type
|
|
Jurisdiction
|
|
Verdict
|
|
Post-Trial Status
|
|
|
|
|
|
|
|
|
|
On August 27, 2008, the court denied the defendants
request for permission to pursue an appeal. On September 9,
2008, the defendants filed an emergency application for writ of
mandamus or supervisory writ with request for stay and expedited
consideration. The same day, the Louisiana Court of Appeals
stayed all proceedings pending further order of the court. On
November 17, 2008, the Court of Appeals granted the
defendants writ and ordered the trial court to sign the
order for appeal. On December 10, 2008, the
plaintiffs application for supervisory writs of certiorari
and or review from the November 17, 2008 ruling was denied by
the Louisiana Supreme Court On December 15, 2008, the trial
court judge signed an order granting the defendants an appeal
from the amended judgment. A briefing schedule has not been set.
|
February 2, 2005
|
|
Smith v. Brown & Williamson Tobacco Corp.
[Individual]
|
|
Circuit Court, Jackson County
(Independence, MO)
|
|
$2 million in compensatory damages which was reduced to $500,000
because of jurys findings that the plaintiff was 75% at
fault; $20 million in punitive damages.
|
|
On June 1, 2005, B&W filed its notice of appeal. On July
31, 2007, the Missouri Court of Appeals affirmed the
compensatory damages award but ordered a new trial on punitive
damages. The Missouri Supreme Court accepted transfer of the
case from the court of appeals, but on July 31, 2008,
retransferred the case to the Missouri Court of Appeals. On
December 16, 2008, the Missouri Court of Appeals issued an
opinion that affirmed in part, reversed in part and remanded the
case for further proceedings on the issue of punitive damages.
On
|
104
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
Date of Verdict
|
|
Case Name/Type
|
|
Jurisdiction
|
|
Verdict
|
|
Post-Trial Status
|
|
|
|
|
|
|
|
|
|
January 27, 2009, the Court of Appeals denied the
defendants motion for rehearing.
|
March 18, 2005
|
|
Rose v. Brown & Williamson Tobacco Corp.
[Individual]
|
|
Supreme Court, New York County (Manhattan, NY)
|
|
RJR Tobacco found not liable; $3.42 million in compensatory
damages against B&W and Philip Morris, of which $1.71
million was assigned to B&W; $17 million in punitive
damages against Philip Morris only.
|
|
On August 18, 2005, B&W filed its notice of appeal.
Pursuant to its agreement to indemnify B&W, RJR Tobacco
posted a supersedeas bond in the amount of $2.058 million on
February 7, 2006. On April 10, 2008, the New York Supreme Court,
Appellate Division reversed the judgment in the plaintiffs
favor and ordered that the case be dismissed. On May 8, 2008,
the plaintiffs filed a notice of appeal. On December 16, 2008,
the New York Court of Appeals affirmed the intermediate
appellate courts order. The plaintiffs filed a motion for
leave to reargue on January 14, 2009.
|
August 17, 2006
|
|
United States v. Philip Morris USA, Inc.
[Governmental Health-Care Cost Recovery]
|
|
U.S. District Court, District of Columbia (Washington, DC)
|
|
RJR Tobacco and B&W were found liable for civil RICO
claims; were enjoined from using certain brand descriptors and
from making certain misrepresentations; and were ordered to make
corrective communications on five subjects, including smoking
and health and addiction, to reimburse the U.S. Department of
Justice appropriate costs associated with the lawsuit, and to
maintain document web sites.
|
|
On September 11, 2006, RJR Tobacco and B&W filed their
notices of appeal. On October 16, 2006, the government filed its
notice of appeal. The court of appeals granted the
defendants motion to stay the district courts order
on October 31, 2006. Oral argument occurred on October 14,
2008. A decision is pending.
|
105
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
Date of Verdict
|
|
Case Name/Type
|
|
Jurisdiction
|
|
Verdict
|
|
Post-Trial Status
|
|
May 2, 2007
|
|
Whiteley v. R. J. Reynolds Tobacco Co. [Individual]
|
|
Superior Court, San Francisco County, (San Francisco,
CA)
|
|
$2.46 million in compensatory damages jointly against RJR
Tobacco and Philip Morris; $250,000 punitive damages against RJR
Tobacco only.
|
|
On September 5, 2007, the court denied RJR Tobaccos motion
for judgment notwithstanding the verdict or, in the alternative,
for a new trial. RJR Tobacco filed its notice of appeal on
October 3, 2007. Briefing is complete. Oral argument has not
been scheduled. RJR Tobacco has deposited with the court
approximately $2.6 million in U.S. Treasury bills in lieu
of a supersedeas bond to stay enforcement of the judgment
pending appeal.
|
Individual
Smoking and Health Cases
As of February 6, 2009, 102 individual cases were pending
in the United States against RJR Tobacco, B&W, as its
indemnitee, or both. This category of cases includes smoking and
health cases alleging personal injury brought by or on behalf of
individual plaintiffs, but does not include the Broin II,
Engle Progeny Cases or West Virginia IPIC Cases discussed
below. A total of 99 of the individual cases are brought by or
on behalf of individual smokers or their survivors, while the
remaining three cases are brought by or on behalf of individuals
or their survivors alleging personal injury as a result of
exposure to ETS.
Below is a description of the individual smoking and health
cases against RJR Tobacco or B&W, or both, which went to
trial or were decided during the period from January 1,
2008, to December 31, 2008, or remained on appeal as of
December 31, 2008.
In Whiteley v. R. J. Reynolds Tobacco Co., the retrial of
Whiteley v. Raybestos-Manhattan, a case filed in
April 1999 in Superior Court, San Francisco County,
California and originally tried in 2000, the jury awarded the
plaintiff $2.46 million in compensatory damages jointly
against RJR Tobacco and Philip Morris on May 2, 2007, and
returned a punitive damages verdict award of $250,000 against
RJR Tobacco on May 9, 2007. RJR Tobaccos motion for
judgment notwithstanding the verdict or, in the alternative, for
a new trial was denied on September 5, 2007. RJR Tobacco
has appealed. Briefing is complete. Oral argument has not been
scheduled. RJR Tobacco deposited with the court approximately
$2.6 million in U.S. Treasury bills in lieu of
supersedeas bond to stay enforcement of the judgment pending
appeal.
On August 15, 2003, a jury returned a verdict in favor of
B&W in Eiser v. Brown & Williamson
Tobacco Corp., a case filed in March 1999 in the Court of
Common Pleas, Philadelphia County, Pennsylvania. The plaintiff,
Lois Eiser, sought compensatory and punitive damages in an
amount in excess of $50,000, together with interest, costs and
attorneys fees in this wrongful death action against
B&W. On January 19, 2006, the Superior Court of
Pennsylvania affirmed the verdict. On September 22, 2006,
the Pennsylvania Supreme Court granted the plaintiffs
petition to appeal, and on December 28, 2007, remanded the
case to the Superior Court for further review. Briefing is
complete. A decision is pending.
On December 18, 2003, in Frankson v. Brown &
Williamson Tobacco Corp., a case filed in August 2000 in
Supreme Court, Kings County, New York, a jury awarded $350,000
in compensatory damages against B&W and two former tobacco
industry organizations, the Tobacco Institute and the Council
for Tobacco Research, in an action brought against the major
U.S. cigarette manufacturers, including RJR Tobacco, who
was dismissed prior to trial,
106
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
and B&W, seeking $270 million in compensatory damages,
unspecified punitive damages, attorneys fees, costs and
disbursements. Other manufacturers were dismissed before trial.
The plaintiff, Gladys Frankson, alleged that Mr. Frankson
became addicted to nicotine, was unable to cease smoking,
developed lung cancer and died as a result. The defendants as a
group and the deceased smoker were each found to be 50% at
fault. On January 8, 2004, the jury awarded
$20 million in punitive damages, assigning $6 million
to B&W, $2 million to American Tobacco, a predecessor
company to B&W, and $6 million to each of the Council
for Tobacco Research and the Tobacco Institute. On June 22,
2004, the trial judge granted a new trial unless the parties
consented to an increase in compensatory damages to $500,000 and
a decrease in punitive damages to $5 million, of which
$4 million would be assigned to B&W. On
January 21, 2005, the plaintiff stipulated to the reduction
in punitive damages.
After all post-trial motions, and appeals therefrom, were
denied, judgment was entered in favor of the plaintiffs for
$175,000 in compensatory damages, the original jury award
reduced by 50%, and $5 million in punitive damages, the
amount to which the plaintiff stipulated. On June 26, 2007,
final judgment was entered against the defendants in the amount
of approximately $6.8 million, including interest and
costs. The defendants filed a notice of appeal to the Appellate
Division, New York Supreme Court, Second Department on
July 3, 2007. Pursuant to its agreement to indemnify
B&W, RJR Tobacco posted a supersedeas bond in the amount of
$8.018 million on July 5, 2007. Oral argument occurred
on January 26, 2009. A decision is pending.
On February 1, 2005, a jury returned a split verdict in
Smith v. Brown & Williamson Tobacco Corp.,
a case filed in May 2003 in Circuit Court, Jackson County,
Missouri, finding in favor of B&W on two counts, fraudulent
concealment and conspiracy, and finding in favor of the
plaintiff on negligence, which incorporates failure to warn and
product defect claims. The plaintiff, Lincoln Smith, claimed
that the defendants tobacco products caused
Mrs. Smiths death from lung cancer and sought an
unspecified amount of compensatory and punitive damages. The
plaintiff was awarded $2 million in compensatory damages
and $20 million in punitive damages; however, the jury
found the plaintiff to be 75% at fault, and B&W 25% at
fault, and thus the compensatory award was reduced to $500,000.
B&W appealed to the Missouri Court of Appeals and on
July 31, 2007, the court affirmed the compensatory damages
and ordered a new trial on punitive damages. The Missouri
Supreme Court agreed to accept transfer of the case from the
Court of Appeals, and on July 31, 2008, retransferred the
case to the Missouri Court of Appeals. On December 16,
2008, the Missouri Court of Appeals issued an opinion that
affirmed in part, reversed in part, and remanded the case for
further proceedings on the issue of punitive damages. On
December 30, 2008, the defendants filed a motion for
rehearing, which was denied on January 27, 2009. A new
trial on the issue of punitive damages is expected to occur in
2009.
On March 18, 2005, in Rose v. Brown &
Williamson Tobacco Corp., a case filed in December 1996 in
New York Supreme Court, County of New York, a jury returned
a verdict in favor of RJR Tobacco, but returned a
$3.42 million compensatory damages verdict against B&W
and Philip Morris, of which $1.71 million was assigned to
B&W. A punitive damages verdict of $17 million against
Philip Morris only was returned by the jury on March 28,
2005. The action was brought against the major
U.S. cigarette manufacturers, including RJR Tobacco and
B&W, seeking to recover $15 million in compensatory
damages and $35 million in punitive damages. The
plaintiffs, Norma Rose and Leonard Rose, allege that their use
of the defendants products caused them to become addicted
to nicotine and develop lung cancer, chronic obstructive
pulmonary disease and other smoking related conditions
and/or
diseases. Oral argument on B&Ws appeal in the
Appellate Division, New York Supreme Court, First Department
occurred on December 12, 2006. Pursuant to its agreement to
indemnify B&W, RJR Tobacco posted a supersedeas bond in the
amount of $2.058 million on February 7, 2006. On
April 10, 2008, the Appellate Division reversed the
judgment in the plaintiffs favor and ordered that the case
be dismissed. On May 8, 2008, the plaintiffs filed a notice
of appeal. On December 16, 2008, the New York Court of
Appeals affirmed the order. The plaintiffs filed a motion for
leave to reargue on January 14, 2009.
West
Virginia IPIC
In West Virginia, there are 729 cases (of which 687 are actions
against RJR Tobacco
and/or
B&W) pending as a consolidated action, In re: Tobacco
Litigation Personal Injury Cases. These cases are proposed
to be tried in a single proceeding. The West Virginia Supreme
Court of Appeals ruled that the U.S. Constitution does not
preclude a trial
107
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
in multiple phases in this case, and the U.S. Supreme Court
declined to review the issue. The current trial plan provides
for a three phase proceeding, with certain elements of liability
and entitlement to punitive damages being tried in Phase I.
Phase II would address the ratio between any compensatory
and punitive damages awarded. Phase III would address all
remaining individual issues including medical and legal
causation and compensatory damages. Trial is scheduled to begin
February 1, 2010.
Engle
Progeny Cases
Pursuant to the Florida Supreme Courts July 6, 2006,
ruling in Engle v. R. J. Reynolds Tobacco Co., which
decertified the class, former class members had one year from
January 11, 2007, in which to file individual lawsuits. In
addition, some individuals who filed suit prior to
January 11, 2007, and who claim they meet the conditions in
Engle, also are attempting to avail themselves of the
Engle ruling. Lawsuits by individuals requesting the
benefit of the Engle ruling, whether filed before or
after the January 11, 2007, mandate, are referred to as the
Engle Progeny Cases. As of February 6, 2009, RJR
Tobacco had been served in 3,156 Engle Progeny Cases in
both state and federal courts in Florida. These cases include
approximately 8,808 plaintiffs. The number of cases will likely
change due to individual plaintiffs being severed from
multi-plaintiff cases. Many of these cases are in active
discovery, and several are expected to be tried in 2009. For
further information on the Engle case, see
Class-Action
Suits Engle Case, below.
Broin II
Cases
As of February 6, 2009, there were 2,620 lawsuits pending
in Florida brought by individual flight attendants for personal
injury as a result of illness allegedly caused by exposure to
ETS in airplane cabins, referred to as the Broin II
cases. In these lawsuits, filed pursuant to the terms of the
settlement of the Broin v. Philip Morris, Inc. class
action, discussed below under
Class-Action
Suits, each individual flight attendant will be required
to prove that he or she has a disease and that the
individuals exposure to ETS in airplane cabins caused the
disease. Punitive damages are not available in these cases.
On October 5, 2000, the Broin court entered an order
applicable to all Broin II cases that the terms of the
Broin settlement agreement do not require the individual
Broin II plaintiffs to prove the elements of strict
liability, breach of warranty or negligence. Under this order,
there is a rebuttable presumption in the plaintiffs favor
on those elements, and the plaintiffs bear the burden of proving
that their alleged adverse health effects actually were caused
by exposure to ETS in airplane cabins, that is, specific
causation.
Class-Action
Suits
Overview. As of February 6, 2009, 15
class-action
cases, exclusive of antitrust class actions, were pending in the
United States against RJR Tobacco or its affiliates or
indemnitees. In May 1996, in Castano v. American Tobacco
Co., the Fifth Circuit Court of Appeals overturned the
certification of a nation-wide class of persons whose claims
related to alleged addiction to tobacco products. Since this
ruling by the Fifth Circuit, most
class-action
suits have sought certification of state-wide, rather than
nation-wide, classes.
Class-action
suits based on claims similar to those asserted in Castano
or claims that class members are at a greater risk of injury
or injured by the use of tobacco or exposure to ETS are pending
against RJR Tobacco and its affiliates and indemnitees in state
or federal courts in California, Illinois, Louisiana, Minnesota,
Missouri, New York, West Virginia and Georgia. All pending
class-action
cases are discussed below.
The pending
class-actions
against RJR Tobacco or its affiliates or indemnitees include
seven cases alleging that the use of the term lights
constitutes unfair and deceptive trade practices under state law
or violates the federal RICO statute. Such suits are pending in
state or federal courts in Illinois, Minnesota, Missouri and New
York and are discussed below under
Lights Cases.
Finally, certain third-party payers have filed health-care cost
recovery actions in the form of
class-actions.
These cases are discussed below under
Health-Care Cost Recovery Cases.
108
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Few smoker
class-action
complaints have been certified or, if certified, have survived
on appeal. Eighteen federal courts, including two courts of
appeals, and most state courts that have considered the issue
have rejected class certification in such cases. Apart from the
Castano case discussed above, only two smoker class
actions have been certified by a federal court In
re Simon (II) Litigation, and Schwab
[McLaughlin] v. Philip Morris USA, Inc., discussed
below under Lights
Cases, both of which were filed in the
U.S. District Court for the Eastern District of New York
and ultimately decertified.
Medical Monitoring and Smoking Cessation
Cases. On November 5, 1998, in
Scott v. American Tobacco Co., a case filed in May
1996 in District Court, Orleans Parish, Louisiana, the trial
court certified a medical monitoring or smoking cessation class
of Louisiana residents who were smokers on or before
May 24, 1996, in an action brought against the major
U.S. cigarette manufacturers, including RJR Tobacco and
B&W, seeking to recover an unspecified amount of
compensatory and punitive damages. The plaintiffs allege that
their use of the defendants products caused them to become
addicted to nicotine. On July 28, 2003, the jury returned a
verdict in favor of the defendants on the plaintiffs claim
for medical monitoring and found that cigarettes were not
defectively designed. However, the jury also made certain
findings against the defendants on claims relating to fraud,
conspiracy, marketing to minors and smoking cessation.
Notwithstanding these findings, this portion of the trial did
not determine liability as to any class member or class
representative. What primarily remained in the case was a
class-wide
claim that the defendants pay for a program to help people stop
smoking.
On March 31, 2004, phase two of the trial began to address
only the scope and cost of smoking cessation programs. On
May 21, 2004, the jury returned a verdict in the amount of
$591 million on the classs claim for a smoking
cessation program. On September 29, 2004, the defendants
posted a $50 million bond, pursuant to legislation that
limits the amount of the bond to $50 million collectively
for MSA signatories, and noticed their appeal. RJR Tobacco
posted $25 million, that is, the portions for RJR Tobacco
and B&W, towards the bond. On February 7, 2007, the
Louisiana Court of Appeals upheld the class certification and
found the defendants responsible for funding smoking cessation
for eligible class members. The appellate court also ruled,
however, that the defendants were not liable for any post-1988
claims, rejected the award of prejudgment interest and struck
eight of the 12 components of the smoking cessation program. In
particular, the appellate court ruled that no class member, who
began smoking after September 1, 1988, could receive any
relief, and that only those smokers, whose claims accrued on or
before September 1, 1988, would be eligible for the smoking
cessation program. Plaintiffs have expressly represented to the
trial court that none of their claims accrued before 1988 and
that the class claims did not accrue until around 1996, when the
case was filed. On March 2, 2007, the defendants
application for rehearing and clarification was denied. The
defendants application for writ of certiorari with the
Louisiana Supreme Court was denied on January 7, 2008. The
defendants petition for writ of certiorari with the
U.S. Supreme Court was denied on June 10, 2008. On
July 21, 2008, the trial court entered an amended judgment
in the case. The court found that the defendants are jointly and
severally liable for funding the cost of a court-supervised
smoking cessation program and ordered the defendants to deposit
approximately $263 million together with interest from
June 30, 2004, into a trust for the funding of the program.
The court also stated that it would favorably consider a motion
to return to defendants a portion of unused funds at the close
of each program year in the event the monies allocated for the
preceding program year were not fully expended because of a
reduction in class size or underutilization by the remaining
plaintiffs.
On August 27, 2008, the court denied the defendants
request for permission to pursue an appeal. On September 9,
2008, the defendants filed an emergency application for writ of
mandamus or supervisory writ with request for stay and expedited
consideration. The same day, the Louisiana Court of Appeals
stayed all proceedings pending further orders of the court. On
November 17, 2008, the Court of Appeals granted the
defendants writ and ordered the trial court to sign the
order for appeal. On December 10, 2008, the
plaintiffs application for supervisory writs of certiorari
and or review from the November 17, 2008 ruling was denied
by the Louisiana Supreme Court. On December 15, 2008, the
trial court judge signed an order granting the defendants an
appeal from the amended judgment. A briefing schedule has not
been set.
Peoples v. Reynolds American, Inc., filed
November 17, 2008 in the U.S. District Court for the
Northern District of Georgia, is a purported RICO class action
on behalf of Georgia smokers claiming that RAI, Altria and
109
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Lorillard,
and/or their
affiliates wrongfully influenced the federal governments
National Cancer Institute not to recommend CT scans as a routine
lung cancer screening test for smokers. Plaintiffs claim that
the NCIs failure to endorse the test leads insurers to
deny reimbursement and persuades doctors not to order the tests
as a result. The plaintiffs seek a variety of damages, including
alleged contemplated damages under RICO, punitive damages,
attorneys fees, interest and costs. The defendants have
moved to dismiss the case based on the plaintiffs failure to
state a claim meeting the basic prerequisites of RICO.
Engle Case. Trial began in July 1998 in
Engle v. R. J. Reynolds Tobacco Co., a case filed in
May 1994, in Circuit Court, Miami-Dade County, Florida, in which
a class consisting of Florida residents, or their survivors,
alleges diseases or medical conditions caused by their alleged
addiction to cigarettes. The action was brought
against the major U.S. cigarette manufacturers, including
RJR Tobacco and B&W, seeking actual damages and punitive
damages in excess of $100 billion each and the creation of
a medical fund to compensate individuals for future health-care
costs. On July 7, 1999, the jury found against RJR Tobacco,
B&W and the other cigarette-manufacturer defendants in the
initial phase, which included common issues related to certain
elements of liability, general causation and a potential award
of, or entitlement to, punitive damages.
The second phase of the trial, which consisted of the claims of
three of the named class representatives, began on
November 1, 1999. On April 7, 2000, the jury returned
a verdict against all the defendants. It awarded plaintiff Mary
Farnan $2.85 million, the estate of plaintiff Angie Della
Vecchia $4.023 million and plaintiff Frank Amodeo
$5.831 million.
The trial court also ordered the jury in the second phase of the
trial to determine punitive damages, if any, on a
class-wide
basis. On July 14, 2000, the jury returned a punitive
damages verdict in favor of the Florida class of
approximately $145 billion against all the defendants, with
approximately $36.3 billion and $17.6 billion being
assigned to RJR Tobacco and B&W, respectively.
On November 6, 2000, the trial judge denied all post-trial
motions and entered judgment. In November 2000, RJR Tobacco and
B&W posted appeal bonds in the amount of $100 million
each and initiated the appeals process. On May 21, 2003,
Floridas Third District Court of Appeal reversed the trial
courts final judgment and remanded the case to the
Miami-Dade County Circuit Court with instructions to decertify
the class. The class appealed, and the Florida Supreme Court
accepted the case on May 12, 2004.
On July 6, 2006, the court affirmed the dismissal of the
punitive damages award and decertified the class, on a
going-forward basis. The court preserved a number of
class-wide
findings from Phase I of the trial, including that cigarettes
can cause certain diseases, that nicotine is addictive and that
defendants placed defective and unreasonably dangerous
cigarettes on the market, and authorized former class members to
avail themselves of those findings under certain conditions in
individual lawsuits, provided they commence those lawsuits
within one year of the date the courts decision became
final. The court specified that the class is confined to those
Florida citizen residents who suffered or died from
smoking-related illnesses that manifested themselves
on or before November 21, 1996, and that were caused by an
addiction to cigarettes. In addition, the court reinstated the
compensatory damages awards of $2.85 million to Mary Farnan
and $4.023 million to Angie Della Vecchia, but ruled that
the claims of Frank Amodeo were barred by the statute of
limitations. Finally, the court reversed the Third District
Court of Appeals 2003 ruling that class counsels
improper statements during trial required reversal.
On August 7, 2006, RJR Tobacco and the other defendants
filed a rehearing motion arguing, among other things, that the
findings from the Engle trial are not sufficiently
specific to serve as the basis for further proceedings and that
the Florida Supreme Courts decision denied defendants due
process. On the same day, the plaintiffs also filed a rehearing
motion arguing that some smokers who became sick after
November 21, 1996, and who are therefore not class members,
should nevertheless have the statute of limitations tolled since
they may have refrained from filing suit earlier in the mistaken
belief that they were Engle class members. On
December 21, 2006, the Florida Supreme Court withdrew its
July 6, 2006, decision and issued a revised opinion, in
which it set aside the jurys findings of a conspiracy to
misrepresent and clarified that the Engle jurys
finding on express warranty were preserved for use by eligible
plaintiffs. The court also denied the plaintiffs motion
and confirmed that the class was limited to those individuals
who developed alleged smoking-related illnesses that manifested
themselves on or
110
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
before November 21, 1996. The court issued its mandate on
January 11, 2007, which began the one-year period for
former class members to file individual lawsuits. As of
February 6, 2009, 3,156 individual cases were filed in
Florida as a result of the Engle decision. These cases
include approximately 8,808 plaintiffs. For further information
on the individual cases, see Engle
Progeny Cases above.
On April 17, 2007, RJR Tobaccos motions for discharge
of RJR Tobaccos and B&Ws civil supersedeas
bonds related to the punitive damages award were granted. During
the second quarter of 2007, RJR Tobacco received the full amount
of the $100 million cash collateral that it had posted. On
October 1, 2007, the defendants petition for writ of
certiorari with the U.S. Supreme Court was denied. On
November 26, 2007, the defendants petition for
rehearing with the U.S. Supreme Court was denied. As a
result, the verdicts in favor of Mary Farnan and Angie Della
Vecchia, mentioned above, became final. On February 8,
2008, RJR Tobacco paid approximately $5.9 million relating
to the compensatory damages verdicts mentioned above, which
amount was determined using the total amount of the verdicts
together with accrued interest beginning November 7, 2000.
On May 14, 2008, the court entered an order granting the
motion for discharge and return of compensatory damages
supersedeas bond. During the second quarter of 2008, RJR Tobacco
received the cash collateral of $3.8 million that it posted
for the compensatory damages bond. Also on May 14, 2008,
plaintiffs Mary Farnan and Ralph Della Vecchia, as
representative of the estate of Angie Della Vecchia, filed
satisfactions of judgment and waived all claims for punitive
damages and acknowledged full payment in satisfaction of the
November 7, 2000, amended final judgment. The same day, the
court granted the parties joint motion to sever moving
plaintiffs claims. Plaintiffs Raymond Lacey, Michael Matyi
and Loren Lowery have filed new cases. Plaintiff Howard Engle
filed a stipulation for dismissal with prejudice, which the
court ordered on July 2, 2008. On January 7, 2009,
plaintiff Marilyn Calhouns motion for relief from
judgment, which sought to extend the deadline for filing
Engle Progeny Cases beyond January 11, 2008, was
denied by the Florida Supreme Court.
Since the Florida Supreme Courts July 6, 2006
opinion, no Engle Progeny Cases have proceeded to trial
against RJR Tobacco or B&W. RJR Tobacco expects that some
Engle Progeny Cases will proceed to trial against RJR
Tobacco
and/or
B&W in 2009, with the first case likely to start in March
2009.
Prior to the Florida Supreme Court ruling on July 6, 2006,
RJR Tobacco
and/or
B&W were named as a defendant(s) in several individual
cases filed by members of the Engle class. One such case,
Lukacs v. Philip Morris, Inc., a case filed in
February 2001, and pending in Circuit Court, Miami-Dade County,
Florida, was tried against Philip Morris, Liggett and B&W,
and resulted in a verdict for the plaintiffs on June 11,
2002, in a personal injury action brought against the major
U.S. cigarette manufacturers, including RJR Tobacco and
B&W, seeking to recover an unspecified amount in
compensatory and punitive damages. The plaintiff, John Lukacs,
alleged that his use of the defendants brands caused his
development of bladder, throat, oral cavity and tongue cancer.
RJR Tobacco was voluntarily dismissed on May 1, 2002. The
Florida state court jury awarded the plaintiffs a total of
$37.5 million in compensatory damages. The jury assigned
22.5% fault to B&W, 72.5% fault to the other defendants and
5% fault to plaintiff John Lukacs. On April 1, 2003, the
Miami-Dade County Circuit Court granted in part the
defendants motion for remittitur and reduced the
jurys award to plaintiff Yolanda Lukacs, on the loss of
consortium claim, from $12.5 million to $0.125 million
decreasing the total award to $25.125 million. On
August 2, 2006, the plaintiff filed a motion for entry of
partial judgment and notice of jury trial on punitive damages.
On January 2, 2007, the defendants asked the court to set
aside the jurys June 11, 2002, verdict for the
plaintiffs and to dismiss the plaintiffs punitive damages
claim. On January 3, 2007, the plaintiffs filed a motion
for entry of judgment, which the court deferred until the
U.S. Supreme Court completed its review of Engle and
after further submissions by the parties. On January 28,
2008, the defendants filed a submission asking the court to set
aside the verdict and to dismiss the case. The court granted the
plaintiffs motion for entry of judgment on August 14,
2008. Pursuant to the verdict rendered, the plaintiff, Robin
Lukacs, as personal representative of the estate of John and
Yolanda Lukacs, will recover the sum of $24.8 million plus
interest applicable at the yearly statutory rates from
June 11, 2002. On October 17, 2008, the plaintiff
withdrew her request for punitive damages. On October 30,
2008, the defendants motion for reconsideration of or, in
the alternative, to alter or amend the order on the
plaintiffs motion for entry of judgment was denied. On
November 12, 2008, the court entered final judgment. On
December 1, 2008, the defendants filed a notice of appeal.
Briefing is underway.
111
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
California Business and Professions Code
Cases. On April 11, 2001, in
Brown v. American Tobacco Co., Inc., a case filed in
June 1997 in Superior Court, San Diego County, California,
the court granted in part the plaintiffs motion for
certification of a class composed of residents of California who
smoked at least one of the defendants cigarettes from
June 10, 1993 through April 23, 2001, and who were
exposed to the defendants marketing and advertising
activities in California. The action was brought against the
major U.S. cigarette manufacturers, including RJR Tobacco
and B&W, seeking to recover restitution, disgorgement of
profits and other equitable relief under California Business and
Professions Code § 17200 et seq. and § 17500
et seq. Certification was granted as to the plaintiffs
claims that the defendants violated § 17200 of the
California Business and Professions Code pertaining to unfair
competition. The court, however, refused to certify the class
under the California Legal Remedies Act and on the
plaintiffs common law claims. On March 7, 2005, the
court granted the defendants motion to decertify the
class. On September 5, 2006, the California Court of Appeal
affirmed the judges order decertifying the class. On
November 1, 2006, the plaintiffs petition for review
with the California Supreme Court was granted. Briefing is
complete. Oral argument is scheduled for March 3, 2009.
Lights Cases. As noted above,
lights
class-action
cases are pending against RJR Tobacco or B&W in Illinois
(2), Missouri (2), Minnesota (2), and New York (1). The classes
in these cases generally seek to recover $50,000 to $75,000 per
class member for compensatory and punitive damages, injunctive
and other forms of relief, and attorneys fees and costs
from RJR Tobacco
and/or
B&W. In general, the plaintiffs allege that RJR Tobacco or
B&W made false and misleading claims that
lights cigarettes were lower in tar and nicotine
and/or were
less hazardous or less mutagenic than other cigarettes. The
cases typically are filed pursuant to state consumer protection
and related statutes.
Many of these lights cases were stayed pending
review of the Good v. Altria Group, Inc. case by the
U.S. Supreme Court. The U.S. Supreme Court decided
that these claims are not preempted by the Cigarette Labeling
Act or by the Federal Trade Commissions, referred to as
FTC, historic regulation of the industry on December 15,
2008. In light of this decision, it is likely that one or more
of the stayed cases will become active in 2009.
The seminal lights
class-action
case involved RJR Tobaccos competitor, Philip Morris, Inc.
Trial began in Price v. Philip Morris, Inc. in
January 2003. In March 2003, the trial judge entered judgment
against Philip Morris in the amount of $7.1 billion in
compensatory damages and $3 billion in punitive damages to
the State of Illinois. Based on Illinois law, the bond required
to stay execution of the judgment was set initially at
$12 billion. Philip Morris pursued various avenues of
relief from the $12 billion bond requirement. In December
2005, the Illinois Supreme Court reversed the lower courts
decision and sent the case back to the trial court with
instructions to dismiss the case. In December 2006, the
defendants motion to dismiss and for entry of final
judgment was granted and the case was dismissed with prejudice
the same day. The plaintiffs motion to vacate
and/or
withhold judgment was dismissed by the court on August 30,
2007. On December 18, 2008, the plaintiffs filed a petition
for relief from judgment stating that the U.S. Supreme
Courts decision in Good v. Altria Group, Inc.
rejected the basis for the reversal. The trial court denied that
motion on February 4, 2009.
In Turner v. R. J. Reynolds Tobacco Co., a case filed in
February 2000 in Circuit Court, Madison County, Illinois, a
judge certified a class on November 14, 2001. On
June 6, 2003, RJR Tobacco filed a motion to stay the case
pending Philip Morriss appeal of the Price v.
Philip Morris Inc. case mentioned above, which the judge
denied on July 11, 2003. On October 17, 2003, the
Illinois Fifth District Court of Appeals denied RJR
Tobaccos emergency stay/supremacy order request. On
November 5, 2003, the Illinois Supreme Court granted RJR
Tobaccos motion for a stay pending the courts final
appeal decision in Price. On October 11, 2007, the
Illinois Fifth District Court of Appeals dismissed RJR
Tobaccos appeal and remanded the case to the circuit
court. There is currently no activity in the case.
In Howard v. Brown & Williamson Tobacco Corp.,
another case filed in February 2000 in Circuit Court,
Madison County, Illinois, a judge certified a class on
December 18, 2001. On June 6, 2003, the trial judge
issued an order staying all proceedings pending resolution of
the Price v. Philip Morris, Inc. case mentioned
above. The
112
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
plaintiffs appealed this stay order to the Illinois Fifth
District Court of Appeals, which affirmed the Circuit
Courts stay order on August 19, 2005. There is
currently no activity in the case.
Schwab [McLaughlin] v. Philip Morris USA, Inc., a
nation-wide lights
class-action,
was filed on May 11, 2004, in the U.S. District Court
for the Eastern District of New York, against RJR Tobacco and
B&W, as well as other tobacco manufacturers. The plaintiffs
brought the case pursuant to RICO, challenging the practices of
the defendants in connection with the manufacturing, marketing,
advertising, promotion, distribution and sale of cigarettes that
were labeled as lights or light. On
September 25, 2006, the court issued its decision, among
other things, granting class certification. On November 16,
2006, the U.S. Court of Appeals for the Second Circuit
granted the defendants motions to stay the district court
proceedings and for review of the class certification ruling. On
April 3, 2008, the Second Circuit decertified the class.
The case was returned to the trial court for further proceedings.
A lights
class-action
case is pending against each of RJR Tobacco and B&W in
Missouri. In Collora v. R. J. Reynolds Tobacco Co.,
a case filed in May 2000 in Circuit Court, St. Louis
County, Missouri, a judge in St. Louis certified a class on
December 31, 2003. On April 9, 2007, the court granted
the plaintiffs motion to reassign Collora and the
following cases to a single general division: Craft v.
Philip Morris Companies, Inc. and Black v.
Brown & Williamson Tobacco Corp., discussed below.
On April 16, 2008, the court stayed the case pending
U.S. Supreme Court review in Good v. Altria Group,
Inc., a lights
class-action
pending against Altria and Philip Morris USA. As a result of the
U.S. Supreme Courts decision in Good v.
Altria Group, Inc., this case is likely to become active in
2009.
In Black v. Brown & Williamson Tobacco Corp., a
case filed in November 2000 in Circuit Court, City of
St. Louis, Missouri, B&W removed the case to the
U.S. District Court for the Eastern District of Missouri on
September 23, 2005. On October 25, 2005, the
plaintiffs filed a motion to remand, which was granted on
March 17, 2006. On April 16, 2008, the court stayed
the case pending U.S. Supreme Court review in
Good v. Altria Group, Inc. As a result of the
U.S. Supreme Courts decision in Good v.
Altria Group, Inc., this case is likely to become active in
2009.
In Dahl v. R. J. Reynolds Tobacco Co., a case filed in
April 2003, and pending in District Court, Hennepin County,
Minnesota, a judge dismissed the case on May 11, 2005,
ruling the lights claims are preempted by the
Federal Cigarette Labeling and Advertising Act. On July 11,
2005, the plaintiffs appealed to the Minnesota Court of Appeals
for the Fourth Judicial District. During the pendency of the
appeal, RJR Tobacco removed the case to the U.S. District
Court for the District of Minnesota. On February 28, 2007,
the Eighth Circuit remanded the case to the Minnesota Court of
Appeals, which on December 4, 2007, reversed the judgment
and remanded the case to the District Court. On
February 27, 2008, RJR Tobaccos motion to stay its
January 3, 2008, petition for review until the completion
of the U.S. Supreme Court review in Good v. Altria
Group, Inc. was granted. On January 20, 2009, the
Minnesota Supreme Court issued an order vacating the
February 27, 2008 order that granted RJR Tobaccos
petition for review. As a result of the U.S. Supreme
Courts decision in Good v. Altria Group, Inc.,
the case is likely to become active in 2009.
In Thompson v. R. J. Reynolds Tobacco Co., a case filed
in February 2005 in District Court, Hennepin County, Minnesota,
RJR Tobacco removed the case on September 23, 2005 to the
U.S. District Court for the District of Minnesota. On
August 7, 2006, the parties filed a stipulation to stay the
case pending resolution of the appeal in Dahl v. R. J.
Reynolds Tobacco Co. On October 29, 2007, the
U.S. District Court remanded the case to the District Court
for Hennepin County. On February 1, 2008, the court stayed
the case until the completion of the appeal in Dahl v.
R. J. Reynolds Tobacco Co. and Good v. Altria Group,
Inc. As a result of the U.S. Supreme Courts
decision in Good v. Altria Group, Inc., this case is
likely to become active in 2009.
In the event RJR Tobacco and its affiliates or indemnitees lose
one or more of the pending lights
class-action
suits, RJR Tobacco could face bonding difficulties depending
upon the amount of damages ordered, if any, which could have a
material adverse effect on RJR Tobaccos, and consequently
RAIs, results of operations, cash flows or financial
position.
113
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Other Class Actions. In Cleary v.
Philip Morris, Inc., a case filed in June 1998, and pending
in Circuit Court, Cook County, Illinois, the plaintiffs filed
their motion for class certification on December 21, 2001,
in an action brought against the major U.S. cigarette
manufacturers, including RJR Tobacco and B&W. The case is
brought on behalf of persons who have allegedly been injured by
(1) the defendants purported conspiracy pursuant to
which defendants concealed material facts regarding the
addictive nature of nicotine, (2) the defendants
alleged acts of targeting its advertising and marketing to
minors, and (3) the defendants claimed breach of the
public right to defendants compliance with the laws
prohibiting the distribution of cigarettes to minors. The
plaintiffs request that the defendants be required to disgorge
all profits unjustly received through its sale of cigarettes to
plaintiffs and the class, which in no event will be greater than
$75,000 per each class member, inclusive of punitive damages,
interest and costs. On March 27, 2006, the court dismissed
count V, public nuisance, and count VI, unjust enrichment.
On July 11, 2006, the plaintiffs filed a motion for class
certification. This case has been virtually dormant; however,
class counsel has indicated the intent to file an amended
complaint and renew activity in the case. As a result, the court
has vacated all scheduling orders pending further action by the
plaintiffs and a ruling on their motion to amend.
Young v. American Tobacco Co., Inc., a case filed in
November 1997 in Circuit Court, Orleans Parish, Louisiana, is an
ETS class action against U.S. cigarette manufacturers,
including RJR Tobacco and B&W, and parent companies of
U.S. cigarette manufacturers, including RJR, on behalf of
all residents of Louisiana who, though not themselves cigarette
smokers, have been exposed to secondhand smoke from cigarettes
which were manufactured by the defendants, and who allegedly
suffered injury as a result of that exposure. The plaintiffs
seek to recover an unspecified amount of compensatory and
punitive damages. On October 13, 2004, the trial court
stayed this case pending the outcome of the appeal in
Scott v. American Tobacco Co., Inc., discussed above
under Medical Monitoring and Smoking
Cessation Cases.
In Parsons v. A C & S, Inc., a case filed in
February 1998 in Circuit Court, Ohio County, West Virginia, the
plaintiff sued asbestos manufacturers, U.S. cigarette
manufacturers, including RJR Tobacco and B&W, and parent
companies of U.S. cigarette manufacturers, including RJR,
seeking to recover $1 million in compensatory and punitive
damages individually and an unspecified amount for the class in
both compensatory and punitive damages. The class is brought on
behalf of persons who allegedly have personal injury claims
arising from their exposure to respirable asbestos fibers and
cigarette smoke. The plaintiffs allege that
Mrs. Parsons use of tobacco products and exposure to
asbestos products caused her to develop lung cancer and to
become addicted to tobacco. The case has been stayed pending a
final resolution of the plaintiffs motion to refer tobacco
litigation to the judicial panel on multi-district litigation
filed in In Re: Tobacco Litigation in the Supreme Court
of Appeals of West Virginia. On December 26, 2000, three
defendants, Nitral Liquidators, Inc., Desseaux Corporation of
North American and Armstrong World Industries, filed bankruptcy
petitions in the U.S. Bankruptcy Court for the District of
Delaware, In re Armstrong World Industries, Inc. Pursuant
to section 362(a) of the Bankruptcy Code, Parsons is
automatically stayed with respect to all defendants.
Finally, in Jones v. American Tobacco Co., Inc., a case
filed in December 1998 in Circuit Court, Jackson County,
Missouri, the defendants removed the case to the
U.S. District Court for the Western District of Missouri on
February 16, 1999. The action was brought against the major
U.S. cigarette manufacturers, including RJR Tobacco and
B&W, and parent companies of U.S. cigarette
manufacturers, including RJR, on behalf of tobacco product users
and purchasers on behalf of all similarly situated Missouri
consumers. The plaintiffs allege that their use of the
defendants tobacco products has caused them to become
addicted to nicotine. The plaintiffs seek to recover an
unspecified amount of compensatory and punitive damages. The
case was remanded to the Circuit Court on February 17,
1999. There has been limited activity in this case.
Broin Settlement. RJR Tobacco, B&W and
other cigarette manufacturer defendants settled Broin v.
Philip Morris, Inc. in October 1997. This case had been
brought in Florida state court on behalf of flight attendants
alleged to have suffered from diseases or ailments caused by
exposure to ETS in airplane cabins. The settlement agreement
required the participating tobacco companies to pay a total of
$300 million in three annual $100 million
installments, allocated among the companies by market share, to
fund research on the early detection and cure of diseases
associated with tobacco smoke. It also required those companies
to pay a total of $49 million for the
114
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
plaintiffs counsels fees and expenses. RJR
Tobaccos portion of these payments was approximately
$86 million; B&Ws portion of these payments was
approximately $57 million. The settlement agreement bars
class members from bringing aggregate claims or obtaining
punitive damages and also bars individual claims to the extent
that they are based on fraud, misrepresentation, conspiracy to
commit fraud or misrepresentation, RICO, suppression,
concealment or any other alleged intentional or willful conduct.
The defendants agreed that, in any individual case brought by a
class member, the defendant will bear the burden of proof with
respect to whether ETS can cause certain specifically enumerated
diseases, referred to as general causation. With
respect to all other issues relating to liability, including
whether an individual plaintiffs disease was caused by his
or her exposure to ETS in airplane cabins, referred to as
specific causation, the individual plaintiff will
have the burden of proof. On September 7, 1999, the Florida
Supreme Court approved the settlement. The Broin II
cases, discussed above, arose out of the settlement of this
case.
Health-Care
Cost Recovery Cases
Health-care cost recovery cases have been brought by a variety
of plaintiffs. Other than certain governmental actions, these
cases largely have been unsuccessful on remoteness grounds,
which means that one who pays an injured persons medical
expenses is legally too remote to maintain an action against the
person allegedly responsible for the injury.
As of February 6, 2009, four health-care cost recovery
cases were pending in the United States against RJR Tobacco,
B&W, as its indemnitee, or both, as discussed below after
the MSA discussion.
MSA. In June 1994, the Mississippi attorney
general brought an action, Moore v. American Tobacco
Co., against various industry members, including RJR Tobacco
and B&W. This case was brought on behalf of the state to
recover state funds paid for health care and other assistance to
state citizens suffering from diseases and conditions allegedly
related to tobacco use. Most other states, through their
attorneys general or other state agencies, sued RJR Tobacco,
B&W and other U.S. cigarette manufacturers based on
similar theories. The cigarette manufacturer defendants,
including RJR Tobacco and B&W, settled the first four of
these cases scheduled for trial Mississippi,
Florida, Texas and Minnesota by separate agreements
with each such state.
On November 23, 1998, the major U.S. cigarette
manufacturers, including RJR Tobacco and B&W, entered into
the Master Settlement Agreement with attorneys general
representing the remaining 46 states, the District of
Columbia, Puerto Rico, Guam, the Virgin Islands, American Samoa
and the Northern Marianas. Effective on November 12, 1999,
the Master Settlement Agreement settled all the health-care cost
recovery actions brought by, or on behalf of, the settling
jurisdictions and released various additional present and future
claims.
In the settling jurisdictions, the MSA released RJR Tobacco,
B&W, and their affiliates and indemnitees, including RAI,
from:
|
|
|
|
|
all claims of the settling states and their respective political
subdivisions and other recipients of state health-care funds,
relating to past conduct arising out of the use, sale,
distribution, manufacture, development, advertising, marketing
or health effects of, the exposure to, or research, statements
or warnings about, tobacco products; and
|
|
|
|
all monetary claims of the settling states and their respective
political subdivisions and other recipients of state health-care
funds, relating to future conduct arising out of the use of or
exposure to, tobacco products that have been manufactured in the
ordinary course of business.
|
115
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Set forth below are tables depicting the unadjusted tobacco
industry settlement payment schedule and the settlement payment
schedule for RAIs operating subsidiaries under the MSA,
including the settlement agreements with the states of
Mississippi, Florida, Texas and Minnesota, and related
information for 2006 and beyond:
Unadjusted
Original Participating Manufacturers Settlement Payment
Schedule
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2012 and
|
|
|
|
2006
|
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
|
2010
|
|
|
2011
|
|
|
thereafter
|
|
|
First Four States Settlements: (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mississippi Annual Payment
|
|
$
|
136
|
|
|
$
|
136
|
|
|
$
|
136
|
|
|
$
|
136
|
|
|
$
|
136
|
|
|
$
|
136
|
|
|
$
|
136
|
|
Florida Annual Payment
|
|
|
440
|
|
|
|
440
|
|
|
|
440
|
|
|
|
440
|
|
|
|
440
|
|
|
|
440
|
|
|
|
440
|
|
Texas Annual Payment
|
|
|
580
|
|
|
|
580
|
|
|
|
580
|
|
|
|
580
|
|
|
|
580
|
|
|
|
580
|
|
|
|
580
|
|
Minnesota Annual Payment
|
|
|
204
|
|
|
|
204
|
|
|
|
204
|
|
|
|
204
|
|
|
|
204
|
|
|
|
204
|
|
|
|
204
|
|
Remaining States Settlement:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Annual Payments (1)
|
|
|
7,004
|
|
|
|
7,004
|
|
|
|
8,004
|
|
|
|
8,004
|
|
|
|
8,004
|
|
|
|
8,004
|
|
|
|
8,004
|
|
Base Foundation Funding
|
|
|
25
|
|
|
|
25
|
|
|
|
25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Growers Trust (2)
|
|
|
500
|
|
|
|
500
|
|
|
|
500
|
|
|
|
295
|
|
|
|
295
|
|
|
|
|
|
|
|
|
|
Offset by federal tobacco buyout(2)
|
|
|
(500
|
)
|
|
|
(500
|
)
|
|
|
(500
|
)
|
|
|
(295
|
)
|
|
|
(295
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
8,389
|
|
|
$
|
8,389
|
|
|
$
|
9,389
|
|
|
$
|
9,364
|
|
|
$
|
9,364
|
|
|
$
|
9,364
|
|
|
$
|
9,364
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RAIs Operating
Subsidiaries Settlement Expenses and Payment
Schedule
|
Settlement expenses
|
|
$
|
2,611
|
|
|
$
|
2,821
|
|
|
$
|
2,703
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Settlement cash payments
|
|
$
|
2,631
|
|
|
$
|
2,616
|
|
|
$
|
2,830
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Projected settlement expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
>2,550
|
|
|
$
|
>2,400
|
|
|
$
|
>2,400
|
|
|
$
|
>2,450
|
|
Projected settlement cash payments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
>2,650
|
|
|
$
|
>2,550
|
|
|
$
|
>2,400
|
|
|
$
|
>2,400
|
|
|
|
|
(1) |
|
Subject to adjustments for changes in sales volume, inflation
and other factors. All payments are to be allocated among the
companies on the basis of relative market share. |
|
(2) |
|
The Growers Trust payments scheduled to expire in 2010
will be offset by obligations resulting from the federal tobacco
buyout legislation, not included in this table, signed in
October 2004. See Tobacco Buyout Legislation
and Related Litigation. |
The MSA also contains provisions restricting the marketing of
tobacco products. Among these provisions are restrictions or
prohibitions on the use of cartoon characters, brand-name
sponsorships, apparel and other merchandise, outdoor and transit
advertising, payments for product placement, free sampling and
lobbying. Furthermore, the MSA required the dissolution of three
industry-sponsored research and trade organizations.
The MSA has materially adversely affected RJR Tobaccos
shipment volumes. RAI believes that these settlement obligations
may materially adversely affect the results of operations, cash
flows or financial position of RAI and RJR Tobacco in future
periods. The degree of the adverse impact will depend, among
other things, on the rate of decline in U.S. cigarette
sales in the premium and value categories, RJR Tobaccos
share of the domestic premium and value cigarette categories,
and the effect of any resulting cost advantage of manufacturers
not subject to the MSA.
Department of Justice Case. On
September 22, 1999, the U.S. Department of Justice
brought an action against RJR Tobacco, B&W and other
tobacco companies in the U.S. District Court for the
District of Columbia. The government initially sought to recover
federal funds expended by the federal government in providing
health care to smokers who developed diseases and injuries
alleged to be smoking-related. In addition, the government
sought, pursuant to the civil provisions of RICO, disgorgement
of profits the government contends were earned as a consequence
of a RICO racketeering enterprise. In September
2000, the court dismissed the governments claims asserted
under the Medical Care Recovery Act as well as those under the
Medicare Secondary Payer provisions of the Social Security Act,
but did not dismiss the RICO claims. In February 2005, the
U.S. Court of Appeals for the
116
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
District of Columbia ruled that disgorgement is not an available
remedy in this case. The governments petition for writ of
certiorari with the U.S. Supreme Court was denied in
October 2005. The non-jury, bench trial began in September 2004,
and closing arguments concluded on June 10, 2005.
On August 17, 2006, the court found certain defendants,
including RJR Tobacco and B&W, liable for the RICO claims,
but did not impose any direct financial penalties. The court
instead enjoined the defendants from committing future
racketeering acts, participating in certain trade organizations,
making misrepresentations concerning smoking and health and
youth marketing, and using certain brand descriptors such as
low tar, light, ultra light,
mild and natural. The court also ordered
defendants to issue corrective communications on
five subjects, including smoking and health and addiction, and
to comply with further undertakings, including maintaining web
sites of historical corporate documents and disseminating
certain marketing information on a confidential basis to the
government. In addition, the court placed restrictions on the
ability of the defendants to dispose of certain assets for use
in the United States, unless the transferee agrees to abide by
the terms of the courts order, and ordered the defendants
to reimburse the U.S. Department of Justice its taxable
costs incurred in connection with the case.
Certain defendants, including RJR Tobacco, filed notices of
appeal to the U.S. Court of Appeals for the District of
Columbia on September 11, 2006. The government filed its
notice of appeal on October 16, 2006. In addition, the
defendants, including RJR Tobacco, filed joint motions asking
the district court to clarify and to stay its order pending the
defendants appeal. On September 28, 2006, the
district court denied the defendants motion to stay. On
September 29, 2006, the defendants, including RJR Tobacco,
filed a motion asking the court of appeals to stay the district
courts order pending the defendants appeal. The
court granted the motion on October 31, 2006.
On November 28, 2006, the court of appeals stayed the
appeals pending the trial courts ruling on the
defendants motion for clarification. The defendants
motion for clarification was granted in part and denied in part
on March 16, 2007. The defendants motion as to the
meaning and applicability of the general injunctive relief of
the August 17, 2006 order was denied. The request for
clarification as to the scope of the provisions in the order
prohibiting the use of descriptors and requiring corrective
statements at retail point of sale was granted. The court also
ruled that the provisions prohibiting the use of express or
implied health messages or descriptors do apply to the actions
of the defendants taken outside of the United States. Oral
argument in the appeals occurred on October 14, 2008. A
decision is pending.
The stay of the district courts order suspends the
enforcement of the order pending the outcome of the
defendants appeal. RJR Tobacco does not know the timing of
an appellate decision or, if the order is affirmed, the
compliance deadlines that will be imposed. If the order is
affirmed without modification, then RJR Tobacco believes that
certain provisions of the order, would have adverse business
effects on the marketing of RJR Tobaccos current product
portfolio and that such effects could be material. Also, if the
order is affirmed, then RJR Tobacco would incur costs in
connection with complying with the order, such as the costs of
corrective communications. Given the uncertainty over the timing
and substance of an appellate decision, RJR Tobacco currently is
not able to estimate reasonably the costs of such compliance.
Moreover, if the order were ultimately affirmed and RJR Tobacco
were to fail to comply with the order on a timely basis, then
RJR Tobacco could be subject to substantial monetary fines or
penalties.
International Cases. A number of foreign
countries have filed suit against RJR Tobacco, B&W and
other tobacco industry defendants to recover funds for
health-care, medical and other assistance paid by those foreign
governments to their citizens. No such cases currently are
pending in the United States against RJR Tobacco and its
affiliates or indemnitees.
Three health-care reimbursement cases are pending against RJR
Tobacco or B&W outside the United States, two in Canada and
one in Israel. Pursuant to the terms of the 1999 sale of RJR
Tobaccos international tobacco business, JTI assumed RJR
Tobaccos liability, if any, in the health-care cost
recovery cases brought by foreign countries.
117
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
On November 12, 1998, the government of British Columbia
enacted legislation creating a civil cause of action permitting
the government to recover the costs of health-care benefits
incurred for B.C. residents arising from tobacco-related
disease. The governments subsequent suit against Canadian
defendants and foreign defendants, including RJR Tobacco was
dismissed in February 2000, when the B.C. Supreme Court ruled
that the legislation was unconstitutional and set aside service
ex juris against the foreign defendants for that reason. The
government then enacted a revised statute and brought a new
action, filed in January 2001, and pending in Supreme Court,
British Columbia. The plaintiff seeks to recover the present
value of the total expenditure by the government for health-care
benefits provided for insured persons resulting from
tobacco-related disease or the risk of tobacco-related disease,
the present value of the estimated total expenditure by the
government for health-care benefits that reasonably could be
expected to be provided for those insured persons resulting from
tobacco-related disease or the risk of tobacco-related disease,
court ordered interest, and costs, or in the alternative,
special or increased costs. The plaintiff alleges that the
defendants are liable under the following theories: defective
product, failure to warn, sale of cigarettes to children and
adolescents, strict liability, deceit and misrepresentation, and
violation of trade practice and competition acts. Trial is
scheduled for September 6, 2010.
On September 1, 1998, the General Health Services filed a
statement of claim against certain cigarette manufacturers,
including RJR Tobacco and B&W, in the District Court of
Jerusalem, Israel. The plaintiff seeks to recover the past and
future value of the total expenditures for health-care services
provided to residents of Israel resulting from tobacco-related
disease, court ordered interest for past expenditures from date
of filing the statement of claim, increased
and/or
punitive
and/or
exemplary damages and costs. The plaintiff alleges that the
defendants are liable under the following theories: negligence,
public nuisance, fraud, misleading advertisement, defective
product, failure to warn, sale of cigarettes to children and
adolescents, strict liability, deceit, concealment,
misrepresentation and conspiracy. In 2002, the plaintiff
obtained leave to serve RJR Tobacco and B&W outside the
jurisdiction. On behalf of RJR Tobacco, JTI filed a motion
challenging the grant of leave, which was denied. JTI appealed
the decision to the Supreme Court of Israel. A hearing occurred
on March 28, 2005. A decision is pending.
On March 13, 2008, a case was filed on behalf of Her
Majesty the Queen in Right of the Province of
New Brunswick, Canada, against certain cigarette
manufacturers, including RJR Tobacco, in the Trial Division in
the Court of Queens Bench of New Brunswick. The plaintiff
seeks to recover the present value of total expenditures by the
Province for health care benefits resulting or expecting to
result from tobacco-related diseases or risk of tobacco-related
diseases, costs or special or increased costs. The plaintiff
alleges that the defendants are liable under the following
theories: deceit and misrepresentation, failure to warn,
promotion of cigarettes to children and adolescents, negligent
design and manufacture, breaches of other common law, equitable
and statutory duties and obligations and conspiracy and
concerted action in Canada. On June 26, 2008, RJR Tobacco
filed a notice of intent to defend.
Native American Tribe Cases. As of
February 6, 2009, one Native American tribe case was
pending before a tribal court in South Dakota against RJR
Tobacco and B&W, Crow Creek Sioux Tribe v. American
Tobacco Co., a case filed in September 1997 in Tribal Court,
Crow Creek Sioux, South Dakota. The plaintiffs seek to recover
actual and punitive damages, restitution, funding of a clinical
cessation program, funding of a corrective public education
program, and disgorgement of unjust profits from sales to
minors. The plaintiffs claim that the defendants are liable
under the following theories: unlawful marketing and targeting
of minors, contributing to the delinquency of minors, unfair and
deceptive acts or practices, unreasonable restraint of trade and
unfair method of competition, negligence, negligence per se,
conspiracy and restitution of unjust enrichment. The case is
dormant.
Hospital Cases. As of February 6, 2009,
one case brought by hospitals was pending against cigarette
manufacturers, including RJR Tobacco and B&W: City of
St. Louis v. American Tobacco Co., Inc., filed in
November 1998, and pending in the Circuit Court of the City of
St. Louis, Missouri. This case seeks recovery of
uncompensated, unreimbursed health-care costs expended or to be
expended by hospitals on behalf of patients who suffer, or have
suffered, from illnesses allegedly resulting from the use of
cigarettes. On June 28, 2005, the court granted the
defendants motion for summary judgment as to claims for
damages which accrued prior to November 16, 1993. The
claims for damages which accrued after November 16, 1993,
are still pending. The case is in discovery. Trial is scheduled
for June 7, 2010. On July 11, 2008, certain
defendants, including RJR Tobacco and B&W, filed a motion
for
118
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
summary judgment based on the plaintiffs lack of proof
linking the defendants allegedly wrongful conduct with the
claimed damages. Oral argument occurred on November 24,
2008. A decision is pending.
Other Cases. On May 20, 2008, the
National Committee to Preserve Social Security and Medicare
filed a case against the major U.S. cigarette
manufacturers, including RJR Tobacco, in the U.S. District
Court for the Eastern District of New York. The case seeks to
recover twice the amount paid by Medicare for health services
provided to Medicare beneficiaries to treat their diseases
attributable to smoking the defendants cigarettes from
May 21, 2002 to the present, for which treatment the
defendants were required or responsible to make
payment under the Medicare Secondary Payer Act. On
July 21, 2008, the defendants filed a motion to dismiss for
failure to state a claim for lack of standing. On the same day,
the plaintiffs filed a motion for summary judgment as to
liability under the Federal Rules of Civil Procedure 56(d)(2).
Oral argument on the plaintiffs motion for partial summary
judgment and the defendants motion to dismiss occurred on
November 20, 2008. A decision is pending.
MSA-Enforcement
and Validity
As of February 6, 2009, there were 60 cases concerning the
enforcement, validity or interpretation of the MSA in which RJR
Tobacco or B&W is a party. This number includes those
cases, discussed below, relating to disputed payments under the
MSA.
On March 28, 2005, the National Association of Attorneys
General, referred to as NAAG, sent a notice, signed by 40
Attorneys General that one or more of the states intended to
initiate proceedings against RJR Tobacco for violating
Section III (r) of the MSA, the various Consent
Decrees implementing the MSA
and/or
consumer fraud statutes in various states, all in connection
with RJR Tobaccos advertisements for Eclipse cigarettes.
After a June 2005 meeting between representatives of RJR
Tobacco and NAAG, the Vermont Attorney General filed suit in
July 2005, in the Vermont Superior Court, Chittenden County,
alleging that certain advertising for the Eclipse cigarette
brand violated both the MSA and the Vermont Consumer Fraud
Statute. The State of Vermont is seeking declaratory,
injunctive, and monetary relief. Trial in this action began on
October 6, 2008. Closing arguments are scheduled for
March 11, 2009.
On April 13, 2005, the Mississippi Attorney General
notified B&W of its intent to seek approximately
$3.9 million in additional payments under the Mississippi
Settlement Agreement. The Mississippi Attorney General asserts
that B&W failed to report in its net operating profit or
its shipments cigarettes manufactured by B&W under contract
for Star Tobacco or its parent, Star Scientific, Inc. On
April 28, 2005, B&W advised the state that it did not
owe the state any money. On August 11, 2005, the
Mississippi Attorney General filed in the Chancery Court of
Jackson County, Mississippi, a Notice of Violation, Motion to
Enforce Settlement Agreement, and Request for an Accounting by
Defendant Brown & Williamson Holdings, Inc., formerly
known as Brown & Williamson Tobacco Corporation. In
this filing, Mississippi estimated that its damages exceeded
$5.0 million. This matter is currently in the discovery
phase.
On May 17, 2006, the State of Florida filed a motion, in
the Circuit Court of the Fifteenth Judicial Circuit, in and for
Palm Beach County, Florida, to enforce the Settlement Agreement,
for an Accounting by Brown & Williamson Holdings,
Inc., and for an Order of Contempt, raising substantially the
same issues as raised by the Mississippi Attorney General and
seeking approximately $12.4 million in additional payments
under the Florida Settlement Agreement, as well as
$17.0 million in interest payments. Discovery in this
matter is underway.
On October 28, 2008, Vibo Corporation, Inc. d/b/a General
Tobacco, referred to as General, filed a complaint in the
U.S. District Court for the Western District of Kentucky
against RJR Tobacco and other participating manufacturers,
referred to as PMs, under the MSA, and the Attorney Generals of
the 52 states and territories that are parties to the MSA.
General sought, among other things, to enjoin enforcement of
certain provisions of the MSA and an order relieving it of
certain of its payment obligations under the MSA and, in the
event such relief was not granted, rescission of Generals
2004 agreement to join the MSA. General also moved for a
preliminary injunction that, among other things, would have
enjoined the states from enforcing certain of Generals
payment obligations under the MSA. On November 14, 2008,
RJR Tobacco and the other defendants moved to dismiss
Generals
119
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
complaint. On January 5, 2009, the court issued a
memorandum opinion and order granting the defendants
motions and dismissing Generals lawsuit.
On December 11, 2008, General filed a second complaint, for
declaratory relief under the MSA in the California Superior
Court for the County of San Diego against the State of
California and RJR Tobacco and other PMs under the MSA.
Generals complaint seeks a declaration that a proposed
amendment to its agreement to join the MSA, under which it would
no longer have to make certain MSA payments, did not trigger the
MSAs most favored nations provision or require
that the settling states agree to make similar terms available
to other PMs. Defendants answer or other response is due
on February 17, 2009.
In December 2007, nine states (California, Connecticut,
Illinois, Maine, Maryland, New York, Ohio, Pennsylvania and
Washington) sued RJR Tobacco claiming that an advertisement
published in a magazine the prior month violated the MSAs
ban on the use of cartoons. The states asserted that the
magazines content adjacent to a Camel gatefold
advertisement included cartoon images prohibited by the MSA and
that certain images used in the Camel ad itself were prohibited
cartoons. In addition, three states (Connecticut, New York and
Maryland) also claimed that a direct mail piece distributed by
RJR Tobacco violated the MSA prohibition against distributing
utilitarian items bearing a tobacco brand name. Each state
sought injunctive relief and punitive monetary sanctions. Seven
of the nine courts have since ruled that the states are not
entitled to the punitive sanctions being sought. (The issue has
not been resolved definitively by the other two courts at this
time). Three of these cases have been ruled upon following bench
trials. In two states (Washington and Maine), RJR Tobacco
received complete defense rulings. In one state (Ohio), the
Court agreed that the Camel advertisement did not use any
cartoons, but ruled that the company should have prevented the
use of cartoons in magazine-created content next to the RJR
Tobacco advertisement. No monetary sanctions were awarded;
however, the state has submitted a petition to recover
approximately $43,000 in attorneys fees and costs. RJR
Tobacco has filed a notice of appeal and believes it has strong
bases for the appeal. RJR Tobacco is awaiting rulings by the
courts in two cases. Finally, in Stewart v. RJR Tobacco,
a
class-action
filed in California state court against the magazines
publisher, Wenner Media, and RJR Tobacco claiming the mention of
bands in the magazine-created content violated their right of
publicity. The plaintiffs seek compensatory and punitive
damages. This case is still in a preliminary phase.
NPM Adjustment. The MSA includes an
adjustment, referred to as an NPM Adjustment, that potentially
reduces the annual payment obligations of RJR Tobacco and the
other participating manufacturers, with all participating
manufacturers referred to as PMs. Certain requirements must be
satisfied before the NPM Adjustment for a given year is
available: (1) an independent auditor designated under the
MSA must determine that the PMs have experienced a market share
loss beyond a triggering threshold to those manufacturers that
do not participate in the MSA, such non-participating
manufacturers referred to as NPMs, and (2) in a binding
arbitration proceeding, a firm of independent economic
consultants must find that the disadvantages of the MSA were a
significant factor contributing to the loss. When these two
requirements are satisfied, the MSA provides that the NPM
Adjustment applies to reduce the annual payment obligation of
the PMs. However, an individual settling state may avoid its
share of the NPM Adjustment if it had in place and diligently
enforced during the entirety of the relevant year a
Qualifying Statute that imposes escrow obligations
on NPMs that are comparable to what the NPMs would have owed if
they had joined the MSA. In such event, the states share
of the NPM Adjustment is reallocated to other settling states,
if any, that did not have in place and diligently enforce a
Qualifying Statute.
NPM Adjustment Claim for 2003. For 2003, the
MSA independent auditor determined that the PMs suffered a
market share loss sufficient to trigger an NPM Adjustment. In
March 2006, the independent economic consulting firm issued a
final, non-appealable determination that the disadvantages of
the MSA were a significant factor contributing to
the 2003 market share loss. Based on these determinations, on
April 17, 2006, RJR Tobacco placed approximately
$647 million of its MSA payment into a disputed payments
account, in accordance with a procedure established by the MSA.
That amount represented RJR Tobaccos share of the 2003 NPM
Adjustment as calculated by the MSA independent auditor. On
March 28, 2007, the independent auditor issued revised
calculations that reduced RJR Tobaccos share of the NPM
Adjustment for 2003 to approximately $615 million. As a
result, on April 19, 2007, RJR Tobacco instructed the
independent auditor to release to the settling states
approximately $32 million from the disputed payments
account.
120
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Following RJR Tobaccos payment of a portion of its 2006
MSA payment into the disputed payments account, 37 of the
settling states filed legal proceedings in their respective MSA
courts seeking declaratory orders that they diligently enforced
their Qualifying Statutes during 2003
and/or
orders compelling RJR Tobacco and the other PMs that placed
money in the disputed payments account to pay the disputed
amounts to the settling states. In response, RJR Tobacco and
other PMs, pursuant to the MSAs arbitration provisions,
moved to compel arbitration of the parties dispute
concerning the 2003 NPM Adjustment, including the States
diligent enforcement claims, before a single, nationwide
arbitration panel of three former federal judges. The settling
states opposed these motions, arguing, among other things, that
the issue of diligent enforcement must be resolved by MSA courts
in each of the 52 settling states and territories.
As of February 6, 2009, all 48 courts that had addressed
the question whether the dispute concerning the 2003 NPM
Adjustment is arbitrable had ruled that arbitration is required
under the MSA. In 42 states, the orders compelling
arbitration are final
and/or
non-appealable.
On December 8, 2008, RJR Tobacco and certain other PMs
entered into an Agreement Regarding Arbitration, referred to as
the Agreement, with 25 of the settling states. The Agreement
establishes October 1, 2009, as the date by which
arbitration begins. To encourage the participation of the
settling states, the Agreement provided certain financial
incentives to the signing settling states, in the form of a
potential reduction in the amount of a given settling
states liability (if any) with respect to the 2003 NPM
Adjustment, as well as the potential for release of a portion of
certain amounts deposited in the disputed payments account by
RJR Tobacco and certain other PMs in connection with the 2005
NPM Adjustment. Other settling states were given until
January 30, 2009, to sign the Agreement and also receive
the benefit of the financial incentives provided in that
agreement. As of January 30, 2009, 45 of the settling
states, representing approximately 90% of the allocable share of
the settling states, had signed the Agreement. By virtue of the
fact that settling states representing allocable share greater
than 80% have signed the Agreement, signing states will have
their ultimate liability (if any) with respect to the 2003 NPM
Adjustment reduced by 20%, and RJR Tobacco and the other PMs
that placed their share of the disputed 2005 NPM Adjustment into
the disputed payments account will, without releasing or waiving
any claims, authorize the release of those funds to the settling
states.
NPM Adjustment Claim for 2004. During 2006,
proceedings were initiated with respect to an NPM Adjustment for
2004. The MSA independent auditor again determined that the PMs
had suffered a market share loss sufficient to trigger an NPM
Adjustment for 2004. On April 17, 2006, RJR Tobacco and
other PMs initiated the significant factor
proceeding before the independent economic consultant called for
under the MSA. On February 12, 2007, the independent
economic consulting firm issued a final, non-appealable
determination that the disadvantages of the MSA were a
significant factor contributing to the 2004 market share
loss. On April 16, 2007, RJR Tobacco placed approximately
$561 million of its 2007 MSA payment into the disputed
payments account. That amount represented RJR Tobaccos
share of the 2004 NPM Adjustment as calculated by the MSA
independent auditor.
NPM Adjustment Claim for 2005. During 2007,
proceedings were initiated with respect to an NPM Adjustment for
2005. The MSA independent auditor again determined that the PMs
had suffered a market share loss sufficient to trigger an NPM
Adjustment for 2005. On April 18, 2007, RJR Tobacco and
other PMs initiated the significant factor
proceeding called for under the MSA. On February 7, 2008,
the independent economic consulting firm issued a final,
non-appealable determination that the disadvantages of the MSA
were a significant factor contributing to the 2005
market share loss. On April 15, 2008, RJR Tobacco placed
approximately $431 million of its 2008 MSA payment into the
disputed payments account. That amount represented RJR
Tobaccos share of the 2005 NPM Adjustment as calculated by
the independent auditor, net of certain slight adjustments to
reflect revised independent auditor calculations of RJR
Tobaccos share of the 2003 and 2004 NPM Adjustments.
NPM Adjustment Claim for 2006. During 2008,
proceedings were initiated with respect to an NPM Adjustment for
2006. The MSA independent auditor again determined that the PMs
had suffered a market share loss sufficient to trigger an NPM
Adjustment for 2006. On April 29, 2008, RJR Tobacco and
other PMs initiated the
121
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
significant factor proceeding called for under the
MSA. On October 6, 2008, RJR Tobacco filed its initial
briefs and expert reports in connection with the significant
factor proceeding. On February 18, 2009, the independent
economic consulting firm issued its preliminary determination
that the disadvantages of the MSA were a significant
factor contributing to the 2006 market share loss. The
firm is scheduled to issue a final determination by
March 24, 2009.
Due to the uncertainty over the final resolution of the NPM
Adjustment claims asserted by RJR Tobacco, no assurances can be
made related to the amounts, if any, that will be realized.
Antitrust
Cases
A number of tobacco wholesalers and consumers have sued
U.S. cigarette manufacturers, including RJR Tobacco and
B&W, in federal and state courts, alleging that cigarette
manufacturers combined and conspired to set the price of
cigarettes in violation of antitrust statutes and various state
unfair business practices statutes. In these cases, the
plaintiffs asked the court to certify the lawsuits as class
actions on behalf of other persons who purchased cigarettes
directly or indirectly from one or more of the defendants. As of
February 6, 2009, all of the federal and state court cases
on behalf of indirect purchasers have been dismissed, except for
one state court case pending in each of Kansas and in New Mexico.
In Smith v. Philip Morris Cos., Inc., a case filed in
February 2000, and pending in District Court,
Seward County, Kansas, the court granted class
certification on November 15, 2001, in an action brought
against the major U.S. cigarette manufacturers, including
RJR Tobacco and B&W, and the parent companies of the major
U.S. cigarette manufacturers, including RJR, seeking to
recover an unspecified amount in actual and punitive damages.
The plaintiffs allege that the defendants participated in a
conspiracy to fix or maintain the price of cigarettes sold in
the United States. The parties are currently engaged in
discovery.
In Romero v. Philip Morris Cos., Inc., a case filed in
April 2000 in District Court, Rio Arriba County,
New Mexico, the court granted class certification on
May 14, 2003, in an action brought against the major
U.S. cigarette manufacturers, including RJR Tobacco and
B&W, and the parent companies of the major
U.S. cigarette manufacturers, including RJR, seeking to
recover an amount not to exceed $74,000 per class member in
actual and punitive damages, exclusive of interest and costs.
The plaintiffs allege that the defendants conspired to fix,
raise, advance
and/or
stabilize prices for cigarettes in the State of New Mexico from
at least as early as January 1, 1998, through the present.
On June 30, 2006, the court granted the defendants
motion for summary judgment. On November 18, 2008, the New
Mexico Court of Appeals reversed the grant of summary judgment
in favor of RJR Tobacco, B&W and Philip Morris. On
January 7, 2009, RJR Tobacco filed a petition of writ of
certiorari with the Supreme Court of the State of New Mexico.
RJR Tobacco awaits a ruling on that petition.
Other
Litigation and Developments
By purchase agreement dated May 12, 1999, referred to as
the 1999 Purchase Agreement, RJR and RJR Tobacco sold the
international tobacco business to JTI. RJR and RJR Tobacco
retained certain liabilities relating to the activities of
Northern Brands, including those relating to a 1998 guilty plea
entered in the U.S. District Court for the Northern
District of New York, as well as an investigation conducted by
the Royal Canadian Mounted Police, referred to as RCMP, for
possible violations of Canadian law related to the activities
that led to the Northern Brands guilty plea and certain conduct
by Stanley Smith, a former executive of RJR-Macdonald, Inc.,
referred to as RJR-MI, which led to the termination of his
severance agreement. Under its reading of the indemnification
provisions of the 1999 Purchase Agreement, JTI has requested
indemnification for any damages arising out of the matters
described below.
|
|
|
|
|
In February 2003, the RCMP filed criminal charges in the
Province of Ontario against, and purported to serve summonses
on, JTI-Macdonald Corp., referred to as JTI-MC, Northern Brands,
R. J. Reynolds Tobacco International, Inc., referred to as
RJR-TI, R. J. Reynolds Tobacco Co., Puerto Rico, referred to as
RJR-PR, and eight individuals associated with RJR-MI
and/or
RJR-TI during the period January 1, 1991, through
December 31, 1996. The charges allege fraud and conspiracy
to defraud Canada and the Provinces
|
122
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
of Ontario and Quebec in connection with the purchase, sale,
export, import
and/or
re-export of cigarettes
and/or fine
cut tobacco. In October 2003, Northern Brands, RJR-TI and RJR-PR
each challenged both the propriety of the service of the
summonses and the jurisdiction of the court. On February 9,
2004, the Superior Court of Justice ruled in favor of these
companies. The government filed a notice of appeal from that
ruling on February 18, 2004, but did not perfect its appeal
until May 8, 2007. At the oral argument on October 29,
2007, the Court of Appeal announced a unanimous decision in
favor of the companies position and dismissed the
governments appeal. A final written order dismissing the
appeal was entered by the Court of Appeal on December 3,
2007.
|
A preliminary hearing was commenced on April 11, 2005, for
the purpose of determining whether the Canadian prosecutor had
sufficient evidence supporting the criminal charges to justify a
trial of the defendants that had been properly served to date.
On May 30, 2007, the court announced its decision to issue
an order committing two of the accused, JTI-MC and Edward Lang,
to stand trial on the charges filed in February 2003 and
discharging the other six accused. JTI-MC and Mr. Lang
separately filed papers seeking an order quashing the order
committing them to stand trial, and the government filed papers
seeking an order quashing the order discharging six of the
accused. On December 19, 2007, JTI-MC abandoned its effort
to have the order committing it to trial quashed. On
February 19, 2008, the Superior Court of Justice in Ontario
denied Mr. Langs request to quash the order
committing him to trial. The court granted the governments
request to quash the order discharging six individuals and
remanded the matter to the preliminary hearing judge for
reconsideration. No appeals were taken from that decision. The
matter is currently being reconsidered by the preliminary
hearing judge.
On July 31, 2007, each of the accused companies, including
RJR-TI, RJR-PR and Northern Brands, and each of the seven
accused individuals were given notice that the Canadian
prosecutor had requested the Attorney General of Ontario to
consent to the issuance of preferred indictments against each of
them. RJR-TI, RJR-PR and Northern Brands as well as the other
accused filed written submissions with the Attorney General
opposing the issuance of the indictments against them. On
October 31, 2007, the Office of the Attorney General of
Ontario confirmed that the prosecutors request for
preferred indictments against RJR-TI, RJR-PR and Northern Brands
had been denied at that point in time.
|
|
|
|
|
In July 2003, a Statement of Claim was filed against JTI-MC and
others in the Superior Court of Justice, Ontario, Canada by
Leslie and Kathleen Thompson. Mr. Thompson is a former
employee of Northern Brands and JTI-MCs predecessor,
RJR-MI. Mr. and Mrs. Thompson have alleged breach of
contract, breach of fiduciary duty and negligent
misrepresentation, among other claims. They are seeking lost
wages and other damages, including punitive damages, in an
aggregate amount exceeding $12 million.
|
|
|
|
On September 18, 2003, RJR, RJR Tobacco, RJR-TI, RJR-PR,
and Northern Brands were served with a Statement of Claim filed
in August 2003 by the Attorney General of Canada in the Superior
Court of Justice, Ontario, Canada. Also named as defendants are
JTI and a number of its affiliates. The Statement of Claim seeks
to recover taxes and duties allegedly not paid as a result of
cigarette smuggling and related activities. As filed, the
Attorney Generals Statement of Claim seeks to recover
$1.5 billion Canadian in compensatory damages and
$50 million Canadian in punitive damages, as well as
equitable and other forms of relief. However, in the
Companies Creditor Arrangement Act proceeding described
below, the Attorney General amended and increased Canadas
claim to $4.3 billion Canadian. The parties have agreed to
a stay of all proceedings pending in the Superior Court of
Justice, subject to notice by one of the parties that it wishes
to terminate the stay. On January 19, 2007, the court
ordered that the case be scheduled for trial no later than
December 31, 2008, subject to further order of the court.
On January 15, 2009, the Court ordered that the deadline
for setting the action for trial is January 31, 2011.
|
|
|
|
In August 2004, the Quebec Ministry of Revenue (1) issued a
tax assessment, covering the period January 1, 1990,
through December 31, 1998, against JTI-MC for alleged
unpaid duties, penalties and interest in an amount of about
$1.36 billion Canadian; (2) issued an order for the
immediate payment of that amount; and (3) obtained an ex
parte judgment to enforce the payment of that amount. On
August 24, 2004, JTI-MC applied
|
123
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
for protection under the Companies Creditor Arrangement
Act in the Ontario Superior Court of Justice, Toronto, Canada,
referred to as CCAA Proceedings, and the court entered an order
staying the Quebec Ministry of Revenues proceedings as
well as other claims and proceedings against JTI-MC. The stay
has been extended to July 21, 2009. In November 2004,
JTI-MC filed a motion in the Superior Court, Province of Quebec,
District of Montreal, seeking a declaratory judgment to set
aside, annul and declare inoperative the tax assessment and all
ancillary enforcement measures and to require the Quebec
Minister of Revenue to reimburse JTI-MC for funds unduly
appropriated, along with interest and other relief. Pursuant to
a court-imposed deadline, Canada and several Provinces filed
Crown claims against JTI-MC in the CCAA Proceedings in the
following amounts: Canada, $4.3 billion Canadian; Ontario,
$1.5 billion Canadian; New Brunswick,
$1.5 billion Canadian; Quebec, $1.4 billion Canadian;
British Columbia, $450 million Canadian; Nova Scotia,
$326 million Canadian; Prince Edward Island,
$75 million Canadian and Manitoba, $23 million
Canadian. In the CCAA Proceedings, the Canadian federal
government and some of the provincial governments have asserted
that they can make the same tax and related claims against RJR
and certain of its subsidiaries, including RJR Tobacco. To date,
none of those provincial governments have filed and served RJR
or any of its affiliates with a formal Statement of Claim like
the Canadian federal government did in August and September
2003. Discussions regarding possible
agreed-upon
procedures for adjudicating and appellate review of the claims
and defenses asserted in the CCAA Proceedings are taking place.
Without waiving any of their rights and defenses, RJR and
certain of its subsidiaries, including RJR Tobacco, may
participate in those proceedings, if procedures are agreed upon,
approved by the court and implemented.
|
|
|
|
|
|
On November 17, 2004, a Statement of Claim was filed
against JTI-MC in the Supreme Court of British Columbia by
Stanley Smith, a former executive of RJR-MI, for alleged breach
of contract and other legal theories. Mr. Smith is claiming
$840,000 Canadian for salary allegedly owed under his severance
agreement with RJR-MI, as well as other unspecified compensatory
and punitive damages.
|
|
|
|
In a letter dated March 31, 2006, counsel for JTI stated
that JTI would be seeking indemnification under the 1999
Purchase Agreement for any damages it may incur or may have
incurred arising out of a Southern District of New York grand
jury investigation, a now-terminated Eastern District of North
Carolina grand jury investigation, and various actions filed by
the European Community and others in the U.S. District
Court for the Eastern District of New York, referred to as the
EDNY, against RJR Tobacco and certain of its affiliates on
November 3, 2000, August 6, 2001, and (as discussed in
greater detail below) October 30, 2002, and against JTI on
January 11, 2002.
|
|
|
|
On December 14, 2007, the European Community and 26 member
states entered into a series of agreements with JTI
and/or its
subsidiaries regarding, principally, contraband and counterfeit
cigarettes bearing JTI trademarks in the European Community.
Collectively, those agreements resolved, in pertinent part, all
claims that the European Community and member states either had
or might have had prior to December 14, 2007 against JTI
and/or its
subsidiaries with respect to any such contraband and counterfeit
cigarettes and claims for which JTI could become the subject of
a claim for indemnity by RJR under the terms of the 1999
Purchase Agreement. In addition, the European Community and
signatory member states agreed to release RJR and its affiliates
from those same claims.
|
Although RJR and RJR Tobacco recognize that, under certain
circumstances, they may have indemnification obligations to JTI
under the 1999 Purchase Agreement, RJR and RJR Tobacco disagree
with JTI as to whether the circumstances relating to any of
these matters give rise to any indemnification obligation by RJR
and RJR Tobacco. RJR and RJR Tobacco conveyed their position to
JTI, and the parties have agreed to resolve their differences at
a later time. In the interim, RJR and RJR Tobacco are paying
defense costs and expenses in connection with certain of the
Canadian litigation described above. Indemnification to JTI was
$11 million in 2008 and $8 million in 2007. In
addition, as of December 31, 2008, RJR, including its
subsidiary RJR Tobacco, had liabilities of $94 million that
were recorded in 1999 in connection with certain of the
indemnification claims asserted by JTI. For further information
on the JTI indemnification claims, see Other
Contingencies below.
124
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
On May 15, 2007, RAI was served with a subpoena issued by
the U.S. District Court for the Middle District of North
Carolina. The subpoena seeks documents relating primarily to the
business of RJR-TI regarding the manufacture and sale of
Canadian brand cigarettes during the period 1990 through 1996.
The subpoena was issued at the request of Canada pursuant to a
Mutual Legal Assistance Treaty between the United States and
Canada.
On October 30, 2002, the European Community and ten of its
member states filed a complaint in the EDNY against RJR, RJR
Tobacco and several currently and formerly related companies.
The complaint contains many of the same or similar allegations
found in an earlier complaint, now dismissed, filed in August
2001 and also alleges that the defendants, together with certain
identified and unidentified persons, engaged in money laundering
and other conduct violating civil RICO and a variety of common
laws. The complaint also alleges that the defendants
manufactured cigarettes that were eventually sold in Iraq in
violation of U.S. sanctions. The plaintiffs seek
compensatory, punitive and treble damages among other types of
relief. This matter has been stayed. The European Community and
the member states have recently suggested that they may file
similar claims regarding the U.S. tobacco business of
B&W, which was acquired in 2004 in the B&W business
combination.
RJR Tobacco was named a defendant in a number of lawsuits
originally filed in various federal courts in 2002 by plaintiffs
alleging descent from persons held in slavery in the United
States and seeking damages from numerous corporate defendants
for having allegedly profited from historic slavery. In October
2002, those actions were consolidated by the Judicial Panel on
Multidistrict Litigation for pre-trial proceedings in the
U.S. District Court for the Northern District of Illinois.
On July 6, 2005, the court dismissed the entire action on a
variety of grounds. On December 13, 2006, the
U.S. Court of Appeals for the Seventh Circuit affirmed
dismissal in all respects but one. It remanded some cases for
further proceedings limited to the claims by some plaintiffs
that
present-day
representations about historic ties to slavery by some
defendants violated state consumer fraud laws. On
October 1, 2007, the U.S. Supreme Court denied
plaintiffs petition for a writ of certiorari. The
plaintiffs in all but one of the cases either voluntarily
dismissed their claims or otherwise abandoned the litigation. On
August 11, 2008, the district court granted the
defendants motion to dismiss the remaining
plaintiffs and terminated the case. However, the motion to
dismiss excluded plaintiffs Timothy and Chester Hurdle, who
filed a third amended complaint on July 31, 2007. No ruling
was made on the motion to dismiss the Hurdle plaintiffs and the
plaintiffs named in the third amended complaint.
On May 23, 2001, and July 30, 2002, Star Scientific,
Inc., referred to as Star, filed two patent infringement
actions, which have been consolidated, against RJR Tobacco in
the U.S. District Court for the District of Maryland. Both
patents at issue are entitled Method of Treating Tobacco
to Reduce Nitrosamine Content, and Products Produced
Thereby, and bear U.S. Patent Nos. 6,202,649 and
6,425,401. The plaintiffs sought: the entry of an injunction
restraining RJR Tobacco from further acts of infringement,
inducement of infringement, or contributory infringement of the
patents; an award of damages, including a reasonable royalty, to
compensate for the infringement; an award of enhanced damages on
account that the defendants conduct was willful; an award
of pre-judgment interest and a further award of post-judgment
interest; an award of reasonable attorneys fees; and an
order requiring RJR Tobacco to deliver up to the court for
destruction all products manufactured from any process which
infringes upon, directly or indirectly or otherwise, any claim
of such patent. RJR Tobacco filed counterclaims seeking a
declaration that the claims of the two Star patents are invalid,
unenforceable and not infringed by RJR Tobacco. Between January
31 and February 8, 2005, the court held a first bench trial
on RJR Tobaccos affirmative defense and counterclaim based
upon inequitable conduct. Additionally, in response to the
courts invitation, RJR Tobacco filed two summary judgment
motions on January 20, 2005.
On January 19, 2007, the court granted RJR Tobaccos
motion for summary judgment of invalidity based on
indefiniteness. The court granted in part and denied in
part RJR Tobaccos other summary judgment motion
concerning the effective filing date of the patents in suit. On
June 26, 2007, the court ruled that Stars patents are
unenforceable due to inequitable conduct by Star and its
representatives in the U.S. Patent & Trademark
Office. On June 26, 2007, the court also entered final
judgment in favor of RJR Tobacco and against Star, dismissing
all of Stars claims with prejudice. On June 27, 2007,
Star filed a notice of appeal with the U.S. Court of
Appeals for the Federal Circuit. Oral argument occurred on
March 7, 2008.
125
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
On August 25, 2008, the Federal Circuit issued a decision
reversing the district courts holdings and remanded the
case to the district court for further proceedings on the issues
of validity and infringement. On September 2, 2008, Star
filed a motion for reassignment of the case on remand to a new
trial judge. On September 5, 2008, the Federal Circuit
denied that motion. The Federal Circuit denied RJR
Tobaccos combined petition for panel hearing and rehearing
en banc on October 22, 2008.
The district court has scheduled the trial to be held during the
period of April 20 to May 29, 2009. On December 31,
2008, RJR Tobacco petitioned the U.S. Patent Office to
reexamine Stars
patents-in-suit.
On January 16, 2009, RJR Tobacco filed a petition for writ
of certiorari to the U.S. Supreme Court. On
January 30, 2009, RJR Tobacco filed summary judgment
motions of invalidity based in indefiniteness, of invalidity
based on 35 U.S.C. § 101, of invalidity based on
anticipation and obviousness, and for noninfringement. On
February 12, 2009, the U.S. Patent Office issued an
order granting request for ex parte reexamination as to the
petition filed on December 31, 2008.
A Civil Investigative Demand, referred to as the CID, was issued
by the FTC to RJR Tobacco on August 23, 2007, to determine
whether RJR Tobaccos advertising and marketing related to
the Camel No. 9 cigarette brand may violate the FTC Act.
The CID requires RJR Tobacco to produce documents and answer
interrogatories. On January 7, 2008, RJR Tobacco certified
as complete its production of documents to the FTC.
Finally, in the first quarter of 2005, Commonwealth Brands,
Inc., referred to as Commonwealth, was served with an individual
smoking and health case, Croft v. Akron Gasket in
Cuyahoga County, Ohio. Commonwealth requested indemnity from RJR
Tobacco pursuant to the Asset Purchase Agreement dated
July 24, 1996, between Commonwealth and B&W, referred
to as the 1996 Purchase Agreement. As a result of the B&W
business combination, RJR Tobacco agreed to indemnify
Commonwealth for this claim to the extent, if any, required by
the 1996 Purchase Agreement. The scope of the indemnity will be
at issue and has not been determined.
Smokeless
Tobacco Litigation
As of February 6, 2009, Conwood Company, LLC was a
defendant in six actions brought by individual plaintiffs in
West Virginia state court seeking damages in connection with
personal injuries allegedly sustained as a result of the usage
of the Conwood companies smokeless tobacco products. These
actions are pending before the same West Virginia court as the
687 consolidated individual smoker cases against RJR Tobacco,
B&W, as RJR Tobaccos indemnitee, or both. Pursuant to
the courts December 3, 2001, order, the smokeless
tobacco claims and defendants remain severed.
Pursuant to a second amended complaint filed in September 2006,
Conwood Company, LLC is a defendant in Vassallo v.
United States Tobacco Company, pending in the Eleventh
Circuit Court in Miami-Dade County, Florida. The individual
plaintiff alleges that he sustained personal injuries, including
addiction and cancer, as a result of his use of smokeless
tobacco products, allegedly including products manufactured by
the Conwood companies. The plaintiff seeks unspecified
compensatory and consequential damages in an amount greater than
$15,000. There is not a punitive damages demand in this case,
though the plaintiff retains the right to seek leave of court to
add such a demand later. Discovery is underway.
Tobacco
Buyout Legislation and Related Litigation
On October 22, 2004, the President signed the Fair and
Equitable Tobacco Reform Act of 2004, referred to as FETRA,
eliminating the U.S. governments tobacco production
controls and price support program. The buyout of tobacco quota
holders provided for in FETRA is funded by a direct quarterly
assessment on every tobacco product manufacturer and importer,
on a market-share basis measured on volume to which federal
excise tax is applied. The aggregate cost of the buyout to the
industry is approximately $9.9 billion, including
approximately $9.6 billion payable to quota tobacco holders
and growers through industry assessments over ten years and
approximately $290 million for the liquidation of quota
tobacco stock. As a result of the tobacco buyout legislation,
the MSA Phase II obligations established in 1999 will be
continued as scheduled through the end of 2010, but will be
offset against the tobacco quota buyout obligations. RAIs
operating subsidiaries annual expense under FETRA,
126
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
excluding the tobacco stock liquidation assessment, is estimated
to be approximately $230 million to $260 million. In
2006, a $9 million favorable adjustment was recorded
relating to the tobacco stock liquidation assessment. Remaining
contingent liabilities for liquidation of quota tobacco stock,
if any, will be recorded when an assessment is made. See
note 1 for additional information related to federal
tobacco buyout expenses.
RAIs operating subsidiaries will record the FETRA
assessment on a quarterly basis as cost of goods sold.
RAIs operating subsidiaries estimate that their overall
share of the buyout will approximate $2.3 billion to
$2.8 billion prior to the deduction of permitted offsets
under the MSA. In addition, future market pricing could impact
the carrying value of inventory, and adversely affect RJR
Tobaccos financial position and results of operations.
As noted above, the MSA Phase II obligations will be offset
against the tobacco quota buyout obligations. Because growers in
two states, Maryland and Pennsylvania, did not participate in
the quota system, they are not eligible for payments under
FETRA. Given that the assessments paid by tobacco product
manufacturers and importers under FETRA would fully offset their
MSA Phase II payment obligations, the growers in Maryland
and Pennsylvania would no longer receive payments under the MSA
Phase II program. Thus, the growers in these two states
would not receive payment under either FETRA or the MSA
Phase II program.
On December 17, 2004, Maryland and Pennsylvania filed in
the North Carolina Business Court a Motion for Clarification or
Modification of the Trust, that is, the Growers Trust that
created the MSA Phase II obligations. They later
supplemented this filing with a Statement of Claim, filed on
June 24, 2005. Maryland and Pennsylvania contend that they
are entitled to relief from the operation of the tax offset
adjustment provision of the Growers Trust and that payments
under the Growers Trust to the growers in their states should
continue. Following discovery, the parties filed cross-motions
for summary judgment on May 5, 2006. On August 17,
2007, the Business Court granted summary judgment in favor of
Maryland and Pennsylvania and denied summary judgment to the
tobacco manufacturers, including RJR Tobacco, that were the
settlors of the Growers Trust. The Business Court ruled that the
Growers Trust, as written and without judicial modification,
requires continuing payments to the Growers Trust for the
benefit of tobacco growers in Maryland and Pennsylvania. RJR
Tobacco and the other tobacco manufacturer/settlors filed their
Notice of Appeal on September 14, 2007. On January 14,
2008, RJR Tobacco and the other tobacco manufacturer/settlors
filed a petition seeking direct discretionary review by the
North Carolina Supreme Court. On February 25, 2008, the
North Carolina Supreme Court denied that petition. On
August 20, 2008, oral arguments were held before the North
Carolina Court of Appeals. On December 16, 2008, the North
Carolina Court of Appeals, in a 2-1 decision, reversed the
Business Court and remanded the case for entry of judgment in
favor of RJR Tobacco and the other tobacco
manufacturers/settlors. On January 20, 2009, Maryland and
Pennsylvania filed an appeal of right based on the dissenting
opinion and also filed a petition for discretionary review on
certain additional issues. On January 30, 2009, RJR Tobacco
and the other tobacco manufacturers/settlors filed a response to
the states petition for discretionary review. The
states brief to the North Carolina Supreme Court on the
appeal of right is due on February 19, 2009.
ERISA
Litigation
On May 13, 2002, in Tatum v. The R.J.R. Pension
Investment Committee of the R. J. Reynolds Tobacco Company
Capital Investment Plan, an employee of RJR Tobacco filed a
class-action
suit in the U.S. District Court for the Middle District of
North Carolina, alleging that the defendants, RJR, RJR Tobacco,
the RJR Employee Benefits Committee and the RJR Pension
Investment Committee, violated the Employee Retirement Income
Security Act of 1974, referred to as ERISA. The actions about
which the plaintiff complains stem from a decision made in 1999
by RJR Nabisco Holdings Corp., subsequently renamed Nabisco
Group Holdings Corp., referred to as NGH, to spin off RJR,
thereby separating NGHs tobacco business and food
business. As part of the spin-off, the 401(k) plan for the
previously related entities had to be divided into two separate
plans for the now separate tobacco and food businesses. The
plaintiff contends that the defendants violated ERISA by not
overriding an amendment to RJRs 401(k) plan requiring
that, prior to February 1, 2000, the stock funds of the
companies involved in the food business, NGH and Nabisco
Holdings Corp., referred to as Nabisco, be eliminated as
investment options from RJRs 401(k) plan. In his
complaint, the plaintiff requests, among other things, that the
court require the defendants to pay
127
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
as damages to the RJR 401(k) plan an amount equal to the
subsequent appreciation that was purportedly lost as a result of
the liquidation of the NGH and Nabisco funds.
The district court granted the defendants motion to
dismiss on December 10, 2003. On December 14, 2004,
the U.S. Court of Appeals for the Fourth Circuit reversed
and remanded the case for further proceedings. On
January 20, 2005, the defendants filed a second motion to
dismiss on other grounds. On March 7, 2007, the court
granted the plaintiff leave to file an amended complaint and
denied all pending motions as moot. On April 6, 2007, the
defendants moved to dismiss the amended complaint. On
May 31, 2007, the court granted the motion in part and
denied it in part, dismissing all claims against the RJR
Employee Benefits Committee and the RJR Pension Investment
Committee. The remaining defendants, RJR and RJR Tobacco, filed
their answer and affirmative defenses on June 14, 2007. On
June 28, 2007, the plaintiff filed a motion to amend the
complaint to add as parties defendant the six members of the RJR
Pension Investment Committee and the RJR Employee Benefits
Committee. On March 13, 2008, the court denied this motion.
On November 19, 2007, the plaintiff filed a motion for
class certification, which the court granted on
September 29, 2008. Court ordered mediation occurred on
July 10, 2008, but no resolution of the case was reached.
On May 29, 2008, the defendants filed a motion for judgment
on the pleadings, which asked the court to dismiss the claims
asserted by class members who voluntarily transferred their
401(k) investments from the NGH and Nabisco funds before
January 31, 2000. That motion remains outstanding. On
September 18, 2008, each of the plaintiffs and the
defendants filed motions for summary judgment. A decision is
pending. Finally, on January 9, 2009, the defendants filed
a motion to decertify the class; that motion remains pending as
well.
Employment
Litigation
On March 19, 2007, in Marshall v. R.J. Reynolds Tobacco
Co., the plaintiff filed a collective action complaint
against RJR Tobacco in the U.S. District Court for the
Western District of Missouri alleging violations of the Fair
Labor Standards Act, referred to as FLSA. The allegations
include failure to keep accurate records of all hours worked by
RJR Tobaccos employees and failure to pay wages and
overtime compensation to non-exempt retail representatives. The
total number of current or former retail representatives
participating is 469, including those who have opted in the
Marshall case and subsequent lawsuits filed in New York
and California as described below.
Two new cases alleging violations of the FLSA and other state
law wage and hour claims were filed in February 2008:
Radcliffe v. R.J. Reynolds Tobacco Co., filed on
February 14, 2008, in federal court in California, was
served on May 9, 2008; and Dinino v. R.J. Reynolds
Tobacco Co., filed on February 29, 2008, in federal
court in New York, was served on April 18, 2008. The
Dinino and Radcliffe matters have been transferred
to the Missouri court in conjunction with the already pending
Marshall case due to the similarity of issues to be
resolved. The plaintiffs in the Dinino and Radcliffe
matters failed to move for class certification on the state
law claims.
On December 22, 2008, RJR Tobaccos motion for partial
summary judgment was granted. The court ruled that the
plaintiffs commutes from their homes to their first
assignment of the day, and their commutes from their last
assignments of the day to their homes, are non-compensable. On
February 5, 2009, the court denied the plaintiffs
motion for reconsideration on this issue or, in the alternative,
plaintiffs request for certification for interlocutory
appeal.
The case is still in the discovery phase. Mediation was held on
February 3, 2009, but the parties were unable to reach a
resolution.
Environmental
Matters
RAI and its subsidiaries are subject to federal, state and local
environmental laws and regulations concerning the discharge,
storage, handling and disposal of hazardous or toxic substances.
Such laws and regulations provide for significant fines,
penalties and liabilities, sometimes without regard to whether
the owner or operator of the property knew of, or was
responsible for, the release or presence of hazardous or toxic
substances. In addition, third parties may make claims against
owners or operators of properties for personal injuries and
property damage associated with releases of hazardous or toxic
substances. In the past, RJR Tobacco has been named a
potentially
128
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
responsible party with third parties under the Comprehensive
Environmental Response, Compensation and Liability Act with
respect to several superfund sites. RAI and its subsidiaries are
not aware of any current environmental matters that are expected
to have a material adverse effect on the business, results of
operations or financial position of RAI or its subsidiaries.
Regulations promulgated by the U.S. Environmental
Protection Agency and other governmental agencies under various
statutes have resulted in, and likely will continue to result
in, substantial expenditures for pollution control, waste
treatment, plant modification and similar activities. RAI and
its subsidiaries are engaged in a continuing program to comply
with federal, state and local environmental laws and
regulations, and dependent upon the probability of occurrence
and reasonable estimation of cost, accrue or disclose any
material liability. Although it is difficult to reasonably
estimate the portion of capital expenditures or other costs
attributable to compliance with environmental laws and
regulations, RAI does not expect such expenditures or other
costs to have a material adverse effect on the business, results
of operations or financial position of RAI or its subsidiaries.
Other
Contingencies
In connection with the sale of the international tobacco
business to JTI, on May 12, 1999, pursuant to the purchase
agreement, RJR and RJR Tobacco agreed to indemnify JTI against:
|
|
|
|
|
any liabilities, costs and expenses arising out of the
imposition or assessment of any tax with respect to the
international tobacco business arising prior to the sale, other
than as reflected on the closing balance sheet;
|
|
|
|
any liabilities, costs and expenses that JTI or any of its
affiliates, including the acquired entities, may incur after the
sale with respect to any of RJRs or RJR Tobaccos
employee benefit and welfare plans; and
|
|
|
|
any liabilities, costs and expenses incurred by JTI or any of
its affiliates arising out of certain activities of Northern
Brands.
|
As described above in Litigation Affecting the
Cigarette Industry Other Litigation and
Developments, RJR Tobacco has received several claims for
indemnification from JTI. Although RJR and RJR Tobacco recognize
that, under certain circumstances, they may have indemnification
obligations to JTI under the 1999 Purchase Agreement, RJR and
RJR Tobacco disagree whether the circumstances described in such
claims give rise to any indemnification obligations by RJR and
RJR Tobacco. RJR and RJR Tobacco have conveyed their position to
JTI, and the parties have agreed to resolve their differences at
a later date. RJR, including its subsidiary RJR Tobacco, have
liabilities totaling $94 million that were recorded in 1999
in connection with these indemnification claims.
RJR Tobacco, Santa Fe, the Conwood companies and Lane have
entered into agreements to indemnify certain distributors and
retailers from liability and related defense costs arising out
of the sale or distribution of their products. Additionally,
Santa Fe has entered into an agreement to indemnify a
supplier from liability and related defense costs arising out of
the sale or use of Santa Fes products. The cost has
been, and is expected to be, insignificant. RJR Tobacco,
Santa Fe, the Conwood companies and Lane believe that the
indemnified claims are substantially similar in nature and
extent to the claims that they are already exposed to by virtue
of their having manufactured those products.
Under certain circumstances, any fair value that results in a
liability position of certain interest rate swaps may require
full collateralization with cash or securities. No swaps were in
a liability position as of December 31, 2008.
Except as otherwise noted above, RAI is not able to estimate the
maximum potential amount of future payments, if any, related to
these guarantees and indemnification obligations.
Lease
Commitments
RAI has operating lease agreements that are primarily for office
space, automobiles, warehouse space and computer equipment. The
majority of these leases expire within the next five years and
some contain renewal or purchase options and escalation clauses
or restrictions relating to subleases. Total rent expense was
$21 million, $20 million and $24 million for
2008, 2007 and 2006, respectively.
129
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Future minimum lease payments as of December 31, 2008, were
as follows:
|
|
|
|
|
|
|
Noncancellable
|
|
|
|
Operating Leases
|
|
|
2009
|
|
$
|
16
|
|
2010
|
|
|
14
|
|
2011
|
|
|
12
|
|
2012
|
|
|
10
|
|
2013
|
|
|
8
|
|
Thereafter
|
|
|
8
|
|
|
|
|
|
|
Total
|
|
$
|
68
|
|
|
|
|
|
|
The B&W business combination restructuring accrual includes
$31 million related to the lease obligations of the former
B&W facilities included in the table above.
Note 17
Shareholders Equity
RAIs authorized capital stock at December 31, 2008,
consisted of 100 million shares of preferred stock, par
value $.01 per share, and 800 million shares of common
stock, par value $.0001 per share. Four million shares of the
preferred stock are designated as Series A Junior
Participating Preferred Stock, none of which is issued or
outstanding. The Series A Preferred Stock will rank junior
as to dividends and upon liquidation to all other series of RAI
preferred stock, unless specified otherwise. Also, of the
preferred stock, one million shares are designated as
Series B Preferred Stock, all of which are issued and
outstanding. The Series B Preferred Stock ranks senior upon
liquidation, but not with respect to dividends, to all other
series of RAI capital stock, unless specified otherwise. As a
part of the B&W business combination, RJR is the holder of
the outstanding Series B Preferred Stock. In 2008, RAI
declared $43 million in dividends to RJR with respect to
the Series B Preferred Stock.
In 2004, RAIs board of directors adopted a shareholder
rights plan, pursuant to which RAI declared a dividend of one
preferred stock purchase right on each share of RAIs
common stock outstanding on July 30, 2004. The board also
authorized the issuance of rights for each share of RAI common
stock issued after the dividend record date, until the
occurrence of certain specified events. The rights will expire
on July 30, 2014, unless earlier redeemed, exercised or
exchanged under the terms of the rights plan.
The rights are not exercisable until a distribution date that is
the earlier of:
|
|
|
|
|
ten days following an announcement that a person or group, other
than BAT and its subsidiaries, except in certain circumstances,
has acquired beneficial ownership of at least 15% of RAIs
common stock, and
|
|
|
|
ten business days, or such later date as may be determined by
the board, following the announcement of a tender offer which
would result in a person becoming an acquiring person.
|
If the acquiring person or tender offeror is BAT or one of its
subsidiaries, then the foregoing 15% threshold is subject to
adjustment. The rights are initially exercisable for
1/100th of a share of RAIs Series A Junior
Participating Preferred Stock at a purchase price of $130,
subject to adjustment. Each fractional share of such preferred
stock would give the holder approximately the same dividend,
voting and liquidation rights as does one share of RAIs
common stock. Until the distribution date, the rights will be
evidenced by RAIs common stock certificates and trade with
such shares. Upon the occurrence of certain events after the
distribution date, holders of rights, other than the acquiring
person, will be entitled to receive upon exercise of the right,
in lieu of shares of preferred stock, RAI common stock or common
stock of the acquiring corporation having in either case a
market value of two times the exercise price of the right.
130
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
RAIs board of directors declared the following quarterly
cash dividends per share of RAI common stock in 2008, 2007 and
2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
First
|
|
$
|
0.85
|
|
|
$
|
0.75
|
|
|
$
|
0.625
|
|
Second
|
|
$
|
0.85
|
|
|
$
|
0.75
|
|
|
$
|
0.625
|
|
Third
|
|
$
|
0.85
|
|
|
$
|
0.85
|
|
|
$
|
0.75
|
|
Fourth
|
|
$
|
0.85
|
|
|
$
|
0.85
|
|
|
$
|
0.75
|
|
RAI repurchases and cancels shares of its common stock forfeited
with respect to the tax liability associated with certain stock
option exercises and vesting of restricted stock grants under
the RAI Long-Term Incentive Plan, referred to as the LTIP. On
February 5, 2008, the board of directors of RAI authorized
the repurchase of up to $30 million of outstanding shares
of RAI common stock to offset the dilution from shares issued
under certain equity-based benefit plans. This $30 million
repurchase program was superseded on April 29, 2008, when
RAIs board of directors authorized RAIs repurchase,
from time to time on or before April 30, 2009, of up to
$350 million of outstanding shares of RAI common stock in
open-market or privately negotiated transactions. The
repurchases are subject to prevailing market and business
conditions, and the program may be terminated or suspended at
any time. In connection with the share repurchase program, RAI
and B&W entered into an agreement, pursuant to which
B&W has agreed to participate in the repurchase program on
a basis approximately proportionate with B&Ws 42%
ownership of RAIs common stock.
Due to RAIs incorporation in North Carolina, which does
not recognize treasury shares, the shares repurchased are
cancelled at the time of repurchase. As of December 31,
2008, RAI had repurchased and cancelled 3,817,095 shares of
RAI common stock for $207 million under the above share
repurchase programs. To preserve liquidity, RAI did not make any
stock purchases under the repurchase program in the fourth
quarter of 2008.
Additionally during 2008, at a cost of $3 million, RAI
purchased 57,223 shares that were forfeited with respect to
tax liabilities associated with restricted stock vesting under
its LTIP.
Changes in RAIs common stock outstanding during 2008 were
as follows:
|
|
|
|
|
|
|
Shares
|
|
|
Shares outstanding as of December 31, 2007
|
|
|
295,007,327
|
|
Shares repurchased and cancelled
|
|
|
(3,817,095
|
)
|
LTIP shares granted
|
|
|
322,585
|
|
LTIP shares forfeited
|
|
|
(96,797
|
)
|
LTIP tax shares repurchased and cancelled
|
|
|
(57,223
|
)
|
Stock options exercised
|
|
|
72,571
|
|
Equity incentive award plan shares issued
|
|
|
19,394
|
|
|
|
|
|
|
Shares outstanding as of December 31, 2008
|
|
|
291,450,762
|
|
|
|
|
|
|
Note 18
Stock Plans
As of December 31, 2008, RAI had two stock plans, the
Equity Incentive Award Plan for Directors of RAI, referred to as
the EIAP, and the LTIP.
The EIAP currently provides for (1) grants of deferred
stock units to eligible directors upon becoming a director or,
provided the director did not receive an initial award upon
his/her
election to the board, upon appointment to the position of
Non-Executive Chairman and (2) grants of deferred stock
units to eligible directors on a quarterly and annual basis
thereafter. Directors may elect to receive shares of common
stock in lieu of their initial and annual grants of deferred
stock units. A maximum of 1,000,000 shares of common stock
may be issued under this plan, of which 599,266 shares were
available for grant as of December 31, 2008. Deferred stock
units
131
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
granted under the EIAP have a value equal to, and bear dividend
equivalents at the same rate as, one share of RAIs common
stock, and have no voting rights. The dividends are paid as
additional units in an amount equal to the number of shares of
common stock that could be purchased with the dividends on the
date of payment. Generally, distribution of a directors
deferred stock units will be made on January 2 following his or
her last year of service on the board; however, for all grants
made under the EIAP after December 31, 2007, a director may
elect to receive his or her deferred stock units on the later of
January 2 of a specified year or January 2 following his or her
last year of service on the board. At the election of a
director, distribution may be made in one lump sum or in up to
ten annual installments. A director is paid in cash for the
units granted quarterly and in common stock for the units
granted initially and annually, unless the director elects to
receive cash for the initial and annual grants. Cash payments
are based on the average closing price of RAIs common
stock during December of the year preceding payment.
Compensation expense related to the EIAP was $1 million
income during 2008, due to the decline of the price of
RAIs common stock during 2008, compared with
$4 million expense during each of 2007 and 2006.
The LTIP provides for grants of incentive stock options, other
stock options, stock appreciation rights, restricted stock,
performance units and performance shares to key employees. Upon
retirement, the holders grant under the LTIP generally
vests on a pro rata basis for the portion of the vesting service
period that has elapsed, thereby maintaining an appropriate
approximation of forfeitures related to retirement.
Historically, forfeitures due to other events have been
immaterial, and therefore, no estimate of forfeitures has been
recorded. The total number of shares of common stock authorized
for grant under the LTIP is 27,545,628 shares. Of this
authorization, 9,290,609 shares were available for grant as
of December 31, 2008.
Activity under the LTIP was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number
|
|
|
|
|
|
|
|
|
Number
|
|
|
Number
|
|
|
|
of
|
|
|
|
|
|
|
|
|
of
|
|
|
of
|
|
|
|
Shares
|
|
|
|
|
|
|
|
|
Shares
|
|
|
Shares
|
|
Grant Year
|
|
Granted
|
|
|
Grant Price
|
|
Type
|
|
Vesting Date
|
|
Cancelled
|
|
|
Vested
|
|
|
2004
|
|
|
972,432
|
|
|
N/A
|
|
Phantom Stock
|
|
Ratably over three years
|
|
|
152,770
|
|
|
|
819,662
|
|
2005
|
|
|
552,194
|
|
|
N/A
|
|
Phantom Stock
|
|
March 2, 2008
|
|
|
56,110
|
|
|
|
496,084
|
|
2006
|
|
|
507,060
|
|
|
$52.60
|
|
Restricted Stock
|
|
March 6, 2009
|
|
|
63,373
|
|
|
|
110,511
|
|
2006
|
|
|
9,084
|
|
|
$66.05
|
|
Restricted Stock
|
|
March 6, 2009
|
|
|
|
|
|
|
|
|
2007
|
|
|
373,082
|
|
|
$59.50
|
|
Restricted Stock
|
|
March 6, 2010
|
|
|
52,838
|
|
|
|
39,899
|
|
2007
|
|
|
1,244
|
|
|
$64.14
|
|
Restricted Stock
|
|
March 6, 2010
|
|
|
|
|
|
|
|
|
2007
|
|
|
34,825
|
|
|
N/A
|
|
Phantom Stock
|
|
34% on December 31, 2007
|
|
|
|
|
|
|
11,841
|
|
|
|
|
|
|
|
|
|
|
|
66% on December 31, 2008
|
|
|
|
|
|
|
22,984
|
|
2008
|
|
|
321,991
|
|
|
$61.89
|
|
Restricted Stock
|
|
March 6, 2011
|
|
|
34,783
|
|
|
|
13,402
|
|
2008
|
|
|
594
|
|
|
$55.13
|
|
Restricted Stock
|
|
March 6, 2011
|
|
|
|
|
|
|
|
|
The phantom stock grants consisted of performance shares awarded
to eligible employees under the LTIP. These shares were payable
in cash, based on the closing price of RAI common stock on the
date of vesting. The actual number of shares granted was fixed.
The amount of the liability for these awards was remeasured each
reporting period based on RAIs current stock price.
Compensation expense includes the effects of changes in the
stock price, the portion of vesting period elapsed and dividend
equivalents paid concurrently with RAI dividends.
The restricted stock grants consist of restricted shares of RAI
common stock awarded to eligible employees under the LTIP. These
restricted shares were granted based on the per share closing
price of RAI common stock on the date of grant. The actual
number of shares granted is fixed. However, because the holder
may elect greater than minimum tax withholding upon vesting, the
2006 grants are accounted for as liability-based, and the amount
of the liability for the award is remeasured each reporting
period based on RAIs current stock price. Compensation
expense includes the effects of changes in the price of RAI
common stock and the portion of vesting period elapsed. The 2007
and 2008 grants are accounted for as equity-based and
compensation expense includes the vesting period elapsed.
132
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Dividends are paid on restricted stock on the same basis as
dividends on shares of RAI common stock, and are recognized as a
reduction of equity. Related realized income tax benefits are
recognized as an increase to additional
paid-in-capital.
The changes in restricted RAI common stock during 2008 were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average
|
|
|
|
Restricted
|
|
|
Grant Date
|
|
|
|
Stock
|
|
|
Fair Value
|
|
|
Outstanding at beginning of year
|
|
|
816,243
|
|
|
$
|
55.78
|
|
Granted
|
|
|
322,585
|
|
|
|
61.88
|
|
Forfeited
|
|
|
(96,797
|
)
|
|
|
58.61
|
|
Vested
|
|
|
(143,782
|
)
|
|
|
55.30
|
|
|
|
|
|
|
|
|
|
|
Outstanding at end of year
|
|
|
898,249
|
|
|
$
|
57.74
|
|
|
|
|
|
|
|
|
|
|
Payments related to stock-based compensation, including dividend
equivalents paid on phantom stock, were $35 million,
$20 million and $22 million for the years ended 2008,
2007 and 2006, respectively.
Total compensation expense, including dividend equivalents on
phantom stock, related to stock-based compensation and the
related tax benefits recognized in selling, general and
administrative expenses in the consolidated statements of income
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2004 LTIP performance shares
|
|
$
|
|
|
|
$
|
3
|
|
|
$
|
17
|
|
2005 LTIP performance shares
|
|
|
1
|
|
|
|
11
|
|
|
|
15
|
|
2006 LTIP restricted stock
|
|
|
(1
|
)
|
|
|
10
|
|
|
|
10
|
|
2007 LTIP restricted stock and performance shares
|
|
|
7
|
|
|
|
8
|
|
|
|
|
|
2008 LTIP restricted stock
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total compensation expense
|
|
$
|
12
|
|
|
$
|
32
|
|
|
$
|
42
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total related tax benefits
|
|
$
|
4
|
|
|
$
|
12
|
|
|
$
|
16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following amounts in the consolidated balance sheet as of
December 31 related to the 2007 LTIP performance share grants
and the 2006, 2007 and 2008 LTIP restricted stock grants:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
Other current liabilities
|
|
$
|
14
|
|
|
$
|
29
|
|
Other noncurrent liabilities
|
|
|
|
|
|
|
19
|
|
Paid-in-capital
|
|
|
15
|
|
|
|
6
|
|
There were $20 million of unrecognized compensation costs
related to restricted stock, calculated at the December 31,
2008, ending stock price or original grant price, which are
expected to be recognized over a weighted-average period of
1.76 years.
In the EIAP and the LTIP, options were granted primarily prior
to 1999 and to a lesser extent through 2003, all of which are
fully vested. For various price ranges, the weighted average
characteristics of stock options outstanding, all of which were
exercisable at December 31, 2008, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
|
|
|
|
|
|
|
Remaining
|
|
|
Weighted
|
|
|
|
|
|
|
Contractual
|
|
|
Average
|
|
Exercise Price Range
|
|
Shares
|
|
|
Life (Years)
|
|
|
Exercise Price
|
|
|
$13.05 - $16.22
|
|
|
368,174
|
|
|
|
1.2
|
|
|
$
|
13.66
|
|
34.90
|
|
|
20,000
|
|
|
|
3.4
|
|
|
|
34.90
|
|
133
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
RAI has a policy of issuing new shares of common stock to
satisfy share option exercises. Of the options outstanding as of
December 31, 2008, 42,800 were issued under the EIAP, and
under the LTIP, 315,374 were issued prior to 1999 and 30,000
were issued in tandem with shares of restricted stock in 1999.
The changes in RAIs stock options during 2008, 2007 and
2006 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
Average
|
|
|
|
|
|
Average
|
|
|
|
|
|
Average
|
|
|
|
|
|
|
Exercise
|
|
|
|
|
|
Exercise
|
|
|
|
|
|
Exercise
|
|
|
|
Options
|
|
|
Price
|
|
|
Options
|
|
|
Price
|
|
|
Options
|
|
|
Price
|
|
|
Outstanding at beginning of year
|
|
|
466,347
|
|
|
$
|
14.59
|
|
|
|
513,924
|
|
|
$
|
14.59
|
|
|
|
817,994
|
|
|
$
|
14.90
|
|
Expired
|
|
|
(5,602
|
)
|
|
|
16.21
|
|
|
|
(2,588
|
)
|
|
|
24.16
|
|
|
|
(61,232
|
)
|
|
|
16.90
|
|
Exercised
|
|
|
(72,571
|
)
|
|
|
13.56
|
|
|
|
(44,989
|
)
|
|
|
14.13
|
|
|
|
(242,838
|
)
|
|
|
15.05
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at end of year
|
|
|
388,174
|
|
|
|
14.75
|
|
|
|
466,347
|
|
|
|
14.59
|
|
|
|
513,924
|
|
|
|
14.59
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at end of year
|
|
|
388,174
|
|
|
|
14.75
|
|
|
|
466,347
|
|
|
|
14.59
|
|
|
|
513,924
|
|
|
|
14.59
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The intrinsic value of options exercised was $2 million,
$2 million and $10 million for the years ended
December 31, 2008, 2007 and 2006, respectively. The
aggregate intrinsic value of fully vested outstanding and
exercisable options at December 31, 2008, was
$10 million. Cash proceeds related to stock options
exercised and excess tax benefits related to stock-based
compensation were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Proceeds from exercise of stock options
|
|
$
|
1
|
|
|
$
|
1
|
|
|
$
|
4
|
|
Excess tax benefits from stock-based compensation
|
|
|
2
|
|
|
|
2
|
|
|
|
4
|
|
Equity compensation plan information is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities
|
|
|
|
|
|
|
|
|
|
Remaining Available for
|
|
|
|
Number of Securities
|
|
|
Weighted Average
|
|
|
Future Issuance under
|
|
|
|
to be Issued Upon
|
|
|
Exercise Price of
|
|
|
Equity Compensation
|
|
|
|
Exercise of
|
|
|
Outstanding
|
|
|
Plans (Excluding
|
|
|
|
Outstanding Options,
|
|
|
Options, Warrants
|
|
|
Securities Reflected in
|
|
Plan Category
|
|
Warrants and Rights
|
|
|
and Rights
|
|
|
Column (a))
|
|
|
|
(a)
|
|
|
(b)
|
|
|
(c)
|
|
|
Equity Compensation Plans Approved by Security Holders
|
|
|
345,374
|
|
|
$
|
13.49
|
|
|
|
9,290,609
|
|
Equity Compensation Plans Not Approved by Security Holders(1)
|
|
|
42,800
|
|
|
|
24.95
|
|
|
|
599,266
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
388,174
|
|
|
|
14.75
|
|
|
|
9,889,875
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The EIAP is the only equity compensation plan not approved by
RAIs or RJRs public shareholders. The EIAP was
approved by RJRs sole shareholder, NGH, prior to
RJRs spin-off on June 15, 1999. |
Note 19
Retirement Benefits
RAI and certain of its subsidiaries sponsor a number of
non-contributory defined benefit pension plans covering most of
their employees, and also provide certain health and life
insurance benefits for most of their retired employees and their
dependents. These benefits are generally no longer provided to
employees hired on or after January 1, 2004.
As a result of the new funding requirements of the Pension
Protection Act of 2006, referred to as the PPA, RAI and the
Pension Benefit Guaranty Corporation amended and restated an
agreement effective December 31, 2007,
134
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
originally entered into in 1999. The amended agreement resulted
in, among other things, RAIs release of the accumulated
excess contributions that were held separately within the
affected plan, sometimes referred to as credit balances, as
allowed under the PPA and subjects RAI to the same contribution
and other requirements of the PPA as other U.S. qualified
defined benefit plans. Upon RAI attaining investment grade
corporate ratings by S&P and Moodys, the amended and
restated agreement with the Pension Benefit Guaranty Corporation
terminated.
The changes in benefit obligations and plan assets, as well as
the funded status of these plans at December 31, were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
|
|
Postretirement Benefits
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
Change in benefit obligation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Obligation at beginning of year
|
|
$
|
5,088
|
|
|
$
|
5,293
|
|
|
$
|
1,485
|
|
|
$
|
1,490
|
|
Service cost
|
|
|
36
|
|
|
|
40
|
|
|
|
5
|
|
|
|
6
|
|
Interest cost
|
|
|
318
|
|
|
|
313
|
|
|
|
90
|
|
|
|
91
|
|
Actuarial gain (loss)
|
|
|
66
|
|
|
|
(182
|
)
|
|
|
(25
|
)
|
|
|
|
|
Plan amendments
|
|
|
26
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
Benefits paid
|
|
|
(424
|
)
|
|
|
(379
|
)
|
|
|
(110
|
)
|
|
|
(102
|
)
|
Settlements
|
|
|
(11
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Curtailment/special termination benefits
|
|
|
7
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Obligation at end of year
|
|
$
|
5,106
|
|
|
$
|
5,088
|
|
|
$
|
1,445
|
|
|
$
|
1,485
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in plan assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets at beginning of year
|
|
$
|
5,421
|
|
|
$
|
5,110
|
|
|
$
|
364
|
|
|
$
|
374
|
|
Actual return on plan assets
|
|
|
(1,631
|
)
|
|
|
391
|
|
|
|
(78
|
)
|
|
|
22
|
|
Employer contributions
|
|
|
21
|
|
|
|
299
|
|
|
|
78
|
|
|
|
70
|
|
Benefits paid
|
|
|
(424
|
)
|
|
|
(379
|
)
|
|
|
(110
|
)
|
|
|
(102
|
)
|
Settlements
|
|
|
(11
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets at end of year
|
|
$
|
3,376
|
|
|
$
|
5,421
|
|
|
$
|
254
|
|
|
$
|
364
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funded status
|
|
$
|
(1,730
|
)
|
|
$
|
333
|
|
|
$
|
(1,191
|
)
|
|
$
|
(1,121
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts recognized in the consolidated balance sheets consist of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Noncurrent assets other assets and deferred charges
|
|
$
|
|
|
|
$
|
465
|
|
|
$
|
|
|
|
$
|
|
|
Accrued benefit other current liability
|
|
|
(6
|
)
|
|
|
(6
|
)
|
|
|
(79
|
)
|
|
|
(80
|
)
|
Accrued benefit long-term retirement benefits
|
|
|
(1,724
|
)
|
|
|
(126
|
)
|
|
|
(1,112
|
)
|
|
|
(1,041
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net amount recognized
|
|
|
(1,730
|
)
|
|
|
333
|
|
|
|
(1,191
|
)
|
|
|
(1,121
|
)
|
Accumulated other comprehensive loss
SFAS No. 158
|
|
|
2,448
|
|
|
|
302
|
|
|
|
271
|
|
|
|
196
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net amounts recognized in the consolidated balance sheets
|
|
$
|
718
|
|
|
$
|
635
|
|
|
$
|
(920
|
)
|
|
$
|
(925
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Due to the adverse changes in the financial markets, RAIs
pension assets have been negatively impacted. In 2008, the
overall rate of return on the investments for the pension assets
was approximately negative 30.1%.
135
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Amounts included in accumulated other comprehensive loss were as
follows as of December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
|
Pension
|
|
|
Postretirement
|
|
|
|
|
|
Pension
|
|
|
Postretirement
|
|
|
|
|
|
|
Benefits
|
|
|
Benefits
|
|
|
Total
|
|
|
Benefits
|
|
|
Benefits
|
|
|
Total
|
|
|
Prior service cost (credit)
|
|
$
|
38
|
|
|
$
|
(17
|
)
|
|
$
|
21
|
|
|
$
|
17
|
|
|
$
|
(28
|
)
|
|
$
|
(11
|
)
|
Net actuarial loss
|
|
|
2,410
|
|
|
|
288
|
|
|
|
2,698
|
|
|
|
285
|
|
|
|
224
|
|
|
|
509
|
|
Deferred income taxes
|
|
|
(969
|
)
|
|
|
(107
|
)
|
|
|
(1,076
|
)
|
|
|
(116
|
)
|
|
|
(76
|
)
|
|
|
(192
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive loss
|
|
$
|
1,479
|
|
|
$
|
164
|
|
|
$
|
1,643
|
|
|
$
|
186
|
|
|
$
|
120
|
|
|
$
|
306
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in accumulated other comprehensive loss were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
|
Pension
|
|
|
Postretirement
|
|
|
|
|
|
Pension
|
|
|
Postretirement
|
|
|
|
|
|
|
Benefits
|
|
|
Benefits
|
|
|
Total
|
|
|
Benefits
|
|
|
Benefits
|
|
|
Total
|
|
|
Prior service cost
|
|
$
|
26
|
|
|
$
|
|
|
|
$
|
26
|
|
|
$
|
2
|
|
|
$
|
|
|
|
$
|
2
|
|
Net actuarial (gain) loss
|
|
|
2,143
|
|
|
|
80
|
|
|
|
2,223
|
|
|
|
(137
|
)
|
|
|
6
|
|
|
|
(131
|
)
|
Amortization of prior service cost (credit)
|
|
|
(5
|
)
|
|
|
11
|
|
|
|
6
|
|
|
|
(2
|
)
|
|
|
12
|
|
|
|
10
|
|
Amortization of net loss
|
|
|
(18
|
)
|
|
|
(16
|
)
|
|
|
(34
|
)
|
|
|
(42
|
)
|
|
|
(23
|
)
|
|
|
(65
|
)
|
Deferred income taxes
|
|
|
(853
|
)
|
|
|
(31
|
)
|
|
|
(884
|
)
|
|
|
70
|
|
|
|
2
|
|
|
|
72
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in accumulated other comprehensive loss
|
|
$
|
1,293
|
|
|
$
|
44
|
|
|
$
|
1,337
|
|
|
$
|
(109
|
)
|
|
$
|
(3
|
)
|
|
$
|
(112
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Postretirement
|
|
|
|
Pension Benefits
|
|
|
Benefits
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
Weighted-average assumptions used to determine benefit
obligations at December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate
|
|
|
6.40
|
%
|
|
|
6.50
|
%
|
|
|
6.39
|
%
|
|
|
6.50
|
%
|
Rate of compensation increase
|
|
|
4.97
|
%
|
|
|
4.97
|
%
|
|
|
5.00
|
%
|
|
|
5.00
|
%
|
The measurement date used for all plans was December 31.
The accumulated benefit obligation, which represents benefits
earned to date, for all pension plans was $4,970 million
and $4,931 million for years ended December 31, 2008
and 2007, respectively.
Pension plans experiencing accumulated benefit obligations in
excess of plan assets are summarized below:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
Projected benefit obligation
|
|
$
|
5,106
|
|
|
$
|
122
|
|
Accumulated benefit obligation
|
|
|
4,970
|
|
|
|
103
|
|
Plan assets
|
|
|
3,376
|
|
|
|
|
|
136
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The components of the total benefit cost and assumptions are set
forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
|
|
Postretirement Benefits
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Components of total benefit cost (income):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost
|
|
$
|
36
|
|
|
$
|
40
|
|
|
$
|
40
|
|
|
$
|
5
|
|
|
$
|
5
|
|
|
$
|
5
|
|
Interest cost
|
|
|
318
|
|
|
|
314
|
|
|
|
308
|
|
|
|
90
|
|
|
|
91
|
|
|
|
86
|
|
Expected return on plan assets
|
|
|
(450
|
)
|
|
|
(436
|
)
|
|
|
(368
|
)
|
|
|
(27
|
)
|
|
|
(27
|
)
|
|
|
(28
|
)
|
Amortization of prior service cost (credit)
|
|
|
5
|
|
|
|
2
|
|
|
|
2
|
|
|
|
(11
|
)
|
|
|
(12
|
)
|
|
|
(12
|
)
|
Amortization of net loss
|
|
|
18
|
|
|
|
42
|
|
|
|
70
|
|
|
|
16
|
|
|
|
23
|
|
|
|
21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit cost (income)
|
|
|
(73
|
)
|
|
|
(38
|
)
|
|
|
52
|
|
|
|
73
|
|
|
|
80
|
|
|
|
72
|
|
Curtailment/special termination benefits
|
|
|
7
|
|
|
|
1
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Settlements
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total benefit cost (income)
|
|
$
|
(62
|
)
|
|
$
|
(37
|
)
|
|
$
|
54
|
|
|
$
|
73
|
|
|
$
|
80
|
|
|
$
|
72
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The estimated net loss and prior service cost for pension plans
that are expected to be amortized from accumulated other
comprehensive loss into net periodic benefit cost during 2009
are $95 million and $4 million, respectively. The
estimated net loss and prior service cost for the postretirement
plans that are expected to be amortized from accumulated other
comprehensive loss into net postretirement health care costs
during 2009 are $19 million and ($23) million,
respectively.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
|
Postretirement Benefits
|
|
|
2008
|
|
2007
|
|
2006
|
|
2008
|
|
2007
|
|
2006
|
|
Weighted-average assumptions used to determine net periodic
benefit cost for years ended December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate
|
|
6.50%
|
|
6.10%
|
|
5.90%
|
|
6.50%
|
|
6.10%
|
|
5.91%
|
Expected long-term return on plan assets
|
|
8.74%
|
|
8.74%
|
|
8.74%
|
|
8.00%
|
|
8.00%
|
|
8.00%
|
Rate of compensation increase
|
|
4.97%
|
|
4.97%
|
|
4.98%
|
|
5.00%
|
|
5.00%
|
|
5.00%
|
RAI generally uses a hypothetical bond matching analysis to
determine the discount rate. The discount rate modeling process
involves selecting a portfolio of high quality corporate bonds
whose cash flows, via coupons and maturities, match the
projected cash flows of the obligations. For some years, there
were no bonds maturing. In these instances, it was assumed that
there would be bonds available with the same yield
characteristics as the available bond maturing in the
immediately preceding year.
RAI incurred special termination benefit costs of
$7 million in 2008 due to changes in the organizational
structure of RJR Tobacco to streamline non-core business
processes and programs. RAI also incurred $4 million of
settlements due to early retirements under non-qualified pension
plans in 2008. RAI incurred special termination benefit costs of
$1 million in 2007 due to RJR Tobacco reorganizations. RAI
incurred curtailment costs of $2 million in 2006 due to
early retirements under a non-qualified pension plan.
The overall expected long-term rate of return on assets
assumptions for pension and postretirement assets are based on:
(1) the target asset allocation for plan assets,
(2) long-term capital markets forecasts for asset classes
employed, and (3) excess return expectations of active
management to the extent asset classes are actively managed.
SFAS Nos. 87 and 106 permit the delayed recognition of
asset fund gains and losses in ratable periods of up to five
years. RAI uses a five-year period wherein asset fund gains and
losses are reflected in the expense calculation at 20% per year,
beginning the year after the gains or losses occur. In 2008, the
combination of a significant decrease in the fair value of plan
assets and benefits paid resulted in an unfavorable change in
funded status through a charge of $2,221 million,
$1,337 million after tax, to accumulated other
comprehensive loss. In 2007, an increase in the discount rate
and additional funding resulted in a favorable change in funded
status through a benefit of $184 million, $112 million
after tax, to accumulated other comprehensive loss.
137
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Plan assets are invested using a combination of active and
passive investment strategies. Active strategies employ multiple
investment management firms. Managers within each asset class
cover a range of investment styles and approaches and are
combined in a way that controls for capitalization, style
biases, and interest rate exposures, while focusing primarily on
security selection as a means to add value. Risk is controlled
through diversification among asset classes, managers, styles
and securities. Risk is further controlled both at the manager
and asset class level by assigning excess return and tracking
error targets against related benchmark indices. Investment
manager performance is evaluated against these targets.
Allowable investment types include U.S. equity,
non-U.S. equity,
global equity, fixed income, real estate, private equity, hedge
funds and global tactical asset allocation. The range of
allowable investment types utilized for pension assets provides
enhanced returns and more widely diversifies the plan.
U.S. equities are composed of common stocks of large,
medium and small companies.
Non-U.S. equities
include equity securities issued by companies domiciled outside
the U.S. and in depository receipts, which represent
ownership of securities of
non-U.S. companies.
Global equities include a combination of both U.S. and
non-U.S. securities.
Fixed income includes fixed income securities issued or
guaranteed by the U.S. government, and to a lesser extent
by
non-U.S. governments,
mortgage backed securities, corporate debt obligations and
dollar-denominated obligations issued in the United States by
non-U.S. banks
and corporations. Up to 25% of the fixed income assets can be in
debt securities that are below investment grade. Real estate
consists of publicly traded real estate investment trust
securities and private real estate investments. Private equity
consists of the unregistered securities of private and public
companies. Hedge funds invest as a limited partner in portfolios
of primarily public securities, including equities and fixed
income. Global tactical asset allocation strategies evaluate
relative value within and across asset categories and overweight
the attractive markets/assets while simultaneously
underweighting less attractive markets/assets.
For pension assets, futures contracts are used for portfolio
rebalancing and to approach fully invested portfolio positions.
Otherwise, a small number of investment managers employ limited
use of derivatives, including futures contracts, options on
futures and interest rate swaps in place of direct investment in
securities to gain efficient exposure to markets.
At December 31, 2008, the target pension asset allocation
was 50% equities, which includes U.S.,
non-U.S. and
global equity, 36% fixed income, 10% opportunistic, which
includes hedge funds and global tactical asset allocation, and
4% alternatives, which include private equity and real estate,
with a rebalancing range of approximately plus or minus 3% to 5%
around the target asset allocations.
At December 31, 2008, the target postretirement asset
allocation was 43% U.S. equities, 38% fixed income, 17%
non-U.S. equities,
1% hedge funds, 1% real estate and other, with a rebalancing
range of approximately plus or minus 5% around the target asset
allocations.
RAIs pension and postretirement plans weighted-average
asset allocations at December 31, 2008 and 2007, by asset
category were as follows:
|
|
|
|
|
|
|
|
|
|
|
Pension Plans
|
|
|
|
2008
|
|
|
2007
|
|
|
Asset Category:
|
|
|
|
|
|
|
|
|
Equities
|
|
|
48
|
%
|
|
|
58
|
%
|
Fixed income
|
|
|
33
|
%
|
|
|
27
|
%
|
Opportunistic
|
|
|
14
|
%
|
|
|
11
|
%
|
Alternatives
|
|
|
5
|
%
|
|
|
4
|
%
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
138
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
Postretirement Plans
|
|
|
|
2008
|
|
|
2007
|
|
|
Asset Category:
|
|
|
|
|
|
|
|
|
U.S. equity securities
|
|
|
41
|
%
|
|
|
43
|
%
|
Fixed income
|
|
|
42
|
%
|
|
|
36
|
%
|
Non-U.S.
equity securities
|
|
|
15
|
%
|
|
|
18
|
%
|
Hedge funds
|
|
|
1
|
%
|
|
|
1
|
%
|
Real estate and other
|
|
|
1
|
%
|
|
|
2
|
%
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
As of December 31, 2008, of securities in the investment
portfolio of RAIs U.S. pension plans, approximately
3%, or approximately $101 million, have direct exposure to
subprime mortgage holdings and approximately 2%, or
approximately $51 million, have indirect exposure to
subprime mortgage holdings. RAI does not believe that the
ultimate returns on such investments will result in a material
impact to future pension expense, future contributions or the
funded status of its plans.
Additional information relating to RAIs significant
postretirement plans is as follows:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
Weighted-average health-care cost trend rate assumed for the
following year
|
|
|
9.49
|
%
|
|
|
9.47
|
%
|
Rate to which the cost trend rate is assumed to decline (the
ultimate trend rate)
|
|
|
5.00
|
%
|
|
|
5.00
|
%
|
Year that the rate reaches the ultimate trend rate
|
|
|
2018
|
|
|
|
2017
|
|
Assumed health-care cost trend rates have a significant effect
on the amounts reported for the health-care plans. A
one-percentage-point change in assumed health-care cost trend
rates would have had the following effects:
|
|
|
|
|
|
|
|
|
|
|
1-Percentage
|
|
|
1-Percentage
|
|
|
|
Point
|
|
|
Point
|
|
|
|
Increase
|
|
|
Decrease
|
|
|
Effect on total of service and interest cost components
|
|
$
|
6
|
|
|
$
|
(5
|
)
|
Effect on benefit obligation
|
|
|
82
|
|
|
|
(71
|
)
|
During 2009, RAI is required to contribute a minimum of
$50 million to its pension plans and expects payments
related to its postretirement plans to be $79 million.
Estimated future benefits payments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Postretirement Benefits
|
|
|
|
|
|
|
Gross Projected
|
|
|
Expected
|
|
|
Net Projected
|
|
|
|
|
|
|
Benefit Payments
|
|
|
Medicare
|
|
|
Benefit Payments
|
|
|
|
Pension
|
|
|
Before Medicare
|
|
|
Part D
|
|
|
After Medicare
|
|
Year
|
|
Benefits
|
|
|
Part D Subsidies
|
|
|
Subsidies
|
|
|
Part D Subsidies
|
|
|
2009
|
|
$
|
440
|
|
|
$
|
119
|
|
|
$
|
3
|
|
|
$
|
116
|
|
2010
|
|
|
401
|
|
|
|
123
|
|
|
|
3
|
|
|
|
120
|
|
2011
|
|
|
379
|
|
|
|
127
|
|
|
|
4
|
|
|
|
123
|
|
2012
|
|
|
376
|
|
|
|
127
|
|
|
|
4
|
|
|
|
123
|
|
2013
|
|
|
375
|
|
|
|
127
|
|
|
|
4
|
|
|
|
123
|
|
2014-2018
|
|
|
1,999
|
|
|
|
613
|
|
|
|
25
|
|
|
|
588
|
|
RAI sponsors qualified defined contribution plans. The expense
related to these plans was $39 million, $41 million
and $42 million, in 2008, 2007 and 2006, respectively.
Included in the plans is a non-leveraged employee stock
ownership plan, which holds shares of the Reynolds Stock Fund.
Participants can elect to contribute
139
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
to the fund. Dividends paid on shares are reflected as a
reduction of equity. All shares are considered outstanding for
earnings per share computations.
Note 20
Segment Information
RAIs reportable operating segments are RJR Tobacco and
Conwood. The RJR Tobacco segment consists of the primary
operations of R. J. Reynolds Tobacco Company. The Conwood
segment consists of Conwood Holdings, Inc., the primary
operations of the Conwood companies and Lane. RAIs wholly
owned subsidiaries, Santa Fe and GPI, among others, are
included in All Other. The segments were identified based on how
RAIs chief operating decision maker allocates resources
and assesses performance. Some of RAIs wholly owned
operating subsidiaries have entered into intercompany agreements
for products or services with other RAI operating subsidiaries.
As a result, certain activities of an operating subsidiary may
be included in a different segment of RAI.
RAIs largest reportable operating segment, RJR Tobacco, is
the second largest cigarette manufacturer in the United States.
RJR Tobaccos largest-selling cigarette brands, CAMEL,
KOOL, PALL MALL, DORAL and WINSTON, were five of the ten
best-selling brands of cigarettes in the United States as of
December 31, 2008. Those brands, and its other brands,
including SALEM, MISTY and CAPRI, are manufactured in a variety
of styles and marketed in the United States. RJR Tobacco also
manages contract manufacturing of cigarette and tobacco products
through arrangements with BAT affiliates. On January 1,
2008, the contract manufacturing business of GPI was transferred
to RJR Tobacco.
RAIs other reportable operating segment, Conwood, is the
second largest smokeless tobacco products manufacturer in the
United States. Conwoods primary brands include its
largest-selling moist snuff brands, GRIZZLY and KODIAK, two of
the seven best-selling brands of moist snuff in the United
States as of December 31, 2008. Conwoods other
products include loose leaf chewing tobacco, dry snuff, plug and
twist tobacco products. Conwoods products held the first
or second position in market share in each category as of
December 31, 2008. As a result of combining certain
operations of Lane with the Conwood companies in 2007, Conwood
began distributing a variety of tobacco products including
WINCHESTER and CAPTAIN BLACK little cigars, and BUGLER
roll-your-own tobacco.
Santa Fe manufactures and markets cigarettes and other
tobacco products under the NATURAL AMERICAN SPIRIT brand. On
January 1, 2008, the management of RJR Tobaccos super
premium cigarette brands, including those licensed from BAT,
including DUNHILL and STATE EXPRESS 555, was transferred to
Santa Fe. During 2008, GPI sold NATURAL AMERICAN SPIRIT in
Europe and Japan, as well as exported tobacco products to
U.S. territories, U.S. duty-free shops and
U.S. overseas military bases. The financial position and
results of operations of these operating segments do not meet
the materiality criteria to be reportable.
RAIs operating subsidiaries sales to foreign
countries, primarily to related parties, for the years ended
December 31, 2008, 2007 and 2006 were $602 million,
$600 million and $578 million, respectively.
Intersegment revenues and items below the operating income line
of the consolidated statements of income are not presented by
segment, since they are excluded from the measure of segment
profitability reviewed by RAIs chief operating decision
maker.
140
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Segment Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Net sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
RJR Tobacco
|
|
$
|
7,678
|
|
|
$
|
7,945
|
|
|
$
|
7,707
|
|
Conwood
|
|
|
723
|
|
|
|
670
|
|
|
|
409
|
|
All Other
|
|
|
444
|
|
|
|
408
|
|
|
|
394
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated net sales
|
|
$
|
8,845
|
|
|
$
|
9,023
|
|
|
$
|
8,510
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income:
|
|
|
|
|
|
|
|
|
|
|
|
|
RJR Tobacco
|
|
$
|
1,756
|
|
|
$
|
1,940
|
|
|
$
|
1,682
|
|
Conwood
|
|
|
232
|
|
|
|
312
|
|
|
|
181
|
|
All Other
|
|
|
153
|
|
|
|
142
|
|
|
|
165
|
|
Corporate expense
|
|
|
(89
|
)
|
|
|
(106
|
)
|
|
|
(98
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated operating income
|
|
$
|
2,052
|
|
|
$
|
2,288
|
|
|
$
|
1,930
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
RJR Tobacco
|
|
$
|
15,338
|
|
|
$
|
15,956
|
|
|
$
|
14,955
|
|
Conwood
|
|
|
4,386
|
|
|
|
4,559
|
|
|
|
4,578
|
|
All Other
|
|
|
1,384
|
|
|
|
1,104
|
|
|
|
996
|
|
Corporate
|
|
|
15,647
|
|
|
|
16,336
|
|
|
|
17,818
|
|
Elimination adjustments
|
|
|
(18,601
|
)
|
|
|
(19,326
|
)
|
|
|
(20,169
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated assets
|
|
$
|
18,154
|
|
|
$
|
18,629
|
|
|
$
|
18,178
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash capital expenditures:
|
|
|
|
|
|
|
|
|
|
|
|
|
RJR Tobacco
|
|
$
|
62
|
|
|
$
|
93
|
|
|
$
|
119
|
|
Conwood
|
|
|
34
|
|
|
|
23
|
|
|
|
6
|
|
All Other
|
|
|
17
|
|
|
|
26
|
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated capital expenditures
|
|
$
|
113
|
|
|
$
|
142
|
|
|
$
|
136
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization expense:
|
|
|
|
|
|
|
|
|
|
|
|
|
RJR Tobacco
|
|
$
|
124
|
|
|
$
|
125
|
|
|
$
|
149
|
|
Conwood
|
|
|
11
|
|
|
|
11
|
|
|
|
7
|
|
All Other
|
|
|
7
|
|
|
|
7
|
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated depreciation and amortization expense
|
|
$
|
142
|
|
|
$
|
143
|
|
|
$
|
162
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation to income from continuing operations before
income taxes and extraordinary item:
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
$
|
2,052
|
|
|
$
|
2,288
|
|
|
$
|
1,930
|
|
Interest and debt expense
|
|
|
275
|
|
|
|
338
|
|
|
|
270
|
|
Interest income
|
|
|
(60
|
)
|
|
|
(134
|
)
|
|
|
(136
|
)
|
Gain on termination of joint venture
|
|
|
(328
|
)
|
|
|
|
|
|
|
|
|
Other (income) expense, net
|
|
|
37
|
|
|
|
11
|
|
|
|
(13
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes and
extraordinary item
|
|
$
|
2,128
|
|
|
$
|
2,073
|
|
|
$
|
1,809
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For information related to trademark impairments, see
note 3.
141
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Sales made to McLane Company, Inc., a distributor, comprised
29%, 28% and 27% of RAIs revenue in 2008, 2007 and 2006,
respectively. McLane Company is a customer in all segments. No
other customer accounted for 10% or more of RAIs revenue
during those periods.
Note 21
Related Party Transactions
RAIs operating subsidiaries engage in transactions with
related parties in the normal course of business. The following
is a summary of balances and transactions with affiliates as of
and for the years ended December 31:
Balances:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
Accounts receivable, BAT
|
|
$
|
91
|
|
|
$
|
80
|
|
Due to BAT
|
|
|
3
|
|
|
|
7
|
|
Deferred revenue, BAT
|
|
|
50
|
|
|
|
35
|
|
Transactions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Net sales, related party, BAT
|
|
$
|
468
|
|
|
$
|
507
|
|
|
$
|
498
|
|
Net sales, related party, other
|
|
|
|
|
|
|
|
|
|
|
2
|
|
Fixed assets sales to related parties
|
|
|
1
|
|
|
|
|
|
|
|
7
|
|
Research and development services billed to BAT
|
|
|
3
|
|
|
|
3
|
|
|
|
5
|
|
BAT related legal indemnification expenses
|
|
|
1
|
|
|
|
1
|
|
|
|
4
|
|
Purchases from related parties
|
|
|
12
|
|
|
|
18
|
|
|
|
7
|
|
RAI common stock purchases from B&W
|
|
|
75
|
|
|
|
|
|
|
|
|
|
Royalty fees due to related parties
|
|
|
1
|
|
|
|
1
|
|
|
|
1
|
|
Secondee fees due from BAT
|
|
|
1
|
|
|
|
2
|
|
|
|
2
|
|
RAIs operating subsidiaries have entered into various
transactions with affiliates of BAT, the indirect parent of
B&W. RAIs operating subsidiaries sell
contract-manufactured cigarettes, processed strip leaf, pipe
tobacco and little cigars to BAT affiliates. Pricing for
contract-manufactured cigarettes is generally calculated based
on 2004 prices, using B&Ws forecasted 2004
manufacturing costs plus 10%, increased by a multiple equal to
the increase in the Producer Price Index for subsequent years,
reported by the U.S. Bureau of Labor Statistics. Net sales
to BAT affiliates, primarily cigarettes, represented
approximately 5.0% of RAIs total net sales in 2008 and
6.0% of RAIs total net sales in each of 2007 and 2006.
RJR Tobacco recorded deferred sales revenue relating to leaf
sold to BAT affiliates that had not been delivered as of
December 31, given that RJR Tobacco had a legal right to
bill the BAT affiliates. Leaf sales revenue to BAT affiliates
will be recognized when the product is shipped to the customer.
In 2008, RJR Tobacco sold miscellaneous fixed assets to BAT for
$1 million, which was higher than net book value.
RJR Tobacco performs certain research and development for BAT
affiliates pursuant to a joint technology sharing agreement
entered into as a part of the B&W business combination.
These services were accrued and billed to BAT affiliates and
were recorded in RJR Tobaccos selling, general and
administrative expenses, net of associated costs.
RAIs operating subsidiaries also purchase unprocessed leaf
at market prices, and imports cigarettes at prices not to exceed
manufacturing costs plus 10%, from BAT affiliates. Royalty
expense is paid to BAT affiliates that own the trademarks to
imported brands of cigarettes and pipe tobacco. The royalty
rates vary, although none is in excess of 10% of the local sales
price. The payable due to related party in the consolidated
balance sheet primarily relates to cigarette purchases.
142
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
In connection with RAIs current share repurchase program,
RAI and B&W entered into an agreement on April 29,
2008, pursuant to which B&W has agreed to participate in
the repurchase program on a basis approximately proportionate
with B&Ws 42% ownership of RAIs common stock.
During 2008, RAI repurchased 1,387,095 shares of RAI common
stock from B&W.
RJR Tobacco recorded in selling, general and administrative
expenses, funds to indemnify B&W and its affiliates for
costs and expenses related to tobacco-related litigation in the
United States. For additional information relating to this
indemnification, see note 16.
RJR Tobacco seconded certain of its employees to BAT in
connection with particular assignments at BAT locations. During
their service with BAT, the seconded employees are paid by RJR
Tobacco and participate in employee benefit plans sponsored by
RAI. BAT will reimburse RJR Tobacco for certain costs of the
seconded employees compensation and benefits during the
secondment period on a quarterly basis.
Note 22
RAI Guaranteed, Unsecured Notes Condensed
Consolidating Financial Statements
The following condensed consolidating financial statements have
been prepared pursuant to
Rule 3-10
of
Regulation S-X,
relating to the Guarantors of RAIs $4.6 billion
guaranteed, unsecured notes. See note 14 for additional
information relating to these notes. RAIs direct, wholly
owned subsidiaries and certain of its indirectly owned
subsidiaries have fully and unconditionally and jointly and
severally, guaranteed these notes. The following condensed
consolidating financial statements include: the accounts and
activities of RAI, the parent issuer; RJR, RJR Tobacco, the
Conwood companies, Conwood Holdings, Inc., Santa Fe, Lane,
GPI and certain of RJR Tobaccos other subsidiaries, the
Guarantors; other indirect subsidiaries of RAI that are not
Guarantors; and elimination adjustments.
143
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Condensed
Consolidating Statements of Income
(Dollars in Millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
|
|
|
Non-
|
|
|
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
For the Year Ended December 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
|
|
|
$
|
8,345
|
|
|
$
|
157
|
|
|
$
|
(125
|
)
|
|
$
|
8,377
|
|
Net sales, related party
|
|
|
|
|
|
|
468
|
|
|
|
|
|
|
|
|
|
|
|
468
|
|
Cost of products sold
|
|
|
|
|
|
|
4,917
|
|
|
|
71
|
|
|
|
(125
|
)
|
|
|
4,863
|
|
Selling, general and administrative expenses
|
|
|
15
|
|
|
|
1,417
|
|
|
|
68
|
|
|
|
|
|
|
|
1,500
|
|
Amortization expense
|
|
|
|
|
|
|
22
|
|
|
|
|
|
|
|
|
|
|
|
22
|
|
Restructuring charge
|
|
|
6
|
|
|
|
81
|
|
|
|
3
|
|
|
|
|
|
|
|
90
|
|
Trademark impairment charges
|
|
|
|
|
|
|
318
|
|
|
|
|
|
|
|
|
|
|
|
318
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
(21
|
)
|
|
|
2,058
|
|
|
|
15
|
|
|
|
|
|
|
|
2,052
|
|
Interest and debt expense
|
|
|
265
|
|
|
|
9
|
|
|
|
1
|
|
|
|
|
|
|
|
275
|
|
Interest income
|
|
|
(1
|
)
|
|
|
(44
|
)
|
|
|
(15
|
)
|
|
|
|
|
|
|
(60
|
)
|
Intercompany interest (income) expense
|
|
|
(81
|
)
|
|
|
76
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
Intercompany dividend income
|
|
|
|
|
|
|
(43
|
)
|
|
|
|
|
|
|
43
|
|
|
|
|
|
Gain on termination of joint venture
|
|
|
|
|
|
|
|
|
|
|
(328
|
)
|
|
|
|
|
|
|
(328
|
)
|
Other (income) expense, net
|
|
|
5
|
|
|
|
33
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
37
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
|
|
|
(209
|
)
|
|
|
2,027
|
|
|
|
353
|
|
|
|
(43
|
)
|
|
|
2,128
|
|
Provision for (benefit from) income taxes
|
|
|
(73
|
)
|
|
|
862
|
|
|
|
1
|
|
|
|
|
|
|
|
790
|
|
Equity income from subsidiaries
|
|
|
1,474
|
|
|
|
352
|
|
|
|
|
|
|
|
(1,826
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1,338
|
|
|
$
|
1,517
|
|
|
$
|
352
|
|
|
$
|
(1,869
|
)
|
|
$
|
1,338
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
|
|
|
$
|
8,494
|
|
|
$
|
123
|
|
|
$
|
(101
|
)
|
|
$
|
8,516
|
|
Net sales, related party
|
|
|
|
|
|
|
507
|
|
|
|
|
|
|
|
|
|
|
|
507
|
|
Cost of products sold
|
|
|
|
|
|
|
5,005
|
|
|
|
54
|
|
|
|
(99
|
)
|
|
|
4,960
|
|
Selling, general and administrative expenses
|
|
|
53
|
|
|
|
1,583
|
|
|
|
51
|
|
|
|
|
|
|
|
1,687
|
|
Amortization expense
|
|
|
|
|
|
|
23
|
|
|
|
|
|
|
|
|
|
|
|
23
|
|
Trademark impairment charges
|
|
|
|
|
|
|
65
|
|
|
|
|
|
|
|
|
|
|
|
65
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
(53
|
)
|
|
|
2,325
|
|
|
|
18
|
|
|
|
(2
|
)
|
|
|
2,288
|
|
Interest and debt expense
|
|
|
324
|
|
|
|
14
|
|
|
|
|
|
|
|
|
|
|
|
338
|
|
Interest income
|
|
|
(4
|
)
|
|
|
(126
|
)
|
|
|
(4
|
)
|
|
|
|
|
|
|
(134
|
)
|
Intercompany interest (income) expense
|
|
|
(114
|
)
|
|
|
109
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
Intercompany dividend income
|
|
|
|
|
|
|
(43
|
)
|
|
|
|
|
|
|
43
|
|
|
|
|
|
Other (income) expense, net
|
|
|
24
|
|
|
|
|
|
|
|
(13
|
)
|
|
|
|
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes and extraordinary item
|
|
|
(283
|
)
|
|
|
2,371
|
|
|
|
30
|
|
|
|
(45
|
)
|
|
|
2,073
|
|
Provision for (benefit from) income taxes
|
|
|
(100
|
)
|
|
|
864
|
|
|
|
2
|
|
|
|
|
|
|
|
766
|
|
Equity income from subsidiaries
|
|
|
1,491
|
|
|
|
28
|
|
|
|
|
|
|
|
(1,519
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before extraordinary item
|
|
|
1,308
|
|
|
|
1,535
|
|
|
|
28
|
|
|
|
(1,564
|
)
|
|
|
1,307
|
|
Extraordinary item gain on acquisition
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1,308
|
|
|
$
|
1,536
|
|
|
$
|
28
|
|
|
$
|
(1,564
|
)
|
|
$
|
1,308
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
|
|
|
$
|
7,984
|
|
|
$
|
90
|
|
|
$
|
(64
|
)
|
|
$
|
8,010
|
|
Net sales, related party
|
|
|
|
|
|
|
500
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
Cost of products sold
|
|
|
|
|
|
|
4,838
|
|
|
|
30
|
|
|
|
(65
|
)
|
|
|
4,803
|
|
Selling, general and administrative expenses
|
|
|
48
|
|
|
|
1,575
|
|
|
|
35
|
|
|
|
|
|
|
|
1,658
|
|
Amortization expense
|
|
|
|
|
|
|
28
|
|
|
|
|
|
|
|
|
|
|
|
28
|
|
Restructuring charges
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
Trademark impairment charges
|
|
|
|
|
|
|
90
|
|
|
|
|
|
|
|
|
|
|
|
90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
(48
|
)
|
|
|
1,952
|
|
|
|
25
|
|
|
|
1
|
|
|
|
1,930
|
|
Interest and debt expense
|
|
|
194
|
|
|
|
76
|
|
|
|
|
|
|
|
|
|
|
|
270
|
|
Interest income
|
|
|
(2
|
)
|
|
|
(133
|
)
|
|
|
(1
|
)
|
|
|
|
|
|
|
(136
|
)
|
Intercompany interest (income) expense
|
|
|
(118
|
)
|
|
|
116
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
Intercompany dividend income
|
|
|
|
|
|
|
(43
|
)
|
|
|
|
|
|
|
43
|
|
|
|
|
|
Other (income) expense, net
|
|
|
7
|
|
|
|
(3
|
)
|
|
|
(17
|
)
|
|
|
|
|
|
|
(13
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes and extraordinary item
|
|
|
(129
|
)
|
|
|
1,939
|
|
|
|
41
|
|
|
|
(42
|
)
|
|
|
1,809
|
|
Provision for (benefit from) income taxes
|
|
|
(44
|
)
|
|
|
712
|
|
|
|
5
|
|
|
|
|
|
|
|
673
|
|
Equity income from subsidiaries
|
|
|
1,295
|
|
|
|
36
|
|
|
|
|
|
|
|
(1,331
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before extraordinary item
|
|
|
1,210
|
|
|
|
1,263
|
|
|
|
36
|
|
|
|
(1,373
|
)
|
|
|
1,136
|
|
Extraordinary item gain on acquisition
|
|
|
|
|
|
|
74
|
|
|
|
|
|
|
|
|
|
|
|
74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1,210
|
|
|
$
|
1,337
|
|
|
$
|
36
|
|
|
$
|
(1,373
|
)
|
|
$
|
1,210
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
144
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Condensed
Consolidating Statements of Cash Flows
(Dollars in Millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
|
|
|
Non-
|
|
|
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
For the Year Ended December 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities
|
|
$
|
1,141
|
|
|
$
|
1,387
|
|
|
$
|
36
|
|
|
$
|
(1,249
|
)
|
|
$
|
1,315
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of short-term investments
|
|
|
(8
|
)
|
|
|
(48
|
)
|
|
|
|
|
|
|
|
|
|
|
(56
|
)
|
Proceeds from sale of short-term investments
|
|
|
7
|
|
|
|
231
|
|
|
|
|
|
|
|
|
|
|
|
238
|
|
Proceeds from settlement of long-term investments
|
|
|
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
8
|
|
Capital expenditures
|
|
|
|
|
|
|
(106
|
)
|
|
|
(7
|
)
|
|
|
|
|
|
|
(113
|
)
|
Distributions from equity investments
|
|
|
|
|
|
|
|
|
|
|
27
|
|
|
|
|
|
|
|
27
|
|
Net proceeds from the sale of fixed assets
|
|
|
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
8
|
|
Proceed from termination of joint venture
|
|
|
|
|
|
|
|
|
|
|
164
|
|
|
|
|
|
|
|
164
|
|
Other, net
|
|
|
|
|
|
|
1
|
|
|
|
1
|
|
|
|
|
|
|
|
2
|
|
Intercompany notes receivable
|
|
|
40
|
|
|
|
(29
|
)
|
|
|
|
|
|
|
(11
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows from (used in) investing activities
|
|
|
39
|
|
|
|
65
|
|
|
|
185
|
|
|
|
(11
|
)
|
|
|
278
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid on common stock
|
|
|
(999
|
)
|
|
|
(1,206
|
)
|
|
|
|
|
|
|
1,206
|
|
|
|
(999
|
)
|
Dividends paid on preferred stock
|
|
|
(43
|
)
|
|
|
|
|
|
|
|
|
|
|
43
|
|
|
|
|
|
Proceeds from exercise of stock options
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
Excess tax benefit from stock-based compensation
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2
|
|
Repurchase of common stock
|
|
|
(210
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(210
|
)
|
Intercompany notes payable
|
|
|
98
|
|
|
|
(40
|
)
|
|
|
(69
|
)
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows from (used in) financing activities
|
|
|
(1,151
|
)
|
|
|
(1,246
|
)
|
|
|
(69
|
)
|
|
|
1,260
|
|
|
|
(1,206
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents
|
|
|
|
|
|
|
|
|
|
|
(24
|
)
|
|
|
|
|
|
|
(24
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents
|
|
|
29
|
|
|
|
206
|
|
|
|
128
|
|
|
|
|
|
|
|
363
|
|
Cash and cash equivalents at beginning of year
|
|
|
243
|
|
|
|
1,885
|
|
|
|
87
|
|
|
|
|
|
|
|
2,215
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year
|
|
$
|
272
|
|
|
$
|
2,091
|
|
|
$
|
215
|
|
|
$
|
|
|
|
$
|
2,578
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities
|
|
$
|
356
|
|
|
$
|
1,067
|
|
|
$
|
6
|
|
|
$
|
(98
|
)
|
|
$
|
1,331
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of short-term investments
|
|
|
|
|
|
|
(3,764
|
)
|
|
|
|
|
|
|
|
|
|
|
(3,764
|
)
|
Proceeds from sale of short-term investments
|
|
|
|
|
|
|
4,655
|
|
|
|
|
|
|
|
|
|
|
|
4,655
|
|
Capital expenditures
|
|
|
(8
|
)
|
|
|
(126
|
)
|
|
|
(8
|
)
|
|
|
|
|
|
|
(142
|
)
|
Distributions from equity investments
|
|
|
|
|
|
|
5
|
|
|
|
10
|
|
|
|
|
|
|
|
15
|
|
Acquisitions, net of cash acquired
|
|
|
|
|
|
|
|
|
|
|
(3
|
)
|
|
|
|
|
|
|
(3
|
)
|
Net proceeds from the sale of fixed assets
|
|
|
|
|
|
|
1
|
|
|
|
2
|
|
|
|
|
|
|
|
3
|
|
Other, net
|
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
Intercompany notes receivable
|
|
|
40
|
|
|
|
(847
|
)
|
|
|
|
|
|
|
807
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows from (used in) investing activities
|
|
|
32
|
|
|
|
(77
|
)
|
|
|
1
|
|
|
|
807
|
|
|
|
763
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
145
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
|
|
|
Non-
|
|
|
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
Cash flows from (used in) financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid on common stock
|
|
$
|
(916
|
)
|
|
$
|
(55
|
)
|
|
$
|
|
|
|
$
|
55
|
|
|
$
|
(916
|
)
|
Dividends paid on preferred stock
|
|
|
(43
|
)
|
|
|
|
|
|
|
|
|
|
|
43
|
|
|
|
|
|
Proceeds from exercise of stock options
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
Excess tax benefit from stock-based compensation
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2
|
|
Repayments of long-term debt
|
|
|
(254
|
)
|
|
|
(75
|
)
|
|
|
|
|
|
|
|
|
|
|
(329
|
)
|
Repayments of term loan
|
|
|
(1,542
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,542
|
)
|
Proceeds from issuance of long-term debt
|
|
|
1,547
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,547
|
|
Repurchase of common stock
|
|
|
(60
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(60
|
)
|
Deferred debt issuance costs
|
|
|
(15
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15
|
)
|
Intercompany notes payable
|
|
|
839
|
|
|
|
(40
|
)
|
|
|
8
|
|
|
|
(807
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows from (used in) financing activities
|
|
|
(441
|
)
|
|
|
(170
|
)
|
|
|
8
|
|
|
|
(709
|
)
|
|
|
(1,312
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents
|
|
|
(53
|
)
|
|
|
820
|
|
|
|
15
|
|
|
|
|
|
|
|
782
|
|
Cash and cash equivalents at beginning of year
|
|
|
296
|
|
|
|
1,065
|
|
|
|
72
|
|
|
|
|
|
|
|
1,433
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year
|
|
$
|
243
|
|
|
$
|
1,885
|
|
|
$
|
87
|
|
|
$
|
|
|
|
$
|
2,215
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities
|
|
$
|
1,023
|
|
|
$
|
1,946
|
|
|
$
|
25
|
|
|
$
|
(1,537
|
)
|
|
$
|
1,457
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of short-term investments
|
|
|
|
|
|
|
(7,677
|
)
|
|
|
|
|
|
|
|
|
|
|
(7,677
|
)
|
Proceeds from sale of short-term investments
|
|
|
|
|
|
|
7,760
|
|
|
|
|
|
|
|
|
|
|
|
7,760
|
|
Capital expenditures
|
|
|
|
|
|
|
(132
|
)
|
|
|
(4
|
)
|
|
|
|
|
|
|
(136
|
)
|
Distributions from equity investments
|
|
|
|
|
|
|
|
|
|
|
18
|
|
|
|
|
|
|
|
18
|
|
Acquisitions, net of cash acquired
|
|
|
|
|
|
|
(3,519
|
)
|
|
|
|
|
|
|
|
|
|
|
(3,519
|
)
|
Net intercompany investments
|
|
|
(211
|
)
|
|
|
211
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net proceeds from the sale of fixed assets
|
|
|
|
|
|
|
22
|
|
|
|
2
|
|
|
|
|
|
|
|
24
|
|
Net proceeds from the sale of businesses
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
3
|
|
Other, net
|
|
|
|
|
|
|
(4
|
)
|
|
|
|
|
|
|
|
|
|
|
(4
|
)
|
Intercompany notes receivable
|
|
|
(3,168
|
)
|
|
|
(105
|
)
|
|
|
|
|
|
|
3,273
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows from (used in) investing activities
|
|
|
(3,379
|
)
|
|
|
(3,441
|
)
|
|
|
16
|
|
|
|
3,273
|
|
|
|
(3,531
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid on common stock
|
|
|
(775
|
)
|
|
|
(1,494
|
)
|
|
|
|
|
|
|
1,494
|
|
|
|
(775
|
)
|
Dividends paid on preferred stock
|
|
|
(43
|
)
|
|
|
|
|
|
|
|
|
|
|
43
|
|
|
|
|
|
Proceeds from exercise of stock options
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
Excess tax benefit from stock-based compensation
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
Repayments of long-term debt
|
|
|
|
|
|
|
(190
|
)
|
|
|
|
|
|
|
|
|
|
|
(190
|
)
|
Repayments of term loan
|
|
|
(8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8
|
)
|
Proceeds from issuance of long-term debt
|
|
|
1,641
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,641
|
|
Principal borrowings under term loan
|
|
|
1,550
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,550
|
|
Deferred debt issuance costs
|
|
|
(52
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(52
|
)
|
Intercompany notes payable
|
|
|
104
|
|
|
|
3,168
|
|
|
|
1
|
|
|
|
(3,273
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows from financing activities
|
|
|
2,425
|
|
|
|
1,484
|
|
|
|
1
|
|
|
|
(1,736
|
)
|
|
|
2,174
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents
|
|
|
69
|
|
|
|
(11
|
)
|
|
|
42
|
|
|
|
|
|
|
|
100
|
|
Cash and cash equivalents at beginning of year
|
|
|
227
|
|
|
|
1,076
|
|
|
|
30
|
|
|
|
|
|
|
|
1,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year
|
|
$
|
296
|
|
|
$
|
1,065
|
|
|
$
|
72
|
|
|
$
|
|
|
|
$
|
1,433
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
146
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Condensed
Consolidating Balance Sheets
(Dollars in Millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
|
|
|
Non-
|
|
|
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
December 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
272
|
|
|
$
|
2,091
|
|
|
$
|
215
|
|
|
$
|
|
|
|
$
|
2,578
|
|
Short-term investments
|
|
|
1
|
|
|
|
22
|
|
|
|
|
|
|
|
|
|
|
|
23
|
|
Accounts receivable, net
|
|
|
|
|
|
|
68
|
|
|
|
16
|
|
|
|
|
|
|
|
84
|
|
Accounts receivable, related party
|
|
|
|
|
|
|
91
|
|
|
|
|
|
|
|
|
|
|
|
91
|
|
Notes receivable
|
|
|
|
|
|
|
1
|
|
|
|
34
|
|
|
|
|
|
|
|
35
|
|
Other receivables
|
|
|
9
|
|
|
|
27
|
|
|
|
1
|
|
|
|
|
|
|
|
37
|
|
Inventories
|
|
|
|
|
|
|
1,145
|
|
|
|
27
|
|
|
|
(2
|
)
|
|
|
1,170
|
|
Deferred income taxes, net
|
|
|
12
|
|
|
|
825
|
|
|
|
1
|
|
|
|
|
|
|
|
838
|
|
Prepaid expenses and other
|
|
|
35
|
|
|
|
128
|
|
|
|
4
|
|
|
|
(4
|
)
|
|
|
163
|
|
Short-term intercompany notes and interest receivable
|
|
|
81
|
|
|
|
65
|
|
|
|
|
|
|
|
(146
|
)
|
|
|
|
|
Other intercompany receivables
|
|
|
68
|
|
|
|
|
|
|
|
6
|
|
|
|
(74
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
478
|
|
|
|
4,463
|
|
|
|
304
|
|
|
|
(226
|
)
|
|
|
5,019
|
|
Property, plant and equipment, net
|
|
|
7
|
|
|
|
999
|
|
|
|
25
|
|
|
|
|
|
|
|
1,031
|
|
Trademarks and other intangible assets, net
|
|
|
|
|
|
|
3,266
|
|
|
|
4
|
|
|
|
|
|
|
|
3,270
|
|
Goodwill
|
|
|
|
|
|
|
8,166
|
|
|
|
8
|
|
|
|
|
|
|
|
8,174
|
|
Long-term intercompany notes
|
|
|
2,080
|
|
|
|
1,409
|
|
|
|
|
|
|
|
(3,489
|
)
|
|
|
|
|
Investment in subsidiaries
|
|
|
9,751
|
|
|
|
430
|
|
|
|
|
|
|
|
(10,181
|
)
|
|
|
|
|
Other assets and deferred charges
|
|
|
349
|
|
|
|
180
|
|
|
|
160
|
|
|
|
(29
|
)
|
|
|
660
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
12,665
|
|
|
$
|
18,913
|
|
|
$
|
501
|
|
|
$
|
(13,925
|
)
|
|
$
|
18,154
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and shareholders equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tobacco settlement accruals
|
|
$
|
|
|
|
$
|
2,321
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
2,321
|
|
Accounts payable and other accrued liabilities
|
|
|
350
|
|
|
|
974
|
|
|
|
29
|
|
|
|
(4
|
)
|
|
|
1,349
|
|
Due to related party
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
3
|
|
Deferred revenue, related party
|
|
|
|
|
|
|
50
|
|
|
|
|
|
|
|
|
|
|
|
50
|
|
Current maturities of long-term debt
|
|
|
189
|
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
200
|
|
Short-term intercompany notes and interest payable
|
|
|
40
|
|
|
|
81
|
|
|
|
25
|
|
|
|
(146
|
)
|
|
|
|
|
Other intercompany payables
|
|
|
|
|
|
|
74
|
|
|
|
|
|
|
|
(74
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
579
|
|
|
|
3,514
|
|
|
|
54
|
|
|
|
(224
|
)
|
|
|
3,923
|
|
Intercompany notes and interest payable
|
|
|
1,409
|
|
|
|
2,080
|
|
|
|
|
|
|
|
(3,489
|
)
|
|
|
|
|
Long-term debt (less current maturities)
|
|
|
4,362
|
|
|
|
124
|
|
|
|
|
|
|
|
|
|
|
|
4,486
|
|
Deferred income taxes, net
|
|
|
|
|
|
|
311
|
|
|
|
|
|
|
|
(29
|
)
|
|
|
282
|
|
Long-term retirement benefits (less current portion)
|
|
|
64
|
|
|
|
2,755
|
|
|
|
17
|
|
|
|
|
|
|
|
2,836
|
|
Other noncurrent liabilities
|
|
|
14
|
|
|
|
375
|
|
|
|
1
|
|
|
|
|
|
|
|
390
|
|
Shareholders equity
|
|
|
6,237
|
|
|
|
9,754
|
|
|
|
429
|
|
|
|
(10,183
|
)
|
|
|
6,237
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity
|
|
$
|
12,665
|
|
|
$
|
18,913
|
|
|
$
|
501
|
|
|
$
|
(13,925
|
)
|
|
$
|
18,154
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
147
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
|
|
|
Non-
|
|
|
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
243
|
|
|
$
|
1,885
|
|
|
$
|
87
|
|
|
$
|
|
|
|
$
|
2,215
|
|
Short-term investments
|
|
|
|
|
|
|
377
|
|
|
|
|
|
|
|
|
|
|
|
377
|
|
Accounts receivable, net
|
|
|
|
|
|
|
61
|
|
|
|
12
|
|
|
|
|
|
|
|
73
|
|
Accounts receivable, related party
|
|
|
|
|
|
|
80
|
|
|
|
|
|
|
|
|
|
|
|
80
|
|
Note receivable
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
Other receivables
|
|
|
7
|
|
|
|
18
|
|
|
|
|
|
|
|
|
|
|
|
25
|
|
Inventories
|
|
|
|
|
|
|
1,167
|
|
|
|
31
|
|
|
|
(2
|
)
|
|
|
1,196
|
|
Deferred income taxes, net
|
|
|
11
|
|
|
|
833
|
|
|
|
1
|
|
|
|
|
|
|
|
845
|
|
Prepaid expenses and other
|
|
|
6
|
|
|
|
169
|
|
|
|
3
|
|
|
|
2
|
|
|
|
180
|
|
Short-term intercompany notes and interest receivable
|
|
|
82
|
|
|
|
127
|
|
|
|
|
|
|
|
(209
|
)
|
|
|
|
|
Other intercompany receivables
|
|
|
153
|
|
|
|
|
|
|
|
23
|
|
|
|
(176
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
502
|
|
|
|
4,718
|
|
|
|
157
|
|
|
|
(385
|
)
|
|
|
4,992
|
|
Property, plant and equipment, net
|
|
|
8
|
|
|
|
1,046
|
|
|
|
20
|
|
|
|
(1
|
)
|
|
|
1,073
|
|
Trademarks and other intangible assets, net
|
|
|
|
|
|
|
3,606
|
|
|
|
3
|
|
|
|
|
|
|
|
3,609
|
|
Goodwill
|
|
|
|
|
|
|
8,166
|
|
|
|
8
|
|
|
|
|
|
|
|
8,174
|
|
Long-term intercompany notes
|
|
|
2,120
|
|
|
|
1,310
|
|
|
|
|
|
|
|
(3,430
|
)
|
|
|
|
|
Investment in subsidiaries
|
|
|
10,848
|
|
|
|
104
|
|
|
|
|
|
|
|
(10,952
|
)
|
|
|
|
|
Other assets and deferred charges
|
|
|
186
|
|
|
|
571
|
|
|
|
49
|
|
|
|
(25
|
)
|
|
|
781
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
13,664
|
|
|
$
|
19,521
|
|
|
$
|
237
|
|
|
$
|
(14,793
|
)
|
|
$
|
18,629
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and shareholders equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tobacco settlement accruals
|
|
$
|
|
|
|
$
|
2,449
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
2,449
|
|
Accounts payable and other accrued liabilities
|
|
|
391
|
|
|
|
993
|
|
|
|
27
|
|
|
|
1
|
|
|
|
1,412
|
|
Due to related party
|
|
|
|
|
|
|
5
|
|
|
|
2
|
|
|
|
|
|
|
|
7
|
|
Deferred revenue, related party
|
|
|
|
|
|
|
35
|
|
|
|
|
|
|
|
|
|
|
|
35
|
|
Short-term intercompany notes and interest payable
|
|
|
34
|
|
|
|
82
|
|
|
|
93
|
|
|
|
(209
|
)
|
|
|
|
|
Other intercompany payables
|
|
|
|
|
|
|
176
|
|
|
|
|
|
|
|
(176
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
425
|
|
|
|
3,740
|
|
|
|
122
|
|
|
|
(384
|
)
|
|
|
3,903
|
|
Intercompany notes and interest payable
|
|
|
1,310
|
|
|
|
2,120
|
|
|
|
|
|
|
|
(3,430
|
)
|
|
|
|
|
Long-term debt (less current maturities)
|
|
|
4,383
|
|
|
|
132
|
|
|
|
|
|
|
|
|
|
|
|
4,515
|
|
Deferred income taxes, net
|
|
|
|
|
|
|
1,209
|
|
|
|
|
|
|
|
(25
|
)
|
|
|
1,184
|
|
Long-term retirement benefits (less current portion)
|
|
|
44
|
|
|
|
1,112
|
|
|
|
11
|
|
|
|
|
|
|
|
1,167
|
|
Other noncurrent liabilities
|
|
|
36
|
|
|
|
358
|
|
|
|
|
|
|
|
|
|
|
|
394
|
|
Shareholders equity
|
|
|
7,466
|
|
|
|
10,850
|
|
|
|
104
|
|
|
|
(10,954
|
)
|
|
|
7,466
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity
|
|
$
|
13,664
|
|
|
$
|
19,521
|
|
|
$
|
237
|
|
|
$
|
(14,793
|
)
|
|
$
|
18,629
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
148
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
Note 23
|
RJR
Guaranteed, Unsecured Notes Condensed Consolidating
Financial Statements
|
The following condensed consolidating financial statements have
been prepared pursuant to
Rule 3-10
of
Regulation S-X,
relating to the guarantees of RJRs $75 million
unsecured notes. See note 14 for additional information
relating to these notes. RAI and certain of its direct or
indirect, wholly owned subsidiaries, have fully and
unconditionally, and jointly and severally, guaranteed these
notes. The following condensed consolidating financial
statements include: the accounts and activities of RAI, the
parent Guarantor; RJR, the issuer of the debt securities; RJR
Tobacco, GPI and certain of RJRs other subsidiaries, the
other Guarantors; other subsidiaries of RAI and RJR, including
Santa Fe, Lane and the Conwood companies, that are not
Guarantors; and elimination adjustments. GPI was added as a
Guarantor in 2006.
149
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Condensed
Consolidating Statements of Income
(Dollars in Millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
|
|
|
Other
|
|
|
Non-
|
|
|
|
|
|
|
|
|
|
Guarantor
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
For the Year Ended December 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
|
|
|
$
|
|
|
|
$
|
7,462
|
|
|
$
|
1,143
|
|
|
$
|
(228
|
)
|
|
$
|
8,377
|
|
Net sales, related party
|
|
|
|
|
|
|
|
|
|
|
460
|
|
|
|
8
|
|
|
|
|
|
|
|
468
|
|
Cost of products sold
|
|
|
|
|
|
|
|
|
|
|
4,690
|
|
|
|
401
|
|
|
|
(228
|
)
|
|
|
4,863
|
|
Selling, general and administrative expenses
|
|
|
15
|
|
|
|
1
|
|
|
|
1,205
|
|
|
|
279
|
|
|
|
|
|
|
|
1,500
|
|
Amortization expense
|
|
|
|
|
|
|
|
|
|
|
21
|
|
|
|
1
|
|
|
|
|
|
|
|
22
|
|
Restructuring charge
|
|
|
6
|
|
|
|
|
|
|
|
81
|
|
|
|
3
|
|
|
|
|
|
|
|
90
|
|
Trademark impairment charges
|
|
|
|
|
|
|
|
|
|
|
176
|
|
|
|
142
|
|
|
|
|
|
|
|
318
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
(21
|
)
|
|
|
(1
|
)
|
|
|
1,749
|
|
|
|
325
|
|
|
|
|
|
|
|
2,052
|
|
Interest and debt expense
|
|
|
265
|
|
|
|
9
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
275
|
|
Interest income
|
|
|
(1
|
)
|
|
|
(2
|
)
|
|
|
(40
|
)
|
|
|
(17
|
)
|
|
|
|
|
|
|
(60
|
)
|
Intercompany interest (income) expense
|
|
|
(81
|
)
|
|
|
(15
|
)
|
|
|
(88
|
)
|
|
|
184
|
|
|
|
|
|
|
|
|
|
Intercompany dividend income
|
|
|
|
|
|
|
(43
|
)
|
|
|
|
|
|
|
|
|
|
|
43
|
|
|
|
|
|
Gain on termination of joint venture
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(328
|
)
|
|
|
|
|
|
|
(328
|
)
|
Other (income) expense, net
|
|
|
5
|
|
|
|
(2
|
)
|
|
|
34
|
|
|
|
|
|
|
|
|
|
|
|
37
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
|
|
|
(209
|
)
|
|
|
52
|
|
|
|
1,843
|
|
|
|
485
|
|
|
|
(43
|
)
|
|
|
2,128
|
|
Provision for (benefit from) income taxes
|
|
|
(73
|
)
|
|
|
1
|
|
|
|
814
|
|
|
|
48
|
|
|
|
|
|
|
|
790
|
|
Equity income from subsidiaries
|
|
|
1,474
|
|
|
|
1,380
|
|
|
|
352
|
|
|
|
|
|
|
|
(3,206
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1,338
|
|
|
$
|
1,431
|
|
|
$
|
1,381
|
|
|
$
|
437
|
|
|
$
|
(3,249
|
)
|
|
$
|
1,338
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
|
|
|
$
|
|
|
|
$
|
7,677
|
|
|
$
|
1,002
|
|
|
$
|
(163
|
)
|
|
$
|
8,516
|
|
Net sales, related party
|
|
|
|
|
|
|
|
|
|
|
492
|
|
|
|
15
|
|
|
|
|
|
|
|
507
|
|
Cost of products sold
|
|
|
|
|
|
|
|
|
|
|
4,784
|
|
|
|
338
|
|
|
|
(162
|
)
|
|
|
4,960
|
|
Selling, general and administrative expenses
|
|
|
53
|
|
|
|
1
|
|
|
|
1,395
|
|
|
|
238
|
|
|
|
|
|
|
|
1,687
|
|
Amortization expense
|
|
|
|
|
|
|
|
|
|
|
22
|
|
|
|
1
|
|
|
|
|
|
|
|
23
|
|
Trademark impairment charges
|
|
|
|
|
|
|
|
|
|
|
33
|
|
|
|
32
|
|
|
|
|
|
|
|
65
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
(53
|
)
|
|
|
(1
|
)
|
|
|
1,935
|
|
|
|
408
|
|
|
|
(1
|
)
|
|
|
2,288
|
|
Interest and debt expense
|
|
|
324
|
|
|
|
14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
338
|
|
Interest income
|
|
|
(4
|
)
|
|
|
(6
|
)
|
|
|
(109
|
)
|
|
|
(15
|
)
|
|
|
|
|
|
|
(134
|
)
|
Intercompany interest (income) expense
|
|
|
(114
|
)
|
|
|
(4
|
)
|
|
|
(75
|
)
|
|
|
193
|
|
|
|
|
|
|
|
|
|
Intercompany dividend income
|
|
|
|
|
|
|
(43
|
)
|
|
|
|
|
|
|
|
|
|
|
43
|
|
|
|
|
|
Other (income) expense, net
|
|
|
24
|
|
|
|
(8
|
)
|
|
|
4
|
|
|
|
(9
|
)
|
|
|
|
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes and extraordinary item
|
|
|
(283
|
)
|
|
|
46
|
|
|
|
2,115
|
|
|
|
239
|
|
|
|
(44
|
)
|
|
|
2,073
|
|
Provision for (benefit from) income taxes
|
|
|
(100
|
)
|
|
|
(1
|
)
|
|
|
795
|
|
|
|
72
|
|
|
|
|
|
|
|
766
|
|
Equity income from subsidiaries
|
|
|
1,491
|
|
|
|
1,350
|
|
|
|
29
|
|
|
|
|
|
|
|
(2,870
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before extraordinary item
|
|
|
1,308
|
|
|
|
1,397
|
|
|
|
1,349
|
|
|
|
167
|
|
|
|
(2,914
|
)
|
|
|
1,307
|
|
Extraordinary item gain on acquisition
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1,308
|
|
|
$
|
1,397
|
|
|
$
|
1,350
|
|
|
$
|
167
|
|
|
$
|
(2,914
|
)
|
|
$
|
1,308
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
150
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
|
|
|
Other
|
|
|
Non-
|
|
|
|
|
|
|
|
|
|
Guarantor
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
For the Year Ended December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
|
|
|
$
|
|
|
|
$
|
7,421
|
|
|
$
|
747
|
|
|
$
|
(158
|
)
|
|
$
|
8,010
|
|
Net sales, related party
|
|
|
|
|
|
|
|
|
|
|
487
|
|
|
|
13
|
|
|
|
|
|
|
|
500
|
|
Cost of products sold
|
|
|
|
|
|
|
|
|
|
|
4,678
|
|
|
|
283
|
|
|
|
(158
|
)
|
|
|
4,803
|
|
Selling, general and administrative expenses
|
|
|
48
|
|
|
|
2
|
|
|
|
1,436
|
|
|
|
172
|
|
|
|
|
|
|
|
1,658
|
|
Amortization expense
|
|
|
|
|
|
|
|
|
|
|
27
|
|
|
|
1
|
|
|
|
|
|
|
|
28
|
|
Restructuring charge
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
Trademark impairment charges
|
|
|
|
|
|
|
|
|
|
|
90
|
|
|
|
|
|
|
|
|
|
|
|
90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
(48
|
)
|
|
|
(2
|
)
|
|
|
1,676
|
|
|
|
304
|
|
|
|
|
|
|
|
1,930
|
|
Interest and debt expense
|
|
|
194
|
|
|
|
70
|
|
|
|
2
|
|
|
|
4
|
|
|
|
|
|
|
|
270
|
|
Interest income
|
|
|
(2
|
)
|
|
|
(9
|
)
|
|
|
(121
|
)
|
|
|
(4
|
)
|
|
|
|
|
|
|
(136
|
)
|
Intercompany interest (income) expense
|
|
|
(118
|
)
|
|
|
23
|
|
|
|
(49
|
)
|
|
|
144
|
|
|
|
|
|
|
|
|
|
Intercompany dividend income
|
|
|
|
|
|
|
(43
|
)
|
|
|
|
|
|
|
|
|
|
|
43
|
|
|
|
|
|
Other (income) expense, net
|
|
|
7
|
|
|
|
(4
|
)
|
|
|
1
|
|
|
|
(17
|
)
|
|
|
|
|
|
|
(13
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes and extraordinary item
|
|
|
(129
|
)
|
|
|
(39
|
)
|
|
|
1,843
|
|
|
|
177
|
|
|
|
(43
|
)
|
|
|
1,809
|
|
Provision for (benefit from) income taxes
|
|
|
(44
|
)
|
|
|
(52
|
)
|
|
|
703
|
|
|
|
66
|
|
|
|
|
|
|
|
673
|
|
Equity income from subsidiaries
|
|
|
1,295
|
|
|
|
1,246
|
|
|
|
32
|
|
|
|
|
|
|
|
(2,573
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before extraordinary item
|
|
|
1,210
|
|
|
|
1,259
|
|
|
|
1,172
|
|
|
|
111
|
|
|
|
(2,616
|
)
|
|
|
1,136
|
|
Extraordinary item gain on acquisition
|
|
|
|
|
|
|
|
|
|
|
74
|
|
|
|
|
|
|
|
|
|
|
|
74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1,210
|
|
|
$
|
1,259
|
|
|
$
|
1,246
|
|
|
$
|
111
|
|
|
$
|
(2,616
|
)
|
|
$
|
1,210
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
151
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Condensed
Consolidating Statements of Cash Flows
(Dollars in Millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
|
|
|
Other
|
|
|
Non-
|
|
|
|
|
|
|
|
|
|
Guarantor
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
For the Year Ended December 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities
|
|
$
|
1,141
|
|
|
$
|
1,035
|
|
|
$
|
1,292
|
|
|
$
|
71
|
|
|
$
|
(2,224
|
)
|
|
$
|
1,315
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions from equity investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27
|
|
|
|
|
|
|
|
27
|
|
Purchases of short-term investments
|
|
|
(8
|
)
|
|
|
(11
|
)
|
|
|
(28
|
)
|
|
|
(9
|
)
|
|
|
|
|
|
|
(56
|
)
|
Proceeds from sale of short-term investments
|
|
|
7
|
|
|
|
4
|
|
|
|
220
|
|
|
|
7
|
|
|
|
|
|
|
|
238
|
|
Proceeds from settlement of long-term investments
|
|
|
|
|
|
|
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
8
|
|
Intercompany notes receivable
|
|
|
40
|
|
|
|
71
|
|
|
|
(105
|
)
|
|
|
|
|
|
|
(6
|
)
|
|
|
|
|
Capital expenditures
|
|
|
|
|
|
|
|
|
|
|
(62
|
)
|
|
|
(51
|
)
|
|
|
|
|
|
|
(113
|
)
|
Net proceeds from the sale of fixed assets
|
|
|
|
|
|
|
|
|
|
|
7
|
|
|
|
1
|
|
|
|
|
|
|
|
8
|
|
Proceeds from termination of joint venture
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
164
|
|
|
|
|
|
|
|
164
|
|
Other, net
|
|
|
|
|
|
|
3
|
|
|
|
(3
|
)
|
|
|
2
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows from (used in) investing activities
|
|
|
39
|
|
|
|
67
|
|
|
|
37
|
|
|
|
141
|
|
|
|
(6
|
)
|
|
|
278
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid on common stock
|
|
|
(999
|
)
|
|
|
(1,126
|
)
|
|
|
(975
|
)
|
|
|
(80
|
)
|
|
|
2,181
|
|
|
|
(999
|
)
|
Dividends paid on preferred stock
|
|
|
(43
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43
|
|
|
|
|
|
Proceeds from exercise of stock options
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
Excess tax benefit from stock-based compensation
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2
|
|
Repurchase of common stock
|
|
|
(210
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(210
|
)
|
Intercompany notes payable
|
|
|
98
|
|
|
|
5
|
|
|
|
|
|
|
|
(109
|
)
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows used in financing activities
|
|
|
(1,151
|
)
|
|
|
(1,121
|
)
|
|
|
(975
|
)
|
|
|
(189
|
)
|
|
|
2,230
|
|
|
|
(1,206
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(24
|
)
|
|
|
|
|
|
|
(24
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents
|
|
|
29
|
|
|
|
(19
|
)
|
|
|
354
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
363
|
|
Cash and cash equivalents at beginning of year
|
|
|
243
|
|
|
|
25
|
|
|
|
1,623
|
|
|
|
324
|
|
|
|
|
|
|
|
2,215
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year
|
|
$
|
272
|
|
|
$
|
6
|
|
|
$
|
1,977
|
|
|
$
|
323
|
|
|
$
|
|
|
|
$
|
2,578
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities
|
|
$
|
356
|
|
|
$
|
224
|
|
|
$
|
808
|
|
|
$
|
180
|
|
|
$
|
(237
|
)
|
|
$
|
1,331
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions from equity investments
|
|
|
|
|
|
|
|
|
|
|
5
|
|
|
|
10
|
|
|
|
|
|
|
|
15
|
|
Purchases of short-term investments
|
|
|
|
|
|
|
(2
|
)
|
|
|
(3,660
|
)
|
|
|
(102
|
)
|
|
|
|
|
|
|
(3,764
|
)
|
Proceeds from sale of short-term investments
|
|
|
|
|
|
|
120
|
|
|
|
4,437
|
|
|
|
98
|
|
|
|
|
|
|
|
4,655
|
|
Intercompany notes receivable
|
|
|
40
|
|
|
|
|
|
|
|
(844
|
)
|
|
|
|
|
|
|
804
|
|
|
|
|
|
Net intercompany investments
|
|
|
|
|
|
|
(260
|
)
|
|
|
260
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
(8
|
)
|
|
|
|
|
|
|
(93
|
)
|
|
|
(41
|
)
|
|
|
|
|
|
|
(142
|
)
|
Acquisitions, net of cash acquired
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3
|
)
|
|
|
|
|
|
|
(3
|
)
|
Net proceeds from the sale of fixed assets
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
2
|
|
|
|
|
|
|
|
3
|
|
Other, net
|
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows from (used in) investing activities
|
|
|
32
|
|
|
|
(143
|
)
|
|
|
106
|
|
|
|
(36
|
)
|
|
|
804
|
|
|
|
763
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid on common stock
|
|
|
(916
|
)
|
|
|
|
|
|
|
(139
|
)
|
|
|
(55
|
)
|
|
|
194
|
|
|
|
(916
|
)
|
Dividends paid on preferred stock
|
|
|
(43
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43
|
|
|
|
|
|
Proceeds from exercise of stock options
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
Excess tax benefit from stock-based compensation
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2
|
|
Repayments of long-term debt
|
|
|
(254
|
)
|
|
|
(75
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(329
|
)
|
Repayments of term loan
|
|
|
(1,542
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,542
|
)
|
Proceeds from issuance of long-term debt
|
|
|
1,547
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,547
|
|
Repurchase of common stock
|
|
|
(60
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(60
|
)
|
Deferred debt issuance costs
|
|
|
(15
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15
|
)
|
Intercompany notes payable
|
|
|
839
|
|
|
|
(3
|
)
|
|
|
|
|
|
|
(32
|
)
|
|
|
(804
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows used in financing activities
|
|
|
(441
|
)
|
|
|
(78
|
)
|
|
|
(139
|
)
|
|
|
(87
|
)
|
|
|
(567
|
)
|
|
|
(1,312
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents
|
|
|
(53
|
)
|
|
|
3
|
|
|
|
775
|
|
|
|
57
|
|
|
|
|
|
|
|
782
|
|
Cash and cash equivalents at beginning of year
|
|
|
296
|
|
|
|
22
|
|
|
|
848
|
|
|
|
267
|
|
|
|
|
|
|
|
1,433
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year
|
|
$
|
243
|
|
|
$
|
25
|
|
|
$
|
1,623
|
|
|
$
|
324
|
|
|
$
|
|
|
|
$
|
2,215
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
152
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
|
|
|
Other
|
|
|
Non-
|
|
|
|
|
|
|
|
|
|
Guarantor
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
For the Year Ended December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities
|
|
$
|
1,023
|
|
|
$
|
1,364
|
|
|
$
|
1,915
|
|
|
$
|
212
|
|
|
$
|
(3,057
|
)
|
|
$
|
1,457
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions from equity investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18
|
|
|
|
|
|
|
|
18
|
|
Purchases of short-term investments
|
|
|
|
|
|
|
(5
|
)
|
|
|
(7,672
|
)
|
|
|
|
|
|
|
|
|
|
|
(7,677
|
)
|
Proceeds from sale of short-term investments
|
|
|
|
|
|
|
|
|
|
|
7,760
|
|
|
|
|
|
|
|
|
|
|
|
7,760
|
|
Intercompany notes receivable
|
|
|
(3,168
|
)
|
|
|
(3,153
|
)
|
|
|
(110
|
)
|
|
|
1
|
|
|
|
6,430
|
|
|
|
|
|
Net intercompany investments
|
|
|
(211
|
)
|
|
|
294
|
|
|
|
(464
|
)
|
|
|
381
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
|
|
|
|
|
|
|
|
(119
|
)
|
|
|
(17
|
)
|
|
|
|
|
|
|
(136
|
)
|
Acquisitions, net of cash acquired
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,519
|
)
|
|
|
|
|
|
|
(3,519
|
)
|
Net proceeds from the sale of businesses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
3
|
|
Net proceeds from the sale of fixed assets
|
|
|
|
|
|
|
|
|
|
|
20
|
|
|
|
4
|
|
|
|
|
|
|
|
24
|
|
Other, net
|
|
|
|
|
|
|
|
|
|
|
(4
|
)
|
|
|
|
|
|
|
|
|
|
|
(4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows used in investing activities
|
|
|
(3,379
|
)
|
|
|
(2,864
|
)
|
|
|
(589
|
)
|
|
|
(3,129
|
)
|
|
|
6,430
|
|
|
|
(3,531
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid on common stock
|
|
|
(775
|
)
|
|
|
(1,494
|
)
|
|
|
(1,520
|
)
|
|
|
|
|
|
|
3,014
|
|
|
|
(775
|
)
|
Dividends paid on preferred stock
|
|
|
(43
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43
|
|
|
|
|
|
Proceeds from exercise of stock options
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
Excess tax benefit from stock-based compensation
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
Repayments of long-term debt
|
|
|
|
|
|
|
(190
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(190
|
)
|
Repayments of term loan
|
|
|
(8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8
|
)
|
Proceeds from issuance of long-term debt
|
|
|
1,641
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,641
|
|
Principal borrowings under term loan
|
|
|
1,550
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,550
|
|
Deferred debt issuance costs
|
|
|
(52
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(52
|
)
|
Intercompany notes payable
|
|
|
104
|
|
|
|
3,173
|
|
|
|
(1
|
)
|
|
|
3,154
|
|
|
|
(6,430
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows from (used in) financing activities
|
|
|
2,425
|
|
|
|
1,489
|
|
|
|
(1,521
|
)
|
|
|
3,154
|
|
|
|
(3,373
|
)
|
|
|
2,174
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents
|
|
|
69
|
|
|
|
(11
|
)
|
|
|
(195
|
)
|
|
|
237
|
|
|
|
|
|
|
|
100
|
|
Cash and cash equivalents at beginning of year
|
|
|
227
|
|
|
|
33
|
|
|
|
1,043
|
|
|
|
30
|
|
|
|
|
|
|
|
1,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year
|
|
$
|
296
|
|
|
$
|
22
|
|
|
$
|
848
|
|
|
$
|
267
|
|
|
$
|
|
|
|
$
|
1,433
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
153
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Condensed
Consolidating Balance Sheets
(Dollars in Millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
|
|
|
Other
|
|
|
Non-
|
|
|
|
|
|
|
|
|
|
Guarantor
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
December 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
272
|
|
|
$
|
6
|
|
|
$
|
1,977
|
|
|
$
|
323
|
|
|
$
|
|
|
|
$
|
2,578
|
|
Short-term investments
|
|
|
1
|
|
|
|
6
|
|
|
|
14
|
|
|
|
2
|
|
|
|
|
|
|
|
23
|
|
Accounts receivable, net
|
|
|
|
|
|
|
|
|
|
|
38
|
|
|
|
46
|
|
|
|
|
|
|
|
84
|
|
Accounts receivable, related party
|
|
|
|
|
|
|
|
|
|
|
88
|
|
|
|
3
|
|
|
|
|
|
|
|
91
|
|
Note receivable
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
34
|
|
|
|
|
|
|
|
35
|
|
Other receivables
|
|
|
9
|
|
|
|
1
|
|
|
|
23
|
|
|
|
4
|
|
|
|
|
|
|
|
37
|
|
Inventories
|
|
|
|
|
|
|
|
|
|
|
784
|
|
|
|
388
|
|
|
|
(2
|
)
|
|
|
1,170
|
|
Deferred income taxes, net
|
|
|
12
|
|
|
|
|
|
|
|
806
|
|
|
|
20
|
|
|
|
|
|
|
|
838
|
|
Prepaid expenses and other
|
|
|
35
|
|
|
|
|
|
|
|
125
|
|
|
|
10
|
|
|
|
(7
|
)
|
|
|
163
|
|
Short-term intercompany notes and interest receivable
|
|
|
81
|
|
|
|
35
|
|
|
|
183
|
|
|
|
|
|
|
|
(299
|
)
|
|
|
|
|
Other intercompany receivables
|
|
|
68
|
|
|
|
19
|
|
|
|
|
|
|
|
2
|
|
|
|
(89
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
478
|
|
|
|
68
|
|
|
|
4,038
|
|
|
|
832
|
|
|
|
(397
|
)
|
|
|
5,019
|
|
Property, plant and equipment, net
|
|
|
7
|
|
|
|
|
|
|
|
856
|
|
|
|
168
|
|
|
|
|
|
|
|
1,031
|
|
Trademarks and other intangible assets, net
|
|
|
|
|
|
|
|
|
|
|
1,869
|
|
|
|
1,401
|
|
|
|
|
|
|
|
3,270
|
|
Goodwill
|
|
|
|
|
|
|
|
|
|
|
5,303
|
|
|
|
2,871
|
|
|
|
|
|
|
|
8,174
|
|
Long-term intercompany notes
|
|
|
2,080
|
|
|
|
207
|
|
|
|
1,408
|
|
|
|
|
|
|
|
(3,695
|
)
|
|
|
|
|
Investment in subsidiaries
|
|
|
9,751
|
|
|
|
8,000
|
|
|
|
413
|
|
|
|
|
|
|
|
(18,164
|
)
|
|
|
|
|
Other assets and deferred charges
|
|
|
349
|
|
|
|
63
|
|
|
|
310
|
|
|
|
161
|
|
|
|
(223
|
)
|
|
|
660
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
12,665
|
|
|
$
|
8,338
|
|
|
$
|
14,197
|
|
|
$
|
5,433
|
|
|
$
|
(22,479
|
)
|
|
$
|
18,154
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and shareholders equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tobacco settlement accruals
|
|
$
|
|
|
|
$
|
|
|
|
$
|
2,288
|
|
|
$
|
33
|
|
|
$
|
|
|
|
$
|
2,321
|
|
Accounts payable and other accrued liabilities
|
|
|
350
|
|
|
|
7
|
|
|
|
857
|
|
|
|
142
|
|
|
|
(7
|
)
|
|
|
1,349
|
|
Due to related party
|
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
1
|
|
|
|
|
|
|
|
3
|
|
Deferred revenue, related party
|
|
|
|
|
|
|
|
|
|
|
50
|
|
|
|
|
|
|
|
|
|
|
|
50
|
|
Current maturities of long-term debt
|
|
|
189
|
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
200
|
|
Short-term intercompany notes and interest payable
|
|
|
40
|
|
|
|
130
|
|
|
|
2
|
|
|
|
127
|
|
|
|
(299
|
)
|
|
|
|
|
Other intercompany payables
|
|
|
|
|
|
|
|
|
|
|
89
|
|
|
|
|
|
|
|
(89
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
579
|
|
|
|
148
|
|
|
|
3,288
|
|
|
|
303
|
|
|
|
(395
|
)
|
|
|
3,923
|
|
Intercompany notes and interest payable
|
|
|
1,409
|
|
|
|
|
|
|
|
|
|
|
|
2,286
|
|
|
|
(3,695
|
)
|
|
|
|
|
Long-term debt (less current maturities)
|
|
|
4,362
|
|
|
|
124
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,486
|
|
Deferred income taxes, net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
505
|
|
|
|
(223
|
)
|
|
|
282
|
|
Long-term retirement benefits (less current portion)
|
|
|
64
|
|
|
|
32
|
|
|
|
2,646
|
|
|
|
94
|
|
|
|
|
|
|
|
2,836
|
|
Other noncurrent liabilities
|
|
|
14
|
|
|
|
106
|
|
|
|
263
|
|
|
|
7
|
|
|
|
|
|
|
|
390
|
|
Shareholders equity
|
|
|
6,237
|
|
|
|
7,928
|
|
|
|
8,000
|
|
|
|
2,238
|
|
|
|
(18,166
|
)
|
|
|
6,237
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity
|
|
$
|
12,665
|
|
|
$
|
8,338
|
|
|
$
|
14,197
|
|
|
$
|
5,433
|
|
|
$
|
(22,479
|
)
|
|
$
|
18,154
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
154
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
|
|
|
Other
|
|
|
Non-
|
|
|
|
|
|
|
|
|
|
Guarantor
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
243
|
|
|
$
|
25
|
|
|
$
|
1,623
|
|
|
$
|
324
|
|
|
$
|
|
|
|
$
|
2,215
|
|
Short-term investments
|
|
|
|
|
|
|
|
|
|
|
377
|
|
|
|
|
|
|
|
|
|
|
|
377
|
|
Accounts receivable, net
|
|
|
|
|
|
|
|
|
|
|
41
|
|
|
|
32
|
|
|
|
|
|
|
|
73
|
|
Accounts receivable, related party
|
|
|
|
|
|
|
|
|
|
|
75
|
|
|
|
5
|
|
|
|
|
|
|
|
80
|
|
Note receivable
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
Other receivables
|
|
|
7
|
|
|
|
1
|
|
|
|
14
|
|
|
|
3
|
|
|
|
|
|
|
|
25
|
|
Inventories
|
|
|
|
|
|
|
|
|
|
|
908
|
|
|
|
290
|
|
|
|
(2
|
)
|
|
|
1,196
|
|
Deferred income taxes, net
|
|
|
11
|
|
|
|
1
|
|
|
|
814
|
|
|
|
19
|
|
|
|
|
|
|
|
845
|
|
Prepaid expenses and other
|
|
|
6
|
|
|
|
|
|
|
|
168
|
|
|
|
6
|
|
|
|
|
|
|
|
180
|
|
Short-term intercompany notes and interest receivable
|
|
|
82
|
|
|
|
109
|
|
|
|
446
|
|
|
|
|
|
|
|
(637
|
)
|
|
|
|
|
Other intercompany receivables
|
|
|
153
|
|
|
|
|
|
|
|
|
|
|
|
29
|
|
|
|
(182
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
502
|
|
|
|
137
|
|
|
|
4,466
|
|
|
|
708
|
|
|
|
(821
|
)
|
|
|
4,992
|
|
Property, plant and equipment, net
|
|
|
8
|
|
|
|
|
|
|
|
936
|
|
|
|
130
|
|
|
|
(1
|
)
|
|
|
1,073
|
|
Trademarks and other intangible assets, net
|
|
|
|
|
|
|
|
|
|
|
2,066
|
|
|
|
1,543
|
|
|
|
|
|
|
|
3,609
|
|
Goodwill
|
|
|
|
|
|
|
|
|
|
|
5,302
|
|
|
|
2,872
|
|
|
|
|
|
|
|
8,174
|
|
Long-term intercompany notes
|
|
|
2,120
|
|
|
|
225
|
|
|
|
1,310
|
|
|
|
|
|
|
|
(3,655
|
)
|
|
|
|
|
Investment in subsidiaries
|
|
|
10,848
|
|
|
|
9,240
|
|
|
|
87
|
|
|
|
|
|
|
|
(20,175
|
)
|
|
|
|
|
Other assets and deferred charges
|
|
|
186
|
|
|
|
34
|
|
|
|
534
|
|
|
|
51
|
|
|
|
(24
|
)
|
|
|
781
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
13,664
|
|
|
$
|
9,636
|
|
|
$
|
14,701
|
|
|
$
|
5,304
|
|
|
$
|
(24,676
|
)
|
|
$
|
18,629
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and shareholders equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tobacco settlement accruals
|
|
$
|
|
|
|
$
|
|
|
|
$
|
2,425
|
|
|
$
|
24
|
|
|
$
|
|
|
|
$
|
2,449
|
|
Accounts payable and other accrued liabilities
|
|
|
391
|
|
|
|
5
|
|
|
|
873
|
|
|
|
143
|
|
|
|
|
|
|
|
1,412
|
|
Due to related party
|
|
|
|
|
|
|
|
|
|
|
4
|
|
|
|
3
|
|
|
|
|
|
|
|
7
|
|
Deferred revenue, related party
|
|
|
|
|
|
|
|
|
|
|
35
|
|
|
|
|
|
|
|
|
|
|
|
35
|
|
Short-term intercompany notes and interest payable
|
|
|
34
|
|
|
|
403
|
|
|
|
3
|
|
|
|
197
|
|
|
|
(637
|
)
|
|
|
|
|
Other intercompany payables
|
|
|
|
|
|
|
14
|
|
|
|
168
|
|
|
|
|
|
|
|
(182
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
425
|
|
|
|
422
|
|
|
|
3,508
|
|
|
|
367
|
|
|
|
(819
|
)
|
|
|
3,903
|
|
Intercompany notes and interest payable
|
|
|
1,310
|
|
|
|
|
|
|
|
2
|
|
|
|
2,343
|
|
|
|
(3,655
|
)
|
|
|
|
|
Long-term debt (less current maturities)
|
|
|
4,383
|
|
|
|
132
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,515
|
|
Deferred income taxes, net
|
|
|
|
|
|
|
2
|
|
|
|
643
|
|
|
|
563
|
|
|
|
(24
|
)
|
|
|
1,184
|
|
Long-term retirement benefits (less current portion)
|
|
|
44
|
|
|
|
18
|
|
|
|
1,046
|
|
|
|
59
|
|
|
|
|
|
|
|
1,167
|
|
Other noncurrent liabilities
|
|
|
36
|
|
|
|
92
|
|
|
|
262
|
|
|
|
4
|
|
|
|
|
|
|
|
394
|
|
Shareholders equity
|
|
|
7,466
|
|
|
|
8,970
|
|
|
|
9,240
|
|
|
|
1,968
|
|
|
|
(20,178
|
)
|
|
|
7,466
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity
|
|
$
|
13,664
|
|
|
$
|
9,636
|
|
|
$
|
14,701
|
|
|
$
|
5,304
|
|
|
$
|
(24,676
|
)
|
|
$
|
18,629
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
155
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Note 24
Quarterly Results of Operations (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First
|
|
|
Second
|
|
|
Third
|
|
|
Fourth
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
2,057
|
|
|
$
|
2,339
|
|
|
$
|
2,272
|
|
|
$
|
2,177
|
|
Gross profit
|
|
|
893
|
|
|
|
1,034
|
|
|
|
1,043
|
|
|
|
1,012
|
|
Net income(1)
|
|
|
505
|
|
|
|
364
|
|
|
|
211
|
|
|
|
258
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Per share data(2):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1.72
|
|
|
$
|
1.24
|
|
|
$
|
0.72
|
|
|
$
|
0.89
|
|
Diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1.71
|
|
|
$
|
1.24
|
|
|
$
|
0.72
|
|
|
$
|
0.89
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
2,148
|
|
|
$
|
2,348
|
|
|
$
|
2,297
|
|
|
$
|
2,230
|
|
Gross profit
|
|
|
973
|
|
|
|
1,005
|
|
|
|
1,047
|
|
|
|
1,038
|
|
Net income from continuing operations(1)
|
|
|
328
|
|
|
|
324
|
|
|
|
358
|
|
|
|
297
|
|
Extraordinary item, net of income taxes
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
328
|
|
|
|
325
|
|
|
|
358
|
|
|
|
297
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Per share data(2):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income from continuing operations
|
|
$
|
1.11
|
|
|
$
|
1.10
|
|
|
$
|
1.22
|
|
|
$
|
1.01
|
|
Extraordinary item, net of income taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1.11
|
|
|
$
|
1.10
|
|
|
$
|
1.22
|
|
|
$
|
1.01
|
|
Diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income from continuing operations
|
|
$
|
1.11
|
|
|
$
|
1.10
|
|
|
$
|
1.21
|
|
|
$
|
1.01
|
|
Extraordinary item, net of income taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1.11
|
|
|
$
|
1.10
|
|
|
$
|
1.21
|
|
|
$
|
1.01
|
|
|
|
|
(1) |
|
First quarter of 2008 net income includes a
$328 million gain on termination of joint venture. Third
quarter of 2008 net income includes a $91 million
restructuring charge and a $173 million trademark
impairment charge. Fourth quarter of 2008 net income
includes a $(1) million restructuring charge and a
$145 million trademark impairment charge. Fourth quarter
2007 net income from continuing operations includes a
$65 million trademark impairment charge. |
|
(2) |
|
Income per share is computed independently for each of the
periods presented. The sum of the income per share amounts for
the quarters may not equal the total for the year. |
Note 25
Subsequent Event
On February 4, 2009, President Obama signed an increase of
$0.62 in the federal excise tax per pack of cigarettes, for a
total of $1.01 per pack of cigarettes, and significant tax
increases on other tobacco products, to fund expansion of the
SCHIP. These tax increases are effective April 1, 2009.
RAIs operating subsidiaries expect the tax increases to
significantly and adversely impact sales volume, but at this
time, cannot quantify the sales volume decline, nor the
resulting adverse impacts to RAIs consolidated results of
operations, financial condition or cash flows. Additionally,
RAIs operating subsidiaries believe that the federal
excise tax increase is an event that will require that their
goodwill and trademarks be tested for impairment during the
first quarter of 2009, and the resulting fair value of certain
trademarks could be less than carrying value. In particular, RJR
Tobacco believes that impairment charges related to support and
non-support cigarette brands are possible and Conwood also
believes that impairment charges related to certain brands are
possible. No reasonable estimate of trademark impairment charges
can be made at this time by RAIs operating subsidiaries.
Because annual impairment testing of the goodwill of RAIs
operating subsidiaries as of November 30, 2008, indicated
significant excesses of fair value over carrying value,
RAIs operating subsidiaries believe that goodwill
impairment as a result of testing in the first quarter of 2009
is unlikely.
156
|
|
Item 9.
|
Changes
in and Disagreements with Accountants on Accounting and
Financial Disclosure
|
None.
|
|
Item 9A.
|
Controls
and Procedures
|
Disclosure
Controls and Procedures
(a) RAIs chief executive officer and chief financial
officer have concluded that RAIs disclosure controls and
procedures were effective as of the end of the period covered by
this report, based on their evaluation of these controls and
procedures.
Internal
Control over Financial Reporting
Limitation
on the Effectiveness of Controls
Internal controls are designed to provide reasonable assurance
that assets are safeguarded and transactions are properly
recorded, executed and reported in accordance with
managements authorization. The effectiveness of internal
controls is supported by qualified personnel and an organization
structure that provides an appropriate division of
responsibility and formalized procedures. An internal audit
staff regularly monitors the adequacy and effectiveness of
internal controls, including reporting to RAIs audit
committee. Because of its inherent limitations, a system of
internal control over financial reporting can provide only
reasonable assurance and may not prevent or detect
misstatements. See Managements Report on Internal
Control over Financial Reporting in Item 8.
Changes
in Controls
There have been no changes in RAIs internal controls over
financial reporting that occurred during the fourth quarter that
have materially affected, or are reasonably likely to materially
affect, RAIs internal controls over financial reporting.
|
|
Item 9B.
|
Other
Information
|
None.
157
PART III
|
|
Item 10.
|
Directors,
Executive Officers and Corporate Governance
|
Item 10 is incorporated by reference to the following
sections of RAIs definitive Proxy Statement to be filed
with the SEC on or about March 23, 2009, referred to as the
Proxy Statement: The Board of Directors
Item 1: Election of Directors; The Board of
Directors Biographies of Board Members;
The Board of Directors Governance
Agreement; The Board of Directors
Committees and Meetings of the Board of Directors
Audit and Finance Committee; The Board of
Directors Code of Conduct; and Security
Ownership of Certain Beneficial Owners and
Management Section 16(a) Beneficial Ownership
Reporting Compliance. For information regarding the
executive officers and certain significant employees of RAI, see
Executive Officers and Certain Significant Employees of
the Registrant in Item 4 of Part I of this
report.
|
|
Item 11.
|
Executive
Compensation
|
Item 11 is incorporated by reference to the following
sections of the Proxy Statement: Executive
Compensation; Executive Compensation
Compensation Committee Report; The Board of
Directors Committees and Meetings of the Board of
Directors Compensation and Leadership Development
Committee; Compensation Committee Interlocks and Insider
Participation; and The Board of
Directors Director Compensation.
|
|
Item 12.
|
Security
Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters
|
Item 12 is incorporated by reference to the following
sections of the Proxy Statement: Security Ownership of
Certain Beneficial Owners and Management Stock
Ownership of Principal Shareholders; Security
Ownership of Certain Beneficial Owners and
Management Stock Ownership of Management;
Security Ownership of Certain Beneficial Owners and
Management Standstill Provisions; Transfer
Restrictions. For information regarding securities
authorized for issuance under equity compensation plans, see
note 18 to consolidated financial statements.
|
|
Item 13.
|
Certain
Relationships and Related Transactions, and Director
Independence
|
Item 13 is incorporated by reference to the following
sections of the Proxy Statement: Certain Relationships and
Related Transactions; and The Board of
Directors Determination of Independence of
Directors.
|
|
Item 14.
|
Principal
Accountant Fees and Services
|
Item 14 is incorporated by reference to the following
sections of the Proxy Statement: Audit Matters
Audit Committees Audit and Non-Audit Services Pre-Approval
Policy; and Audit Matters Fees of
Independent Auditors.
158
PART IV
|
|
Item 15.
|
Exhibits
and Financial Statement Schedules
|
(a) The following documents are filed as a part of this
report:
|
|
|
|
(1)
|
Consolidated Statements of Income for the years ended
December 31, 2008, 2007 and 2006.
|
Consolidated Statements of Cash Flows for the years ended
December 31, 2008, 2007 and 2006.
Consolidated Balance Sheets as of December 31, 2008 and
2007.
Consolidated Statements of Shareholders Equity and
Comprehensive Income for the years ended December 31, 2008,
2007 and 2006.
|
|
|
|
(2)
|
Financial Statement Schedules have been omitted because the
information required has been separately disclosed in the
consolidated financial statements or notes.
|
|
|
(3)
|
See (b) below.
|
|
|
|
|
(b)
|
Exhibit Numbers 10.29 through 10.69 below are management
contracts, compensatory plans or arrangements. The following
exhibits are filed or furnished, as the case may be, as part of
this report:
|
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
|
|
|
2
|
.1
|
|
Purchase Agreement, dated April 24, 2006, by and among(i)
Reynolds American Inc., (ii) Reynolds American Inc.s
direct, wholly owned acquisition subsidiary, Pinch Acquisition
Corporation, (iii) Karl J. Breyer, Marshall E. Eisenberg
and Thomas J. Pritzker, not individually, but solely as
co-trustees of those certain separate and distinct trusts listed
therein, and (iv) GP Investor, L.L.C. (incorporated by
reference to Exhibit 2.1 to Reynolds American Inc.s
Form 8-K
dated April 24, 2006).
|
|
2
|
.2
|
|
Amendment No. 1, dated as of May 31, 2006, to the
Purchase Agreement, dated as of April 24, 2006, by and
among Karl J. Breyer, Marshall E. Eisenberg and Thomas J.
Pritzker, not individually, but solely as co-trustees of those
certain separate and distinct trusts listed therein, GP
Investor, L.L.C., Reynolds American Inc. and Conwood Holdings,
Inc. (f/k/a Pinch Acquisition Corporation) (incorporated by
reference to Exhibit 2.1 to Reynolds American Inc.s
Form 8-K
dated May 31, 2006).
|
|
3
|
.1
|
|
Amended and Restated Certificate of Incorporation of Reynolds
American Inc. (incorporated by reference to Exhibit 1 to
Reynolds American Inc.s
Form 8-A
filed July 29, 2004).
|
|
3
|
.2
|
|
Articles of Amendment of Amended and Restated Articles of
Incorporation of Reynolds American Inc. (incorporated by
reference to Exhibit 3.1 to Reynolds American Inc.s
Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2007, filed August 2,
2007).
|
|
3
|
.3
|
|
Amended and Restated Bylaws of Reynolds American Inc., dated
December 4, 2008 (incorporated by reference to
Exhibit 3.1 to Reynolds American Inc.s
Form 8-K
dated December 4, 2008).
|
|
4
|
.1
|
|
Rights Agreement, between Reynolds American Inc. and The Bank of
New York, as rights agent (incorporated by reference to
Exhibit 3 to Reynolds American Inc.s
Form 8-A
filed July 29, 2004).
|
|
4
|
.2
|
|
Amended and Restated Indenture, dated as of July 24, 1995,
between RJR Nabisco, Inc. and The Bank of New York (incorporated
by reference to Exhibit 4.1 to RJR Nabisco, Inc.s
Quarterly Report on
Form 10-Q
for the quarter ended June 30, 1995, filed August 8,
1995).
|
|
4
|
.3
|
|
First Supplemental Indenture and Waiver, dated as of
April 27, 1999, between RJR Nabisco, Inc. and The Bank of
New York, to the Amended and Restated Indenture, dated as of
July 24, 1995, between RJR Nabisco, Inc. and The Bank of
New York, as successor trustee (incorporated by reference to
Exhibit 10.3 to R.J. Reynolds Tobacco Holdings, Inc.s
Form 8-A
filed May 19, 1999).
|
|
4
|
.4
|
|
Indenture, dated as of May 15, 1999, among RJR Nabisco,
Inc., R.J. Reynolds Tobacco Company and The Bank of New York, as
trustee (incorporated by reference to Exhibit 10.2 to R.J.
Reynolds Tobacco Holdings, Inc.s
Form 8-A
filed May 19, 1999).
|
|
4
|
.5
|
|
Guarantee, dated as of May 18, 1999, by R.J. Reynolds
Tobacco Company to the holders and to The Bank of New York, as
Trustee, issued in connection with the Indenture, dated as of
May 15, 1999, among RJR Nabisco, Inc., R.J. Reynolds
Tobacco Company and The Bank of New York, as Trustee
(incorporated by reference to Exhibit 10.6 to R.J. Reynolds
Tobacco Holdings, Inc.s
Form 8-A
filed May 19, 1999).
|
159
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
|
|
|
4
|
.6
|
|
First Supplemental Indenture, dated as of December 12,
2000, among RJR Acquisition Corp., R. J. Reynolds Tobacco
Holdings, Inc., R.J. Reynolds Tobacco Company and The Bank of
New York, as Trustee, to the Indenture, dated as of May 15,
1999, among RJR Nabisco, Inc., R.J. Reynolds Tobacco Company and
The Bank of New York, as Trustee (incorporated by reference to
Exhibit 4.6 to R.J. Reynolds Tobacco Holdings, Inc.s
Annual Report on
Form 10-K
for the fiscal year ended December 31, 2000, filed
March 1, 2001).
|
|
4
|
.7
|
|
Second Supplemental Indenture, dated as of June 30, 2003,
among GMB, Inc., FSH, Inc., R.J. Reynolds Tobacco Co., Santa Fe
Natural Tobacco Company, Inc., RJR Packaging, LLC, R.J. Reynolds
Tobacco Holdings, Inc., R.J. Reynolds Tobacco Company, RJR
Acquisition Corp. and The Bank of New York, as Trustee, to the
Indenture, dated May 15, 1999, among RJR Nabisco, Inc.,
R.J. Reynolds Tobacco Company and The Bank of New York, as
Trustee (incorporated by reference to Exhibit 4.1 to R.J.
Reynolds Tobacco Holdings, Inc.s Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2003, filed August 8,
2003).
|
|
4
|
.8
|
|
Third Supplemental Indenture, dated as of July 30, 2004,
among R.J. Reynolds Tobacco Holdings, Inc., Reynolds American
Inc., R.J. Reynolds Tobacco Company, RJR Acquisition Corp., GMB,
Inc., FHS, Inc., R.J. Reynolds Tobacco Co., RJR Packaging, LLC,
BWT Brands, Inc. and The Bank of New York, as Trustee, to the
Indenture dated May 15, 1999, among RJR Nabisco, Inc., R.J.
Reynolds Tobacco Company and The Bank of New York, as Trustee
(incorporated by reference to Exhibit 4.2 to Reynolds
American Inc.s
Form 8-K
dated July 30, 2004).
|
|
4
|
.9
|
|
Fourth Supplemental Indenture, dated July 6, 2005, by and
among R.J. Reynolds Tobacco Holdings, Inc., Reynolds American
Inc. and various subsidiaries of Reynolds American Inc. as
guarantors, and The Bank of New York, as Trustee (incorporated
by reference to Exhibit 4.1 to Reynolds American
Inc.s From
8-K dated
July 6, 2005).
|
|
4
|
.10
|
|
Fifth Supplemental Indenture, dated May 31, 2006, to
Indenture dated May 15, 1999, among R.J. Reynolds Tobacco
Holdings, Inc., Reynolds American Inc. and certain subsidiaries
of R.J. Reynolds Tobacco Holdings, Inc. as guarantors and The
Bank of New York Trust Company, N.A. as Trustee
(incorporated by reference to Exhibit 4.5 to Reynolds
American Inc.s
Form 8-K
dated May 31, 2006).
|
|
4
|
.11
|
|
Sixth Supplemental Indenture, dated June 20, 2006, to
Indenture, dated May 15, 1999, among R.J. Reynolds Tobacco
Holdings, Inc., Reynolds American Inc. and certain subsidiaries
of R.J. Reynolds Tobacco Holdings, Inc. as guarantors and The
Bank of New York Trust Company, N.A. as Trustee
(incorporated by reference to Exhibit 4.6 to Reynolds
American Inc.s
Form 8-K
dated June 20, 2006).
|
|
4
|
.12
|
|
Seventh Supplemental Indenture, dated September 30, 2006,
to Indenture, dated May 15, 1999, among R.J. Reynolds
Tobacco Holdings, Inc., Reynolds American Inc. and certain
subsidiaries of R.J. Reynolds Tobacco Holdings, Inc. as
guarantors, and The Bank of New York Trust Company, N.A.,
as successor to The Bank of New York, as Trustee, as amended
(incorporated by reference to Exhibit 4.3 to Reynolds
American Inc.s
Form 8-K
dated September 30, 2006).
|
|
4
|
.13
|
|
Indenture, dated as of May 20, 2002, by and among R.J.
Reynolds Tobacco Holdings, Inc., R. J. Reynolds Tobacco Company,
RJR Acquisition Corp. and The Bank of New York (incorporated by
reference to Exhibit 4.3 to R.J. Reynolds Tobacco Holdings,
Inc.s
Form 8-K
dated May 15, 2002).
|
|
4
|
.14
|
|
First Supplemental Indenture dated as of June 30, 2003,
among GMB, Inc., FSH, Inc., R. J. Reynolds Tobacco Co., Santa Fe
Natural Tobacco Company, Inc., RJR Packaging, LLC, R. J.
Reynolds Tobacco Holdings, Inc., R.J. Reynolds Tobacco Company,
RJR Acquisition Corp. and The Bank of New York, as Trustee, to
the Indenture dated as of May 20, 2002, among R. J.
Reynolds Tobacco Holdings, Inc., R.J. Reynolds Tobacco Company,
RJR Acquisition Corp. and The Bank of New York, as Trustee
(incorporated by reference to Exhibit 4.2 to R.J. Reynolds
Tobacco Holdings, Inc.s Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2003, filed August 8,
2003).
|
|
4
|
.15
|
|
Second Supplemental Indenture, dated as of July 30, 2004,
among R.J. Reynolds Tobacco Holdings, Inc., Reynolds American
Inc., R.J. Reynolds Tobacco Company, RJR Acquisition Corp., GMB,
Inc., FSH, Inc., R.J. Reynolds Tobacco Co., RJR Packaging, LLC,
BWT Brands, Inc. and The Bank of New York, as Trustee, to the
Indenture dated May 20, 2002, among R.J. Reynolds Tobacco
Holdings, Inc., R.J. Reynolds Tobacco Company, RJR Acquisition
Corp. and The Bank of New York (incorporated by reference to
Exhibit 4.3 to Reynolds American Inc.s
Form 8-K
dated July 30, 2004).
|
160
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
|
|
|
4
|
.16
|
|
Third Supplemental Indenture, dated May 31, 2006, to
Indenture, dated May 20, 2002, among R.J. Reynolds Tobacco
Holdings, Inc., Reynolds American Inc. and certain subsidiaries
of R.J. Reynolds Tobacco Holdings, Inc. as guarantors and The
Bank of New York Trust Company, N.A. as Trustee
(incorporated by reference to Exhibit 4.6 to Reynolds
American Inc.s
Form 8-K
dated May 31, 2006).
|
|
4
|
.17
|
|
Fourth Supplemental Indenture, dated June 20, 2006, to
Indenture, dated May 20, 2002, among R.J. Reynolds Tobacco
Holdings, Inc., Reynolds American Inc. and certain subsidiaries
of R.J. Reynolds Tobacco Holdings, Inc. as guarantors and The
Bank of New York Trust Company, N.A. as Trustee
(incorporated by reference to Exhibit 4.7 to Reynolds
American Inc.s
Form 8-K
dated June 20, 2006).
|
|
4
|
.18
|
|
Fifth Supplemental Indenture, dated September 30, 2006, to
Indenture, dated May 20, 2002, among R.J. Reynolds Tobacco
Holdings, Inc., Reynolds American Inc. and certain subsidiaries
of R.J. Reynolds Tobacco Holdings, Inc. as guarantors, and The
Bank of New York Trust Company, N.A., as successor to The
Bank of New York, as Trustee, as amended (incorporated by
reference to Exhibit 4.2 to Reynolds American Inc.s
Form 8-K
dated September 30, 2006).
|
|
4
|
.19
|
|
Indenture, dated May 31, 2006, among Reynolds American Inc.
and certain of its subsidiaries as guarantors and The Bank of
New York Trust Company, N.A. as Trustee (incorporated by
reference to Exhibit 4.1 to Reynolds American Inc.s
Form 8-K
dated May 31, 2006).
|
|
4
|
.20
|
|
First Supplemental Indenture, dated September 30, 2006, to
Indenture, dated May 31, 2006, among Reynolds American Inc.
and certain of its subsidiaries as guarantors and The Bank of
New York Trust Company, N.A., as successor to The Bank of
New York, as Trustee (incorporated by reference to
Exhibit 4.1 to Reynolds American Inc.s
Form 8-K
dated September 30, 2006).
|
|
4
|
.21
|
|
Second Supplemental Indenture, dated February 6, 2009, to
Indenture, dated May 31, 2006, as supplemented by the First
Supplemental Indenture, dated September 30, 2006, among
Reynolds American Inc. and certain of its subsidiaries as
guarantors and The Bank of New York Mellon Trust Company,
N.A., f/k/a The Bank of New York Trust Company, N.A., as
Trustee.
|
|
4
|
.22
|
|
In accordance with Item 601(b)(4)(iii) of
Regulation S-K,
Reynolds American Inc. agrees to furnish to the SEC, upon
request, a copy of each instrument that defines the rights of
holders of such long term debt not filed or incorporated by
reference as an exhibit to its Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, filed
February 27, 2007.
|
|
10
|
.1
|
|
Fifth Amended and Restated Credit Agreement, dated as of
June 28, 2007, among Reynolds American Inc., the agents and
other parties named therein, and the lending institutions listed
from time to time on Annex I thereto (incorporated by
reference to Exhibit 10.1 to Reynolds American Inc.s
Form 8-K
dated June 28, 2007).
|
|
10
|
.2
|
|
First Amendment to Credit Agreement, dated March 31, 2008,
among Reynolds American Inc., the agents and other parties named
therein, and the lending institutions listed from time to time
on Annex I thereto (incorporated by reference to
Exhibit 10.1 to Reynolds American Inc.s
Form 8-K
dated April 7, 2008).
|
|
10
|
.3
|
|
Sixth Amended and Restated Subsidiary Guaranty, dated as of
June 28, 2007, among certain of the subsidiaries of
Reynolds American Inc. as guarantors and JPMorgan Chase Bank,
N.A. as administrative agent (incorporated by reference to
Exhibit 10.4 to Reynolds American Inc.s
Form 8-K
dated June 28, 2007).
|
|
10
|
.4
|
|
Joinder Agreement to Sixth Amended and Restated Subsidiary
Guaranty, dated as of January 1, 2009, among JPMorgan Chase
Bank, N.A., as Administrative Agent, and RAI Services Company.
|
|
10
|
.5
|
|
Underwriting Agreement, dated June 18, 2007, by and among
Reynolds American Inc., as issuer, Reynolds American Inc.s
subsidiaries that are guaranteeing the Notes and Citigroup
Global Markets Inc., J.P. Morgan Securities Inc., Lehman
Brothers Inc. and Morgan Stanley & Co. Incorporated,
as representatives of the several underwriters named therein
(incorporated by reference to Exhibit 1.1 to Reynolds
American Inc.s
Form 8-K
dated June 18, 2007).
|
|
10
|
.6
|
|
Formation Agreement, dated as of July 30, 2004, among
Brown & Williamson Tobacco Corporation (n/k/a
Brown & Williamson Holdings, Inc.), Brown &
Williamson U.S.A., Inc. (n/k/a R. J. Reynolds Tobacco Company)
and Reynolds American Inc. (incorporated by reference to
Exhibit 10.1 to Reynolds American Inc.s
Form 8-K
dated July 30, 2004).
|
161
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
|
|
|
10
|
.7
|
|
Governance Agreement, dated as of July 30, 2004, among
British American Tobacco p.l.c., Brown & Williamson
Tobacco Corporation (n/k/a Brown & Williamson
Holdings, Inc.) and Reynolds American Inc. (incorporated by
reference to Exhibit 10.2 to Reynolds American Inc.s
Form 8-K
dated July 30, 2004).
|
|
10
|
.8
|
|
Amendment No. 1 to the Governance Agreement, dated as of
November 18, 2004, among British American Tobacco p.l.c.,
Brown & Williamson Holdings, Inc. and Reynolds
American Inc. (incorporated by reference to Exhibit 10.1 to
Reynolds American Inc.s
Form 8-K
dated November 18, 2004).
|
|
10
|
.9
|
|
Amendment No. 2, dated April 29, 2008, to the
Governance Agreement, dated as of July 30, 2004, by and
among British American Tobacco p.l.c., Brown &
Williamson Holdings, Inc. and Reynolds American Inc.
(incorporated by reference to Exhibit 10.2 to Reynolds
American Inc.s
Form 8-K
dated April 29, 2008).
|
|
10
|
.10
|
|
Share Repurchase Agreement, dated April 29, 2008, by and
between Reynolds American Inc. and Brown & Williamson
Holdings, Inc. (incorporated by reference to Exhibit 10.1
to Reynolds American Inc.s
Form 8-K
dated April 29, 2008).
|
|
10
|
.11
|
|
Non-Competition Agreement, dated as of July 30, 2004,
between Reynolds American Inc. and British American Tobacco
p.l.c. (incorporated by reference to Exhibit 10.3 to
Reynolds American Inc.s
Form 8-K
dated July 30, 2004).
|
|
10
|
.12
|
|
Contract Manufacturing Agreement, dated as of July 30,
2004, by and between R. J. Reynolds Tobacco Company and BATUS
Japan, Inc. (incorporated by reference to Exhibit 10.4 to
Reynolds American Inc.s
Form 8-K
dated July 30, 2004).
|
|
10
|
.13
|
|
October 2005 Amendments to the Contract Manufacturing Agreement,
dated as of July 30, 2004, by and between R. J. Reynolds
Tobacco Company and BATUS Japan, Inc. (incorporated by reference
to Exhibit 10.2 to Reynolds American Inc.s Quarterly
Report on
Form 10-Q
for the quarter ended September 30, 2005, filed
November 3, 2005).
|
|
10
|
.14
|
|
April 30, 2007 Amendments to the Contract Manufacturing
Agreement, dated July 30, 2004, by and between R. J.
Reynolds Tobacco Company and BATUS Japan, Inc. (incorporated by
reference to Exhibit 10.9 to Reynolds American Inc.s
Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2007, filed August 2,
2007).
|
|
10
|
.15
|
|
June 12, 2007 Amendments to the Contract Manufacturing
Agreement, dated July 30, 2004, by and between R. J.
Reynolds Tobacco Company and BATUS Japan, Inc. (incorporated by
reference to Exhibit 10.10 to Reynolds American Inc.s
Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2007, filed August 2,
2007).
|
|
10
|
.16
|
|
Letter Agreement, dated March 13, 2008, amending the
Contract Manufacturing Agreement, dated July 30, 2004, by
and between R. J. Reynolds Tobacco Company and BATUS Japan, Inc.
(incorporated by reference to Exhibit 10.3 to Reynolds
American Inc.s Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2008, filed August 4,
2008).
|
|
10
|
.17
|
|
Contract Manufacturing Agreement, dated as of July 30,
2004, by and between R. J. Reynolds Tobacco Company and B.A.T.
(U.K. & Export) Limited (incorporated by reference to
Exhibit 10.5 to Reynolds American Inc.s
Form 8-K
dated July 30, 2004).
|
|
10
|
.18
|
|
Amendment, effective January 2, 2007, to Contract
Manufacturing Agreement, dated as of July 30, 2004, by and
between R. J. Reynolds Tobacco Company and B.A.T. (U.K. &
Export) Limited (incorporated by reference to Exhibit 10.2
to Reynolds American Inc.s Quarterly Report on
Form 10-Q
for the quarter ended March 31, 2007, filed May 4,
2007).
|
|
10
|
.19
|
|
Purchase Agreement dated as of March 9, 1999, as amended
and restated as of May 11, 1999, among R. J. Reynolds
Tobacco Company, RJR Nabisco, Inc. and Japan Tobacco Inc.
(incorporated by reference to Exhibit 2.1 to R. J. Reynolds
Tobacco Holdings, Inc.s
Form 8-K
dated May 12, 1999).
|
|
10
|
.20
|
|
Settlement Agreement dated August 25, 1997, between the
State of Florida and settling defendants in The State of
Florida v. American Tobacco Co. (incorporated by reference
to Exhibit 2 to R. J. Reynolds Tobacco Holdings,
Inc.s
Form 8-K
dated August 25, 1997).
|
|
10
|
.21
|
|
Comprehensive Settlement Agreement and Release dated
January 16, 1998, between the State of Texas and settling
defendants in The State of Texas v. American Tobacco Co.
(incorporated by reference to Exhibit 2 to R. J. Reynolds
Tobacco Holdings, Inc.s
Form 8-K
dated January 16, 1998).
|
162
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
|
|
|
10
|
.22
|
|
Settlement Agreement and Release in re: The State of
Minnesota v. Philip Morris, Inc., by and among the State of
Minnesota, Blue Cross and Blue Shield of Minnesota and the
various tobacco company defendants named therein, dated as of
May 8, 1998 (incorporated by reference to Exhibit 99.1
to R. J. Reynolds Tobacco Holdings, Inc.s Quarterly Report
on
Form 10-Q
for the quarter ended March 30, 1998, filed May 15,
1998).
|
|
10
|
.23
|
|
Settlement Agreement and Stipulation for Entry of Consent
Judgment in re: The State of Minnesota v. Philip Morris,
Inc., by and among the State of Minnesota, Blue Cross and Blue
Shield of Minnesota and the various tobacco company defendants
named therein, dated as of May 8, 1998 (incorporated by
reference to Exhibit 99.2 to R. J. Reynolds Tobacco
Holdings, Inc.s Quarterly Report on
Form 10-Q
for the quarter ended March 30, 1998, filed May 15,
1998).
|
|
10
|
.24
|
|
Form of Consent Judgment by Judge Kenneth J. Fitzpatrick, Judge
of District Court in re: The State of Minnesota v. Philip
Morris, Inc. (incorporated by reference to Exhibit 99.3 to
R. J. Reynolds Tobacco Holdings, Inc.s Quarterly Report on
Form 10-Q
for the quarter ended March 30, 1998, filed May 15,
1998).
|
|
10
|
.25
|
|
Stipulation of Amendment to Settlement Agreement and for Entry
of Agreed Order dated July 2, 1998, by and among the
Mississippi Defendants, Mississippi and the Mississippi Counsel
in connection with the Mississippi Action (incorporated by
reference to Exhibit 99.2 to R. J. Reynolds Tobacco
Holdings, Inc.s Quarterly Report on
Form 10-Q
for the quarter ended June 30, 1998, filed August 14,
1998).
|
|
10
|
.26
|
|
Stipulation of Amendment to Settlement Agreement and for Entry
of Consent Decree dated July 24, 1998, by and among the
Texas Defendants, Texas and the Texas Counsel in connection with
the Texas Action (incorporated by reference to Exhibit 99.4
to R. J. Reynolds Tobacco Holdings, Inc.s Quarterly Report
on
Form 10-Q
for the quarter ended June 30, 1998, filed August 14,
1998).
|
|
10
|
.27
|
|
Stipulation of Amendment to Settlement Agreement and for Entry
of Consent Decree dated September 11, 1998, by and among
the State of Florida and the tobacco companies named therein
(incorporated by reference to Exhibit 99.1 to R. J.
Reynolds Tobacco Holdings, Inc.s Quarterly Report on
Form 10-Q
for the quarter ended September 30, 1998, filed
November 12, 1998).
|
|
10
|
.28
|
|
Master Settlement Agreement, referred to as the MSA, dated
November 23, 1998, between the Settling States named in the
MSA and the Participating Manufacturers also named therein
(incorporated by reference to Exhibit 4 to R. J. Reynolds
Tobacco Holdings, Inc.s
Form 8-K
dated November 23, 1998).
|
|
10
|
.29
|
|
Amended and Restated Directors and Officers Indemnification
Agreement (incorporated by reference to Exhibit 10.1 to
Reynolds American Inc.s
Form 8-K
dated February 1, 2005).
|
|
10
|
.30
|
|
Reynolds American Inc. Outside Directors Compensation
Summary, effective January 1, 2008 (incorporated by
reference to Exhibit 10.39 to Reynolds American Inc.s
Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, filed
February 27, 2008).
|
|
10
|
.31
|
|
Equity Incentive Award Plan for Directors of Reynolds American
Inc. (Amended and Restated Effective November 30, 2007)
(incorporated by reference to Exhibit 10.40 to Reynolds
American Inc.s Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, filed
February 27, 2008).
|
|
10
|
.32
|
|
Form of Deferred Stock Unit Agreement between Reynolds American
Inc. and the Director named therein, pursuant to the Equity
Incentive Award Plan for Directors of Reynolds American Inc.
|
|
10
|
.33
|
|
Form of Deferred Stock Unit Agreement between R. J. Reynolds
Tobacco Holdings, Inc. and the Director named therein, pursuant
to the EIAP (incorporated by reference to Exhibit 10.9 to
R. J. Reynolds Tobacco Holdings, Inc.s Quarterly Report on
Form 10-Q
for the quarter ended June 30, 1999, filed August 16,
1999).
|
|
10
|
.34
|
|
Deferred Compensation Plan for Directors of Reynolds American
Inc. (Amended and Restated Effective November 30, 2007)
(incorporated by reference to Exhibit 10.43 to Reynolds
American Inc.s Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, filed
February 27, 2008).
|
|
10
|
.35
|
|
Amended and Restated (effective as of May 11,
2007) Reynolds American Inc. Long-Term Incentive Plan
(incorporated by reference to Exhibit 10.6 to Reynolds
American Inc.s Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2007, filed August 2,
2007).
|
163
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
|
|
|
10
|
.36
|
|
Form of Performance Unit Agreement (one-year vesting), dated
February 5, 2008, between Reynolds American Inc. and the
grantee named therein (incorporated by reference to
Exhibit 10.10 to Reynolds American Inc.s Quarterly
Report on
Form 10-Q
for the quarter ended March 31, 2008, filed May 2,
2008).
|
|
10
|
.37
|
|
Form of Performance Unit Agreement (three-year vesting), dated
March 6, 2006, between Reynolds American Inc. and the
grantee named therein (incorporated by reference to
Exhibit 10.3 to Reynolds American Inc.s Quarterly
Report on
Form 10-Q
for the quarter ended March 31, 2006, filed May 5,
2006).
|
|
10
|
.38
|
|
Form of Performance Unit Agreement (three-year vesting), dated
March 6, 2007, between Reynolds American Inc. and the
grantee named therein (incorporated by reference to
Exhibit 10.9 to Reynolds American Inc.s Quarterly
Report on
Form 10-Q
for the quarter ended March 31, 2007, filed May 4,
2007).
|
|
10
|
.39
|
|
Form of Performance Unit Agreement (three-year vesting), dated
March 6, 2008, between Reynolds American Inc. and the
grantee named therein (incorporated by reference to
Exhibit 10.11 to Reynolds American Inc.s Quarterly
Report on
Form 10-Q
for the quarter ended March 31, 2008, filed May 2,
2008).
|
|
10
|
.40
|
|
Performance Unit Agreement (three-year vesting), dated
March 6, 2007, between Reynolds American Inc. and Jeffrey
A. Eckmann (incorporated by reference to Exhibit 10.10 to
Reynolds American Inc.s Quarterly Report on
Form 10-Q
for the quarter ended March 31, 2007, filed May 4,
2007).
|
|
10
|
.41
|
|
Performance Unit Agreement (three-year vesting), dated
March 6, 2008, between Reynolds American Inc. and Jeffrey
A. Eckmann (incorporated by reference to Exhibit 10.12 to
Reynolds American Inc.s Quarterly Report on
Form 10-Q
for the quarter ended March 31, 2008, filed May 2,
2008).
|
|
10
|
.42
|
|
Performance Share Agreement, dated January 1, 2007, between
Reynolds American Inc. and Daniel M. Delen (incorporated by
reference to Exhibit 10.48 to Reynolds American Inc.s
Annual Report of
Form 10-K
for the fiscal year ended December 31, 2006, filed
February 27, 2007).
|
|
10
|
.43
|
|
Form of Restricted Stock Agreement, dated March 6, 2006,
between Reynolds American Inc. and the grantee named therein
(incorporated by reference to Exhibit 10.4 to Reynolds
American Inc.s Quarterly Report on
Form 10-Q
for the quarter ended March 31, 2006, filed May 5,
2006).
|
|
10
|
.44
|
|
Form of Restricted Stock Agreement, dated March 6, 2007,
between Reynolds American Inc. and the grantee named therein
(incorporated by reference to Exhibit 10.11 to Reynolds
American Inc.s Quarterly Report on
Form 10-Q
for the quarter ended March 31, 2007, filed May 4,
2007).
|
|
10
|
.45
|
|
Form of Restricted Stock Agreement, dated March 6, 2008,
between Reynolds American Inc. and the grantee named therein
(incorporated by reference to Exhibit 10.13 to Reynolds
American Inc.s Quarterly Report on
Form 10-Q
for the quarter ended March 31, 2008, filed May 2,
2008).
|
|
10
|
.46
|
|
Restricted Stock Agreement, dated March 6, 2007, between
Reynolds American Inc. and Jeffrey A. Eckmann (incorporated by
reference to Exhibit 10.12 to Reynolds American Inc.s
Quarterly Report on
Form 10-Q
for the quarter ended March 31, 2007, filed May 4,
2007).
|
|
10
|
.47
|
|
Offer of Employment Letter, dated July 29, 2004, by
Reynolds American Inc. and Susan M. Ivey, accepted by
Ms. Ivey on July 30, 2004 (incorporated by reference
to Exhibit 10.22 to Reynolds American Inc.s Quarterly
Report on
Form 10-Q
for the quarter ended September 30, 2004, filed
November 5, 2004).
|
|
10
|
.48
|
|
Letter Agreement, dated December 19, 2007, regarding
Severance Benefits and Change of Control Protections and
amending July 29, 2004 offer of employment letter, between
Reynolds American Inc. and Susan M. Ivey (incorporated by
reference to Exhibit 10.57 to Reynolds American Inc.s
Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, filed
February 27, 2008).
|
|
10
|
.49
|
|
Offer of Employment Letter dated July 29, 2004, by Reynolds
American Inc. and Jeffrey A. Eckmann, accepted by
Mr. Eckmann on July 29, 2004 (incorporated by
reference to Exhibit 10.24 to Reynolds American Inc.s
Quarterly Report on
Form 10-Q
for the quarter ended September 30, 2004, filed
November 5, 2004).
|
|
10
|
.50
|
|
Letter Agreement, dated February 2, 2005, between Reynolds
American Inc. and Jeffrey A. Eckmann, amending July 29,
2004 offer letter (incorporated by reference to
Exhibit 10.5 to Reynolds American Inc.s
Form 8-K
dated February 1, 2005).
|
|
10
|
.51
|
|
Letter Agreement, dated December 19, 2007, regarding
Severance Benefits and Change of Control Protections and
amending certain prior letter agreements, between Reynolds
American Inc. and Jeffrey A. Eckmann (incorporated by reference
to Exhibit 10.60 to Reynolds American Inc.s Annual
Report on
Form 10-K
for the fiscal year ended December 31, 2007, filed
February 27, 2008).
|
164
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
|
|
|
10
|
.52
|
|
Offer of Employment Letter, dated August 18, 2006, by
Reynolds American Inc. and E. Julia (Judy) Lambeth, accepted by
Ms. Lambeth on August 19, 2006 (incorporated by
reference to Exhibit 10.1 to Reynolds American Inc.s
Form 8-K
dated August 19, 2006).
|
|
10
|
.53
|
|
Offer of Employment Letter, dated December 4, 2006, between
R. J. Reynolds Tobacco Company and Daniel M. Delen (incorporated
by reference to Exhibit 10.1 to Reynolds American
Inc.s Quarterly Report on
Form 10-Q
for the quarter ended March 31, 2007, filed May 4,
2007).
|
|
10
|
.54
|
|
Retention Bonus Letter, dated February 20, 2007, between
Reynolds American Inc. and McDara P, Folan, III
(incorporated by reference to Exhibit 10.58 to Reynolds
American Inc.s
Form 10-K
for the fiscal year ended December 31, 2006, filed
February 27, 2007).
|
|
10
|
.55
|
|
May 24, 1999, July 21, 1999 and June 16, 2000
Letter Agreements between R.J. Reynolds Tobacco Company and
Thomas R. Adams (incorporated by reference to Exhibit 10.64
to Reynolds American Inc.s Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, filed
February 27, 2008).
|
|
10
|
.56
|
|
Retention Bonus Letter, dated March 22, 2007, between
Reynolds American Inc. and Thomas R. Adams (incorporated by
reference to Exhibit 10.65 to Reynolds American Inc.s
Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, filed
February 27, 2008).
|
|
10
|
.57
|
|
Form of Amended Letter Agreement regarding Severance Benefits
and Change of Control Protections between Reynolds American Inc.
and the officer named therein (incorporated by reference to
Exhibit 10.67 to Reynolds American Inc.s Annual
Report on
Form 10-K
for the fiscal year ended December 31, 2007, filed
February 27, 2008).
|
|
10
|
.58
|
|
Reynolds American Inc. Executive Severance Plan, as amended and
restated effective February 1, 2009 (incorporated by
reference to Exhibit 10.1 to Reynolds American Inc.s
Form 8-K
dated February 3, 2009).
|
|
10
|
.59
|
|
Reynolds American Inc. Annual Incentive Award Plan, as amended
and restated as of January 1, 2009.
|
|
10
|
.60
|
|
Amendment No. 1 to the Reynolds American Inc. Annual
Incentive Award Plan, as amended and restated as of
January 1, 2009 (incorporated by reference to
Exhibit 10.2 to Reynolds American Inc.s
Form 8-K
dated February 3, 2009).
|
|
10
|
.61
|
|
Retention Trust Agreement dated May 13, 1998, by and
between RJR Nabisco, Inc. and Wachovia Bank, N.A. (incorporated
by reference to Exhibit 10.6 to RJR Nabisco Holdings,
Inc.s Quarterly Report on
Form 10-Q
for the quarter ended June 30, 1998, filed August 14,
1998).
|
|
10
|
.62
|
|
Amendment No. 1 to Retention Trust Agreement, dated
May 13, 1998, by and between RJR Nabisco, Inc. and Wachovia
Bank, N.A., dated October 1, 2006 (incorporated by
reference to Exhibit 10.56 to Reynolds American Inc.s
S-4 filed
October 3, 2006).
|
|
10
|
.63
|
|
Amendment No. 2 to Retention Trust Agreement, dated
May 13, 1998, as amended, by and between R.J. Reynolds
Tobacco Holdings, Inc., as successor to RJR Nabisco, Inc., and
Wachovia Bank, N.A. (incorporated by reference to
Exhibit 10.66 to Reynolds American Inc.s Annual
Report on
Form 10-K
for the fiscal year ended December 31, 2006, filed
February 27, 2007).
|
|
10
|
.64
|
|
Supplemental Pension Plan for Executives of Brown &
Williamson Tobacco Corporation (n/k/a Brown &
Williamson Holdings, Inc.) (as amended through July 29,
2004) (incorporated by reference to Exhibit 10.67 to
Reynolds American Inc.s Annual Report on
Form 10-K
for the fiscal year ended December 31, 2004, filed
March 9, 2005).
|
|
10
|
.65
|
|
Form of Reynolds American Inc. Trust Agreement, by and
among the executive officer named therein, J.P. Morgan
Trust Company of Delaware, the trustee, as successor to
United States Trust Company, N.A., and Reynolds American
Inc., as administrative agent for the executive.
|
|
10
|
.66
|
|
Brown & Williamson Tobacco Corporation (n/k/a
Brown & Williamson Holdings, Inc.) Health Care Plan
for Salaried Employees (as amended through July 29, 2004 by
Amendment Nos. 1 and 2) (incorporated by reference to
Exhibit 10.69 to Reynolds American Inc.s Annual
Report on
Form 10-K
for the fiscal year ended December 31, 2004, filed
March 9, 2005).
|
|
10
|
.67
|
|
Amendment No. 3, entered into as of December 31, 2004,
to the Brown & Williamson Tobacco Corporation (n/k/a
Brown & Williamson Holdings, Inc.) Health Care Plan
for Salaried Employees (incorporated by reference to
Exhibit 10.70 to Reynolds American Inc.s Annual
Report on
Form 10-K
for the fiscal year ended December 31, 2004, filed
March 9, 2005).
|
165
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
|
|
|
10
|
.68
|
|
Amendment No. 4, entered into as of April 20, 2005, to
the Brown & Williamson Tobacco Corporation Health Care
Plan for Salaried Employees (incorporated by reference to
Exhibit 10.71 to Reynolds American Inc.s Annual
Report on
Form 10-K
for the fiscal year ended December 31, 2006, filed
February 27, 2007).
|
|
10
|
.69
|
|
Amendment No. 5, entered into as of December 29, 2006,
to the Brown & Williamson Tobacco Corporation Health
Care Plan for Salaried Employees (incorporated by reference to
Exhibit 10.72 to Reynolds American Inc.s Annual
Report on
Form 10-K
for the fiscal year ended December 31, 2006, filed
February 27, 2007).
|
|
10
|
.70
|
|
Supply Agreement, dated May 2, 2005, by and between R. J.
Reynolds Tobacco Company and Alcan Packaging Food and Tobacco
Inc. (incorporated by reference to Exhibit 10.1 to Reynolds
American Inc.s
Form 8-K
dated May 2, 2005).
|
|
10
|
.71
|
|
First Amendment to Supply Agreement, dated September 16,
2005, by and between R. J. Reynolds Tobacco Company and Alcan
Packaging Food and Tobacco Inc. (incorporated by reference to
Exhibit 10.1 to Reynolds American Inc.s Quarterly
Report on
Form 10-Q
for the quarter ended September 30, 2005, filed
November 3, 2005).
|
|
10
|
.72
|
|
Second Amendment to Supply Agreement, effective
December 31, 2008, between R. J. Reynolds Tobacco Company
and Alcan Packaging Food and Tobacco Inc. (incorporated by
reference to Exhibit 10.1 to Reynolds American Inc.s
Form 8-K
dated December 31, 2008).
|
|
10
|
.73
|
|
Supply Agreement, dated May 2, 2005, by and between R. J.
Reynolds Tobacco Company and Alcoa Flexible Packaging, LLC
(incorporated by reference to Exhibit 10.2 to Reynolds
American Inc.s
Form 8-K
dated May 2, 2005).
|
|
10
|
.74
|
|
Letter, dated January 28, 2008, between R. J. Reynolds
Tobacco Company and Alcoa Flexible Packaging, LLC regarding the
May 2, 2005 Supply Agreement between the parties
(incorporated by reference to Exhibit 10.6 to Reynolds
American Inc.s Quarterly Report on
Form 10-Q
for the quarter ended March 31, 2008, filed May 2,
2008).
|
|
10
|
.75
|
|
Supply Agreement, dated May 2, 2005, by and between R. J.
Reynolds Tobacco Company and Mundet Inc. (incorporated by
reference to Exhibit 10.3 to Reynolds American Inc.s
Form 8-K
dated May 2, 2005).
|
|
10
|
.76
|
|
Valuation Payment Settlement Agreement, dated February 20,
2008, by and between R. J. Reynolds Tobacco C.V. and Gallaher
Limited (incorporated by reference to Exhibit 10.1 to
Reynolds American Inc.s
Form 8-K
dated February 20, 2008).
|
|
10
|
.77
|
|
Guarantee of JT International Holding B.V., dated
February 20, 2008, in favor of R. J. Reynolds Tobacco C.V.
(incorporated by reference to Exhibit 10.2 to Reynolds
American Inc.s
Form 8-K
dated February 20, 2008).
|
|
12
|
.1
|
|
Computation of Ratio of Earnings to Fixed Charges for each of
the five years within the period ended December 31, 2008.
|
|
21
|
.1
|
|
Subsidiaries of the Registrant.
|
|
23
|
.1
|
|
Consent of Independent Registered Public Accounting Firm.
|
|
31
|
.1
|
|
Certification of Chief Executive Officer relating to RAIs
Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008.
|
|
31
|
.2
|
|
Certification of Chief Financial Officer relating to RAIs
Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008.
|
|
32
|
.1
|
|
Certification of Chief Executive Officer and Chief Financial
Officer relating to RAIs Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, pursuant to
Section 18 U.S.C. §1350, adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 (furnished
herewith).
|
166
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
REYNOLDS AMERICAN INC.
(Registrant)
|
|
|
|
|
|
Dated: February 23, 2009
|
|
By:
|
|
/s/ Susan
M. Ivey
|
|
|
|
|
|
|
|
|
|
Susan M. Ivey
|
|
|
|
|
Chairman of the Board,
President and Chief Executive Officer
|
Pursuant to the requirements of the Securities Exchange Act of
1934, this report has been signed below by the following persons
on behalf of the registrant and in the capacities and on the
date indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Susan
M. Ivey
Susan
M. Ivey
|
|
Chairman of the Board, President and Chief Executive Officer
(principal executive officer)
|
|
February 23, 2009
|
|
|
|
|
|
/s/ Thomas
R. Adams
Thomas
R. Adams
|
|
Executive Vice President and
Chief Financial Officer
(principal financial officer)
|
|
February 23, 2009
|
|
|
|
|
|
/s/ Frederick
W. Smothers
Frederick
W. Smothers
|
|
Senior Vice President and
Chief Accounting Officer
(principal accounting officer)
|
|
February 23, 2009
|
|
|
|
|
|
/s/ Betsy
S. Atkins
Betsy
S. Atkins
|
|
Director
|
|
February 23, 2009
|
|
|
|
|
|
/s/ Nicandro
Durante
Nicandro
Durante
|
|
Director
|
|
February 23, 2009
|
|
|
|
|
|
/s/ Martin
D. Feinstein
Martin
D. Feinstein
|
|
Director
|
|
February 23, 2009
|
|
|
|
|
|
/s/ Luc
Jobin
Luc
Jobin
|
|
Director
|
|
February 23, 2009
|
|
|
|
|
|
/s/ Holly
K. Koeppel
Holly
K. Koeppel
|
|
Director
|
|
February 23, 2009
|
|
|
|
|
|
/s/ Nana
Mensah
Nana
Mensah
|
|
Director
|
|
February 23, 2009
|
|
|
|
|
|
/s/ Lionel
L. Nowell III
Lionel
L. Nowell III
|
|
Director
|
|
February 23, 2009
|
|
|
|
|
|
/s/ H.G.L.
Powell
H.G.L.
Powell
|
|
Director
|
|
February 23, 2009
|
|
|
|
|
|
/s/ Joseph
P. Viviano
Joseph
P. Viviano
|
|
Director
|
|
February 23, 2009
|
167
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Thomas
C. Wajnert
Thomas
C. Wajnert
|
|
Director
|
|
February 23, 2009
|
|
|
|
|
|
/s/ Neil
R. Withington
Neil
R. Withington
|
|
Director
|
|
February 23, 2009
|
|
|
|
|
|
/s/ John
J. Zillmer
John
J. Zillmer
|
|
Director
|
|
February 23, 2009
|
168